
<html lang="en"     class="pb-page"  data-request-id="58c49d89-0452-4981-bb55-ec8f213fccf5"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/jm200208d;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2011.54.issue-9;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design and Synthesis of Novel N-Hydroxy-Dihydronaphthyridinones as Potent and Orally Bioavailable HIV-1 Integrase Inhibitors" /></meta><meta name="dc.Creator" content="Ted W.  Johnson" /></meta><meta name="dc.Creator" content="Steven P.  Tanis" /></meta><meta name="dc.Creator" content="Scott L.  Butler" /></meta><meta name="dc.Creator" content="Deepak  Dalvie" /></meta><meta name="dc.Creator" content="Dorothy M.  DeLisle" /></meta><meta name="dc.Creator" content="Klaus R.  Dress" /></meta><meta name="dc.Creator" content="Erik J.  Flahive" /></meta><meta name="dc.Creator" content="Qiyue  Hu" /></meta><meta name="dc.Creator" content="Jon E.  Kuehler" /></meta><meta name="dc.Creator" content="Atsuo  Kuki" /></meta><meta name="dc.Creator" content="Wen  Liu" /></meta><meta name="dc.Creator" content="Guy A.  McClellan" /></meta><meta name="dc.Creator" content="Qinghai  Peng" /></meta><meta name="dc.Creator" content="Michael B.  Plewe" /></meta><meta name="dc.Creator" content="Paul F.  Richardson" /></meta><meta name="dc.Creator" content="Graham L.  Smith" /></meta><meta name="dc.Creator" content="Jim  Solowiej" /></meta><meta name="dc.Creator" content="Khanh T.  Tran" /></meta><meta name="dc.Creator" content="Hai  Wang" /></meta><meta name="dc.Creator" content="Xiaoming  Yu" /></meta><meta name="dc.Creator" content="Junhu  Zhang" /></meta><meta name="dc.Creator" content="Huichun  Zhu" /></meta><meta name="dc.Description" content="HIV-1 integrase (IN) is one of three enzymes encoded by the HIV genome and is essential for viral replication, and HIV-1 IN inhibitors have emerged as a new promising class of therapeutics. Recentl..." /></meta><meta name="Description" content="HIV-1 integrase (IN) is one of three enzymes encoded by the HIV genome and is essential for viral replication, and HIV-1 IN inhibitors have emerged as a new promising class of therapeutics. Recentl..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 13, 2011" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm200208d" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2011 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm200208d" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm200208d" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm200208d" /></link>
        
    
    

<title>Design and Synthesis of Novel N-Hydroxy-Dihydronaphthyridinones as Potent and Orally Bioavailable HIV-1 Integrase Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm200208d" /></meta><meta property="og:title" content="Design and Synthesis of Novel N-Hydroxy-Dihydronaphthyridinones as Potent and Orally Bioavailable HIV-1 Integrase Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0027.jpeg" /></meta><meta property="og:description" content="HIV-1 integrase (IN) is one of three enzymes encoded by the HIV genome and is essential for viral replication, and HIV-1 IN inhibitors have emerged as a new promising class of therapeutics. Recently, we reported the synthesis of orally bioavailable azaindole hydroxamic acids that were potent inhibitors of the HIV-1 IN enzyme. Here we disclose the design and synthesis of novel tricyclic N-hydroxy-dihydronaphthyridinones as potent, orally bioavailable HIV-1 integrase inhibitors displaying excellent ligand and lipophilic efficiencies." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm200208d"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm200208d">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm200208d&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm200208d&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm200208d&amp;href=/doi/10.1021/jm200208d" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2011</span><span class="cit-fg-volume">, 54</span><span class="cit-fg-issue">, 9</span><span class="cit-fg-pageRange">, 3393-3417</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/54/9" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm200180f" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm2002124" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design and Synthesis of Novel <i>N</i>-Hydroxy-Dihydronaphthyridinones as Potent and Orally Bioavailable HIV-1 Integrase Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ted+W.++Johnson">Ted W. Johnson</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven+P.++Tanis">Steven P. Tanis</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Scott+L.++Butler">Scott L. Butler</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Deepak++Dalvie">Deepak Dalvie</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dorothy+M.++DeLisle">Dorothy M. DeLisle</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Klaus+R.++Dress">Klaus R. Dress</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Erik+J.++Flahive">Erik J. Flahive</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qiyue++Hu">Qiyue Hu</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jon+E.++Kuehler">Jon E. Kuehler</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Atsuo++Kuki">Atsuo Kuki</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wen++Liu">Wen Liu</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guy+A.++McClellan">Guy A. McClellan</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qinghai++Peng">Qinghai Peng</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+B.++Plewe">Michael B. Plewe</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul+F.++Richardson">Paul F. Richardson</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Graham+L.++Smith">Graham L. Smith</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jim++Solowiej">Jim Solowiej</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Khanh+T.++Tran">Khanh T. Tran</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hai++Wang">Hai Wang</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaoming++Yu">Xiaoming Yu</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Junhu++Zhang">Junhu Zhang</a></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Huichun++Zhu">Huichun Zhu</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Pfizer Global Research and Development, La Jolla Laboratories, 10770 Science Center Drive, San Diego, California 92121, United States </span></div><div class="corresp-info"><strong>*</strong>For T.W.J.: phone, 858-526-4683; E-mail, <a href="/cdn-cgi/l/email-protection#ec988988c29bc2868384829f8382ac9c8a8596899ec28f8381"><span class="__cf_email__" data-cfemail="91e5f4f5bfe6bffbfef9ffe2feffd1e1f7f8ebf4e3bff2fefc">[emailÂ protected]</span></a> or <a href="/cdn-cgi/l/email-protection#cebab9a4fefe8eb7afa6a1a1e0ada1a3"><span class="__cf_email__" data-cfemail="3d494a570d0d7d445c555252135e5250">[emailÂ protected]</span></a>. For S.P.T.: phone 760-918-2484. E-mail <a href="/cdn-cgi/l/email-protection#32414246535c5b4172415051555e5d50535e1c5c5746"><span class="__cf_email__" data-cfemail="483b383c2926213b083b2a2b2f24272a292466262d3c">[emailÂ protected]</span></a> or <a href="/cdn-cgi/l/email-protection#b1c2c1c5d0dfd8c2f1d6dcd0d8dd9fd2dedc"><span class="__cf_email__" data-cfemail="94e7e4e0f5fafde7d4f3f9f5fdf8baf7fbf9">[emailÂ protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm200208d&amp;href=/doi/10.1021%2Fjm200208d" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2011</span></span><span class="cit-volume">, 54</span><span class="cit-issue">, 9</span><span class="cit-pageRange">, 3393â3417</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 29, 2011</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>23 February 2011</li><li><span class="item_label"><b>Published</b> online</span>13 April 2011</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 May 2011</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm200208d" title="DOI URL">https://doi.org/10.1021/jm200208d</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2011 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3393%26pageCount%3D25%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DTed%2BW.%2BJohnson%252C%2BSteven%2BP.%2BTanis%252C%2BScott%2BL.%2BButler%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D54%26issueNum%3D9%26contentID%3Djm200208d%26title%3DDesign%2Band%2BSynthesis%2Bof%2BNovel%2BN-Hydroxy-Dihydronaphthyridinones%2Bas%2BPotent%2Band%2BOrally%2BBioavailable%2BHIV-1%2BIntegrase%2BInhibitors%26numPages%3D25%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3417%26publicationDate%3DMay%2B2011">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm200208d"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2870</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">31</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm200208d" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design and Synthesis of Novel N-Hydroxy-Dihydronaphthyridinones as Potent and Orally Bioavailable HIV-1 Integrase Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Ted&quot;,&quot;last_name&quot;:&quot;W. Johnson&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;P. Tanis&quot;},{&quot;first_name&quot;:&quot;Scott&quot;,&quot;last_name&quot;:&quot;L. Butler&quot;},{&quot;first_name&quot;:&quot;Deepak&quot;,&quot;last_name&quot;:&quot;Dalvie&quot;},{&quot;first_name&quot;:&quot;Dorothy&quot;,&quot;last_name&quot;:&quot;M. DeLisle&quot;},{&quot;first_name&quot;:&quot;Klaus&quot;,&quot;last_name&quot;:&quot;R. Dress&quot;},{&quot;first_name&quot;:&quot;Erik&quot;,&quot;last_name&quot;:&quot;J. Flahive&quot;},{&quot;first_name&quot;:&quot;Qiyue&quot;,&quot;last_name&quot;:&quot;Hu&quot;},{&quot;first_name&quot;:&quot;Jon&quot;,&quot;last_name&quot;:&quot;E. Kuehler&quot;},{&quot;first_name&quot;:&quot;Atsuo&quot;,&quot;last_name&quot;:&quot;Kuki&quot;},{&quot;first_name&quot;:&quot;Wen&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Guy&quot;,&quot;last_name&quot;:&quot;A. McClellan&quot;},{&quot;first_name&quot;:&quot;Qinghai&quot;,&quot;last_name&quot;:&quot;Peng&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;B. Plewe&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;F. Richardson&quot;},{&quot;first_name&quot;:&quot;Graham&quot;,&quot;last_name&quot;:&quot;L. Smith&quot;},{&quot;first_name&quot;:&quot;Jim&quot;,&quot;last_name&quot;:&quot;Solowiej&quot;},{&quot;first_name&quot;:&quot;Khanh&quot;,&quot;last_name&quot;:&quot;T. Tran&quot;},{&quot;first_name&quot;:&quot;Hai&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Xiaoming&quot;,&quot;last_name&quot;:&quot;Yu&quot;},{&quot;first_name&quot;:&quot;Junhu&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Huichun&quot;,&quot;last_name&quot;:&quot;Zhu&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2011&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;13&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;volume&quot;:&quot;54&quot;,&quot;pages&quot;:&quot;3393-3417&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm200208d&quot;},&quot;abstract&quot;:&quot;HIV-1 integrase (IN) is one of three enzymes encoded by the HIV genome and is essential for viral replication, and HIV-1 IN inhibitors have emerged as a new promising class of therapeutics. Recently, we reported the synthesis of orally bioavailable azaindole hydroxamic acids that were potent inhibitors of the HIV-1 IN enzyme. Here we disclose the design and synthesis of novel tricyclic N-hydroxy-dihydronaphthyridinones as potent, orally bioavailable HIV-1 integrase inhibitors displaying excellent ligand and lipophilic efficiencies.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200208d&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200208d" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200208d&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200208d" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200208d&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200208d" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm200208d&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200208d&amp;href=/doi/10.1021/jm200208d" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm200208d" /></input><a href="/doi/pdf/10.1021/jm200208d" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm200208d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm200208d%26sid%3Dliteratum%253Aachs%26pmid%3D21446745%26genre%3Darticle%26aulast%3DJohnson%26date%3D2011%26atitle%3DDesign%2Band%2BSynthesis%2Bof%2BNovel%2BN-Hydroxy-Dihydronaphthyridinones%2Bas%2BPotent%2Band%2BOrally%2BBioavailable%2BHIV-1%2BIntegrase%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D54%26issue%3D9%26spage%3D3393%26epage%3D3417%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291362" title="Antimicrobial agents">Antimicrobial agents</a>,</li><li><a href="/action/doSearch?ConceptID=291285" title="Ethers">Ethers</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292504" title="Permeability">Permeability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/54/9" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jmcmar.2011.54.issue-9/production/jmcmar.2011.54.issue-9.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0027.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200208d&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">HIV-1 integrase (IN) is one of three enzymes encoded by the HIV genome and is essential for viral replication, and HIV-1 IN inhibitors have emerged as a new promising class of therapeutics. Recently, we reported the synthesis of orally bioavailable azaindole hydroxamic acids that were potent inhibitors of the HIV-1 IN enzyme. Here we disclose the design and synthesis of novel tricyclic <i>N</i>-hydroxy-dihydronaphthyridinones as potent, orally bioavailable HIV-1 integrase inhibitors displaying excellent ligand and lipophilic efficiencies.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28887" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28887" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Human immunodeficiency virus type 1 (HIV-1), the causative pathogen of AIDS, replicates utilizing three essential enzymes encoded in the HIV pol gen: reverse transcriptase (RT), protease (PR), and integrase (IN). Many anti-HIV agents target either RT<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> or PR.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Recently, inhibitors of the integrase enzyme have emerged as a new promising class of therapeutics for the treatment of AIDS,<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> highlighted by the recent approval of Raltegravir (<b>1</b>)<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> and encouraging phase II clinical trial results with Elvitegravir (<b>2</b>)<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and S/GSK-1349572 (<b>3</b>).<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8-10)</a> Several drivers remain, however, to discover new chemical classes with complementary or improved properties regarding resistance,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> dosing, and tolerability.</div><div class="NLM_p"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0001.gif" alt="" id="fx1" /></img></div><div class="NLM_p">We recently disclosed the discovery of azaindole <i>N</i>-methyl hydroxamic acids<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> such as <b>4</b> and described subsequent improvements in ADME properties leading to <b>5</b>.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, the introduction of an appropriate side chain onto the pyrrolyl-Î²-position of <b>4</b> results in the aminomethyl <b>5</b> with significant alterations to the calculated log <i>P</i>, log <i>D</i>, and tPSA values. These changes lead to a dramatic improvement in the extraction ratio (ER) as measured with human hepatocytes. The improved stability exhibited by <b>5</b> allowed us to examine the pharmacokinetic profile of <b>5</b> in the dog. Amide <b>5</b> exhibited moderate clearance (Cl = 15 mL/min/kg), a moderate volume of distribution (Vdss = 2.32 L/kg), and a moderate half-life (<i>T</i><sub>1/2</sub> = 6.2 h). Unfortunately, the side chain additions are also associated with a loss in enzymatic activity (IC<sub>50</sub>) and a diminution in antiviral activity (EC<sub>50</sub>). In the present article, we describe the design, synthesis, and identification of highly potent, ligand and lipophilic efficient, and metabolically stable HIV-1 integrase inhibitors belonging to the <i>N-</i>hydroxy-dihydronaphthyridinone class.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. A Comparison of Azaindole Hydroxamates and 3-Substituted Azaindole Hydroxamates</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0014.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top"><td><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0015.gif" alt="" id="_i3" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Strand transfer scintillation proximity assay.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">HIV-1 cytopathic effect (CPE) inhibition assay; EC<sub>50</sub>, 50% effective concentration, CC<sub>50</sub>, 50% cytotoxic concentration.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">Extraction ratio in human hepatocytes (hHEP) after 4 h incubation; ER = (fu Ã CL<sub>int</sub>)/(<i>Q</i> + (fu Ã CL<sub>int</sub>)).</p></div></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42575" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42575" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Bis-Metal Binder Design</h3><div class="NLM_p">The catalytic core domain of IN contains two aspartate (Asp64, Asp116) and one glutamate (Glu152) residues that are critical for the catalytic activity of IN and are believed to bind Mg<sup>2+</sup> and Mn<sup>2+</sup> ions.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> More recently, data suggests that Mg<sup>2+</sup> is the biologically relevant divalent metal critical for IN activity.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> It is generally believed that IN inhibitors such as diketo acids (DKA (A)) or the dihydroxy pyrimidines carboxamide class (B) bind these two metal ions in the active site while the hydrophobic aryl group participates in a specific interaction with an adjacent hydrophobic pocket or surface (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> Using these notions, we can represent our previously disclosed azaindole hydroxamate class (C) as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0004.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Metal binding of DKA (A), dihydroxypyrimidine carboxamide (B), and azaindole hydroxamate (C).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200208d&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition to the dipoleâdipole interactions which must be dealt with as the precursors of (A), (B), and (C) traverse the path from their global minima to a binding conformation, the azaindole hydroxamates, as shown in (C) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), develop an A-strain type of steric interaction as the hydroxamate <i>N</i>-methyl begins to eclipse the 4-H of the pyridine portion of the bicyclic system. To better understand the energetic costs of this binding requirement and to estimate the impact it might have on measured enzymatic and antiviral activity, we undertook the conformational analysis<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> of a simplified picolinamide-<i>N</i>-methyl hydroxamate system <b>6</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0005.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Conformational analysis of picolinamide-<i>N</i>-methyl hydroxamate <b>6</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200208d&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As might have been predicted, the global minimum calculated for hydroxamate <b>6</b> was found to be a pyridineâN-H-bonded conformer <b>a</b> (NCCO torsion = â179.42Â°, ONCO torsion = â178.77Â°) with all relevant atoms from the pyridine-N to the hydroxamate-O in essentially the same plane. Conformer <b>a</b> was assigned a relative Î<i>E</i> = 0.0 kcal/mol. Conformer <b>b</b> (NCCO torsion â16.26Â°, ONCO torsion â33.65Â°), which presents the carbonyl on the same face of the molecule as the pyridine-N but significantly twisted out of planarity, was calculated to be Î<i>E</i> = 1.057 kcal/mol higher in energy than <b>a</b>. Conformer <b>c</b> (NCCO torsion = â159.68Â°, ONCO torsion = 1.44Â°), a carbonyl-H-bonded relative of <b>a</b>, was found to be Î<i>E</i> = 1.804 kcal/mol higher in energy than <b>a</b>. Still higher in energy (Î<i>E</i> = 3.108 kcal/mol; NCCO torsion = 163.46Â°, OCNO torsion = â31.80Â°) was conformer <b>d</b>, devoid of an H-bond but exhibiting the carbonyl and pyridine-N in relatively close proximity to a binding mode. Finally, conformer <b>e</b>, in which we have constrained the atoms comprising the bis-metal binding domain to be essentially coplanar (NCCO torsion = 0.34Â°, ONCO torsion = â0.32Â°) was calculated to be Î<i>E</i> = 5.926 kcal/mol higher in energy than the global minimum <b>a</b>. We surmise that the energetic penalty that must be paid for molecules such as <b>4</b> or <b>5</b> to assume the putative bis-metal binding conformation might be responsible for the modest enzymatic and antiviral activities obtained in the azaindole hydroxamate series. If we wish to avail ourselves of the improved characteristics offered by the 3-substituted azaindoles such as <b>5</b>, we must design more potent molecules.</div><div class="NLM_p">Should the bis-metal binding conformation be difficult to access due to the energetic considerations described above, we should be easily able to correct this problem through the introduction of a conformational restriction, a ring. Hence we will endeavor to alter the structure of the azaindole hydroxamates such as <b>4</b> to arrive at the conformationally locked tetrahydro-pyrrolo-naphthyridinone <b>7</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0006.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Evolution of azaindole hydroxamate based HIV-integrase inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200208d&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Chemistry</h3><div class="NLM_p">Our initial synthesis of the target tetrahydro-pyrrolo-naphthyridinone <b>7</b> is shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. The commercial pyrrole <b>8</b> was easily benzylated to provide 4-F-Bn-pyrrole <b>9</b> in 95% yield. A two-phase tribromination ((1) pyrrolyl dibromination NBS, EtOAc; (2) benzylic bromination (PhCO<sub>2</sub>)<sub>2</sub>, reflux) gave <b>10</b> (88%), which was smoothly coupled with <i>N</i>-Ts-glycine methyl ester (KO<i>t-</i>Bu) to provide dibromo-pyrrole <b>11</b> (81%). Despite extensive experimentation, we discovered that we could not avoid electrophilic aromatic bromination, a reaction which proceeded much faster than benzylic halogenation, hence we resorted to this two-phase procedure. Cyclization to the dibromo-azaindole <b>12</b> (LiHMDS, 86%) and hydrogenolysis of the dibromide afforded azaindole <b>13</b> (95%), setting the stage for the addition of the third ring via a Stille reaction<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> with (<i>Z</i>)-2-ethoxy-vinyl-tributylstannane.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Pyridinol <b>13</b> was treated with Tf<sub>2</sub>O to provide triflate <b>14</b> (90%), which was coupled with (<i>Z</i>)-2-ethoxy-vinyl-tributylstannane to afford enol ether <b>15</b> (70%). Closure to the tricyclic enol lactone was realized after ester hydrolysis and treatment of the resulting acid with HOAc to give <b>16</b> (92%). Hydrogenation of the enol lactone gave <b>17</b> (81%) and exposure of the lactone to H<sub>2</sub>NOTHP and LiHMDS led to the ring-opened, protected hydroxamate <b>18</b> (57%). A nonselective (<i>O</i>- vs <i>N</i>-) Mitsunobu closure provided the <i>N</i>-OTHP-tetrahydro-pyrrolo-naphthyridinone <b>19</b> in a disappointing 37% yield. The sequence was concluded with an acidic hydrolysis of the THP-ether to give the target <i>N</i>-OH compound <b>7</b> (24%). The sequence successfully provided the first member of this targeted class of conformationally locked pyridyl hydroxamates, however ,at 13 steps and 1.3% overall yield, it did not auger well for a profitable analogue program. The length and poor yield of the sequence was troubling, especially in light of the additional steps required to functionalize at the pyrrolyl-Î²-position. Of particular concern was the use of tin in the Stille coupling (<b>14</b> to <b>15</b>), the tedious conversion of the enol ether-ester <b>15</b> to the protected hydroxamate <b>18</b>, the total lack of selectivity in the Mitsunobu closure of <b>18</b> to give <b>19</b>, and the poor yield of <b>7</b> from the hydrolysis of the <i>O</i>-THP congener <b>19</b>. We targeted these areas for improvement, and the chemistry developed to circumvent these difficulties is presented in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0007.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. The Synthesis of Tetrahydro-pyrrolo-naphthyridinone <b>7</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200208d&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 4-FPhCH<sub>2</sub>Br, KO<i>t-</i>Bu, THF, 95%; (b) (1) NBS (3 equiv), EtOAc, rt; (2) (PhCO<sub>2</sub>)<sub>2</sub>, reflux, 88%; (c) TsNHCH<sub>2</sub>CO<sub>2</sub>Me, KO<i>t-</i>Bu, THF, rt, 81%; (d) LiHMDS, THF, â78 Â°C, 86%; (e) H<sub>2</sub> (40 psi), Pd/C, MeOH, 95%; (f) Tf<sub>2</sub>O, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 0 Â°C, 90%; (g) PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, LiCl, (<i>Z</i>)-EtOCHCHSn(<i>n</i>-Bu)<sub>3</sub>, 1,4-dioxane, 70 Â°C, 70%; (h) LiOH, aq MeOH, 50 Â°C; (i) HOAc, 100 Â°C, 92%; (j) H<sub>2</sub> (35 psi), Pd/Al<sub>2</sub>O<sub>3</sub>, MeOH, 81%; (k) H<sub>2</sub>NOTHP, LiHMDS, THF, 57%; (l) D<i>t-</i>BAD, PPh<sub>3</sub>, THF, rt, 1:1 <i>N</i>- vs <i>O</i>-, 37% isolated; (m) 1 N aq HCl, 24%.</p></p></figure><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0008.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Improved End-Game for the Synthesis of Tetrahydro-pyrrolo-naphthyridinone <b>7</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200208d&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) C<sub>4</sub>H<sub>9</sub>OCHâCH<sub>2</sub> Pd<sub>2</sub>(dba)<sub>3</sub>, (<i>c</i>-C<sub>6</sub>H<sub>11</sub>)<sub>2</sub>NMe, (<i>t</i>-Bu)<sub>3</sub>PHBF<sub>4</sub>, LiCl, 1,4-dioxane, 70 Â°C, 86%; (b) H<sub>2</sub>NOSEM, <i>p</i>-TsOH, THF, 94%; (c) NaBH<sub>3</sub>CN, HOAc, rt, 84%; (d) HCl, THF, rt, 80%.</p></p></figure><div class="NLM_p">Tin could be readily eliminated from the sequence of Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> by utilizing the Î²-selective enol ether Heck reaction reported by Fu.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> In the event, triflate <b>14</b> was coupled with butyl vinyl ether to afford the desired enol ether <b>20</b> with <5% of the undesired Î±-coupled enol ether detected in the crude mixture. To avoid the <i>N</i>- vs<i> O</i>-cyclization conundrum which plagued the <b>18</b> to <b>19</b> closure (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>), we envisioned installing the protected hydroxylamine utilizing the butyl enol ether as a acetaldehyde equivalent, with oximino-ether reduction and cyclization completing the formation of the third ring. The first two steps envisioned were poorly precedented in the literature and required a series of reagent and optimization studies that eventually culminated in the successful formation of the cyclic protected <i>N</i>-hydroxy-dihydronaphthyridinone <b>22</b> in excellent yield. Our plan called for an exchange of the enol ether to afford an oximino-ether upon treatment of <b>20</b> with a selected H<sub>2</sub>NOR. The H<sub>2</sub>NOR blocking group must survive acid-mediated exchange, oximino-ether reduction, and subsequent cyclization, yet be of sufficient fragility to provide <b>7</b> in yields decidedly better than the 24% hydrolysis of <b>19</b> to <b>7</b> in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. A SEM blocking group in the form of H<sub>2</sub>N-OSEM seemed to be ideally suited to our needs, however, this entity was unknown. SEM-blocked hydroxylamine was readily prepared as shown in eq <a class="ref internalNav" href="#eq1" aria-label="1">1</a>. SEM-protection of <i>N</i>-OH phthalimide provided the desired <i>N</i>-OSEM phthalimide in 96% yield. The target H<sub>2</sub>OSEM was then easily prepared (99%) upon treatment of the phthalimide with MeNHNH<sub>2</sub>.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Treatment of the butyl vinyl ether <b>20</b> with SEM protected hydroxyl amine under acidic conditions (<i>p</i>-TsOH, THF) formed the oximino-ether <b>21</b> (94%), which was reduced using sodium cyanoborohydride/HOAc and subsequently cyclized in situ to give the desired product <b>22</b> in excellent yield. It is interesting to note that many reducing agents were used to attempt the reduction-cyclization sequence, but only sodium cyanoborohydride was found to effect the reduction while other reagents provided starting material or significant byproduct formation. The sequence was completed by the treatment of <b>22</b> with HCl in THF to give the target <i>N</i>-OH <b>7</b> in 80% yield. Alternatively, compound <b>7</b> can be prepared directly from <b>20</b> in good yield by treatment with hydroxylamine and hydrochloride acid in ethanol at reflux, followed by treatment of the oximino-ether intermediate with acetic acid and sodium cyanoborohydride in methanol at room temperature. The chemistry described shortens the route to nine steps and 34% overall yield to achieve a useful intermediate <b>22</b> for an analogue effort vs the 12 steps and 5% overall yield to <b>19</b> shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>.</div><div class="NLM_p">Equation <a class="ref internalNav" href="#eq1" aria-label="1">1</a>: Formation of NH<sub>2</sub>OSEM<span class="NLM_disp-formula" id="eq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0003.gif" alt="" id="_i9" /></img></span></div><div class="NLM_p">During our study of azaindole hydroxamates,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> we had examined a variety of benzylic groups on the pyrrolyl-<i>N</i>-position. It was likely that we would also desire to examine an assortment of benzylic groups in the tricyclic tetrahydro-pyrrolo-naphthyridinone class; however, the chemistry of Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a> was poorly suited to such a study as the benzylic diversity is introduced in step 1 of the nine-step sequence. We selected a benzenesulfonyl blocking group for the pyrrolyl-<i>N</i> for its relative stability but ease of removal under basic conditions late in the synthesis endeavor.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The chemistry developed for these purposes is presented in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>.</div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0009.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Late Stage Functionalization: The Synthesis of Differentially Benzyl Substituted Tetrahydro-pyrrolo-naphthyridinones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200208d&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) PhSO<sub>2</sub>Cl, <i>n</i>-Bu<sub>4</sub>NBr, toluene, aq NaOH, 86%; (b) (1) NBS, CCl<sub>4</sub>, (PhCO<sub>2</sub>)<sub>2</sub>, reflux, 92%; (c) TsNHCH<sub>2</sub>CO<sub>2</sub>Me, KO<i>t-</i>Bu, THF, rt, 81%; (d) LiHMDS, THF, â78 Â°C, 63%; (e) Tf<sub>2</sub>O, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 0 Â°C, 86%; (f) C<sub>4</sub>H<sub>9</sub>OCHâCH<sub>2</sub> Pd<sub>2</sub>(dba)<sub>3</sub>, (<i>c</i>-C<sub>6</sub>H<sub>11</sub>)<sub>2</sub>NMe, (<i>t</i>-Bu)<sub>3</sub>PHBF<sub>4</sub>, LiCl, 1,4-dioxane, 70 Â°C, 84%; (g) NaOEt, ethanol, 84%; (h) H<sub>2</sub>NOSEM, <i>p</i>-TsOH, THF; (i) NaBH<sub>3</sub>CN, HOAc, rt, 76%; (j) ArCH<sub>2</sub>Br, NaH, THF, 40â72%; (k) H<sub>2</sub>SO<sub>4</sub>, <i>i</i>-PrOH, 78â95%.</p></p></figure><div class="NLM_p">Pyrrole <b>8</b> sulfonylation proceeded smoothly (PhSO<sub>2</sub>Cl, phase transfer) to provide the protected pyrrole <b>23</b> in good yield, and this was followed by benzylic bromination (NBS, benzoyl peroxide), leading to bromide <b>24</b> in 92% yield. It is noteworthy that sulfonylation completely suppressed the aromatic electrophilic substitution which was observed in the benzylic bromination of Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Alkylation with tosyl glycine provided the coupled product <b>25</b> (81%), which was transformed into the phenol <b>26</b> in good yield by treatment with lithium hexamethyl disilazide in tetrahydrofuran at low temperature. Activation of the phenol with triflic anhydride and triethyl amine gave the azaindole triflate <b>27</b> (86%), which was selectively coupled with butyl vinyl ether, as previously described (Pd<sub>2</sub>(dba)<sub>3</sub>, (<i>c</i>-C<sub>6</sub>H<sub>11</sub>)<sub>2</sub>NMe, (<i>t</i>-Bu)<sub>3</sub>PHBF<sub>4</sub>, LiCl, 1,4-dioxane, 70 Â°C) to yield enol ether <b>28</b> (84%). Deprotection of the benzene sulfonyl protecting group was accomplished in 81% yield using a solution of sodium ethoxide in ethanol to give the <i>N</i>-H azaindole <b>29</b> (84%), which was subjected to H<sub>2</sub>NOSEM, and <i>p</i>-TsOH as described in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, to form the oximino ether <b>30</b>. Reductive cyclization of <b>30</b> (NaBH<sub>3</sub>CN, HOAc) gave the <i>N</i>-H tricyclic compound <b>31</b> in 76% yield, setting the stage for the introduction of the benzylic function deep within the synthetic sequence. Tricycle <b>31</b> was readily alkylated with 2-CN, 4-F-benzyl bromide (NaH, THF), yielding <b>32</b> (74%) which suffered <i>O</i>-SEM cleavage after exposure to sulfuric acid in <i>i</i>-PrOH to provide the target tricycle <b>33</b> (88%). Utilizing the chemistry of Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>, a small group of modified benzylic analogues were prepared as shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>.</div><div class="NLM_p">Having secured reasonable sequences to the target tricyclic cores, we wished to examine the impact of altering physicochemical properties of our putative HIV integrase inhibitors via the incorporation of a side chain at the pyrrolyl Î²-position as we had described for our azaindole hydroxamates.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Tricycle <b>22</b> should suffer ready aminomethylation as well as iodination and bromination, setting the stage for facile functionalization. Tricycle <b>22</b> was treated with <i>N</i>,<i>N</i>-dimethyl(methylene)ammonium chloride (MeCN)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> to give (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>) the desired aminomethyl compound <b>34</b> in good yield (89%); likewise, the exposure of <b>22</b> to <i>N</i>-iodo-succinimide (NIS) or <i>N</i>-bromosuccinimide (NBS) in DMF results in smooth iodination or bromination of the reactive pyrrolyl ring to afford <b>35a</b> or <b>35b</b> in excellent yields.</div><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0010.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Î²-Functionalization of the Pyrrolo-Ring of <b>22</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200208d&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Me<sub>2</sub>NâCH<sub>2</sub> Cl, MeCN, reflux, 89%; (b) NIS, DMF, 92% or NBS, DMF, 97%.</p></p></figure><div class="NLM_p">Dimethylaminomethyl-tetrahydro-pyrrolo-naphthyridinone <b>34</b> provided access to the compounds of this study as shown in Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>. Treatment of <b>34</b> with EtOCOCl or PhOCOCl in DCM<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a> afforded the reactive intermediate benzylic chloride <b>36</b>, which was directly coupled with selected nucleophiles in situ. The reaction of <b>36</b> with a primary or secondary amine in the presence of <i>i</i>-Pr<sub>2</sub>NEt gave the aminomethyl analogue precursors <b>37</b> in good yields. SEM removal as described above led to the target structures <b>38</b>. Similarly, the treatment of <b>36</b> with an alcohol or water in the presence of <i>i</i>-Pr<sub>2</sub>NEt led to SEM-blocked ethers <b>39</b> in good yields. Removal of the SEM-blocking group then afforded ethers <b>40</b>.</div><figure id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0011.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of 1-Substituted 3-(4-fluorobenzyl)-7-hydroxy-8,9-dihydro-3<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6(7<i>H</i>)-ones from Compound <b>34</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200208d&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) EtOCOCl or PhOCOCl, DCM, rt; (b) R<sub>1</sub>R<sub>2</sub>NH, <i>i</i>-Pr<sub>2</sub>NEt; (c) R<sub>1</sub>OH, <i>i</i>-Pr<sub>2</sub>NEt, THF; (d) HCl, 1,4-dioxane.</p></p></figure><div class="NLM_p">The preparation of analogues with longer carbon chains at the 1-position of the 3-(4-fluorobenzyl)-7-hydroxy-8,9-dihydro-3<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6(7<i>H</i>)-one core was achieved via the palladium mediated coupling of iodide <b>35a</b> with alkynes (Sonogashira reaction) and alkenes (Heck reaction, Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>). Iodide <b>35a</b> was easily converted to alkynes <b>41</b> under standard Sonogashira conditions, and these alkynes were readily converted to targeted analogues <b>44</b> after hydrogenation and SEM removal. Likewise, iodide <b>35a</b> afforded alkenes <b>42</b>, which provided carbon chain extended analogues <b>44</b> after hydrogenation and deprotection.</div><figure id="sch6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0012.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Carbon Chain Extended 1-Substituted 3-(4-fluorobenzyl)-7-hydroxy-8,9-dihydro-3<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6(7<i>H</i>)-ones from Compounds <b>35</b> via Palladium Chemistry<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200208d&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R<sub>1</sub>-alkyne, PdCl<sub>2</sub>(Ph<sub>3</sub>P)<sub>2</sub>, CuI-SMe<sub>2</sub>, Et<sub>3</sub>N, DMF, or R<sub>1</sub>-CH<sub>2</sub>âCH<sub>2</sub>, tri-<i>o</i>-tolylphosphine, Pd(OAc)<sub>2</sub>, Et<sub>3</sub>N, DMF; (b) H<sub>2</sub> (1 atm), Pd(OH)<sub>2</sub>, MeOH; (c) HCl, 1,4,-dioxane, MeOH.</p></p></figure><div class="NLM_p">The final analogues designed for this study were planned to alter physical properties through the incorporation of a sulfonamide moiety at the pyrrolyl-Î²-position. Although we had considered the incorporation of an amide moiety to achieve these ends, our experience with amides in the azaindole series<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> caused us to consider sulfonamides in their stead. The preparation of these sulfonamide containing entities is illustrated in Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>. The conditions required for chlorosulfonylation at the azaindole pyrrolyl-Î²-position were sufficiently acidic (ClSO<sub>3</sub>H, SOCl<sub>2</sub>) that we were concerned for the survival of the NO-SEM moiety of the cyclic hydroxamate <b>22</b>. Therefore, we elected to start the chemistry of Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a> with the less advanced, but more stable, lactone <b>17</b>. Lactone <b>17</b> was exposed to chlorosulfonic acid and thionyl chloride, a modification of literature conditions<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> required to drive the reaction to completion, leading to sulfonyl chloride <b>45</b> in quantitative yield. Sulfonyl chloride <b>45</b> readily provided sulfonamides <b>46</b> (R<sub>1</sub>R<sub>2</sub>NH, Et<sub>3</sub>N, DMF), which suffered smooth lactone opening when reacted with H<sub>2</sub>NOTHP/LiHMDS (THF), giving OTHP-hydroxamates <b>47</b> in reasonable yields. Ring closure (<i>p</i>-TsCl, <i>i</i>-Pr<sub>2</sub>NEt, CH<sub>2</sub>Cl<sub>2</sub>) led to 7-OTHP-naphthyridinones <b>48</b>, and the target sulfonamido-substituted tricycles <b>49</b> were obtained after OTHP hydrolysis (<i>p</i>-TsOH, aq MeOH).</div><figure id="sch7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0013.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. The Synthesis of 1-Sulfonamido-substituted 3-(4-fluorobenzyl)-7-hydroxy-8,9-dihydro-3<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6(7<i>H</i>)-ones from Lactone <b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200208d&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ClSO<sub>3</sub>H, SOCl<sub>2</sub>, 100%; (b) R<sub>1</sub>R<sub>2</sub>NH, Et<sub>3</sub>N, DMF, 69â78%; (c) H<sub>2</sub>NOTHP, LiHMDS, THF, 40â57%; (d) <i>p</i>-TsCl, <i>i</i>-Pr<sub>2</sub>NEt, CH<sub>2</sub>Cl<sub>2</sub>, 33â40%; (e) <i>p</i>-TsOH, MeOH, H<sub>2</sub>O, 39â45%.</p></p></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> In Vitro Potency, Efficiency, and ADME</h3><div class="NLM_p">We theorized (vide supra) that tethering of the <i>N-</i>Me group of compound <b>4</b> back onto the azaindole core to give <b>7</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) would provide a more rigid, more potent integrase inhibitor by locking the metal binding motif into the most productive binding conformation. We were gratified by the large enhancement in potency from the acyclic <i>N-</i>methyl hydroxamate <b>4</b> (IC<sub>50</sub> 250 nM) to the cyclic <i>N-</i>hydroxy-dihydronaphthyridinone <b>7</b> (IC<sub>50</sub> 2.9 nM), representing a nearly 100-fold improvement. This progression in potency was also coupled to a significant increase in the LipE<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> from the acyclic <b>4</b> (LipE 5.3) to the cyclic <b>7</b> (LipE 7.6) metal binding motifs, resulting from a concomitant improvement in antiviral potency and a lowering of log <i>D</i>. The change in LipE observed in the transition from the azaindole <b>4</b> to the tricycle <b>7</b> (2.3 log units) is in excess with respect to the impact on LipE expected as a result of the Î log <i>D</i> (0.65 log units), hence our surmise regarding stronger metal binding and a resulting improvement in antiviral activity appears to be validated.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Enzymatic and Antiviral Activity, Metabolic Stability and Lipophilic Ligand Efficiency of the Acyclic Azaindole <i>N-</i>Methyl Hydroxamate <b>4</b> and the Cyclic <i>N-</i>Hydroxy-dihydronaphthyridinone <b>7</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0016.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0029.gif" alt="" id="fx100" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Strand transfer scintillation proximity assay.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">HIV-1 cytopathic effect (CPE) inhibition assay; EC<sub>50</sub>, 50% effective concentration, CC<sub>50</sub>, 50% cytotoxic concentration.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Extraction ratio in human hepatocytes (hHEP) after 4 h incubation; ER = (fu Ã CL<sub>int</sub>)/(<i>Q</i> + (fu Ã CL<sub>int</sub>)).</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">LipE = âlog EC<sub>50</sub> â log <i>D</i>.</p></div></div></div><div class="NLM_p">In addition to the six-membered <i>N</i>-hydroxy-dihydronaphthyridinone <b>7</b>, both the seven-membered and the five-membered analogues were prepared. Interestingly, the seven-membered ring retained low nanomolar biochemical and cellular potencies (IC<sub>50</sub> 23 nM and EC<sub>50</sub> 18 nM, respectively), while the five-membered ring lost significant potency, presumably directly related to the modified âbiteâ angles differentially affecting the metal-binding abilities (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). The six-membered ring was ultimately pursued over the seven-membered ring based on synthetic complexity considerations.</div><div class="NLM_p">Moderate human liver microsome clearance and high human hepatic clearance for <b>4</b> and <b>7</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) prompted investigation into route and extent of clearance in vitro. As with our previous series of uncyclized azaindole <i>N</i>-methyl hydroxamates,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> the cyclic <i>N</i>-hydroxy-dihydronaphthyridinones are cleared mostly via glucuronidation of the relatively acidic <i>N</i>-hydroxy group. Studies of glucuronidation rates with catechols in rat liver concluded that rates are highest for hydrophobic catechols with a p<i>K</i><sub>a</sub> between 8 and 9.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a> Because the <i>N</i>-hydroxy functionality (typical p<i>K</i><sub>a</sub> between 8 and 9)<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> was critical for activity, we explored whether metabolic rates could be altered by modifying physical properties, for example basicity/acidity/lipophilicity as expressed in a log <i>D</i> value. In general, we focused on human hepatocyte clearance measurements to assess glucuronidation while monitoring oxidative clearance via human liver microsomes, although phase I-type clearance seemed to be less relevant based on low in vitro clearance values obtained and metabolic identification studies.</div><div class="NLM_p">The large improvement in LipE increased our confidence that we could produce a low molecular weight, potent tricyclic inhibitor with acceptable ADME properties by minor modifications to the relatively simple tricycle analogue <b>7</b>.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Our objective is defined as lowering clearance without compromising antiviral activity or permeability.</div><div class="NLM_p">Fortuitously, both the fluorobenzyl group and the Î² position (R<sub>Î²</sub>) in the azaindole ring were readily accessible for introduction of a variety of functional groups covering a range of polarities and it was our assumption, based upon our prior experience,<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> that this could be accomplished without substantial loss in antiviral activity. We surveyed an assortment of substituents in the Î² position of the pyrrole or fluorobenzyl substitutions through parallel medicinal chemistry and singleton synthesis, and wish to report potencies and metabolic stabilities (determined in human hepatocytes) of representative examples.</div><div class="NLM_p">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> highlights potency, stability, permeability, and lipophilic efficiency comparisons of the fluorobenzyl substituted analogues <b>33a</b>â<b>d</b>. Fluorobenzyl modifications are well tolerated, and all compounds displayed excellent biochemical and cellular potencies. Also, compounds <b>33a</b> and <b>33b</b> provided comparable LipE values to the original tricyclic lead <b>7</b>. Although analogue <b>33a</b> and <b>33b</b> lost potency relative to the original tricyclic lead, both provide low molecular weight analogues, significantly lower clearance, and reveal good in vitro permeability.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> In general, clearance values changed with a lowering of log <i>D</i>, especially in human hepatocytes, wherein phase II type metabolism is assessed. Oxidative metabolism, as measured by human liver microsome clearance, was not an issue in the <i>N</i>-hydroxy-dihydronaphthyridinone series unless log <i>D</i> values were higher or the inhibitors contained metabolic soft spots.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Enzymatic and Antiviral Activity and Lipophilic Ligand Efficiency of the 3-Substituted 3,7,8,9-Tetrahydro-7-hydroxy-6<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6-ones <b>7</b> and <b>33a</b>â<b>d</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0017.gif" alt="" id="fx6" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0018.gif" alt="" id="fx7" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Strand transfer scintillation proximity assay.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">HIV-1 cytopathic effect (CPE) inhibition assay; EC<sub>50</sub>, 50% effective concentration, CC<sub>50</sub>, 50% cytotoxic concentration.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">Extraction ratio in human hepatocytes (hHEP) after 4 h incubation; ER = (fu Ã CL<sub>int</sub>)/(<i>Q</i> + (fu Ã CL<sub>int</sub>)).</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">Permeability assessed using Caco-2 flux assay.</p></div><div class="footnote" id="t3fn5"><sup>e</sup><p class="last">LipE = âlog EC<sub>50</sub> â log <i>D</i>.</p></div></div></div><div class="NLM_p">Likewise, substitution on the Î²-position of the pyrrole allowed property modulation without loss of antiviral potency. A variety of amines with differing p<i>K</i><sub>a</sub> values were prepared and fully characterized regarding potency and in vitro ADME. The biochemical and cellular potencies for the aminomethyl analogues (<b>38a</b>â<b>f</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) highlight the tolerability of this position to substitution, and the similar LipE numbers (6.9â7.6) calculated underscore the parallel impact of lipophilicity on the cellular potencies in this series. Compounds <b>38c</b> and <b>38f</b> represent good combinations of antiviral potency, clearance in both human liver microsomes and human hepatocytes, and in vitro permeability, a discernible improvement over the parent <i>N</i>-hydroxy-dihydronaphthyridinone <b>7</b>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Enzymatic and Antiviral Activity, Metabolic Stability and Lipophilic Ligand Efficiency of 1-Aminomethyl Substituted 3,7,8,9-Tetrahydro-7-hydroxy-6<i>H</i>-Pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6-ones <b>38a</b>â<b>f</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0019.gif" alt="" id="fx8" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0020.gif" alt="" id="fx9" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Strand transfer scintillation proximity assay.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">HIV-1 cytopathic effect (CPE) inhibition assay; EC<sub>50</sub>, 50% effective concentration, CC<sub>50</sub>, 50% cytotoxic concentration.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">Extraction ratio in human hepatocytes (hHEP) after 4 h incubation; ER = (fu Ã CL<sub>int</sub>)/(Q + (fu Ã CL<sub>int</sub>)).</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">Permeability assessed using Caco-2 flux assay.</p></div><div class="footnote" id="t4fn5"><sup>e</sup><p class="last">LipE = âlog EC<sub>50</sub> â log <i>D</i>.</p></div></div></div><div class="NLM_p">Ethers <b>40a</b>â<b>f</b> were also prepared, providing a subseries (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>) with slightly higher log <i>D</i> values due to the absence of the amine found in the aminomethyl series illustrated. As an expected consequence of elevated log <i>D</i> values, the in vitro clearance, both in human liver microsomes and human hepatocytes, were slightly elevated. Consequently, cellular potencies and permeabilities were improved, and as expected there was a parallel relationship between improvements in EC<sub>50</sub> and increases in log <i>D</i> resulting in LipE values clustered around the LipE = 7 line. Overall, compound <b>40d</b> provided good cellular potency, in vitro clearance values, and in vitro permeability.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Enzymatic and Antiviral Activity, Metabolic Stability and Lipophilic Ligand Efficiency of 1-Alkoxymethyl Substituted 3,7,8,9-Tetrahydro-7-hydroxy-6<i>H</i>-Pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6-ones <b>40a</b>â<b>f</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0021.gif" alt="" id="fx10" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0022.gif" alt="" id="fx11" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Strand transfer scintillation proximity assay.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">HIV-1 cytopathic effect (CPE) inhibition assay; EC<sub>50</sub>, 50% effective concentration, CC<sub>50</sub>, 50% cytotoxic concentration.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">Extraction ratio in human hepatocytes (hHEP) after 4 h incubation; ER = (fu Ã CL<sub>int</sub>)/(<i>Q</i> + (fu Ã CL<sub>int</sub>)).</p></div><div class="footnote" id="t5fn4"><sup>d</sup><p class="last">Permeability assessed using Caco-2 flux assay.</p></div><div class="footnote" id="t5fn5"><sup>e</sup><p class="last">LipE = âlog EC<sub>50</sub> â log <i>D</i>.</p></div></div></div><div class="NLM_p">Despite the excellent potencies and in vitro ADME data displayed by the aminomethyl (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) and ether subseries (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>), the potential for this chemotype to undergo transformation to reactive intermediates was recognized.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The ejection of the corresponding amines or alcohols, whether through metabolic activation or not, could afford reactive intermediates that produce toxicities in vivo. Although metabolic activation was performed in the presence of glutathione,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> no reactive metabolite glutathione adducts were observed. We must also point to the good yields of final compounds obtained under strongly acidic <i>N</i>-OSEM deblocking conditions wherein the possibility of forming reactive intermediates is obvious and palpable. Despite these results, the lingering potential to form reactive metabolites convinced us to explore other Î²-pyrrolyl substitution offering mechanistic exclusion from reactive imino-methide formation so reminiscent of gramines.</div><div class="NLM_p">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a> features a variety of 3-carbon analogues that were prepared allowing further exploration of this chemical space and also alternatives to the 1-carbon variants that may show unpredictable toxicities. Overall, antiviral potencies were excellent and LipE values were high, confirming that this 3-substitution was also well tolerated. Both compound <b>44a</b> and <b>44b</b> showed higher-than-usual LipE values. Considering each subseries (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>â<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>), there is a general trend toward higher LipE values at lower log <i>D</i>, which is of interest and perhaps is counterintuitive. The increased polarity in the Î²-substituted moeity and the impact on log <i>D</i> is well-tolerated relative to other proteinâligand interactions. Perhaps the Î² substituent is solvent exposed, not requiring extensive desolvation for binding; however, additional interactions with the protein or metal bound to the protein cannot be discounted. It is also possible that the components of LipE, lipophilicity and potency, have varying contributions over large log <i>D</i> ranges or at very low log <i>D</i> values. It is very surprising, given the low in vitro permeability measurements, that we are observing any substantial antiviral potencies for these very polar substrates. A possible explanation for the discrepancy between the poor permeability assessment using Caco2 AB data and the excellent antiviral cellular potency, may rest in the time course of the two experiments. The antiviral assay is performed over a three-day period, while the Caco2 assay is on the order of minutes. Although the acid afforded excellent cellular potency along with low in vitro clearance, the resulting significant drop in lipophilicity (log <i>D</i>) caused the in vitro permeability to suffer, obliging us to deprioritize these potentially poorly orally absorbed compounds. A number of the compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a> offer a reasonable combination of cellular potency and clearance properties (<b>44b</b>, <b>44c</b>, <b>44d</b>), however A to B permeability for these compounds falls into the low bin. The trifluoropropyl analogue <b>44f</b>, the simplest analogue in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>, offered a good combination of cellular potency and permeability data with somewhat improved clearance vs <b>7</b>.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Enzymatic and Antiviral Activity, Metabolic Stability and Lipophilic Ligand Efficiency of 1-(3-Carbon) Substituted 3,7,8,9-Tetrahydro-7-hydroxy-6<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6-ones <b>44a</b>â<b>f</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0023.gif" alt="" id="fx12" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0024.gif" alt="" id="fx13" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Strand transfer scintillation proximity assay.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">HIV-1 cytopathic effect (CPE) inhibition assay; EC<sub>50</sub>, 50% effective concentration, CC<sub>50</sub>, 50% cytotoxic concentration.</p></div><div class="footnote" id="t6fn3"><sup>c</sup><p class="last">Extraction ratio in human hepatocytes (hHEP) after 4 h incubation; ER = (fu Ã CL<sub>int</sub>)/(<i>Q</i> + (fu Ã CL<sub>int</sub>)).</p></div><div class="footnote" id="t6fn4"><sup>d</sup><p class="last">Permeability assessed using Caco-2 flux assay.</p></div><div class="footnote" id="t6fn5"><sup>e</sup><p class="last">LipE = âlog EC<sub>50</sub> â log <i>D</i>.</p></div></div></div><div class="NLM_p">Finally, a series of sulfonamides (<b>49a</b>â<b>e</b>) were tested for their ability to inhibit HIV integrase and also for their in vitro ADME properties (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). In general, the sulfonamides demonstrated good antiviral potencies and good LipE values relative to the fluorobenzyl analogues (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) and the other Î² pyrrole-substituted analogues (Tables <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>â<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). While lower log <i>D</i> compounds exhibited good in vitro clearance values in the human hepatocyte assay, the increase in tPSA resulted in very poor permeability for this series in general. Compounds in this class, such as <b>49a</b>, were ultimately withheld from in vivo studies based on predicted poor absorption from in vitro permeability assessments in the Caco2-AB cell flux assay.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Enzymatic and Antiviral Activity, Metabolic Stability, and Ligand Lipophilic Efficiency of Sulfonamide Substituted 3,7,8,9-Tetrahydro-7-hydroxy-6<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6-ones <b>49a</b>â<b>e</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0025.gif" alt="" id="fx14" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0026.gif" alt="" id="fx15" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Strand transfer scintillation proximity assay.</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last">HIV-1 cytopathic effect (CPE) inhibition assay; EC<sub>50</sub>, 50% effective concentration, CC<sub>50</sub>, 50% cytotoxic concentration.</p></div><div class="footnote" id="t7fn3"><sup>c</sup><p class="last">Extraction ratio in human hepatocytes (hHEP) after 4 h incubation; ER = (fu Ã CL<sub>int</sub>)/(<i>Q</i> + (fu Ã CL<sub>int</sub>)).</p></div><div class="footnote" id="t7fn4"><sup>d</sup><p class="last">Permeability assessed using Caco-2 flux assay.</p></div><div class="footnote" id="t7fn5"><sup>e</sup><p class="last">LipE = âlog EC<sub>50</sub> â log <i>D</i>.</p></div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> In Vivo PK</h3><div class="NLM_p last">Encouraged by the reduction in glucuronidation rates in vitro coupled with excellent antiviral potency, compound <b>38c</b> emerged as an early candidate for further assessment of its pharmacokinetic (PK) parameters in animal species. Unlike our previous series of bicyclic analogues (i.e., <b>4</b>) that were hydrolyzed to their corresponding carboxylic acids in rodent plasma,<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35, 36)</a> most likely mediated by carboxyesterases, the tricyclic <i>N-</i>hydroxy-dihydronaphthyridinones were stable in rat plasma. Despite stability in rat plasma and low in vitro rat microsomal stability, we observed clearance at rat liver blood flow in rat PK studies and were obliged to perform in vivo studies in dog. Pharmacokinetic studies in dog for <b>38c</b> showed improved in vivo parameters (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>), predicting favorable human pharmacokinetics via single species scaling. Ultimately, compound <b>38c</b> provided comparable in vivo human PK predictions relative to <b>5</b> (Cl 5.5 mL/min/kg; Vdss 2.2 L/kg; <i>F</i> 41%; <i>T</i><sub>1/2</sub> 4.5 h)<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> but offered a 300-fold improvement in antiviral potency resulting in a significantly improved predicted human dose<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> (32 mg, BID) and safety margins.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Selectivity Profile against Relevant Targets</h3><div class="NLM_p">Because HIV integrase is a metal dependent DNA processing enzyme and <b>38c</b> has a metal binding motif, the selectivity of <b>38c</b> for HIV integrase was determined by testing the inhibitor against a variety of human DNA modifying and metal-dependent enzymes.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Results from these experiments indicate that <b>38c</b> demonstrates no inhibition of any of these enzymes up to the highest concentrations tested (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>). Additionally, 10 Î¼M <b>38c</b> was tested against 102 human Mg-dependent protein kinases, included in the CEREP profile, and no inhibition was observed.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Pharmacokinetic Profile of Compound <b>38c</b> in Dog and Human PK Prediction Using Single-Species Scaling</div></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0030.gif" alt="" id="fx101" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">Dose: iv, 1.0 mg/kg, citrate buffer, pH = 4; po, 4.2 mg/kg, citrate buffer, pH = 4.</p></div><div class="footnote" id="t8fn2"><sup>b</sup><p class="last">Plasma clearance.</p></div><div class="footnote" id="t8fn3"><sup>c</sup><p class="last">Volume of distribution.</p></div><div class="footnote" id="t8fn4"><sup>d</sup><p class="last">Effective half-life.</p></div><div class="footnote" id="t8fn5"><sup>e</sup><p class="last">Oral bioavailability.</p></div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34322" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34322" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last"><i>N</i>-Hydroxy-dihydronaphthyridinones are potent HIV integrase inhibitors with antiviral cell-based activities comparable to the currently marketed HIV integrase inhibitor Raltegravir <b>1</b> (EC<sub>50</sub> 10 nM). We were able to dramatically improve LipE through cyclization of the <i>N</i>-methyl hydroxamate <b>4</b> to the restricted rotamer <i>N</i>-hydroxy-dihydronaphthyridinone <b>7</b>, locking the metal binding motif into the bioactive conformation. We were also able to attenuate clearance rates in human hepatocytes through introduction of groups at the Î²-pyrrolyl position of the azaindole core and fluorobenzyl group modification without significant loss in antiviral potencies, endowing several inhibitors with in vitro potency and ADME improvements over the original leads <b>4</b> and <b>7</b>. Alignment of in vitro ADME and antiviral potency coupled with favorable pharmacokinetic parameters displayed by <b>38c</b>, culminated in a substantially lower predicted dose and improved safety margins.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51530" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51530" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Biology</h3><div class="NLM_p">Compounds were assessed for activity against the purified HIV-1 enzyme in a strand-transfer scintillation proximity assay. Data is reported as the mean IC<sub>50</sub>. All other enzymatic data is IC<sub>50</sub> of the curve fit parameter from replicate compound doses in a single experiment. The antiviral activities were determined in a HIV-1 cell protection assay using the RF strain if HIV-1, CEM-SS cells, and the XTT dye-reduction method.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Compounds were tested in one or more independent experiments. Variability was typically less than 30% for replicate data.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Integrase Strand-Transfer Scintillation Proximity Assay (SPA)</h4><div class="NLM_p last">A detailed description of the integrase strand-transfer scintillation proximity assay is described<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> and briefly summarized here. Full-length HIV-1 integrase constructed with an amino terminal 6-histidine tag and mutations described by Chen et al.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> was expressed in <i>E. coli</i> and purified following standard methods. Double-stranded donor DNA (ds-DNA) representing preprocessed ds-DNA derived from the LTR U5 sequence of the viral genome was synthesized (TriLink BioTechnologies; San Diego, CA) as a 5â² biotinylated strand and a CA base-pair overhang at the 5â² end of the nonbiotinylated strand. A 3â² dideoxy derivative of the donor DNA was generated as a control ds-DNA to test for nonspecific interactions. Target ds-DNA was prepared as a [<sup>3</sup>H]-thymidine labeled product (PerkinElmer Life Sciences Inc., Boston, MA) from enzymatic extension of overhanging 3â² ends of poly(dA) DNA. The final product consists of 5â²-blunt end ds-DNA with six [<sup>3</sup>H]-thymidine nucleotides at both 5â² ends and specific activity of >900 Ci/mmol. Biotinylated donor ds-DNA bound to streptavidin-coated polyvinyltoluene SPA beads (Amersham Pharmacia; Piscataway, NJ) was incubated with enzyme 15 min at 22 Â°C to form an integraseâdonor DNA complex. The strand-transfer reaction was initiated by addition of [<sup>3</sup>H]-thymidine labeled target DNA. Final assay conditions were 2 pmol donor DNA, 246 nM integrase, and 50 nM target DNA in 22.5 mM MOPS (pH 7.2), 20 mM NaCl, 4 mM CHAPS, 0.05% NP40, 4 mM MgCl<sub>2</sub>, 1% DMSO, and 10 mM DTT. Reactions were for 50 min at 37 Â°C, followed by addition of 150 mM EDTA, 90 mM NaOH, and 6 M CsCl to stop the reaction and dissociate integraseâDNA complexes. Compounds solvated and diluted in 100% DMSO were transferred to the assay well in 10% DMSO prior to addition of assay components. Activity was measured in the TopCount plate-based scintillation counter programmed with quench correction to normalize data for potential color absorption of the compounds (PerkinElmer Life Sciences Inc., Boston, MA). Compounds are tested as 2â3 replicates per concentration in 1 or more independent experiments. The corrected percentage inhibition for a compound was fit to a four-parameter logistic equation with variable Hill slope using GraphPad Prism software (GraphPad Software, La Jolla, CA). Acceptable criteria for a curve fit is a percent correlation coefficient (<i>R</i><sup>2</sup>) exceeding 92%. Data is reported as the mean IC<sub>50</sub>. All other enzymatic data is IC<sub>50</sub> of the curve fit parameter from replicate compound doses in a single experiment.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> HIV-1 Cytopathic Effect (CPE) Inhibition Assay</h4><div class="NLM_p last">The antiviral activities of potential modulator compounds (test compounds) were determined as a function of their ability to protect T-cells from the cytopathic effects of HIV-1 infection using the XTT dye reduction method.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> CEM-SS cells seeded at 2 Ã 10<sup>4</sup> cells per well into 96-well plates were mock infected or infected with HIV-1 RF virus at an moi resulting in 90% cell death after 6 days. Test compounds at two or more replicate wells per half-log dilution were added to the cells at the time of seeding and prior to the mock or HIV-1 RF virus infection. On day 6, 50 Î¼L of XTT (1 mg/mL XTT tetrazolium and 0.02 nM phenazine methosulfate) was added to the wells for additional 4 h incubation. Cell viability, as determined by the amount of XTT formazan produced, was quantified spectrophotometrically by absorbance at 450 nm. Data from CPE assays were expressed as the percent of formazan produced in compound-treated cells compared to formazan produced in wells of uninfected, compound-free cells. The 50% effective concentration (EC<sub>50</sub>) was calculated as the concentration of compound that increased the percentage of formazan production in infected, compound-treated cells to 50% of that produced by uninfected, compound-free cells. The 50% cytotoxic concentration (CC<sub>50</sub>) was calculated as the concentration of compound that decreased the percentage of formazan produced in uninfected, compound-treated cells compared to uninfected, compound-free cells. Compounds were tested in one or more independent experiments. Variability was typically less than 30% for replicate data.</div></div></div><div id="sec5_110" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Chemistry</h3><div class="NLM_p">Starting materials and other reagents were purchased from commercial suppliers and were used without further purification unless otherwise indicated. All reactions were performed under a positive pressure of nitrogen, argon, or with a drying tube, at ambient temperature (unless otherwise stated), in anhydrous solvents, unless otherwise indicated. Analytical thin-layer chromatography was performed on glass-backed Silica Gel 60 Â°F 254 plates (Analtech (0.25 mm)) and eluted with the appropriate solvent ratios (v/v). The reactions were assayed by high-performance liquid chromotagraphy (HPLC) or thin-layer chromatography (TLC) and terminated as judged by the consumption of starting material. The TLC plates were visualized by UV, phosphomolybdic acid stain, or iodine stain. Microwave assisted reactions were run in a SmithCreator (Personal Chemistry). <sup>1</sup>H NMR spectra were recorded on a Bruker instrument operating at 300 MHz unless otherwise indicated. <sup>1</sup>H NMR spectra are obtained as DMSO-<i>d</i><sub>6</sub> or CDCl<sub>3</sub> solutions as indicated (reported in ppm), using chloroform as the reference standard (7.25 ppm) or DMSO-<i>d</i><sub>6</sub> (2.50 ppm). Other NMR solvents were used as needed. When peak multiplicities are reported, the following abbreviations are used: s = singlet, d = doublet, t = triplet, m = multiplet, br = broadened, dd = doublet of doublets, dt = doublet of triplets. Coupling constants, when given, are reported in hertz. The mass spectra were obtained using liquid chromatography mass spectrometry (LC-MS) on an Agilent instrument using atmospheric pressure chemical ionization (APCI) or electrospray ionization (ESI). High resolution mass measurements were carried out on an Agilent TOF 6200 series with ESI. All test compounds showed â¥95% purity as determined by combustion analysis or by high-performance liquid chromatography (HPLC). HPLC conditions were as follows: Eclipse XDB C8, 4.6 mm Ã 150 mm, 5 Î¼m, 5% â 95% CH<sub>3</sub>CN/H<sub>2</sub>O/0.1% TFA, 10 min run, flow rate 1.5 mL/min, UV detection (Î» = 254, 224 nm), or 5% â 95% CH<sub>3</sub>CN/H<sub>2</sub>O/0.1%TFA, 9 min run, hold 95% CH<sub>3</sub>CN/H<sub>2</sub>O/0.1%TFA for 3 min, flow rate 1.5 mL/min. Combustion analyses were performed by Atlantic Microlab, Inc. (Norcross, Georgia).</div><div id="sec5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Ethyl 1-(4-Fluorobenzyl)-2-methyl-1<i>H</i>-pyrrole-3-carboxylate (<b>9</b>)</h4><div class="NLM_p last">To a solution of ethyl 2-methyl-1<i>H</i>-pyrrole-3-carboxylate <b>8</b> (106.26 g, 0.694 mol) (prepared by the method of Wee, et al.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a>) in anhydrous THF (1.0 L), under nitrogen, was added solid potassium <i>t</i>-butoxide (85.6 g, 0.763 mol) in five portions over 1 h. The mixture was allowed to stir for 30 min, and then 4-fluorobenzyl bromide (131.13 g, 0.694 mol) in anhydrous THF (0.2 L) was added via pressure equalized addition funnel over 45 min. The mixture was allowed to stir at room temperature for 16 h after the addition was complete and then was poured into water (1.4 L) in a 4 L separatory funnel. The mixture was extracted with diethyl ether (5 Ã 1.0 L), and the combined organic phases were washed with brine (3.0 L) and dried (Na<sub>2</sub>SO<sub>4</sub>). Filtration, rinsing of the filter cake with diethyl ether (0.5 L), and concentration in vacuo (house vacuum) gave the crude product as an orange oil. The crude product was purified by chromatography on a column of silica gel (125 mm OD, 1 kg 230â400 mesh, packed with hexanes/EtOAc 95:5) eluted with hexanes/EtOAc (95:5, 2.0 L) and hexanes/EtOAc (90:10, 8.0 L) while collecting 500 mL fractions, using the flash technique. Fractions <b>4</b>â<b>18</b> were combined to afford ethyl 1-(4-fluorobenzyl)-2-methyl-1<i>H</i>-pyrrole-3-carboxylate <b>9</b> (172.3 g, 95%) as a clear, pale-yellow, viscous liquid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 1.33 (t, <i>J</i> = 7.06 Hz, 3H), 2.43 (s, 3H), 4.26 (q, <i>J</i> = 7.06 Hz, 2H), 5.00 (s, 2H), 6.52 (d, <i>J</i> = 3.20 Hz, 1H), 6.58 (d, <i>J</i> = 3.20 Hz, 1H), 6.92â7.04 (4H). LC-MS (APCI) <i>m</i>/<i>z</i> 262.1 (M + H)<sup>+</sup>. Anal. Calcd for C<sub>15</sub>H<sub>16</sub>FNO<sub>2</sub>: C, 68.95; H, 6.17; N, 5.36. Found: C, 69.21; H, 6.43; N, 5.07.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Ethyl 4,5-Dibromo-2-(bromomethyl)-1-(4-fluorobenzyl)-1<i>H</i>-pyrrole-3-carboxylate (<b>10</b>)</h4><div class="NLM_p last">NBS (267.5 g, 1.503 mol, 3 equiv) was added in five portions over 1.5 h to a solution ethyl 1-(4-fluorobenzyl)-2-methyl-1<i>H</i>-pyrrole-3-carboxylate <b>9</b> (130.9 g, 0.501 mol) in EtOAc (2 L), in a 5 L 3 N round-bottom flask, equipped with an internal temperature monitoring probe and reflux condenser. The internal temperature rose to 43 Â°C during the addition and a transient red color developed, which faded upon completion of the addition. The mixture was allowed to stir for 15 min, and then benzoyl peroxide (1.21 g, 5 mmol, 0.01 equiv) was added and the mixture was heated to reflux and maintained at that temperature for 1.5 h. At this time point, LC-MS (APCI) indicated complete reaction. The mixture was cooled to room temperature, poured into hexanes (2 L), and the precipitated solid was removed by filtration, the filter cake was rinsed with hexanes/EtOAc (0.3 L 90:10), and the combined filtrates were concentrated in vacuo to give the crude tribromide as a redâbrown semisolid. The crude material was treated with dichloromethane (50 mL) and hexanes (250 mL) to produce a tan solid and a redâbrown liquid. The solid was isolated by filtration, rinsed with dichloromethane/hexanes (10:90, 0.5 L), and was dried in vacuo at room temperature to furnish 216.8 g (88%) of ethyl 4,5-dibromo-2-(bromomethyl)-1-(4-fluorobenzyl)-1<i>H</i>-pyrrole-3-carboxylate <b>10</b> as a pale, tan solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 1.39 (t, <i>J</i> = 7.16 Hz, 3H), 4.35 (q, <i>J</i> = 7.16 Hz, 2H), 4.77 (s, 2H), 5.36 (s, 2H), 6.96â7.07 (4H). LC-MS (APCI) <i>m</i>/<i>z</i> 416.0 (M + H)<sup>+</sup>.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Ethyl 4,5-Dibromo-1-(4-fluorobenzyl)-2-({(2-methoxy-2-oxoethyl)[(4-methylphenyl)sulfonyl]amino}methyl)-1<i>H</i>-pyrrole-3-carboxylate (<b>11</b>)</h4><div class="NLM_p last">To a stirring solution of methyl <i>N</i>-[(4-methylphenyl)sulfonyl]glycinate (51.75 g, 0.213 mol, prepared by the method of Ginzel, et al.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a>) in anhydrous THF (0.5 L) was added solid potassium <i>t</i>-butoxide (24.13 g, 0.215 mol) in one portion. The mixture was allowed to stir for 30 min (warms and returns to room temperature), at which time a solution ethyl 4,5-dibromo-2-(bromomethyl)-1-(4-fluorobenzyl)-1<i>H</i>-pyrrole-3-carboxylate <b>10</b> (105.92 g, 0.213 mol) in anhydrous THF (0.5 L) was added over 1 h. The mixture was allowed to stir at room temperature for 16 h, and then the THF was removed in vacuo and the oily residue was dissolved in dichloromethane (0.75 L), and the solution was washed with satd aq NH<sub>4</sub>Cl (0.5 L), brine (0.5 L), and dried (Na<sub>2</sub>SO<sub>4</sub>). Filtration and concentration in vacuo provided the crude alkylated material as a viscous reddish oil. The crude material was heated in the presence of MeOH (0.75 L) until the MeOH was boiling, and then dichloromethane was added slowly until solution was achieved. The red solution was cooled to room temperature (see off-white crystals), and the crystallization was completed by cooling in a refrigerator (4 Â°C) for 16 h. The ivory solid was isolated by filtration, the solid was rinsed with diethyl ether/hexanes (0.5 L, 10:90), and the solid was dried in a vacuum oven (house vacuum, 50 Â°C) overnight to furnish ethyl 4,5-dibromo-1-(4-fluorobenzyl)-2-({(2-methoxy-2-oxoethyl)[(4-methylphenyl) sulfonyl]amino}methyl)-1<i>H</i>-pyrrole-3-carboxylate 11 (113.8 g, 81%) as a free-flowing, fine ivory solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 1.24 (t, <i>J</i> = 7.16 Hz, 3H), 2.14 (s, 3H), 3.49 (s, 3H), 3.89 (s, 2H), 4.19 (q, <i>J</i> = 7.16 Hz, 2H), 4.55 (s, 2H), 7.02 (d, <i>J</i> = 2.45 Hz, 2H), 7.04 (s, 2H), 7.28 (d, <i>J</i> = 8.19 Hz, 2H), 7.59 (d, <i>J</i> = 8.19 Hz, 2H). LC/MS <i>m</i>/<i>z</i> 680.8 (M + Na)<sup>+</sup>. Anal. Calcd for C<sub>25</sub>H<sub>25</sub>Br<sub>2</sub>FN<sub>2</sub>O<sub>6</sub>S: C, 45.47; H, 3.82; N, 4.24. Found: C, 45.81; H, 4.06; N, 4.13.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Methyl 2,3-Dibromo-1-(4-fluorobenzyl)-4-hydroxy-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine-5-carboxylate (<b>12</b>)</h4><div class="NLM_p last">To solid LiHMDS (61.27 g, 0.366 mol), in a 3 L 3-neck round-bottom flask equipped with a 0.5 L pressure equalized addition funnel and an internal temperature probe, was added anhydrous THF (0.5 L). The mixture was placed under nitrogen and immersed in a dry ice-<i>i</i>-PrOH bath. The solution was allowed to stir until the internal temperature reached â78 Â°C (1.25 h). To this stirring cold solution was added a solution of ethyl 4,5-dibromo-1-(4-fluorobenzyl)-2-({(2-methoxy-2-oxoethyl)[(4-methylphenyl) sulfonyl]amino}methyl)-1<i>H</i>-pyrrole-3-carboxylate <b>11</b> (107.63 g, 0.163 mol) in anhydrous THF (0.5 L) at such a rate that the internal temperature does not exceed â70 Â°C (2 h). During the course of the addition, a yellow color was first noticed giving way to an orangeâyellow solution, which then produced a precipitate and an orangeâyellow solution. The reaction was allowed to stir for 30 min after the addition was complete, at which point HPLC/MS (sample taken at 15 min after addition) indicated the reaction was complete. The mixture was rapidly poured into a 6 L separatory funnel, which had been charged with satd aq NH<sub>4</sub>Cl (1.5 L) and dichloromethane/methanol (95:5, 2 L). The mixture was rapidly shaken to distribute the reaction mixture and quench the reaction. The organic phase was separated, the aqueous layer was extracted with dichloromethane/methanol (95:5, 1 L), and the combined organic phases were filtered to remove a fine white precipitate and then were dried (Na<sub>2</sub>SO<sub>4</sub>). Concentration in vacuo afforded the crude cyclized material as a yellow solid which was triturated with EtOH (0.6 L) and the resulting white solid was isolated by filtration, washed with anhydrous ethyl ether (50 mL), and dried in a vacuum oven (house vacuum, 50 Â°C, 16 h) to give 51.15 g (68.5%) of methyl 2,3-dibromo-1-(4-fluorobenzyl)-4-hydroxy-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine-5-carboxylate <b>12</b> as a powdery white solid after drying in a vacuum oven . The filtrate was concentrated in vacuo, and the residue was triturated with diethyl ether/hexanes (50:50, 0.25 L) to give 10.68 g (14.3%) of <b>12</b> as a powdery white solid after drying in a vacuum oven (house vacuum, 50 Â°C, 16 h). The filtrate was again treated under the same conditions (0.1 L, 50:50 diethyl ether/hexanes) to give an additional 2.39 g (3.2%) of <b>12</b> for a total yield of 64.22 g (86%). TLC (Merck, CH<sub>2</sub>Cl<sub>2</sub>/EtOAc 50:50, UVÂ±, cerium molybdateÂ±): <i>R</i><sub>f</sub> = 0.57. LC-MS (Eclipse XDB-C8, 0.8 mL/min, gradient 80:20 to 5:95 H<sub>2</sub>O (+0.1% HOAc)/CH<sub>3</sub>CN, 5 min, ESI, + mode): RT 3.790 min, <i>m</i>/<i>e</i> = 456.9 (55), 458.8 (base), 459.9 (15) â M+, 480.9 â (M + Na)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 4.03 (s, 3H), 5.48 (s, 2H), 7.00 (m, 2H), 7.08 (m, 2H), 8.28 (s, 1H), 11.60 (s, 1H). Anal. Calcd for C<sub>16</sub>H<sub>11</sub>Br<sub>2</sub>FN<sub>2</sub>O<sub>3</sub>: C, 41.95; H, 2.42; N, 6.12. Found: C, 42.13; H, 2.71; N, 5.88.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Methyl 1-(4-Fluorobenzyl)-4-hydroxy-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine-5-carboxylate (<b>13</b>)</h4><div class="NLM_p last">To a 2.5 L Parr flask was added methyl 2,3-dibromo-1-(4-fluorobenzyl)-4-hydroxy-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine-5-carboxylate <b>12</b> (67.34 g, 0.147 mol), methanol (1.5 L), and triethyl amine (32.70 g, 0.323 mol). Into this mixture was bubbled nitrogen for 10 min, and then 10% Pd/C (15.6 g) was carefully added. The bottle was placed on a Parr apparatus, evacuated/purged with nitrogen (3Ã), and hydrogen was added to 40 psi. Shaking was commenced, and after 5 min, the pressure had gone to zero and the bottle was repressurized to 40 psi. This was repeated two times, at which point the pressure lowered to 35 psi and remained. TLC and LC/MS then indicated the reaction was complete (total time ca. 1 h). The palladium was removed by filtration through a pad of Celite, the filter cake was rinsed with dichloromethane (1.0 L), and the combined filtrates were concentrated in vacuo to give the crude product <b>12</b> plus amine salts. The mixture was taken into EtOAc (2 L) and water (1.0 L), the organic phase was separated, the aqueous layer was extracted with EtOAc (0.6 L), and the combined organic phases were washed with brine (1.0 L) and dried (Na<sub>2</sub>SO<sub>4</sub>). Filtration and concentration in vacuo gave a powdery white solid which was dried in a vacuum oven (house vacuum, 50 Â°C, 16 h) to afford 41.93 g (95%) of methyl 1-(4-fluorobenzyl)-4-hydroxy-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine-5-carboxylate <b>13</b> as a free-flowing, powdery white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 4.02 (s, 3H), 5.36 (s, 2H), 6.83 (d, <i>J</i> = 3.10 Hz, 1H), 6.99 (2H), 7.11 (2H), 7.17 (d, <i>J</i> = 3.10 Hz, 1H), 8.31 (s, 1H), 11.40 (s, 1H). LC/MS (APCI) <i>m</i>/<i>z</i> 301.1 (M + H)<sup>+</sup>. Anal. Calcd for C<sub>16</sub>H<sub>13</sub>FN<sub>2</sub>O<sub>3</sub>: C, 64.00; H, 4.36; N, 9.33. Found: C, 64.27; H, 4.69; N, 9.15.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Methyl 1-(4-Fluorobenzyl)-4-(trifluoromethylsulfonyloxy)-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine-5-carboxylate (<b>14</b>)</h4><div class="NLM_p last">To a stirred solution of the methyl 1-(4-fluorobenzyl)-4-hydroxy-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine-5-carboxylate <b>13</b> (19.13 g, 63.7 mmol) and triethylamine (44.4 mL, 318.5 mmol) in dichloromethane (150 mL) at 0 Â°C was added trifluoromethanesulfonic anhydride (32.0 mL, 190.1 mmol) dropwise, and the reaction stirred for 1 h. The reaction was quenched with water (100 mL), the organic phase was separated, the aqueous phase was extracted with ethyl acetate (3 Ã 250 mL). The combined organic extracts were dried over sodium sulfate, filtered, concentrated under reduced pressure and purified by flash column chromatography (silica gel, ethyl acetate/hexane 1:1) to provide the title compound <b>14</b> as a pale-brown solid (24.8 g, 90% yield), which was employed directly without additional purification. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´ 4.11 (s, 3H), 5.64 (s, 2H), 6.74 (d, <i>J</i> = 3.10 Hz, 1H), 7.18 (t, <i>J</i> = 3.10 Hz, 2H), 7.41 (m, 2H), 8.08 (m, 1H), 8.10 (s, 1H). LC/MS (APCI) <i>m</i>/<i>z</i> 433.0 (M + H)<sup>+</sup>.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> (<i>Z</i>)-Methyl 4-(2-Ethoxyvinyl)-1-(4-fluorobenzyl)-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine-5-carboxylate (<b>15</b>)</h4><div class="NLM_p last">A mixture of triflate <b>14</b> (4.32 g, 10 mmol), <i>Z</i>-2-ethoxy-vinyl-tributylstannane (3.97 g, 11 mmol, 1.1 equiv), and anhydrous LiCl (1.27 g, 30 mmol) were dissolved in anhydrous DMF (50 mL), and the solution was sparged with argon for 10 min. To this oxygen-free mixture was added PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (0.35 g, 0.5 mmol, 5 mol %), and the flask was placed in an oil bath which had been heated to 60 Â°C and was stirred for 18 h. DMF was removed in vacuo to give a dark, viscous oil which was triturated with CH<sub>2</sub>Cl<sub>2</sub> (100 mL). The solvent was removed in vacuo, and the residue was dissolved in a minimum of CH<sub>2</sub>Cl<sub>2</sub> and was purified by chromatography on a column of silica gel using the flash technique (70 mm OD, 500 g, 230â400 mesh, 0â50% EtOAc/CH<sub>2</sub>Cl<sub>2</sub>, 100 mL fractions). Fractions <b>20</b>â<b>24</b> were combined to provide 2.48 g (70%) of <b>15</b> as a clear, colorless, viscous oil. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) Î´ 1.37 (t, <i>J</i> = 7.06 Hz, 3H), 3.90 (s, 3H), 4.02 (q, <i>J</i> = 7.06 Hz, 2H), 5.53 (s, 2H), 5.86 (d, <i>J</i> = 6.97 Hz, 1H), 6.46 (d, <i>J</i> = 6.97 Hz, 1H), 6.71 (m, 1H), 7.05 (m, 2H), 7.25 (m, 2H), 7.60 (m, 1H), 8.52 (s, 1H). LC/MS (APCI) <i>m</i>/<i>z</i> 355.1 (M + H)<sup>+</sup>. Anal. Calcd for C<sub>20</sub>H<sub>19</sub>FN<sub>2</sub>O<sub>3</sub>: C, 67.79; H, 5.40; N, 7.91. Found: C, 67.66, H, 5.43; N, 8.04.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 7-(4-Fluorobenzyl)pyrano[3,4-<i>b</i>]pyrrolo[3,2-<i>d</i>]pyridin-4(7<i>H</i>)-one (<b>16</b>)</h4><div class="NLM_p last">(a) To a stirring solution of (<i>E</i>)-methyl 4-(2-ethoxyvinyl)-1-(4-fluorobenzyl)-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine-5-carboxylate (10.0 g, 28.2 mmol) <b>15</b> in methanol (150 mL) was added 3 M aq LiOH (28.2 mL, 84.6 mmol, 3 equiv). The resulting mixture was heated to an oil bath temperature of 60 Â°C until hydrolysis was complete by LCMS (5 h). When the reaction was complete, the mixture was cooled to room temperature, and the solvent was removed in vacuo and evaporated under reduced pressure, and the residue was taken into DCM (0.25 L) (Li<sup>+</sup> salt is organic soluble). The organic material was washed with water (0.25 L), brine (0.25 L), and was then dried over Na<sub>2</sub>SO<sub>4</sub>. The solution was filtered and concentrated in vacuo to give a slightly sticky, ivory solid. The residue was triturated with hexanes (3Ã) and dried in a vacuum oven to afford the crude lithium salt (10.2 g), which was carried into the next step without any further purification or characterization. LC/MS (APCI) <i>m</i>/<i>z</i> 341.1 (M + H)<sup>+</sup>. (b) The crude lithium salt of (<i>E</i>)-4-(2-ethoxyvinyl)-1-(4-fluorobenzyl)-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine-5-carboxylate (10.2 g), prepared in (a) above, was taken into AcOH (100 mL), and the solution was heated to reflux. After 6 h, the reaction was checked by LCMS and was determined to be complete. At this point, the reaction was cooled to room temperature, and an ivory solid precipitated upon cooling. The solid was filtered and washed with hexanes (3Ã) and dried in a vacuum oven at 75 Â°C overnight to provide 7.55 g (91%) of the target 7-(4-fluorobenzyl)pyrano[3,4-<i>b</i>]pyrrolo[3,2-<i>d</i>]pyridin-4(7<i>H</i>)-one (<b>16</b>) as an ivory powder. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 5.66 (s, 2H), 7.12â7.25 (m, 4H), 7.36 (dd, <i>J</i> = 8.57, 5.56 Hz, 2H), 7.73 (d, <i>J</i> = 5.46 Hz, 1H), 7.97 (d, <i>J</i> = 3.01 Hz, 1H), 9.13 (s, 1H). LC/MS (APCI) <i>m</i>/<i>z</i> 295.1 (M + H)<sup>+</sup>. Anal. Calcd for C<sub>17</sub>H<sub>11</sub>FN<sub>2</sub>O<sub>2</sub>: C, 69.38; H, 3.77; N, 9.52. Found: C, 69.12; H, 3.57; N, 9.23.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 7-(4-Fluorobenzyl)-1,7-dihydropyrano[3,4-<i>b</i>]pyrrolo[3,2-<i>d</i>]pyridin-4(2<i>H</i>)-one (<b>17</b>)</h4><div class="NLM_p last">A solution/suspension of 7-(4-fluorobenzyl)pyrano[3,4-<i>b</i>]pyrrolo[3,2-<i>d</i>]pyridin-4(7<i>H</i>)-one <b>16</b> (17.90 g, 60.82 mmol) in THF/MeOH/H<sub>2</sub>O (1 L, 85:14:1) was sparged with nitrogen for 15 min in a 2 L Parr hydrogenation bottle. To this solution, under N<sub>2</sub>, was added 5% Pd/Al<sub>2</sub>O<sub>3</sub> (1.79 g, 10 wt %), and the mixture was hydrogenated under 35 psi of H<sub>2</sub> for 18 h. HPLC and HPLC/MS indicated completion of the reaction, the mixture was sparged with nitrogen, filtered through a pad of Celite (wet with CH<sub>2</sub>Cl<sub>2</sub>/MeOH 95:5), and the Parr bottle was rinsed with CH<sub>2</sub>Cl<sub>2</sub>/MeOH (750 mL, 95:5) and the combined filtrates were concentrated in vacuo to afford the crude product as a tan/pale-yellow foam. The crude material was purified by Biotage chromatography in three portions (4 g, 65 + M column gradient CH<sub>2</sub>Cl<sub>2</sub>/MeOH 99:1 to 95:5, 120 mL fractions), fractions <b>24</b>â<b>27</b> afforded 7-(4-fluorobenzyl)-1,7-dihydropyrano[3,4-<i>b</i>]pyrrolo[3,2-<i>d</i>]pyridin-4(2<i>H</i>)-one <b>17</b> as a clearâcolorless oil which solidified and was recrystallized from ether/CH<sub>2</sub>Cl<sub>2</sub> to furnish the target compound as white plates. The 4 g purification was repeated (65 + M column gradient CH<sub>2</sub>Cl<sub>2</sub>/MeOH 99:1 to 95:5, 120 mL fractions), fractions <b>25</b>â<b>27</b> afforded the desired lactone as a clearâcolorless oil which was seeded with saturated lactone and recrystallized from ether/CH<sub>2</sub>Cl<sub>2</sub> to furnish the target compound as white plates. The remaining 11 g of crude product was purified on the Biotage (65 + M column gradient CH<sub>2</sub>Cl<sub>2</sub>/MeOH 99:1 to 95:5, 120 mL fractions), fractions <b>25</b>â<b>28</b> gave the desired lactone as a clearâcolorless oil which was seeded with saturated lactone and recrystallized from ether/CH<sub>2</sub>Cl<sub>2</sub> to furnish the target compound as white plates. The combined material was recrystallized from ether/CH<sub>2</sub>Cl<sub>2</sub> to afford 14.7 g (81%) of 7-(4-fluorobenzyl)-1,7-dihydropyrano[3,4-<i>b</i>]pyrrolo[3,2-<i>d</i>]pyridin-4(2<i>H</i>)-one <b>17</b> as white plates. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 3.33 (t, <i>J</i> = 6.12 Hz, 2H), 4.64 (t, <i>J</i> = 6.12 Hz, 2H), 5.45 (s, 2H), 6.68 (d, <i>J</i> = 3.01 Hz, 1H), 7.02 (m, 2H), 7.13 (m, 2H), 7.39 (d, <i>J</i> = 3.01 Hz, 1H), 8.79 (s, 1H). LC/MS (APCI) <i>m</i>/<i>z</i> 297.1 (M + H)<sup>+</sup>. Anal. Calcd for C<sub>17</sub>H<sub>13</sub>FN<sub>2</sub>O<sub>2</sub>: C, 68.91; H, 4.42; N, 9.45. Found: C, 69.02; H, 4.57; N, 9.21.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 1-(4-Fluorobenzyl)-4-(2-hydroxyethyl)-<i>N</i>-(tetrahydro-2<i>H</i>-pyran-2-yloxy)-1<i>H</i>-pyrrolo[2,3<i>c</i>]pyridine-5-carboxamide (<b>18</b>)</h4><div class="NLM_p last">Lactone <b>17</b> (3.50 g, 11.81 mmol) and <i>O</i>-(tetrahydro-2<i>H</i>-pyran-2-yl)hydroxylamine (2.77 g, 23.62 mmol, 2 equiv) were rigorously dried by evaporation from anhydrous THF (3 Ã 20 mL), and the mixture was then dissolved in anhydrous THF (80 mL). The resulting solution was treated with solid LiHMDS (3.95 g, 23.62 mmol, 2 equiv) to give a cloudy orange solution which was warmed to near reflux and then was allowed to cool to room temperature with stirring overnight. The mixture was concentrated in vacuo to provide an orange oil which was dissolved in CH<sub>2</sub>Cl<sub>2</sub>/MeOH (250 mL, 95:5), and the organic phase was washed satd aq NH<sub>4</sub>Cl (200 mL), <sup>1</sup>/<sub>2</sub> saturated brine (200 mL), brine (200 mL), and dried (Na<sub>2</sub>SO<sub>4</sub>). Filtration and concentration in vacuo afforded crude <b>18</b> as a brown oil which was purified by flash chromatography on a column of silica gel, eluting with a gradient from CH<sub>2</sub>Cl<sub>2</sub> to CH<sub>2</sub>Cl<sub>2</sub>/MeOH (98:2) to provide <b>18</b> (3.81 g, 78%) as a clear, colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 1.44â1.72 (3H), 1.81â2.02 (3H), 3.67 (m, 2H), 3.86â4.13 (4H), 5.12 (s, 1H), 5.38 (s, 2H), 6.69 (m, 1H), 6.96â7.20 (4H), 7.31 (m, 1H), 8.42(s, 1H), 10.46 (s, 1H). LC/MS <i>m</i>/<i>z</i> 414.2 (M + H)<sup>+</sup>. Anal. Calcd for C<sub>22</sub>H<sub>24</sub>FN<sub>3</sub>O<sub>4</sub>: C, 63.91; H, 5.85; N, 10.16. Found: C, 63.75; H, 5.77; N, 10.02.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 3-[(4-Fluorophenyl)methyl]-3,7,8,9-tetrahydro-7-[(tetrahydro-2<i>H</i>-pyran-2-yl)oxy]-6<i>H</i>-Pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6-one (<b>19</b>)</h4><div class="NLM_p last">To a stirred solution of alcohol <b>18</b> (1.60 g, 3.9 mmol) in anhydrous THF (100 mL) was added triphenylphosphine (1.20 g, 4.6 mmol) followed by the addition of a solution diisopropyl azodicarboxylate (0.9 mL, 0.94 g, 4.6 mmol) in anhydrous THF (10 mL) over 10 min. The mixture was allowed to stir at room temperature for 1 h, and then the solvent was removed in vacuo to provide crude <b>19</b> as a viscous oil. The crude material was purified by chromatography on a Biotage SP-4 (gradient CH<sub>2</sub>Cl<sub>2</sub>/MeOH 99:1 to 95:5, 10 mL fractions) to give 0.57 g (37%) of <b>19</b> as a clear, colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 1.52â1.72 (3H), 1.80â2.01 (3H), 3.40 (m, 2H), 3.66 (m, 1H), 3.92â4.20 (3H), 5.28 (s, 1H), 5.42 (s, 2H), 6.64 (m, 1H), 7.02 (m, 2H), 7.26 (m, 2H), 7.32 (m, 1H), 8.78 (s, 1H). LC/MS <i>m</i>/<i>z</i> 396.2 (M + H)<sup>+</sup>. Anal. Calcd for C<sub>22</sub>H<sub>22</sub>FN<sub>3</sub>O<sub>3</sub>: C, 66.82; H, 5.61; N, 10.63. Found: C, 66.91; H, 5.70; N, 10.65.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 3-[(4-Fluorophenyl)methyl]-3,7,8,9-tetrahydro-7-hydroxy-6<i>H</i>-Pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6-one (<b>7</b>)</h4><div class="NLM_p last">To a solution of THP/ether <b>19</b> (0.12 g, 0.30 mmol) in MeOH (2 mL), was added HCl in dioxane (4.0 M, 0.45 mL, 1.8 mmol, 6 equiv) at room temperature. LC-MS showed complete conversion to the product after stirring overnight at room temperature. The solution was concentrated in vacuo, treated with saturated aqueous sodium bicarbonate solution (10 mL), and extracted with DCM (2 Ã 10 mL). The combined organic layers were dried over sodium sulfate, filtered, and concentrated under reduced pressure to provide crude <b>7</b>. The crude product was purified by prep-HPLC to afford 0.023 g, 24% of <b>7</b> as a white powder. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 3.30 (m, 2H), 3.80 (m, 2H), 5.57 (s, 2H), 6.72 (d, <i>J</i> = 3.0 Hz, 1H), 7.15 (m, 2H), 7.21 (m, 2H), 7.85 (d, <i>J</i> = 3.0 Hz, 1H), 8.84 (s, 1H), 9.87 (s, 1H). LC/MS (APCI) <i>m</i>/<i>z</i> 312.1 (M + H)<sup>+</sup>. HRMS Calcd for C<sub>17</sub>H<sub>15</sub>FN<sub>3</sub>O<sub>2</sub> (M + H)<sup>+</sup>: 312.1148. Found: 312.1158.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Methyl 4-[(<i>E</i>)-2-Butoxyvinyl]-1-(4-fluorobenzyl)-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine-5-carboxylate (<b>20</b>)</h4><div class="NLM_p last">To a three-neck round-bottom flask equipped with a stir bar, a dry ice coldfinger, two rubber septa, under a blanket of N<sub>2</sub>, was added <b>14</b> (51.77 g, 0.12 mol), Pd<sub>2</sub>(dba)<sub>3</sub> (3.29 g, 3.6 mmol, 0.03 equiv), (<i>t</i>-Bu)<sub>3</sub>PÂ·HBF<sub>4</sub> (1.042 g, 3.59 mmol, 0.03 equiv), LiCl (15.23 g, 359.23 mmol, 3 equiv), and anhydrous 1,4-dioxane (780 mL, 6.5 mL/mmole of <b>14</b>). With stirring, <i>n</i>-butyl vinyl ether (48.1 g, 0.48 mol, 4 equiv) and Cy<sub>2</sub>NMe (26.48 g, 156 mmol, 1.13 equiv) were added. The dry ice coldfinger was filled with dry ice and IPA, and the reaction was heated in an oil bath to an external temperature of 70 Â°C. After 60 min of heating, the reaction changed from dark-red to a yellowâgreen. The reaction was checked by HPLC and LCMS and was complete. The reaction was removed from the oil bath and allowed to cool to room temperature. When room temperature was reached, the reaction was filtered through pad of Celite, and the filter cake was washed with EtOAc until no color was observed coming from the filter. The solvents were evaporated under reduced pressure to provide a viscous oil. The oil was dissolved (sonication was used to help dissolve the viscous oil) in EtOAc (1 L). The solution was stirred rapidly for 2â3 h at which time a solid precipitated. The solid was removed by filtration, and the filtrate was concentrated in vacuo to provide crude <b>20</b> as a sticky solid. The crude material was purified by flash chromatography eluting with 100% DCM and increasing polarity with EtOAc (0â100%). The pure fractions were concentrated in vacuo to yield an oily solid. The solid was recrystallized from EtOAc to give off <b>20</b> (39.4 g, 86%) as off-white needles. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 0.96 (t, <i>J</i> = 7.2 Hz, 3H), 1.43 (m, 2H), 1.72 (m, 2H), 4.03 (s, 3H), 4.06 (t, <i>J</i> = 7.2 Hz, 2H), 5.78 (s, 2H), 6.63 (d, <i>J</i> = 12.4 Hz, 1H), 7.20 (m, 2H), 7.33 (d, <i>J</i> = 2.6 Hz, 1H), 7.42 (m, 2H), 7.54 (d, <i>J</i> = 12.4 Hz, 1H), 8.41 (d, <i>J</i> = 2.6 Hz, 1H), 9.15 (s, 1H). LC/MS <i>m</i>/<i>z</i> 383.2 (M + H)<sup>+</sup>. Anal. Calcd for C<sub>22</sub>H<sub>23</sub>FN<sub>2</sub>O<sub>3</sub>: C, 68.09; H, 6.06; N, 7.33. Found: C, 68.21; H, 4.29; N, 7.19.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 2-((2-(Trimethylsilyl)ethoxy)methoxy)isoindoline-1,3-dione</h4><div class="NLM_p last">To a 2 L 3-neck round-bottom flask, equipped with a stir bar, addition funnel (w/N<sub>2</sub> line attached), and digital thermometer, under a static head of nitrogen, was added <i>N</i>-hydroxyphthalimide (51.13 g, 0.313 mmol), SEM chloride (73.07 mL, 73.07 g, 0.438 mmol), and dichloromethane (700 mL). The flask was cooled to 0 Â°C, and then triethyl amine (60.96 mL, 44.32 g, 0.438 mmol) was placed in the addition funnel and added dropwise to the suspension at such a rate that the internal temperature does not exceed 10 Â°C. During the addition, a transient red color is observed, remaining in the presence of an excess of amine base. Once the addition was complete, the cooling bath was removed and the reaction was stirred at room temperature for 4 h. The reaction was checked by adding an additional 1 mL of triethyl amine, if any red color is observed, then the mixture was allowed to stir for an additional hour and then the test was repeated. Once the reaction was complete, it was cast into dichloromethane (0.5 L) and washed with satd aq NaHCO<sub>3</sub> (750 mL) and brine (750 mL). The organic layer was separated, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The crude solid was recrystallized from hexanes, and the crystals were filtered, washed with cold hexanes, and dried to provide 2-((2-(trimethylsilyl)ethoxy)methoxy)isoindoline-1,3-dione, 88.1 g (96%) as a white crystalline solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 0.01 (s, 9H), 0.89 (m, 2H), 3.93 (m, 2H), 5.11 (s, 2H), 7.86â7.95 (4H). LC/MS <i>m</i>/<i>z</i> 294.1 (M + H)<sup>+</sup>. Anal. Calcd for C<sub>14</sub>H<sub>19</sub>NO<sub>4</sub>Si: C, 57.31; H, 6.53; N, 4.77. Found: C, 57.33; H, 6.61; N, 4.62.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> <i>O</i>-{[2-(Trimethylsilyl)ethoxy]methyl}hydroxylamine</h4><div class="NLM_p last">To a 2 L three-neck round-bottom flask, equipped with an overhead stirrer, an addition funnel (w/N<sub>2</sub> line attached), and a digital thermometer was added 2-((2-(trimethylsilyl)ethoxy)methoxy)isoindoline-1,3-dione 1 (77.69 g, 0.265 mmol) and Et<sub>2</sub>O (700 mL). The mixture was cooled in an iceâsalt bath (to ca. 0 Â°C) and <i>N</i>-methyl hydrazine (20.9 mL, 18.29 g, 0.397 mmol) was added (with rapid stirring) at such a rate that the internal temperature did not exceed 5 Â°C. When the addition was complete, the bath was removed and the reaction was allowed to stir at room temperature for 4 h. The white precipitate, which was formed during the reaction, was removed by filtration, rinsed with Et<sub>2</sub>O (0.5 L), and the combined filtrates were concentrated in vacuo to furnish the crude product as a pale-yellow oil. The crude oil was purified by distillation (55â58 Â°C, 760 mmHg) to give <i>O</i>-{[2-(trimethylsilyl)ethoxy]methyl}hydroxylamine (39.4 g, 91%) as a clear colorless liquid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 0.00 (s, 9 H), 0.87 (m, 2 H), 3.57 (m, 2 H), 4.60 (s, 2 H), 6.04 (s, 2 H). LC/MS (APCI) <i>m</i>/<i>z</i> 164.1 (M + H)<sup>+</sup>. Anal. Calcd for C<sub>6</sub>H<sub>17</sub>NO<sub>2</sub>Si: C, 44.14; H, 10.49; N, 8.58. Found: C, 43.99; H, 10.52; N, 8.52.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> Methyl 1-(4-Fluorobenzyl)-4-(2-((2-(trimethylsilyl)ethoxy)methoxyimino)ethyl)-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine-5-carboxylate (<b>21</b>)</h4><div class="NLM_p last">To (<i>E</i>)-methyl 1-(4-fluorobenzyl)-4-(2-butoxyvinyl)-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine-5-carboxylate <b>20</b> (10.00 g, 26.15 mmol) in anhydrous THF (250 mL) was added in order H<sub>2</sub>NOSEM (4.91 g, 30.07 mmol, <i>d</i> = 0.81 g/mL, 6.06 mL) and <i>p</i>-TsOHâH<sub>2</sub>O (12.93 g, 67.99 mmol). HPLC-MS after 1 h showed no reaction. HPLC-MS after 14.5 h suggested 20% conversion to the target compound and a clean reaction. At 24 h, HPLC-MS suggested ca. 35% conversion; 38.5 h, ca. 60% completion. Stirring was continued for an additional ca. 22 h (60 h total), at which time HPLC-MS suggested that the reaction was complete (RT = 1.76 min, <i>m</i>/<i>e</i> = 472). The mixture was diluted with ether (0.25 L) and was cast into CH<sub>2</sub>Cl<sub>2</sub> (0.5 L) and satd aq NaHCO<sub>3</sub> (0.75 L). The organic phase was separated, the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (0.5 L), and the combined organic phases were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo to furnish the crude product as a tan oil. The crude material was triturated with ether, producing a fine, brown solid which was removed by filtration. Removal of the ether from the filtrate gave a beige oil. The crude product was purified by a short, flash column (50 mm OD, 100 g 230â400 mesh, packed DCM; eluted ether/DCM 10:90, 1.0 L; ether/DCM 17.5:82.5 1.0 L; 50 mL fractions). Fractions <b>14</b>â<b>24</b> were combined to afford the desired product <b>21</b> as a clear, colorless, viscous oil 10.0 g (94%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 0.03 (s, 9H), 0.98 (m, 2H), 3.68 (m, 1H), 3.77 (m, 1H), 4.01 (s, 3H), 4.26 (d, <i>J</i> = 6.22 Hz, 1H), 4.43 (d, <i>J</i> = 5.09 Hz, 1H), 5.11 (m, 1H), 5.28 (m, 1H), 5.42 (m, 2H), 6.92 (m, 1H) 7.04 (m, 2H) 7.15 (m, 2H) 7.34 (d, <i>J</i> = 3.20 Hz, 1H) 8.69 (d, <i>J</i> = 3.96 Hz, 1H). LC/MS (APCI) <i>m</i>/<i>z</i> 472.2 (M + H)<sup>+</sup>. Anal. Calcd for C<sub>24</sub>H<sub>30</sub>FN<sub>3</sub>O<sub>4</sub>Si: C, 61.12; H, 6.41; N, 8.91. Found: C, 61.38; H, 6.73; N, 8.76.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 3-(4-Fluorobenzyl)-7-((2-(trimethylsilyl)ethoxy)methoxy)-8,9-dihydro-3<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6(7<i>H</i>)-one (<b>22</b>)</h4><div class="NLM_p last">To methyl 1-(4-fluorobenzyl)-4-(2-((2-(trimethylsilyl)ethoxy)methoxyimino)ethyl)-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine-5-carboxylate <b>21</b> (7.48 g, 15.86 mmol) in glacial HOAc (125 mL) was added sodium cyanoborohydride (2.10 g, 95%, 31.72 mmol) in two portions (2 Ã 1.05 g) at the start of the reaction and after 1 h. The reaction was monitored by HPLC and HPLC-MS and appeared to be ca. 80â90% complete after 1 h. After the addition of the second equivalent of NaBH<sub>3</sub>CN, the mixture was allowed to stir for 1 additional hour, at which time HPLC-MS suggested that the reaction was complete. The HOAc was then removed at full pump vacuum to give a clear, yellow viscous oil which was treated with 1.0 L of 95:5 ether/DCM and 0.8 L of satd aq NaHCO<sub>3</sub>. The mixture was placed in a 2 L separatory funnel, shaken, and the organic phase was separated, the aqueous phase was extracted with an additional 0.5 L of DCM, and the combined organic phases were dried (Na<sub>2</sub>SO<sub>4</sub>). Filtration and concentration in vacuo gave the crude product <b>22</b> as a pale-yellow glass, which provided a white foam upon exposure to pump vacuum. The crude product was purified by Biotage (65, gradient 2% MeOH to 12% MeOH; 98% to 88% DCM over 12 column volumes, collection by UV, 240 mL fractions). UV detection initiated collection at ca. 5% MeOH in DCM, and collection continued until the gradient reached 6+% MeOH in DCM, a total of two fractions. Concentration in vacuo afforded 5.86 g (84%) of the target compound <b>22</b> as a clear, colorless glass/foam. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 0.02 (s, 9H), 0.97 (m, 2H), 3.38 (t, <i>J</i> = 6.88 Hz, 2H), 3.85 (m, 2H), 3.99 (t, <i>J</i> = 6.88 Hz, 2H), 5.11 (s, 2 H), 5.40 (s, 2H), 6.62 (d, <i>J</i> = 3.20 Hz, 1H), 6.98 (t, <i>J</i> = 8.67 Hz, 2H), 7.09 (m, 2H), 7.33 (d, <i>J</i> = 3.20 Hz, 1H), 8.78 (s, 1H). LC/MS (APCI) <i>m</i>/<i>z</i> 442.2 (M + H)<sup>+</sup>. Anal. Calcd for C<sub>23</sub>H<sub>28</sub>FN<sub>3</sub>O<sub>3</sub>Si: C, 62.56; H, 6.39; N, 9.52. Found: C, 62.79; H, 6.61; N, 9.33.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 3-(4-Fluorobenzyl)-7-hydroxy-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6-one (<b>7</b>)</h4><div class="NLM_p last">To a stirring solution of the SEM-protected <i>N</i>-hydroxy-dihydropyridone <b>22</b> (1.00 g, 2.26 mmol) in isopropyl alcohol (20 mL) was added sulfuric acid (0.604 mL, 11.30 mmol) and the reaction stirred at room temperature. After 24 h, LCMS showed no remaining starting material. Diethyl ether (100 mL) was added, and the resulting solid hydrogen sulfate salt of the product was filtered through a medium glass fritted filter, rinsed with diethyl ether (100 mL), and dried overnight in a vacuum oven at 40 Â°C to provide the salt of the desired product <b>7</b> as a white solid (700 mg, 80%). <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) Î´ 3.62 (t, <i>J</i> = 7.5 Hz, 2H), 4.10 (t, <i>J</i> = 7.5 Hz, 2H), 5.74 (s, 2H), 7.12 (m, 2H), 7.20 (dd, <i>J</i> = 3.3, 0.8 Hz, 1H), 7.37 (m, 2H), 8.32 (d, <i>J</i> = 3.3 Hz, 1H), 9.08 (s, 1H). LC/MS (APCI) <i>m</i>/<i>z</i> 312.2 (M + H)<sup>+</sup>. Anal. Calcd for C<sub>17</sub>H<sub>14</sub>FN<sub>3</sub>O<sub>2</sub>âH<sub>2</sub>SO<sub>4</sub>âH<sub>2</sub>O: C, 47.77; H, 4.24; N, 9.83. Found: C, 47.59; H, 4.31; N, 9.76.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> Ethyl 2-Methyl-1-(phenylsulfonyl)-1<i>H</i>-pyrrole-3-carboxylate (<b>23</b>)</h4><div class="NLM_p last">To a solution of ethyl 2-methyl-1<i>H</i>-pyrrole-3-carboxylate <b>8</b> (15.2 g, 99.3 mmol) and tetra-<i>n</i>-butylammonium bromide (3.2 g, 9.9 mmol) in toluene (500 mL) was added benzenesulfonyl chloride (26.4 g, 14.9 mmol) followed by a solution of sodium hydroxide (38 g, 0.95 mol) in water (50 mL). The mixture was vigorously stirred for 45 min. The reaction was monitored by TLC (20% ethyl acetate in hexanes). Upon completion, water (250 mL) was added to the reaction mixture and the organic layer separated. The aqueous was extracted with a further portion of toluene (100 mL). The combined organics were dried over sodium sulfate, and the solvent was removed to afford the product as a viscous oil that was purified by passing through a plug of silica gel, eluting with ethyl acetate/heptanes (initially 10% being increased to 15%). Upon concentration in vacuo, the product began to crystallize from solution, evaporation was halted, and the mixture was cooled in an iceâwater bath. The resulting solid was collected by filtration and washed with heptanes to provide the desired product <b>23</b> (22.12 g, 76%) as a colorless solid. On standing, a second crop of product (2.75 g, 10%, total 24.87 g, 86%) was isolated. LC/MS (APCI) <i>m</i>/<i>z</i> 294.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 1.32 (t, <i>J</i> = 7.16 Hz, 3H), 2.63 (s, 3H), 4.25 (q, <i>J</i> = 7.16 Hz, 2H), 6.63 (d, <i>J</i> = 3.58 Hz, 1H), 7.31 (d, <i>J</i> = 3.58 Hz, 1H), 7.56 (m, 2H), 7.62 (m, 1H), 7.84 (m, 2H). HPLC (254, 224 nm): >95% purity.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> Ethyl 2-(Bromomethyl)-1-(phenylsulfonyl)-1<i>H</i>-pyrrole-3-carboxylate (<b>24</b>)</h4><div class="NLM_p last">To ethyl 2-methyl-1-(phenylsulfonyl)-1<i>H</i>-pyrrole-3-carboxylate <b>23</b> (30.0 g, 100 mmol) in 400 mL of carbon tetrachloride was added <i>N</i>-bromosuccinimide (27.3 g, 153 mmol) and benzoyl peroxide (0.743 mg, 3.07 mmol). The suspension was heated to reflux (oil bath, 100 Â°C) for 2 h, after which time the reaction mixture was allowed to cool to room temperature and the solid was removed by filtration. The filtrate was concentrated in vacuo, and the resulting residue was dissolved in ethyl acetate (0.5 L) and washed with saturated sodium bicarbonate solution (2 Ã 0.5 L). The combined aqueous layers were extracted with an additional portion of ethyl acetate (0.25 L). The organic layers were combined, dried over sodium sulfate, filtered, and concentrated in vacuo to give an oily solid. The resulting solid was precipitated from diethyl ether/hexanes solution using sonication and was then filtered and dried to provide the title compound <b>24</b> (36.4 g, 96%). LC/MS (APCI) <i>m</i>/<i>z</i> 372.0 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 1.36 (t, <i>J</i> = 7.16 Hz, 3H), 4.32 (q, <i>J</i> = 7.16 Hz, 2H), 5.19 (s, 2H), 6.71 (d, <i>J</i> = 3.58 Hz, 1H), 7.37 (d, <i>J</i> = 3.58 Hz, 1H), 7.57 (m, 2H), 7.66 (m, 1H) 7.97 (m, 2H). HPLC (254, 224 nm): >95% purity.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> Ethyl 2-({(2-Methoxy-2-oxoethyl)[(4-methylphenyl)sulfonyl]amino}methyl)-1-(phenylsulfonyl)-1<i>H</i>-pyrrole-3-carboxylate (<b>25</b>)</h4><div class="NLM_p last">Ethyl 2-(bromomethyl)-1-(phenylsulfonyl)-1<i>H</i>-pyrrole-3-carboxylate <b>24</b> (30.0 g, 80.6 mmol) and tosyl-glycine methyl ester (19.6 g, 80.6 mmol) were dissolved in DMF (220 mL) and added over 1 h to sodium hydride (6.45 g, 161 mmol, 60% in mineral oil which was washed by hexanes three times) suspended in DMF (100 mL) and cooled in a dry ice-<i>i</i>-PrOH bath to â20 Â°C internal. During the addition, the temperature was kept between â20 Â°C and â10 Â°C by altering the rate of addition. After the addition was complete, the mixture was transferred to an iceâwater bath and stirring was continued for 2 h. Saturated aqueous ammonium chloride was then added to the reaction mixture (1 L), and the mixture was extracted with ethyl acetate (2 Ã 1 L). The organic layers were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to afford the crude product as an oily solid. The material was triturated with hexanes and dried in vacuo overnight to afford 31.5 g (73%) of <b>25</b> as a white solid. LC/MS (APCI) <i>m</i>/<i>z</i> 535.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 1.25 (t, <i>J</i> = 7.16 Hz, 3H), 2.44 (s, 3H), 3.27 (s, 3H), 3.69 (s, 2H), 4.20 (q, <i>J</i> = 7.16 Hz, 2H), 5.08 (s, 2H), 6.64 (d, <i>J</i> = 3.58 Hz, 1H), 7.33 (m, 2H), 7.39 (d, <i>J</i> = 3.58 Hz, 1H), 7.59 (m, 2H) 7.67 (m, 1H), 7.72 (m, 2H), 8.03 (m, 2H). HPLC (254, 224 nm): >95% purity.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> Methyl 4-Hydroxy-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine-5-carboxylate (<b>26</b>)</h4><div class="NLM_p last">To a stirring solution of ethyl 2-((<i>N</i>-(2-methoxy-2-oxoethyl)-4-methylphenylsulfonamido)methyl)-1-(phenylsulfonyl)-1<i>H</i>-pyrrole-3-carboxylate <b>25</b> (31.84 g, 59.56 mmol) in THF (400 mL), cooled in a dry ice-<i>I</i>-PrOH bath, was added LiHMDS (178 mL, 178 mmol, 1.0 M in THF) via a jacketed (dry ice-<i>I</i>-PrOH) addition funnel over 2 h. The resulting mixture was allowed to stir at â78 Â°C for an additional 1 h, after which time reaction was quenched with aqueous ammonium chloride (400 mL). The resulting mixture was extracted with ethyl acetate (2 Ã 600 mL), the combined organic layers were washed with water (2 Ã 400 mL), and the combined aqueous layers were extracted with additional ethyl acetate (2 Ã 400 mL). The resulting organic layers were combined, washed with saturated sodium chloride solution (1 L), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo until crystalline material was present. The remaining solution was then cooled to room temperature and left in a refrigerator overnight to provide the title compound <b>26</b> as a white crystalline solid 12.47 g (63%). LC/MS (APCI) <i>m</i>/<i>z</i> 333.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 4.06 (s, 3H), 6.95 (d, <i>J</i> = 3.58 Hz, 1H), 7.50 (m, 2H), 7.62 (m, 1H), 7.67 (d, <i>J</i> = 3.58 Hz, 1H), 7.95 (m, 2H), 8.96 (s, 1H), 11.25 (s, 1H). HPLC (254, 224 nm): >95% purity.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> Methyl 1-(Phenylsulfonyl)-4-{[(trifluoromethyl)sulfonyl]oxy}-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine-5-carboxylate (<b>27</b>)</h4><div class="NLM_p last">A solution of phenol <b>26</b> (20.00 g, 60.02 mmol), triethylamine (42.00 mL, 300.0 mmol), and anhydrous dichloromethane (400 mL) was cooled to â5 Â°C in an ice/brine bath. To the mixture was added triflic anhydride (25.40 mL, 150.4 mmol) at a rate such that the internal temperature of the mixture was kept below 0 Â°C. After addition was complete, the reaction mixture was stirred for an additional 30 min. Sodium bicarbonate solution (satd, 600 mL) was added and the mixture was extracted with dichloromethane (3 Ã 400 mL). The combined organic layers were washed with brine (500 mL), dried over sodium sulfate, filtered, and concentrated in vacuo to provide the crude product as an oil which purified by column chromatography (silica gel, 3:1 hexanes/EtOAc) to provide <b>27</b> (24.78 g, 86%) as a viscous oil. LC/MS (APCI) <i>m</i>/<i>z</i> 465.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 4.04 (s, 3H), 6.89 (d, <i>J</i> = 3.58 Hz, 1H), 7.56 (m, 2H), 7.68 (m, 1H), 7.86 (d, <i>J</i> = 3.58 Hz, 1H), 7.97 (m, 2 H), 9.37 (s, 1 H) . HPLC (254, 224 nm): >95% purity.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> Methyl 4-[(<i>E</i>)-2-Butoxyethenyl]-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine-5-carboxylate (<b>28</b>)</h4><div class="NLM_p last">To a solution of the triflate <b>27</b> (1.00 g, 2.15 mmol, 1.00 equiv) in anhydrous 1,4-dioxane (20 mL, degassed with argon balloon and needle) in a Teflon, capped, and sealed tube was added LiCl (274 mg, 6.46 mmol, 3.00 equiv), Pd<sub>2</sub>(dba)<sub>3</sub> (0.099 g, 0.100 mmol, 0.03 equiv), and (<i>t</i>-Bu)<sub>3</sub>P-HBF<sub>4</sub> (62.4 mg, 0.20 mmol, 0.05 equiv). While stirring, <i>n</i>-butyl vinyl ether (2.78 mL, 21.6 mmol, 10 equiv) and Cy2Nme (0.56 mL, 2.6 mmol, 1.20 equiv) were added and the resulting mixture was heated to 80 Â°C for 16 h and was then allowed to cool. Sodium bicarbonate solution was then added, and the mixture was extracted with ethyl acetate to provide a redâblack oil. The residue was dissolved in dichloromethane and purified by flash chromatography (silica gel, 2:1 hexanes/EtOAc to 1:1 hexanes/EtOAc) to provide the title compound <b>28</b> as a viscous, colorless glass 0.499 g (56% yield). LC-MS (APCI) <i>m</i>/<i>z</i> 415.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 1.40â1.65 (4H), 3.96 (s, 3H), 5.93 (d, <i>J</i> = 12.4 Hz, 1H), 6.52 (d, <i>J</i> = 12.4 Hz, 1H), 6.78 (m, 1H), 7.41â7.53 (2H), 7.59 (m, 1H), 7.70 (m, 1H), 7.89â7.99 (2H), 9.21 (s, 1H). HRMS Calcd for C<sub>21</sub>H<sub>22</sub>N<sub>2</sub>O<sub>5</sub>S + H<sup>+</sup>: 415.1328. Found: 415.1334.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> Ethyl 4-[(<i>E</i>)-2-Butoxyethenyl]-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine-5-carboxylate (<b>29</b>)</h4><div class="NLM_p last">To a solution of methyl 4-[(<i>E</i>)-2-butoxyethenyl]-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine-5-carboxylate (<b>28</b>) (3.76 g, 9.06 mmol) in anhydrous EtOH (65 mL) was added NaOEt (2.60 M in EtOH, 4.40 mL, 11.8 mmol). The reaction mixture was stirred at room temperature for 8 h, then was quenched by the addition of satd aq NH<sub>4</sub>Cl (0.25 L). Then the mixture was extracted by 2 Ã 300 mL of EtOAc. The organic layers were combined, dried over sodium sulfate, filtered, and concentrated in vacuo to provide the crude products that was further purified by ISCO 180 g flash column (3% to 5% MeOH/DCM) to yield yellow fine crystal of the desired product (<b>29</b>) 2.06 g (79%). LC-MS <i>m</i>/<i>z</i> 289.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 1.27 (t, <i>J</i> = 7.06 Hz, 3H), 1.40â1.65 (4H), 3.95 (t, <i>J</i> = 7.16 Hz, 2H) 4.46 (q, <i>J</i> = 7.16 Hz, 2H), 5.93 (d, <i>J</i> = 12.4 Hz, 1H), 6.51 (d, <i>J</i> = 12.4 Hz, 1H), 6.72 (d, <i>J</i> = 3.01 Hz, 1H) 7.43 (d, <i>J</i> = 3.01 Hz, 1H), 8.79 (s, 1H), 9.05 (brs, 1H). HPLC (254, 224 nm): >95% purity.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> Ethyl 4-[(9<i>E</i>)-2,2-Dimethyl-5,7-dioxa-8-aza-2-siladec-9-en-10-yl]-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine-5-carboxylate (<b>30</b>)</h4><div class="NLM_p last">To a clear yellow solution of ethyl 4-[(<i>E</i>)-2-butoxyethenyl]-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine-5-carboxylate (2.77 g, 9.64 mmol) in anhydrous 1,4-dioxane (80 mL) was added H<sub>2</sub>NOSEM (2.09 mL, 10.6 mmol) and <i>p</i>-TsOH-H<sub>2</sub>O (4.77 g, 25.1 mmol). After stirring 5.5 h at room temperature, the reaction was complete. It was quenched by saturated sodium bicarbonate solution (0.5 L) and extracted with ethyl acetate (2 Ã 400 mL). The organic layers were dried over sodium sulfate, filtered, and concentrated in vacuo to give crude product (contaminated by leftover NH<sub>2</sub>OSEM) as a light-yellow solid (3.64 g). LC-MS (APCI) <i>m</i>/<i>z</i> 378.2 (M + H)<sup>+</sup>. The crude product was carried on to the next step without further purification.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 7-{[2-(Trimethylsilyl)ethoxy]methoxy}-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6-one (<b>31</b>)</h4><div class="NLM_p last">To ethyl 4-[(9<i>E</i>)-2,2-dimethyl-5,7-dioxa-8-aza-2-siladec-9-en-10-yl]-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine-5-carboxylate <b>30</b> (2.59 g, 7.13 mmol) in glacial acetic acid (25 mL) was added sodium cyanoborohydride (0.896 g, 14.26 mmol) in two portions, and the resulting reaction mixture was stirred at room temperature for 2 h. The acetic acid was removed, and the residue was dissolved in EtOAc (0.25 L) and washed with satd aq sodium bicarbonate solution (0.25 L). The aqueous layer was extracted with EtOAc (0.125 L), and the combined organic layers were dried over sodium sulfate, filtered, and concentrated under reduced pressure. The crude residue was treated with 1.0 L of 95:5 ether/DCM and 0.8 L of saturated aqueous sodium bicarbonate. The mixture was placed in a 2 L separatory funnel, shaken, and the organic phase was separated. The aqueous phase was extracted with an additional 0.5 L of DCM, and the combined organic phases were dried over sodium sulfate, filtered, and the residue was dried in vacuo. The crude product was purified by chromatography (100% EtOAc then 20% MeOH/DCM as eluant) to provide <b>31</b> as a solid (0.95 g, 76% yield, two steps). LC-MS (APCI) <i>m</i>/<i>z</i> 334.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 0.03 (s, 9H), 1.00 (m, 2H), 3.42 (t, <i>J</i> = 6.78 Hz, 2H), 3.85 (m, 2H), 4.02 (t, <i>J</i> = 6.88 Hz, 2H), 5.16 (s, 2H), 6.63 (d, <i>J</i> = 3.01 Hz, 1H), 7.69 (d, <i>J</i> = 2.83 Hz, 1H), 9.16 (s, 1H). HPLC (254, 224 nm): >95% purity.</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 5-Fluoro-2-[(6-oxo-7-{[2-(trimethylsilyl)ethoxy]methoxy}-6,7,8,9-tetrahydro-3<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-3-yl)methyl]benzonitrile (<b>32c</b>)</h4><div class="NLM_p last">To a solution of 7-{[2-(trimethylsilyl)ethoxy]methoxy}-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[3,2-<i>f</i>]isoquinolin-6-one <b>31</b> (2.5 g, 6.75 mmol) in anhydrous THF (50 mL), cooled in an iceâwater bath, was added NaH as a 60% mineral oil dispersion (1.44 g, 8.10 mmol). After stirring for 30 min, 2-(bromomethyl)-5-fluorobenzonitrile (1.44 g, 6.75 mmol) was added and reaction was stirred for 1 h and then was quenched with saturated sodium bicarbonate solution (100 mL) and extracted with ethyl acetate (3 Ã 125 mL). The organic layer was dried over sodium sulfate, filtered, and concentrated in vacuo to provide crude <b>32c</b> which purified by chromatography (silica gel, 2% to 6% MeOH/DCM) to provide the title compound <b>32c</b> as white solid (2.34 g, 74% yield). LC-MS <i>m</i>/<i>z</i> 467.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 0.03 (9H), 1.02 (m, 2H), 3.43 (t, <i>J</i> = 6.78 Hz, 2H), 3.89 (m, 2H), 4.04 (t, <i>J</i> = 6.78 Hz, 2H), 5.17 (s, 2H), 5.65 (s, 2H), 6.70 (dd, <i>J</i> = 3.20, 0.75 Hz, 1H), 7.04 (dd, <i>J</i> = 8.76, 5.18 Hz, 1H), 7.22 (m, 1H), 7.45 (m, 2H), 8.82 (s, 1H). HPLC (254, 224 nm): >95% purity.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 5-Fluoro-2-[(7-hydroxy-6-oxo-6,7,8,9-tetrahydro-3<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-3-yl)methyl]benzonitrile (<b>33c</b>)</h4><div class="NLM_p last">To a solution of 5-fluoro-2-[(6-oxo-7-{[2-(trimethylsilyl)ethoxy]methoxy}-6,7,8,9-tetrahydro-3<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-3-yl)methyl]benzonitrile <b>32c</b> (2.33 g, 4.99 mmol) in isopropyl alcohol (50 mL) was added sulfuric acid (1.33 mL, 25.0 mmol). The reaction mixture was stirred at 40 Â°C for 22 h. The reaction mixture was then cooled to room temperature, and diethyl ether (40 mL) was added. The mixture was filtered to provide the title compound <b>33c</b> as white solid sulfate salt (2.426 g). The salt of <b>33</b> was dissolved in DCM (300 mL) and washed with satd aq sodium bicarbonate (2 Ã 300 mL). The aqueous layers were combined and extracted with DCM (4 Ã 300 mL). The combined organic layers were dried over sodium sulfate, filtered, and concentrated in vacuo to give <b>33c</b> as a white solid (1.48 g, 88% yield). LC-MS <i>m</i>/<i>z</i> 337.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) Î´ 3.48 (t, <i>J</i> = 7.06 Hz, 2H), 4.00 (m, 2H), 5.82 (s, 2H), 6.86 (d, <i>J</i> = 3.20 Hz, 1H), 7.23 (dd, <i>J</i> = 8.67, 5.27 Hz, 1H), 7.42 (td, <i>J</i> = 8.67, 2.73 Hz, 1H), 7.70 (m, 2H) 8.77 (s, 1H). HRMS Calcd for C<sub>18</sub>H<sub>13</sub>FN<sub>4</sub>O<sub>2</sub> + H<sup>+</sup>: 337.1095. Found: 337.1092.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 3-[(5-Fluoropyridin-2-yl)methyl]-7-{[2-(trimethylsilyl)ethoxy]methoxy}-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6-one (<b>32a</b>)</h4><div class="NLM_p last">According to the procedure described for the preparation of <b>32d</b>, <b>31</b> and 2-(bromomethyl)-5-fluoropyridine were combined to provide <b>32a</b> in 65% yield. LC-MS <i>m</i>/<i>z</i> 443.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>Cl) Î´ 0.06 (9H), 1.01 (m, 2H), 3.42 (t, <i>J</i> = 6.78 Hz, 2H), 3.88 (dd, <i>J</i> = 9.42, 7.72 Hz, 2H), 4.02 (t, <i>J</i> = 6.78 Hz, 2H), 5.16 (s, 2H), 5.55 (s, 2H), 6.67 (m, 1H), 6.98 (dd, <i>J</i> = 8.67, 4.14 Hz, 1H), 7.32 (td, <i>J</i> = 8.34, 2.92 Hz, 1H), 7.47 (d, <i>J</i> = 2.92 Hz, 1H), 8.42 (d, <i>J</i> = 2.64 Hz, 1H), 8.84 (s, 1H). HPLC (254, 224 nm): >95% purity.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 3-[(5-Fluoropyridin-2-yl)methyl]-7-hydroxy-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6-one (<b>33a</b>)</h4><div class="NLM_p last">According to the procedure described for the preparation of <b>33c</b>, <b>32b</b> provided <b>33a</b> in 95% yield. LC-MS <i>m</i>/<i>z</i> 313.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 3.51 (brs, 2H), 4.01 (t, <i>J</i> = 7.06 Hz, 2H), 5.94 (s, 2H), 7.23 (d, <i>J</i> = 2.83 Hz, 1H), 7.58 (dd, <i>J</i> = 8.67, 4.52 Hz, 1H), 7.80 (td, <i>J</i> = 8.67, 2.83 Hz, 1H), 8.48 (m, 2H), 9.32 (s, 1H). HRMS, Calcd for C<sub>16</sub>H<sub>13</sub>FN<sub>4</sub>O<sub>2</sub> + H<sup>+</sup>: 313.1095. Found: 313.1094.</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 3-[(3,5-Difluoropyridin-2-yl)methyl]-7-{[2-(trimethylsilyl)ethoxy]methoxy}-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6-one (<b>32b</b>)</h4><div class="NLM_p last">As described for the preparation of <b>32d</b>, <b>31</b> and 2-bromomethyl-3,5-difluoropyridine hydrobromide were reacted to provide <b>32b</b> in 72% yield. LC/MS (APCI) 461.4 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 0.05 (9H), 1.01 (m, 2H), 3.42 (t, <i>J</i> = 6.76 Hz, 2H), 3.88 (dd, <i>J</i> = 9.42, 7.72 Hz, 2H), 4.02 (t, <i>J</i> = 6.76 Hz, 2H), 5.17 (s, 2H), 5.62 (s, 2H), 7.16 (m, 1H), 7.32 (m, 1H), 8.15 (m, 1H), 8.42 (m, 1H), 8.84 (s, 1H). HPLC (254, 224 nm): >95% purity.</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 3-[(3,5-Difluoropyridin-2-yl)methyl]-7-hydroxy-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6-one (<b>33b</b>)</h4><div class="NLM_p last">As described for the preparation of <b>33c</b>, <b>32b</b> was hydrolyzed to provide <b>33c</b> in 78% yield. LC/MS (APCI) 331.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, DMDSO-<i>d</i><sub>6</sub>) Î´ 3.35 (m, 2H), 3.90 (m, 2H), 5.67 (s, 2H), 6.68 (m, 1H), 7.50â7.70 (2H), 8.25 (brs, 1H), 8.79 (s, 1H). HPLC (254, 224 nm): >95% purity.</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 5-Fluoro-6-chloro-2-[(6-oxo-7-{[2-(trimethylsilyl)ethoxy]methoxy}-6,7,8,9-tetrahydro-3<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-3-yl)methyl]benzonitrile (<b>32d</b>)</h4><div class="NLM_p last">As described for the preparation of <b>32d</b>, <b>31</b> was reacted with 6-(bromomethyl)-2-chloro-3-fluorobenzonitrile to give <b>32d</b> in 40% yield. LC-MS <i>m</i>/<i>z</i> 501.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 0.01 (s, 9H), 0.97 (m, 2H), 3.39 (t, <i>J</i> = 6.69 Hz, 2H), 3.85 (m, 2H), 4.00 (t, <i>J</i> = 6.69 Hz, 2H), 5.12 (s, 2H), 5.61 (s, 2H), 6.67 (d, <i>J</i> = 3.20 Hz, 1H), 6.83 (dd, <i>J</i> = 8.67, 4.52 Hz, 1H), 7.24 (m, 1H), 7.42 (d, <i>J</i> = 3.20 Hz, 1H), 8.76 (s, 1H). HPLC (254, 224 nm): >95% purity.</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 5-Fluoro-6-chloro-2-[(7-hydroxy-6-oxo-6,7,8,9-tetrahydro-3<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-3-yl)methyl]benzonitrile (<b>33d</b>)</h4><div class="NLM_p last">According to the proceedure described for the preparation of <b>33c</b>, <b>32d</b> gave <b>33d</b> in 95% yield. LC-MS <i>m</i>/<i>z</i> 371.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) Î´ 3.62 (t, <i>J</i> = 7.06 Hz, 2H), 4.09 (t, <i>J</i> = 7.06 Hz, 2H), 5.98 (s, 2H), 7.23 (m, 2H), 7.58 (t, <i>J</i> = 8.76 Hz, 1H), 8.23 (d, <i>J</i> = 3.01 Hz, 1H), 9.21 (s, 1H). HRMS. Calcd for C<sub>18</sub>H<sub>12</sub>ClFN<sub>4</sub>O<sub>2</sub> + H<sup>+</sup>: 371.0706. Found: 371.0709.</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 3-(4-Fluorobenzyl)-1-((dimethylamino)methyl)-7-((2-(trimethylsilyl)ethoxy)methoxy)-8,9-dihydro-3<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6(7<i>H</i>)-one (<b>34</b>)</h4><div class="NLM_p last">To 3-(4-fluorobenzyl)-7-((2-(trimethylsilyl)ethoxy)methoxy)-8,9-dihydro-3<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6(7<i>H</i>)-one <b>22</b> (7.82 g, 17.71 mmol) in acetonitrile (0.3 L) was added <i>N</i>,<i>N</i>-dimethyliminium chloride (Fluka, 6.63 g, 70.84 mmol). The mixture was allowed to stir under nitrogen at room temperature for 21 h, at which point HPLC-MS suggested ca. 40â45% conversion to the desired dimethylaminomethyl compound. The flask was equipped with a reflux condenser, and the mixture was immersed in a 90 Â°C oil bath and warmed to reflux (under N<sub>2</sub>) for 4 h, HPLC-MS at this time point suggested complete reaction, hence reflux was discontinued. The cooled reaction mixture was concentrated in vacuo, and the resulting semisolid was partitioned between EtOAc/DCM (1 L, 95:5) and satd aq sodium bicarbonate (0.75 L). The organic phase was separated, washed with brine (0.75 L), and dried (Na<sub>2</sub>SO<sub>4</sub>). HPLC-MS analysis of the organic phase and the initial NaHCO<sub>3</sub> wash suggested that all target material was present in the initial organic phase. Concentration in vacuo then afforded the crude dimethylaminomethyl-substituted-SEM-blocked dihydro tricycle <b>34</b> as a tan solid. The crude solid (1 peak by LC-MS was further purified by trituration with hot ether/hexanes (90:10) to give 3-(4-fluorobenzyl)-1-((dimethylamino)methyl)-7-((2-(trimethylsilyl)ethoxy)methoxy)-8,9-dihydro-3<i>H</i>-pyrrolo[2,3-c][1,7]naphthyridin-6(7<i>H</i>)-one <b>34</b> (6.82 g) as fine ivory needles. The filtrate was passed through a small Biotage column (40M, 2â10% MeOH/DCM over 19 column volumes, 3 CV to waste, then collect 50 mL fractions). Fraction <b>12</b> [9CV] provided an additional 1.17 g of <b>34</b> as a tan crystalline solid. Total purified yield 7.89 g (85%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 0.05 (s, 9H), 1.03 (m, 2H), 2.23 (s, 6H), 3.51 (s, 2H), 3.77 (t, <i>J</i> = 6.03 Hz, 2H), 3.92 (m, 4H), 5.15 (d, <i>J</i> = 2.07 Hz, 2H), 5.35 (s, 2H), 7.00 (m, 2H), 7.03â7.17 (3H), 8.74 (s, 1H). LC-MS (APCI) <i>m</i>/<i>z</i> 499.2 (M + H)<sup>+</sup>. Anal. Calcd for C<sub>26</sub>H<sub>35</sub>FN<sub>4</sub>O<sub>3</sub>Si: C, 62.62; H, 7.07; N, 11.24. Found: C, 62.91; H, 7.28; N, 10.99.</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 3-(4-Fluorobenzyl)-1-iodo-7-{[2-(trimethylsilyl)ethoxy]methoxy}-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6-one (<b>35a</b>)</h4><div class="NLM_p last">To a stirring solution of SEM protected tricycle <b>22</b> (4.23 g, 9.58 mmol) in DMF (100 mL) was added NIS (4.31 g, 19.16 mmol). The reaction was stirred for 1 h at room temperature and was then checked by LCMS and determined to be complete. The reaction was diluted with DCM (250 mL) and washed with a satd aq solution of sodium thiosulfate (2 Ã 150 mL), satd aq sodium bicarbonate (2 Ã 150 mL), and brine (1 Ã 100 mL) and dried over Na<sub>2</sub>SO<sub>4</sub>. The solution was filtered and concentrated in vacuo, yielding crude <b>35a</b> as an orange oil. The crude <b>35a</b> was purified on a Biotage SP4 (column: 75+S, eluent: 100% DCM 2CV then 0â10% MeOH in DCM over 12CV). The purified material came off in one fraction and was pure by HPLC. The material was concentrated in vacuo, yielding the desired iodide <b>35a</b> as a pale-yellow solid (5.03 g, 92%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 0.00 (s, 9H), 0.96 (m, 2H), 3.83 (m, 2H), 3.86 (m, 2H), 3.92 (m, 2H), 5.10 (s, 2H), 5.10 (s, 2H), 6.98 (m, 2H), 7.09 (m, 2H), 7.32 (s, 1H), 8.75 (s, 1H). LC-MS (APCI) <i>m</i>/<i>z</i> 568.2 (M + H)<sup>+</sup>. Anal. Calcd for C<sub>23</sub>H<sub>27</sub>FIN<sub>3</sub>O<sub>3</sub>Si: C, 46.68; H, 4.80; N, 7.40. Found: C, 47.04; H, 5.13; N, 7.12.</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 3-(4-Fluorobenzyl)-1-bromo-7-((2-(trimethylsilyl)ethoxy)methoxy)-8,9-dihydro-3<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6(7<i>H</i>)-one (<b>35b</b>)</h4><div class="NLM_p last">To a solution of 3-(4-fluorobenzyl)-7-((2-(trimethylsilyl)ethoxy)methoxy)-8,9-dihydro-3<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6(7<i>H</i>)-one <b>22</b> (10.00 g, 22.65 mmol) in anhyd DMF (110 mL) was added <i>N</i>-bromosuccinimide (4.43 g, 24.9 mmol), and the reaction was stirred under nitrogen atmosphere at room temperature overnight. The reaction was monitored by LCMS, which indicated starting material consumption and complete conversion of starting material to the desired product. The reaction mixture was concentrated in vacuo to afford a viscous reddish semisolid which was dissolved in dichloromethane (250 mL), washed with 10% sodium carbonate solution (3 Ã 500 mL), brine (1 Ã 500 mL), dried over sodium sulfate, filtered, and concentrated in vacuo to give <b>35b</b> as an off-white solid (11.5 g, 97% yield). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 0.05 (s, 9H), 1.02 (m, 2H), 3.85 (m, 2H), 3.89 (m, 2H), 3.99 (q, <i>J</i> = 6.6 Hz, 2H), 5.15 (s, 2H), 5.37 (s, 2H), 7.04 (m, 2H), 7.15 (m, 2H), 7.30 (s, 1H), 8.79 (s, 1H), LC-MS (APCI) <i>m</i>/<i>z</i> 521.2 (M + H)<sup>+</sup>. HRMS <i>m</i>/<i>z</i> Calcd for C<sub>23</sub>H<sub>27</sub>BrFN<sub>3</sub>O<sub>3</sub>Si: 520.1067 (M + H)<sup>+</sup>. Found: 520.1074.</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 1-[(Dimethylamino)methyl]-3-(4-fluorobenzyl)-7-hydroxy-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>]-1,7-naphthyridin-6-one (<b>38a</b>)</h4><div class="NLM_p last">To a stirring solution of the protected dihydronaphthyridinone <b>34</b> (1.45 g, 2.3 mmol) in methanol (15 mL) was added hydrogen chloride solution (4 M in dioxane, 10 mL, 40 mmol) at room temperature and the mixture was stirred for 5 h, at which time LC-MS confirmed complete conversion to the desired product. The mixture was concentrated, treated with satd aq sodium bicarbonate solution (200 mL), and extracted with dichloromethane (2 Ã 200 mL). The organic layers were combined, dried over sodium sulfate, and concentrated under reduced pressure. The crude product was suspended in diethyl ether:dichloromethane and filtered to provide 1-[(dimethylamino)methyl]-3-(4-fluorobenzyl)-7-hydroxy-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>]-1,7-naphthyridin-6-one <b>38a</b> as a white solid (0.53 g, 48%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 2.16 (s, 6H), 3.47 (brs, 2H), 3.63 (m, 2H), 3.77 (m, 2H), 5.52 (s, 2H), 7.13 (m, 2H), 7.29 (m, 2H), 7.71 (brs, 1H), 8.80 (s, 1H), 9.71 (s, 1H). LC/MS (APCI) <i>m</i>/<i>z</i>: 369.2 (M + H)<sup>+</sup>. HRMS calcd for C<sub>20</sub>H<sub>21</sub>FN<sub>4</sub>O<sub>2</sub> (M + H)<sup>+</sup> 369.1722; found 369.1713. Anal. Calcd for: C<sub>20</sub>H<sub>21</sub>FN<sub>4</sub>O<sub>2</sub>: C, 65.20; H, 5.75; N, 15.21. Found: C, 65.42; H, 5.66; N, 14.81.</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 1-{[(Cyclopropylmethyl)(methyl)amino]methyl}-3-(4-fluorobenzyl)-7-{[2-(trimethylsilyl)ethoxy]methoxy}-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6-one (<b>37e</b>)</h4><div class="NLM_p last">To a stirring solution of the SEM protected 3-dimethylaminomethylpyridone <b>34</b> (2.5 g, 5.0 mmol) in dichloromethane (15 mL) was added phenyl chloroformate (0.77 mL, 5.45 mmol). The mixture was allowed to stir for 0.5 h at room temperature to generate the desired chloride <b>36</b>, then cyclopropylmethyl methyl amine hydrochloride (1.22 g, 10 mmol) and DIEA (10 mL, 57 mmol) were added and the mixture was allowed to stir for 1 h at room temperature, at which time the reaction was judged to be complete. The solution was diluted with DCM (75 mL) and washed with satd aq NaHCO<sub>3</sub> (75 mL). The aq phase was extracted with DCM (75 mL) and the combined organic phases were washed with brine (150 mL), and dried (Na<sub>2</sub>SO<sub>4</sub>). Filtration and concentration in vacuo afforded the crude <b>37e</b> as a viscous oil which was purified by silica gel chromatography with MeOH in DCM (5â10%) as eluent to provide <b>37e</b> as an amorphous white solid (0.99 g, 37%). LC/MS (APCI) <i>m</i>/<i>z</i> 539.4 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 0.03 (s, 9H), 0.46 (m, 2H), 0.48 (m, 2H), 0.92 (m, 2H), 2.14 (s, 3H), 2.25 (d, <i>J</i> = 6.6 Hz, 2H), 3.59 (s, 2H), 3.75 (t, <i>J</i> = 6.0 Hz, 2H), 3.75 (d, <i>J</i> = 6.0 Hz, 2H), 3.79â3.88 (4H), 4.99 (s, 2H), 5.53 (s, 2H), 7.17 (m, 2H), 7.29 (m, 2H), 7.72 (s, 1H), 8.83 (s, 1H). HPLC (254, 224 nm): >95% purity.</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 1-{[(Cyclopropylmethyl)(methyl)amino]methyl}-3-(4-fluorobenzyl)-7-hydroxy-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6-one (<b>38e</b>)</h4><div class="NLM_p last">Prepared from <b>37e</b> (1.29 g, 2.39 mmol) according to the procedure for the preparation of <b>38a</b> to give <b>38e</b> (0.695 g, 71%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ â0.07 (m, 2H), 0.45 (m, 2H), 0.86 (m, 1H), 2.16 (s, 3H), 2.25 (d, <i>J</i> = 6.59 Hz, 2H), 3.59 (s, 2H), 3.66â3.86 (4H), 5.53 (s, 2H), 7.17 (m, 2H), 7.31 (m, 2H), 7.71 (s, 1H), 8.81 (s, 1H), 9.71 (s, 1H). LC/MS (APCI) <i>m</i>/<i>z</i> 409.2 (M + H)<sup>+</sup>. Anal. Calcd for C<sub>23</sub>H<sub>25</sub>FN<sub>4</sub>O<sub>2</sub>: C, 67.63; H, 6.17; N, 13.72. Found: C, 67.49; H, 6.18; N, 13.58.</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 3-(4-Fluorobenzyl)-7-hydroxy-1-{[(2-hydroxyethyl)(methyl)amino]methyl}-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>]-1,7-naphthyridin-6-one (<b>38b</b>)</h4><div class="NLM_p last">Prepared from <b>37b</b> according to general procedure for <b>38a</b> to provide the <i>N</i>-hydroxynaphthyridinone <b>38b</b> in 29% yield. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) Î´ 2.43 (m, 2H), 2.56 (s, 3H), 3.66 (m, 2H), 3.73 (m, 2H), 3.91 (s, 2H), 3.96 (m, 2H), 5.50 (s, 2H), 7.01 (m, 2H), 7.21 (m, 2H), 7.66 (s, 1H), 8.69 (s, 1H). LC/MS (APCI) <i>m</i>/<i>z</i> 399.2 (M + H)<sup>+</sup>. HPLC (254, 222 nm): >95% purity. HRMS Calcd for C<sub>21</sub>H<sub>22</sub>FN<sub>4</sub>O<sub>3</sub> + H<sup>+</sup>: 399.1827. Found: 399.1838.</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 1-{[(2-Methoxy-ethyl)(methyl)amino]methyl}-3-(4-fluorobenzyl)-7-{[2-(trimethylsilyl)ethoxy]methoxy}-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6-one (<b>37d</b>)</h4><div class="NLM_p last">Compound <b>34</b> (2.0 g, 4.01 mmol) was converted to the chloromethyl entity <b>36</b> as described for <b>37e</b> and then reacted with <i>N</i>-methyl-<i>N</i>-2-methoxyethyl amine (1.43 g, 16 mmol) in DIEA (10 mL, 57 mmol) to give <b>37d</b>, which was purified by silica gel chromatography with MeOH in DCM (5â10%) as eluent to provide <b>37d</b> as a sticky pale-yellow solid which was recrystallized (hexanes/ether, 90:10) to give <b>37d</b> (2.01 g, 92%) as a pale-yellow solid. LC/MS (APCI) <i>m</i>/<i>z</i> 543.4 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 0.04 (s, 9H), 0.99 (m, 2H), 2.20 (s, 3H), 2.60 (m, 2H), 3.33 (s, 3H), 3.30â4.00 (12H), 5.35 (s, 2H), 6.98 (m, 2H), 7.05â7.20 (3H), 8.77 (s, 1H). HPLC (254, 224 nm): >95% purity.</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 1-{[(2-Methoxy-ethyl)(methyl)amino]methyl}-3-(4-fluorobenzyl)-7-hydroxy-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6-one (<b>38d</b>)</h4><div class="NLM_p last">Prepared from <b>37d</b> (2.48 g, 4.58 mmol) according to general procedure for <b>38a</b> to provide, after neutralization and trituration with diethyl ether, the <i>N</i>-hydroxynaphthyridinone <b>38d</b> (0.99 g, 53%) as an amorphous, tan solid. LC/MS (APCI) <i>m</i>/<i>z</i> 413.20 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 2.14 (s, 3H), 2.60 (m, 2H), 3.19 (s, 3H), 3.10â3.90 (6H), 5.52 (s, 2H), 7.15 (m, 2H), 7.30 (m, 2H), 7.70 (s, 1H), 8.80 (s, 1H), 9.69 (brs, 1H). HPLC (254, 224 nm): >95% purity.</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 1-[(3,3-Difluoropyrrolidin-1-yl)methyl]-3-(4-fluorobenzyl)-7-{[2-(trimethylsilyl)ethoxy]methoxy}-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6-one (<b>37f</b>)</h4><div class="NLM_p last">As described for the preparation of <b>37e</b>, compound <b>34</b> (0.1 g, 0.2 mmol) was treated with phenyl chloroformate (250 Î¼L, 0.20 mmol) to provide the related chloromethyl compound <b>36</b>. Compound <b>36</b> was reacted with 3,3-difluoropyrrolidine hydrochloride (0.058 g, 0.40 mmol) and diisopropyl ethylamine (0.14 mL, 0.81 mmol) in DMF (5.0 mL) to give <b>37f</b>, which was filtered through a short plug of silica gel and used in the next reaction without further characterization or purification. LC/MS (APCI) <i>m</i>/<i>z</i> 561.4 (M + H)<sup>+</sup>.</div></div><div id="sec5_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 1-[(3,3-Difluoropyrrolidin-1-yl)methyl]-3-(4-fluorobenzyl)-7-hydroxy-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>]-1,7-naphthyridin-6-one (<b>38f</b>)</h4><div class="NLM_p last">Prepared from <b>37f</b> according to general procedure for the preparation of <b>38a</b> to provide the <i>N</i>-hydroxynaphthyridinone <b>38f</b> in 13% yield. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) Î´ 2.28 (m, 2H), 2.76 (m, 2H), 2.91 (m, 2H), 3.86â3.93 (4H), 3.96 (m, 2H), 5.55 (s, 2H), 7.07 (m, 2H), 7.27 (m, 2H), 7.79 (m, 1H), 8.78 (s, 1H). LCMS <i>m</i>/<i>z</i> 431.2 (M + H)<sup>+</sup>. HPLC (254, 450 nm): >98% purity. HRMS calcd for C<sub>22</sub>H<sub>21</sub>F<sub>3</sub>N<sub>4</sub>O<sub>2</sub> + H<sup>+</sup> 431.1689; found, 431.1693.</div></div><div id="sec5_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 3-(4-Fluorobenzyl)-1-(piperidin-1-ylmethyl)-7-{[2-(trimethylsilyl)ethoxy]methoxy}-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6-one (<b>37c</b>)</h4><div class="NLM_p last">Prepared from <b>34</b> (11.2 g, 2.25 mmol) according to general procedure for the preparation of <b>37e</b> to provide the 3-piperidinomethyl substituted <b>37c</b> (4.0 g, 33%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 0.03 (s, 9H), 0.92 (m, 2H), 1.30â1.56 (6H), 2.22â2.43 (4H), 3.52 (s, 2H), 3.69 (t, <i>J</i> = 6.69 Hz, 2H), 3.78â3.92 (4H), 5.00 (s, 2H), 5.52 (s, 2H), 7.16 (m, 2H), 7.32 (m, 2H), 7.69 (s, 1H), 8.83 (s, 1H). LC/MS (APCI) <i>m</i>/<i>z</i> 539.4 (M + H)<sup>+</sup>. HPLC (254, 224 nm): >95% purity.</div></div><div id="sec5_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> 3-(4-Fluorobenzyl)-7-hydroxy-1-(piperidin-1-ylmethyl)-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>]-1,7-naphthyridin-6-one (<b>38c</b>)</h4><div class="NLM_p last">Prepared from <b>37c</b> (3.40 g, 6.35 mmol) according to general procedure for the preparation of <b>38a</b> to provide the <i>N</i>-hydroxynaphthyridinone <b>38c</b> (2.77 g, 91%) as a bis-HCl salt. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) Î´ 1.61 (m, 2H), 1.77â2.13 (4H), 3.04â3.17 (4H), 3.65 (m, 2H), 3.91 (m, 2H), 4.25 (s, 2H), 5.54 (s, 2H), 7.05 (m, 2H), 7.26 (m, 2H), 7.82 (m, 1H), 8.68 (s, 1H). LC/MS (APCI) <i>m</i>/<i>z</i> 409.2 (M + H)<sup>+</sup>. HRMS calcd for C<sub>23</sub>H<sub>25</sub>FN<sub>4</sub>O<sub>2</sub> (M + H)<sup>+</sup> 409.2034; found, 409.2046. Anal. Calcd for C<sub>23</sub>H<sub>25</sub>FN<sub>4</sub>O<sub>2</sub>: C, 67.63; H, 6.17; N, 13.72. Found: C, 67.39; H, 6.12; N, 13.62.</div></div><div id="sec5_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 1-[[2-(2-Pyridinyl)ethoxy]methyl]-3-(4-fluorobenzyl)-7-{[2-(trimethylsilyl)ethoxy] methoxy}-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6-one (<b>39a</b>)</h4><div class="NLM_p last">To a stirring solution of <b>34</b> (0.45 g, 0.902 mmol) in DCM (10 mL) was added phenyl chloroformate (0.143 g, 0.115 mL, 0.902 mmol) in one portion. The mixture was allowed to stir for 1 h at room temperature, at which point clean conversion to <b>36</b> had been realized (LC-MS). To the stirring solution was added DIEA (0.41 g, 0.55 mL, 3.16 mmol) followed by 2-(2-pyridyl)-ethanol (0.278 g, 2.256 mmol) and DMF (10 mL). The reaction mixture was then immersed in a preheated 50 Â°C oil bath and was allowed to stir for 16 h. The mixture was cooled to room temperature, was diluted with DCM (70 mL) and was cast into water (65 mL) and brine (10 mL). The organic phase was separated, the aqueous phase was extracted with DCM (2 Ã 70 mL), and the combined organic layers were washed with satd aq NaHCO<sub>3</sub> (150 mL) and brine (150 mL) and dried (Na<sub>2</sub>SO<sub>4</sub>). Filtration and concentration in vacuo afforded crude <b>39a</b> as a yellow oil, which was purified by chromatography on a Biotage SP1 (0â5% MeOH/DCM) to give <b>39a</b> (0.39 g, 75%) as a clear, colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 0.05 (s, 9H), 1.03 (m, 2H), 3.05 (m, 2H), 3.52 (m, 2H), 3.77 (t, <i>J</i> = 6.03 Hz, 2H), 3.92 (m, 4H), 4.68 (s, 2H), 5.15 (m, 2H), 5.35 (s, 2H), 7.00 (m, 2H), 7.03â7.22 (5H), 7.58 (m, 1H), 8.44 (m, 1H), 8.74 (s, 1H). LC/MS (APCI) <i>m</i>/<i>z</i> 577.8 (M + H)<sup>+</sup>. Anal. Calcd for C<sub>31</sub>H<sub>37</sub>FN<sub>4</sub>O<sub>4</sub>Si: C, 64.56; H, 6.47; N, 9.71. Found. C, 64.73; H, 6.82; N, 9.59.</div></div><div id="sec5_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 1-[[2-(2-Pyridinyl)ethoxy]methyl]-3-(4-fluorobenzyl)-7-hydroxy-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6-one (<b>40a</b>)</h4><div class="NLM_p last">To a stirring solution of <b>39a</b> (0.34 g, 0.589 mmol) in MeOH (30 mL) was added HCl in dioxane (4 M, 2.5 mL, 10 mmol), and the resulting solution was allowed to stir at room temperature for 15 h. The solvent was removed in vacuo, and the crude pale-yellow solid was recrystallized from <i>i</i>-PrOH to provide the bis-HCl salt of <b>40a</b> (0.153 g, 50%) as pale-yellow needles. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 3.17 (m, 2H), 3.30 (m, 2H), 3.81 (m, 2H), 3.90 (m, 2H), 4.80 (s, 2H), 5.79 (s, 2H), 7.21 (m, 2H), 7.43 (m, 2H), 7.60 (m, 1H), 7.65â7.75 (2H), 8.13 (m, 1H), 8.43 (brs, 1H), 8.61 (m, 1H). LC/MS (APCI) <i>m</i>/<i>z</i> 447.2 (M + H)<sup>+</sup>. Anal. Calcd for: C<sub>25</sub>H<sub>23</sub>FN<sub>4</sub>O<sub>3</sub>Â·2HCl: C, 57.81; H, 4.85; N, 10.79. Found: C, 57.81; H, 4.91; N, 10.86.</div></div><div id="sec5_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 1-[(2-Pyridinylmethoxy)methyl]-3-(4-fluorobenzyl)-7-{[2-(trimethylsilyl)ethoxy]methoxy}-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6-one (<b>39b</b>)</h4><div class="NLM_p last">As described for the preparation of <b>39a</b>, dimethylaminomethyl compound <b>34</b> (0.90 g, 1.80 mmol) was converted to chloromethyl compound <b>36</b>, which was reacted with 2-pyridyl-methanol (0.49 g, 4.50 mmol) to provide SEMâether <b>39b</b> (0.82 g, 81%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 0.06 (s, 9H), 0.96 (m, 2H), 3.55 (m, 2H), 3.80â4.00 (4H), 4.68 (s, 2H), 4.80 (s, 2H), 5.15 (s, 2H), 5.30 (s, 2H), 7.00 (m, 2H), 7.04â7.22 (5H), 7.58 (m, 1H), 8.60 (brs, 1H), 8.80 (s, 1H). LC/MS (APCI) <i>m</i>/<i>z</i> 563.2 (M + H)<sup>+</sup>. Anal. Calcd for C<sub>30</sub>H<sub>35</sub>FN<sub>4</sub>O<sub>4</sub>Si: C, 64.03; H, 6.27; N, 9.96. Found: C, 64.14; H, 6.39; N, 9.78.</div></div><div id="sec5_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 1-[(2-Pyridinylmethoxy)methyl]-3-(4-fluorobenzyl)-7-hydroxy-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6-one (<b>40b</b>)</h4><div class="NLM_p last">As described for the preparation of <b>40a</b>, SEMâether <b>39b</b> (0.70 g, 1.24 mmol) was treated with HCl in dioxane to give the bis-HCl salt of <b>40b</b> (0.48 g, 76%) as a pale-yellow solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 3.67 (m, 2H), 3.95 (m, 2H), 4.76 (s, 2H), 4.95 (s, 2H), 5.77 (s, 2H), 7.20 (m, 2H), 7.40 (m, 2H), 7.53 (m, 1H), 7.65 (m, 1H), 8.06 (m, 1H), 8.54 (brs, 1H), 8.65 (m, 1H), 9.36 (s, 1H). LC/MS (APCI) <i>m</i>/<i>z</i> 433.2 (M + H)<sup>+</sup>. Anal. Calcd for C<sub>24</sub>H<sub>21</sub>FN<sub>4</sub>O<sub>3</sub>Â·2HCl: C, 57.04; H, 4.59; N, 11.09. Found: C, 57.01; H, 4.73; N, 10.72.</div></div><div id="sec5_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> 1-(Tetrahydro-2<i>H</i>-pyran-4-yl)methoxy]methyl]-3-(4-fluorobenzyl)-7-{[2-(trimethylsilyl)ethoxy]methoxy}-3,7,8,9-tetrahydro-6<i>H</i>-Pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6-one (<b>39c</b>)</h4><div class="NLM_p last">As described for the preparation of <b>39a</b>, dimethylaminomethyl compound <b>34</b> (1.00 g, 2.00 mmol) was converted to chloromethyl compound <b>36</b>, which was reacted with (tetrahydro-2<i>H</i>-pyran-4-yl)methanol (0.58 g, 5.00 mmol) to provide SEMâether <b>39c</b> (0.97 g, 85%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 0.06 (s, 9H), 0.97 (m, 2H), 1.30 (m, 4H), 1.55â2.00 (6H), 3.20â3.42 (4H), 3.52 (m, 1H), 3.67 (m, 2H), 4.62 (s, 2H), 5.15 (s, 2H), 5.35 (s, 2H), 6.95â7.05 (3H), 7.12 (m, 2H), 8.79 (s, 1H). LC/MS (APCI) <i>m</i>/<i>z</i> 570.3 (M + H)<sup>+</sup>. Anal. Calcd for C<sub>30</sub>H<sub>40</sub>FN<sub>3</sub>O<sub>5</sub>Si: C, 63.24; H, 7.08; N, 7.38. Found: C, 63.19; H, 7.21; N, 7.29.</div></div><div id="sec5_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> 1-(Tetrahydro-2<i>H</i>-pyran-4-yl)methoxy]methyl]-3-(4-fluorobenzyl)-7-hydroxy3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6-one (<b>40c</b>)</h4><div class="NLM_p last">As described for the preparation of <b>40a</b>, SEMâether <b>39c</b> (0.75 g, 1.31 mmol) was treated with HCl in dioxane to give the HCl salt of <b>40c</b> (0.42 g, 61%) as an ivory solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 1.16 (m, 2H), 1.55 (m, 2H), 1.78 (m, 1H), 3.15â3.32 (4H), 3.64 (m, 2H), 3.77 (m, 2H), 3.96 (m, 2H), 4.69 (s, 2H), 5.75 (s, 2H), 7.20 (m, 2H), 7.40 (m, 2H), 8.44 (s, 1H), 9.35 (s, 1H), 10.35 (brs, 1H)). LC/MS (APCI) <i>m</i>/<i>z</i> 440.2 (M + H)<sup>+</sup>. Anal. Calcd for C<sub>24</sub>H<sub>26</sub>FN<sub>3</sub>O<sub>4</sub>Â·HCl: C, 60.57; H, 5.72; N, 8.83. Found: C, 60.62; H, 5.69; N, 8.91.</div></div><div id="sec5_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> 1-[[2-(1-Methylethoxy)ethoxy]methyl]-3-(4-fluorobenzyl)-)-7-{[2-(trimethylsilyl)ethoxy]methoxy}-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6-one (<b>39d</b>)</h4><div class="NLM_p last">As described for the preparation of <b>39a</b>, dimethylaminomethyl compound <b>34</b> (0.40 g, 0.79 mmol) was converted to chloromethyl compound <b>36</b>, which was reacted with 2-isopropoxyethanol (0.21 g, 1.98 mmol) to provide SEMâether <b>39d</b> (0.35 g, 79%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 0.05 (s, 9H), 0.97 (m, 2H), 1.15 (d, <i>J</i> = 7.0 Hz, 6H), 1.30 (m, 4H), 3.50â3.75 (7H), 3.85 (m, 2H), 3.97 (m, 2H), 4.69 (s, 2H), 5.13 (s, 2H), 5.34 (s, 2H), 6.98 (m, 2H), 7.18 (m, 2H), 7.27 (s, 1H), 8.82 (s, 1H). LC/MS (APCI) <i>m</i>/<i>z</i> 558.2 (M + H)<sup>+</sup>. Anal. Calcd for C<sub>29</sub>H<sub>40</sub>FN<sub>3</sub>O<sub>5</sub>Si: C, 62.45; H, 7.23; N, 7.53. Found: C, 62.47; H, 7.29; N, 7.36.</div></div><div id="sec5_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> 1-[[2-(1-Methylethoxy)ethoxy]methyl]-3-(4-fluorobenzyl)-7-hydroxy-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6-one (<b>40d</b>)</h4><div class="NLM_p last">As described for the preparation of <b>40a</b>, SEMâether <b>39d</b> (0.324 g, 0.58 mmol) was treated with HCl in dioxane to give the HCl salt of <b>40d</b> (0.135 g, 50%) as an ivory solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 1.02 (d, <i>J</i> = 7.0 Hz, 6H), 3.40â3.55 (7H), 3.75 (m, 2H), 4.62 (s, 2H), 5.52 (s, 2H), 7.16 (m, 2H), 7.81 (s, 1H), 8.85 (s, 1H), 9.74 (s, 1H). LC/MS (APCI) <i>m</i>/<i>z</i> 428.2 (M + H)<sup>+</sup>. Anal. Calcd for C<sub>23</sub>H<sub>26</sub>FN<sub>3</sub>O<sub>4</sub>Â·HCl: C, 59.54; H, 5.87; N, 9.06. Found: C, 59.38; H, 5.59; N, 8.93.</div></div><div id="sec5_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> 1-[[3-(2-Pyridinyl)propoxy]methyl]-3-(4-fluorobenzyl)-7-{[2-(trimethylsilyl)ethoxy]methoxy}-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6-one (<b>39e</b>)</h4><div class="NLM_p last">As described for the preparation of <b>39a</b>, dimethylaminomethyl compound <b>34</b> (0.80 g, 1.58 mmol) was converted to chloromethyl compound <b>36</b>, which was reacted with 3-(2-pyridyl)-propan-1-ol (0.54 g, 3.95 mmol) to provide SEMâether <b>39e</b> (0.72 g, 77%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 0.05 (s, 9H), 0.97 (m, 2H), 1.85 (m, 2H), 2.87 (m, 2H), 3.50â3.75 (6H), 3.90 (m, 2H), 4.71 (s, 2H), 5.10 (s, 2H), 5.36 (s, 2H), 7.00 (m, 2H), 7.10â7.20 (3H), 7.24â7.32 (2H), 7.60 (m, 1H), 8.39 (m, 1H), 8.79 (s, 1H). LC/MS (APCI) <i>m</i>/<i>z</i> 591.2 (M + H)<sup>+</sup>. Anal. Calcd for C<sub>32</sub>H<sub>39</sub>FN<sub>3</sub>O<sub>4</sub>Si: C, 65.06; H, 6.65; N, 9.48. Found: C, 65.04; H, 6.72; N, 9.36.</div></div><div id="sec5_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> 1-[[3-(2-Pyridinyl)propoxy]methyl]-3-(4-fluorobenzyl)-7-hydroxy-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6-one (<b>40e</b>)</h4><div class="NLM_p last">As described for the preparation of <b>40a</b>, SEMâether <b>39e</b> (0.60 g, 1.01 mmol) was treated with HCl in dioxane to give the bis-HCl salt of <b>40e</b> (0.275 g, 51%) as a pale-yellow solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 1.94 (m, 2H), 2.76 (m, 2H). 3.45â3.62 (4H), 3.81 (m, 2H), 4.62 (s, 2H), 5.54 (s, 2H), 7.10â7.22 (4H), 7.32 (m, 2H), 7.60 (m, 1H), 7.83 (s, 1H), 8.44 (m, 1H), 8.88 (s, 1H), 9.77 (brs, 1H). LC/MS (APCI) <i>m</i>/<i>z</i> 461.2 (M + H)<sup>+</sup>. Anal. Calcd for C<sub>26</sub>H<sub>25</sub>FN<sub>4</sub>O<sub>3</sub>Â·2HCl: C, 58.54; H, 5.10; N, 10.50. Found: C, 58.15; H, 5.14; N, 10.43.</div></div><div id="sec5_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> 1-[[(2-Fluorophenyl)methoxy]methyl]-3-(4-fluorobenzyl)-3,7,8,9-tetrahydro-7-{[2-(trimethylsilyl)ethoxy]methoxy}-6<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6-one (<b>37f</b>)</h4><div class="NLM_p last">As described for the preparation of <b>39a</b>, dimethylaminomethyl compound <b>34</b> (0.45 g, 0.90 mmol) was converted to chloromethyl compound <b>36</b>, which was reacted with 2-fluoro-benzyl alcohol (0.29 g, 2.25 mmol) to provide SEMâether <b>39f</b> (0.41 g, 79%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 0.04 (s, 9H), 1.01 (m, 2H), 3.61 (m, 2H), 3.80â3.92 (4H), 4.60 (s, 2H), 4.70 (s, 2H), 5.14 (s, 2H), 5.34 (s, 2H), 6.95â7.15 (6H), 7.23 (m, 1H), 7.27 (s, 1H), 7.35 (m, 1H), 8.76 (s, 1H). LC/MS (APCI) <i>m</i>/<i>z</i> 580.2 (M + H)<sup>+</sup>. Anal. Calcd for C<sub>31</sub>H<sub>35</sub>F<sub>2</sub>N<sub>3</sub>O<sub>4</sub>Si: C, 64.23; H, 6.09; N, 7.25. Found: C, 64.19; H, 6.18; N, 7.22.</div></div><div id="sec5_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> 1-[[(2-Fluorophenyl)methoxy]methyl]-3-(4-fluorobenzyl)-3,7,8,9-tetrahydro-7-hydroxy-6<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6-one (<b>40f</b>)</h4><div class="NLM_p last">As described for the preparation of <b>40a</b>, SEMâether <b>39f</b> (0.340 g, 0.58 mmol) was treated with HCl in dioxane to give the HCl salt of <b>40f</b> (0.141 g, 50%) as an ivory solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 3.62 (m, 2H), 3.92 (m, 2H), 4.61 (s, 2H), 4.80 (s, 2H), 5.76 (s, 2H), 7.10â7.22 (4H), 7.30â7.46 (4H), 8.49 (s, 1H), 9.35 (s, 1H), 10.56 (brs, 1H). LC/MS (APCI) <i>m</i>/<i>z</i> 450.2 (M + H)<sup>+</sup>. Anal. Calcd for C<sub>25</sub>H<sub>21</sub>F<sub>2</sub>N<sub>3</sub>O<sub>3</sub>Â·HCl: C, 61.79; H, 4.56; N, 8.65. Found: C, 61.84; H, 4.49; N, 8.63.</div></div><div id="sec5_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> 3-(4-Fluorobenzyl)-1-(3-(4-morpholinyl)-prop-1-yn-1-yl)-7-{[2-(trimethylsilyl)ethoxy]methoxy}-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>]-1,7-naphthyridin-6-one (<b>41b</b>)</h4><div class="NLM_p last">To a stirring solution of iodide <b>35a</b> (9.97 g, 17.6 mmol), 4-prop-2-yn-1-ylmorpholine (2.20 g, 17.6 mmol), and TEA (3.56 g, 4.90 mL, 35.2 mmol) in DMF (100 mL) was added Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (0.625 g, 0.88 mmol) and CuI (0.334 g, 1.76 mmol). After the addition was complete, the color of the solution went from pale-yellow, to orange, to black, and after 20 min, the reaction was judged to be complete by HPLC-MS analysis. The reaction was diluted with dichloromethane (1.0 L), washed with a satd aq ammonium chloride (2 Ã 1.0 L), water (1.0 L), and brine (0.75 L), dried over sodium sulfate, and concentrated in vacuo, yielding a brown residue. The crude <b>41b</b> was purified on silica gel using a Biotage SP4 chromatography system (eluent: 0â6% EtOH in DCM over 16CV). The purified fractions were combined and concentrated in vacuo, yielding the desired alkyne <b>41b</b> (7.71 g, 78%) as pale-yellow solid. TLC: (Merck, CH<sub>2</sub>Cl<sub>2</sub>/MeOH 98:2, UV) <i>R</i><sub>f</sub> = 0.30. LC/MS: (Eclipse XDB-C8, 0.8 mL/min, gradient 80:20 to 5:95 H<sub>2</sub>O (+0.1% HOAc):CH<sub>3</sub>CN, 3 min, APCI, + mode), RT 1.608 min, <i>m</i>/<i>e</i> = 565.4 (M + H<sup>+</sup>, base). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 0.05 (s, 9H), 1.02 (m, 2H), 2.64 (m, 4H), 3.54 (m, 2H), 3.60â3.80 (6H), 3.88 (m, 2H), 3.99 (s, 2H), 5.15 (s, 2H), 5.36 (s, 2H), 7.04 (m, 2H), 7.14 (m, 2H), 7.43 (s, 1H), 8.77 (s, 1H). Anal. Calcd for C<sub>30</sub>H<sub>37</sub>FN<sub>4</sub>O<sub>4</sub>Si: C, 63.80; H, 6.60; N 9.92%. Found: C, 64.11; H, 6.89; N, 10.01%.</div></div><div id="sec5_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> 3-(4-Fluorobenzyl)-1-(3-morpholin-4-ylpropyl)-7-{[2-(trimethylsilyl)ethoxy]methoxy}-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>]-1,7-naphthyridin-6-one (<b>43b</b>)</h4><div class="NLM_p last">To a rapidly stirring solution of alkyne <b>41b</b> (7.70 g, 13.65 mmol) in methanol (150 mL) was added palladium hydroxide (1.54 g, 20 wt %), and the mixture was placed under 1 atm of hydrogen. After 2 h, the reduction was determined to be complete by HPLC-MS. The catalyst was removed by filtration through a pad of Celite. The filter cake was rinsed with DCM (0.5 L), and the combined filtrates were concentrated in vacuo to furnish crude <b>43b</b> as a sticky, pale-yellow solid. Crude <b>43b</b> was purified by flash chromatography (eluent: 0â6% EtOH in DCM) to furnish <b>43b</b> (4.68 g, 60%) as an amorphous white solid. TLC: (Merck, CH<sub>2</sub>Cl<sub>2</sub>:MeOH 98:2, UV) <i>R</i><sub>f</sub> = 0.139. LC/MS (Eclipse XDB-C8, 0.8 mL/min, gradient 80:20 to 5:95 H<sub>2</sub>O (+0.1% HOAc):CH<sub>3</sub>CN, 3 min, APCI, + mode): RT 1.247 min, <i>m</i>/<i>e</i> = 569.0 (M + H<sup>+</sup>, base). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 0.05 (s, 9H), 1.02 (m, 2H), 1.87 (m, 2H), 2.37â2.47 (6H), 2.89 (m, 2H), 3.60 (t, <i>J</i> = 6.69 Hz, 2H), 3.72 (m, 4H), 3.89 (m, 2H), 3.98 (t, <i>J</i> = 6.69 Hz, 2H), 5.16 (s, 2H), 5.33 (s, 2H), 6.97â7.13 (5H), 8.75 (s,1H). Anal. Calcd for C<sub>30</sub>H<sub>41</sub>FN<sub>4</sub>O<sub>4</sub>Si: C, 63.35; H, 7.27; N 9.85%. Found: C, 63.27; H, 7.33; N, 9.77.</div></div><div id="sec5_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> 3-(4-Fluorobenzyl)-7-hydroxy-1-(3-morpholin-4-ylpropyl)-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>]-1,7-naphthyridin-6-one (<b>44b</b>)</h4><div class="NLM_p last">As described for the hydrolysis of <b>38a</b>, SEMâether <b>43b</b> (4.68 g 8.23 mmol) was treated with HCl in methanol to provide <b>44b</b> (2.66 g, 72%) as an ivory powder after neutralization of the bis-HCl salt and trituration with diethyl ether. LC/MS (Eclipse XDB-C8, 0.8 mL/min, gradient 80:20 to 5:95 H<sub>2</sub>O (+0.1% HOAc) CH<sub>3</sub>CN 3 min, APCI, + mode): RT0.549 min, <i>m</i>/<i>e</i> = 439.0 (M + H<sup>+</sup>, base). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 1.86 (m, 2H), 2.38â2.52 (6H), 2.88 (t, <i>J</i> = 7.63 Hz, 2H), 3.60 (t, <i>J</i> = 6 0.97 Hz, 2H), 3.72 (m, 4H), 3.99 (t, <i>J</i> = 6.97 Hz, 2H), 5.34 (s, 2H), 6.97â7.13 (5H), 8.72 (s, 1H). Anal. Calcd for C<sub>24</sub>H<sub>27</sub>FN<sub>4</sub>O<sub>3</sub>Â·0.50H<sub>2</sub>O: C, 64.41; H, 6.31; N 12.52%. Found: C, 64.24; H, 6.25; N, 12.15.</div></div><div id="sec5_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> (<i>E</i>)-<i>tert</i>-Butyl 3-(3-(4-Fluorobenzyl)-6-oxo-7-((2-(trimethylsilyl)ethoxy)methoxy)-6,7,8,9-tetrahydro-3<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-1-yl)acrylate (<b>42a</b>)</h4><div class="NLM_p last">Compound <b>35a</b> (2.0 g, 3.524 mmol) was stirred with <i>tert</i>-butylacrylate (0.516 mL, 3.52 mmol), tri-<i>o</i>-tolylphosphine (0.043 g, 0.141 mmol), Pd(OAc)<sub>2</sub> (0.016 g, 0.0705 mmol) in triethylamine (10 mL), and DMF (50 mL) at 80 Â°C under nitrogen for 3 h. The dark-red solution was concentrated and the residue diluted with ethyl acetate (100 mL). The organic solution was washed with water (2 Ã 100 mL) and brine (75 mL). The organic solution was dried over sodium sulfate and concentrated in vacuo, yielding a red residue. The red residue was purified on silica gel using a Biotage SP4 chromatography system. The purified fractions were combined and concentrated in vacuo, yielding the desired alkene <b>42a</b> (1.528 g, 76%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 0.06 (s, 9H), 1.03 (m, 2H), 1.53 (s, 9H), 3.66 (t, <i>J</i> = 6.78 Hz, 2H), 3.89 (m, 2H), 4.00 (t, <i>J</i> = 6.78 Hz, 2H), 5.15 (s, 2H), 5.40 (s, 2H), 6.18 (d, <i>J</i> = 15.64 Hz, 1H), 7.05 (m, 2H), 7.16 (m, 2H), 7.59 (s, 1H), 7.95 (d, <i>J</i> = 15.64 Hz, 1H), 8.80 (s, 1H). LC/MS (APCI) <i>m</i>/<i>z</i> 568.4 (M + H)<sup>+</sup>. Anal. Calcd for C<sub>30</sub>H<sub>38</sub>FN<sub>3</sub>O<sub>5</sub>Si: C, 63.47; H, 6.75; N, 7.40. Found: C, 63.72; H, 6.89; N, 7.22.</div></div><div id="sec5_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> <i>tert-</i>Butyl 3-(3-(4-Fluorobenzyl)-6-oxo-7-((2-(trimethylsilyl)ethoxy)methoxy)-6,7,8,9-tetrahydro-3<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-1-yl)propanoate (<b>43a</b>)</h4><div class="NLM_p last">Compound <b>42a</b> (1.528 g, 2.691 mmol) was reduced as described for the preparation of <b>43b</b>, yielding <b>43a</b> as an ivory foam (1.327 g, 87%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 0.05 (s, 9H), 1.01 (m, 2H), 1.40 (s, 9H), 2.59 (t, <i>J</i> = 7.54 Hz, 2H), 3.16 (t, <i>J</i> = 7.44 Hz, 2H), 3.62 (t, <i>J</i> = 6.78 Hz, 2H), 3.89 (m, 2H), 3.99 (t, <i>J</i> = 6.78 Hz, 2H), 5.15 (s, 2H), 5.32 (s, 2H), 6.99 (t, <i>J</i> = 8.67 Hz, 2H), 7.09 (m, 3H), 8.75 (s, 1 H). LC/MS (APCI) <i>m</i>/<i>z</i> 570.4 (M + H)<sup>+</sup>. Anal. Calcd for C<sub>30</sub>H<sub>40</sub>FN<sub>3</sub>O<sub>5</sub>Si: C, 63.24; H, 7.08; N, 7.38. Found: C, 63.59; H, 7.23; N, 7.03.</div></div><div id="sec5_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> 3-(3-(4-Fluorobenzyl)-7-hydroxy-6-oxo-6,7,8,9-tetrahydro-3<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-1-yl)propanoic acid (<b>44a</b>)</h4><div class="NLM_p last">Compound <b>43a</b> (1.322 g, 2.32 mmol) was stirred in isopropyl alcohol (20 mL) with sulfuric acid (0.6 mL) at 40 Â°C for 24 h and then heated to reflux for a further 3 h. The solution was concentrated to give a green oil which was diluted with water (10 mL), and the pH was adjusted to ca. pH 10 with sodium carbonate. The aqueous phase was extracted with DCM:MeOH (95:5 4 Ã 50 mL). The organic phase was dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated in vacuo to afford a brown foam. The foam was dissolved in methanol (40 mL) and water (10 mL) added. After the addition of 3 M aq LiOH solution (1.0 mL, 2.95 mmol), the solution was stirred at room temperature for 24 h and then warmed to 45 Â°C overnight. The reaction mixture was filtered through Celite to remove particulates and then was concentrated to remove methanol. The aqueous solution was treated with 1 M HCl (4.5 mL, 4.5 mmol) to ca. pH 4. An off-white solid precipitated which was isolated by filtration, washed with water and isopropyl alcohol, then dried under vacuum at 75 Â°C overnight to give <b>44a</b> as an off-white powder (0.765 g, 86%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 2.62 (s, 2H), 3.12 (s, 2H), 3.52 (s, 2H), 3.81 (s, 2H), 5.54 (s, 2H), 7.16 (s, 2H), 7.32 (s, 2H, 7.63 (s, 1H), 8.83 (s, 1H), 9.75 (s, 1H), 12.20 (s, 1H). LC/MS (APCI) <i>m</i>/<i>z</i> 384.0 (M + H)<sup>+</sup>. HPLC (254, 222 nm): >95% purity. Anal. Calcd for C<sub>20</sub>H<sub>18</sub>FN<sub>3</sub>O<sub>4</sub>Â·1.54H<sub>2</sub>O: C, 58.44; H, 5.17; N 10.22%. Found: C, 58.43; H, 5.02; N, 10.01%.</div></div><div id="sec5_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> 3-(4-Fluorobenzyl)-1-(3-(<i>N</i>-methyl-acetamido)-prop-1-yn-1-yl)-7-{[2-(trimethylsilyl)ethoxy]methoxy}-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>]-1,7-naphthyridin-6-one (<b>41c</b>)</h4><div class="NLM_p last">Iodide <b>35a</b> (1.00 g, 1.77 mmol) was coupled with <i>N</i>-methyl-<i>N</i>-2-propyn-1-yl-acetamide (0.20 g, 1.77 mmol) according to the procedure for the preparation of <b>41b</b> to provide <b>41c</b> (0.94 g, 96%) as an ivory solid after chromatography on a Biotage SP-4, exhibiting <sup>1</sup>H NMR signals of amide rotamers. LC/MS (Eclipse XDB-C8, 0.8 mL/min, gradient 80:20 to 5:95 H<sub>2</sub>O (+0.1% HOAc):CH<sub>3</sub>CN, 3 min, APCI, + mode): RT 1.818 min, <i>m</i>/<i>e</i> = 551.40 (M + H<sup>+</sup>, base). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 0.04 (s, 9H), 1.01 (m, 2H), 2.08â2.22 (3H), 2.87â3.14 (5H), 3.60â4.45 (6H), 5.15 (s, 2H), 5.35 (s, 2H), 7.02 (m, 2H), 7.14 (m, 2H), 7.67 (s, 1H), 8.77 (s, 1H).). Anal. Calcd for C<sub>29</sub>H<sub>35</sub>FN<sub>4</sub>O<sub>4</sub>Si: C, 63.25; H, 6.41; N 10.17%. Found: C, 63.37; H, 6.44; N, 9.94.</div></div><div id="sec5_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> 3-(4-Fluorobenzyl)-1-(3-(<i>N</i>-methyl-acetamido)-propyl)-7-{[2-(trimethylsilyl)ethoxy]methoxy}-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>]-1,7-naphthyridin-6-one (<b>43c</b>)</h4><div class="NLM_p last">As described for the preparation of <b>43b</b>, alkyne <b>41c</b> (1.06 g, 1.92 mmol) was hydrogenated to provide <b>43c</b> (0.92 g, 86%) as an amorphous white solid after flash chromatography. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 0.03 (s, 9H), 1.00 (m, 2H), 1.85 (m, 2H), 2.05 (m, 2H), 2.08 (s, 3H), 2.77â3.10 (4H), 2.99 (s, 3H), 3.48 (m, 2H), 3.97 (m, 2H), 5.13 (s, 2H), 5.33 (s, 2H), 6.95 (m, 2H), 7.08 (m, 2H), 7.21 (s, 1H), 8.72 (s, 1H). LC/MS (Eclipse XDB-C8, 0.8 mL/min, gradient 80:20 to 5:95 H<sub>2</sub>O (+0.1% HOAc):CH<sub>3</sub>CN, 3 min, APCI, + mode): RT 1.726 min, <i>m</i>/<i>e</i> = 555.4 (M + H<sup>+</sup>, base). Anal. Calcd for C<sub>29</sub>H<sub>39</sub>FN<sub>4</sub>O<sub>4</sub>Si: C, 62.79; H, 7.09; N 10.10%. Found: C, 63.04; H, 7.19; N, 9.87.</div></div><div id="sec5_69" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> 3-(4-Fluorobenzyl)-1-(3-(<i>N</i>-methyl-acetamido)-propyl)-7-hydroxy-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>]-1,7-naphthyridin-6-one (<b>44c</b>)</h4><div class="NLM_p last">As described for the hydrolysis of <b>43a</b>, SEMâether <b>43c</b> (1.36 g 2.45 mmol) was treated with sulfuric acid in <i>i</i>-PrOH to provide the hydrogen sulfate salt of <b>44c</b> (1.00 g, 96%) as an ivory powder after trituration with diethyl ether. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 1.94 (brs, 1H), 1.91 (m, 2H), 1.96 (s, 3H), 2.89 (m, 2H), 2.96 (s, 3H), 3.35 (m, 2H), 3.65 (m, 2H), 3.96 (m, 2H), 5.73 (s, 2H), 7.18 (m, 2H), 7.35 (m, 2H), 8.35 (s, 1H), 9.28 (s, 1H). LC/MS (Eclipse XDB-C8, 0.8 mL/min, gradient 80:20 to 5:95 H<sub>2</sub>O (+0.1% HOAc):CH<sub>3</sub>CN, 3 min, APCI, + mode): RT 1.246 min, <i>m</i>/<i>e</i> = 425.2 (M + H<sup>+</sup>, base). Anal. Calcd for C<sub>23</sub>H<sub>25</sub>FN<sub>4</sub>O<sub>4</sub>Â·H<sub>2</sub>SO<sub>4</sub>: C, 52.87; H, 5.21; N 10.72%. Found: C, 52.92; H, 5.04; N, 10.45.</div></div><div id="sec5_70" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> 3-(4-Fluorobenzyl)-1-(3-hydroxy-3-methylbut-1-ynyl)-7-((2-(trimethylsilyl)ethoxy)methoxy)-8,9-dihydro-3<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6(7<i>H</i>)-one (<b>41d</b>)</h4><div class="NLM_p last">Iodide <b>35a</b> (1.51 g, 2.66 mmol) was coupled to 2-methyl-3-butyn-2-ol (0.650 mL, 6.65 mmol) under the standard conditions as described for the preparation of <b>41b</b>, yielding the desired alkyne <b>41d</b> (0.907 g, 70%) as a pale-yellow oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 0.04 (s, 9H), 1.01 (m, 2H), 1.52 (s, 3H), 1.64 (s, 3H), 3.80 (m, 2H), 3.90 (m, 2H), 4.00 (m, 2H), 5.15 (s, 2H), 5.34 (s, 2H), 7.02 (m, 2H), 7.13 (m, 2H), 7.42 (bs, 1H), 8.76 (bs, 1H). LC/MS (APCI) <i>m</i>/<i>z</i> 524.3 (M + H)<sup>+</sup>. HPLC (254, 222 nm): >95% purity. Anal. Calcd for C<sub>28</sub>H<sub>34</sub>FN<sub>3</sub>O<sub>4</sub>Si: C, 64.22; H, 6.54; N, 8.02. Found: C, 64.49; H, 6.72; N, 7.84.</div></div><div id="sec5_71" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> 3-(4-Fluorobenzyl)-1-(3-hydroxy-3-methylbutyl)-7-((2-(trimethylsilyl)ethoxy)methoxy)-8,9-dihydro-3<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6(7<i>H</i>)-one (<b>43d</b>)</h4><div class="NLM_p last">Compound <b>41d</b> (0.907 g, 1.85 mmol) was reduced as described for the preparation of <b>43b</b>, yielding a yellow oil which crystallized upon cooling. The crude crystals were recrystallized from hot ethyl acetate, giving <b>43d</b> (0.965 g, 99%) as white needles. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 0.06 (s, 9H), 1.03 (m, 2H), 1.34 (s, 6H), 1.85 (m, 2H), 2.98 (m, 2H), 3.64 (m, 2H), 3.89 (m, 2H), 3.99 (m, 2H), 5.16 (s, 2H), 5.34 (s, 2H), 6.98â7.13 (5H), 7.42 (bs, 1H), 8.76 (bs, 1H), LC/MS (APCI) <i>m</i>/<i>z</i> 528.4 (M + H)<sup>+</sup>. HPLC (254, 222 nm): >95% purity. Anal. Calcd for C<sub>28</sub>H<sub>38</sub>FN<sub>3</sub>O<sub>4</sub>Si: C, 63.73; H, 7.26; N, 7.96. Found: C, 63.98; H, 7.49; N, 7.73.</div></div><div id="sec5_72" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> 3-(4-Fluorobenzyl)-7-hydroxy-1-(3-hydroxy-3-methylbutyl)-8,9-dihydro-3<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6(7<i>H</i>)-one (<b>44d</b>)</h4><div class="NLM_p last">To a stirring solution of <b>43d</b> (0.907 mg, 1.72 mmol) in THF (50 mL) was added HFâpyridine (3.0 mL, 35 mmol). The solution was stirred at room temperature for 2 h at 40 Â°C for an additional 2 h. The reaction was diluted in 7:2:1 EtOAc/DCM/MeOH (100 mL) and the organic solution washed with satd aq sodium bicarbonate (100 mL). The organic solution was separated and dried over Na<sub>2</sub>SO<sub>4</sub>. The solution was filtered and concentrated in vacuo and purified by prep HPLC, yielding the desired product <b>44d</b> as an ivory powder (0.284 g, 39%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 1.18 (s, 6H), 2.87 (m, 2H), 3.52 (m, 2H), 3.76 (m, 2H), 5.49 (s, 2H), 7.15 (m, 2H), 7.31 (m, 2H), 7.57 (s, 1H), 8.79 (s, 1H), 9.74 (bs, 1H). LC/MS (APCI) <i>m</i>/<i>z</i> 398.2 (M + H)<sup>+</sup>. HPLC (254, 222 nm): >95% purity. Anal. Calcd for C<sub>20</sub>H<sub>17</sub>F4N<sub>3</sub>O<sub>2</sub>Â·0.8H<sub>2</sub>O: C, 64.16; H, 6.27; N 10.20%. Found: C, 63.89; H, 6.08; N, 9.94.</div></div><div id="sec5_73" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> 3-(4-Fluorobenzyl)-1-(3-(tetrahydro-2<i>H</i>-pyran-4-yl)oxy]-1-propyn-1-yl)-7-{[2-(trimethylsilyl)ethoxy]methoxy}-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>]-1,7-naphthyridin-6-one (<b>41e</b>)</h4><div class="NLM_p last">Iodide <b>35a</b> (1.32 g, 1.77 mmol) was coupled with propyn-3-ol (0.15 g, 2.71 mmol) according to the procedure for the preparation of <b>41b</b> to provide <b>41e</b> (1.03 g, 95%) as a pale-yellow solid after chromatography on a Biotage SP-4. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 0.03 (s, 9H), 1.00 (m, 2H), 1.64 (m, 2H), 1.92 (m, 2H), 3.45 (m, 2H), 3.72â3.80 (3H), 3.82â4.00 (6H), 4.44 (s, 2H), 5.14 (s, 2H), 5.35 (s, 2H), 7.01 (m, 2H), 7.12 (m, 2H), 7.45 (s, 1H), 8.75 (s, 1H). LC/MS (Eclipse XDB-C8, 0.8 mL/min, gradient 80:20 to 5:95 H<sub>2</sub>O (+0.1% HOAc):CH<sub>3</sub>CN, 3 min, APCI, + mode): RT 1.945 min, <i>m</i>/<i>e</i> = 580.4 (M + H<sup>+</sup>, base). Anal. Calcd for C<sub>31</sub>H<sub>38</sub>FN<sub>3</sub>O<sub>5</sub>Si: C, 64.22; H, 6.61; N 7.25%. Found: C, 64.29; H, 6.43; N, 7.18.</div></div><div id="sec5_74" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> 3-(4-Fluorobenzyl)-1-(3-(tetrahydro-2<i>H</i>-pyran-4-yl)oxy-propyl)-7-{[2-(trimethylsilyl)ethoxy]methoxy}-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>]-1,7-naphthyridin-6-one (<b>43e</b>)</h4><div class="NLM_p last">As described for the preparation of <b>43b</b>, alkyne <b>41e</b> (1.37 g, 2.76 mmol) was hydrogenated to provide <b>43e</b> (0.83 g, 60%) as an ivory solid after flash chromatography. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 0.05 (s, 9H), 0.99 (m, 2H), 1.47â1.72 (4H), 1.81â1.99 (4H), 2.92 (m, 2H), 3.37â3.52 (6H), 3.62 (t, J = 6.69 Hz, 2H), 3.81â4.01 (6H), 5.16 (s, 2H), 5.34 (s, 2H), 6.95â7.26 (5H), 8.76 (s, 1H). LC/MS (Eclipse XDB-C8, 0.8 mL/min, gradient 80:20 to 5:95 H<sub>2</sub>O (+0.1% HOAc):CH<sub>3</sub>CN 3 min, APCI, + mode): RT 1.892 min, <i>m</i>/<i>e</i> = 584.4 (M + H<sup>+</sup>, base). Anal. Calcd for C<sub>31</sub>H<sub>42</sub>FN<sub>3</sub>O<sub>5</sub>Si: C, 63.78; H, 7.25; N 7.20%. Found: C, 63.94; H, 7.43; N, 6.98.</div></div><div id="sec5_75" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105"> 3-(4-Fluorobenzyl)-1-(3-(tetrahydro-2<i>H</i>-pyran-4-yl)oxy-propyl)-7-hydroxy-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>]-1,7-naphthyridin-6-one (<b>44e</b>)</h4><div class="NLM_p last">As described for the hydrolysis of <b>43a</b>, SEMâether <b>43e</b> (0.838 g 1.43 mmol) was treated with sulfuric acid in <i>i</i>-PrOH to provide the hydrogensulfate salt of <b>44e</b> (0.579 g, 89%) as a white powder after trituration with diethyl ether. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 1.38 (m, 2H), 1.70â1.95 (4H), 2.96 (t, <i>J</i> = 7.63 Hz, 2H), 3.20â3.50 (6H), 3.68 (m, 2H), 3.78 (m, 2H), 3.95 (t, <i>J</i> = 6.95 Hz, 2H), 5.72 (s, 2H), 7.18 (m, 2H), 7.36 (m, 2H), 8.28 (s, 1H), 9.28 (s, 1H), 10.51 (brs, 1H). LC/MS (Eclipse XDB-C8, 0.8 mL/min, gradient 80:20 to 5:95 H<sub>2</sub>O (+0.1% HOAc):CH<sub>3</sub>CN 3 min, APCI, + mode): RT 1.383 min, <i>m</i>/<i>e</i> = 454.2 (M + H<sup>+</sup>, base). Anal. Calcd for C<sub>25</sub>H<sub>28</sub>FN<sub>3</sub>O<sub>4</sub>Â·H<sub>2</sub>SO<sub>4</sub>: C, 54.44; H, 5.48; N 7.62%. Found: C, 54.19; H, 5.27; N, 7.39.</div></div><div id="sec5_76" class="NLM_sec NLM_sec_level_3"><div id="ac_i106" class="anchor-spacer"></div><h4 class="article-section__title" id="_i106"> 3-(4-Fluorobenzyl)-1-(3,3,3-trifluoroprop-1-ynyl)-7-((2-(trimethylsilyl)ethoxy)methoxy)-8,9-dihydro-3<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6(7<i>H</i>)-one (<b>41f</b>)</h4><div class="NLM_p last">Diisopropylamine (0.89 mL, 5.98 mmol) was stirred in tetrahydrofuran (10 mL) under nitrogen at â78 Â°C, and 1.6 M <i>n</i>-butyl lithium (2.39 mL, 5.98 mmol) was added, keeping temperature below â55 Â°C. After 15 min, 2-bromo-3,3,3-trifluoro-1-propene (0.28 mL, 2.72 mmol) was added in tetrahydrofuran (2 mL), keeping the temperature below â60 Â°C, giving a dark-red suspension. After 10 min, a 0.5 M solution of zinc chloride (5.98 mL, 2.99 mmol) was added, keeping the temperature below â65 Â°C. The reaction was stirred at â78 Â°C for 30 min and then allowed to warm to room temperature. After a further 30 min, <b>35a</b> (1.029 g, 1.813 mmol) and Pd(PPh<sub>3</sub>)<sub>4</sub> (0.0105 g, 0.0907 mmol) was added and the brown solution heated to 50 Â°C for 7 h. The reaction was diluted to 80 mL with the addition of ethyl acetate. The organic solution was washed with a saturated solution of ammonium chloride (2 Ã 100 mL), water (100 mL), and brine (75 mL). The organic solution was dried over sodium sulfate and concentrated in vacuo, yielding a brown residue. The brown residue was purified on silica gel using a Biotage SP4 chromatography system. The purified fractions were combined and concentrated in vacuo, yielding the desired alkyne <b>41f</b> (0.205 g, 21%) 60% purity contaminated with residual <b>35a</b>. LC/MS (APCI) <i>m</i>/<i>z</i> 534.2 (M + H)<sup>+</sup>.</div></div><div id="sec5_77" class="NLM_sec NLM_sec_level_3"><div id="ac_i107" class="anchor-spacer"></div><h4 class="article-section__title" id="_i107"> 3-(4-Fluorobenzyl)-1-(3,3,3-trifluoropropyl)-7-((2-(trimethylsilyl)ethoxy)methoxy)-8,9-dihydro-3<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6(7<i>H</i>)-one (<b>43f</b>)</h4><div class="NLM_p last">Compound <b>41f</b> (0.205 g, 0.25 mmol) was hydrogenated as described for the preparation of <b>43b</b> to give a orange oil which was purified on silica gel using a Biotage SP4 chromatography system. The purified fractions were combined and concentrated in vacuo, yielding the desired product <b>43f</b> (0.130 g, 100%) 60% purity contaminated with residual des-iodo <b>22</b>. LC/MS (APCI) <i>m</i>/<i>z</i> 538.2 (M + H)<sup>+</sup>.</div></div><div id="sec5_78" class="NLM_sec NLM_sec_level_3"><div id="ac_i108" class="anchor-spacer"></div><h4 class="article-section__title" id="_i108"> 3-(4-Fluorobenzyl)-7-hydroxy-1-(3,3,3-trifluoropropyl)-8,9-dihydro-3<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6(7<i>H</i>)-one (<b>44f</b>)</h4><div class="NLM_p last">Compound <b>43f</b> (0.130 g, 0.145 mmol) was stirred for 24 h at room temperature in methanol (10 mL) with 4 M HCl in dioxane (0.39 mL, 1.54 mmol). The solution was concentrated in vacuo, yielding a yellow solid. The yellow residue was purified by prep HPLC yielding the TFA salt of <b>44f</b> as an ivory powder (0.055 g, 93%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 2.68 (m, 2H), 3.13 (m, 2H), 3.53 (t, <i>J</i> = 6.78 Hz, 2H), 3.80 (t, <i>J</i> = 6.78 Hz, 2H), 5.53 (s, 2 H), 7.16 (t, <i>J</i> = 8.76 Hz, 2H), 7.32 (dd, <i>J</i> = 8.48, 5.46 Hz, 2H), 7.78 (s, 1 H), 8.88 (s, 1H), 9.83 (s, 1H). LC/MS (APCI) <i>m</i>/<i>z</i> 408.4 (M + H)<sup>+</sup>. HPLC (254, 222 nm): >95% purity. Anal. Calcd For C<sub>20</sub>H<sub>17</sub>F<sub>4</sub>N<sub>3</sub>O<sub>2</sub>âCF<sub>3</sub>CO<sub>2</sub>H: C, 50.68; H, 3.48; N 8.06%. Found: C, 50.37; H, 3.23; N, 7.86%.</div></div><div id="sec5_79" class="NLM_sec NLM_sec_level_3"><div id="ac_i109" class="anchor-spacer"></div><h4 class="article-section__title" id="_i109"> 7-(4-Fluorobenzyl)-4-oxo-1,2,4,7-tetrahydropyrano[3,4-<i>b</i>]pyrrolo[3,2-<i>d</i>]pyridine-9-sulfonyl Chloride (<b>45</b>)</h4><div class="NLM_p last">To a stirring solution of azaindole lactone <b>17</b> (1.00 g, 3.39 mmol) in chlorosulfonic acid (3 mL) was slowly added thionyl chloride (1.50 mL) and the reaction mixture stirred overnight at room temperature. The reaction was quenched by dropwise addition of the reaction mixture onto ice. A precipitate formed, which was filtered and dried under vacuum to provide the product <b>45</b> as an off-white solid (1.33 g, 100%). The material was carried to the next reaction without further purification. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 4.00 (m, 2H), 4.78 (m, 2H), 5.80 (s, 2H), 7.22 (m, 2H), 7.50 (m, 2H), 8.51 (s, 1H), 9.55 (s, 1H). LC/MS (APCI) <i>m</i>/<i>z</i> 395.0 (M + H)<sup>+</sup>. HPLC (254, 224 nm): >95% purity.</div></div><div id="sec5_80" class="NLM_sec NLM_sec_level_3"><div id="ac_i110" class="anchor-spacer"></div><h4 class="article-section__title" id="_i110"> 7-(4-Fluorobenzyl)-<i>N</i>,<i>N</i>-dimethyl-4-oxo-1,2,4,7-tetrahydropyrano[3,4-<i>b</i>]pyrrolo[3,2-<i>d</i>]pyridine-9-sulfonamide (<b>46c</b>)</h4><div class="NLM_p last">To a stirring solution of the sulfonyl chloride <b>45</b> (0.137 g, 0.35 mmol) and dimethylamine hydrochloride (0.031 g, 0.38 mmol) in DMF (mL) at room temperature was added triethylamine (0.146 mL, 1.05 mmol) dropwise. The reaction was stirred overnight and judge to be complete by LCMS. The mixture was concentrated under reduced pressure. The crude material was dissolved in dichloromethane and washed with water and then brine. The organic layer was dried over magnesium sulfate, filtered, and concentrated under reduced pressure to provide the product <b>46c</b> as a colorless semisolid (0.107 g, 75%). LC/MS (APCI) <i>m</i>/<i>z</i> 404.0 (M + H)<sup>+</sup>. HPLC >95% purity. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 2.71 (s, 6H), 3.21 (m, 2H), 4.60 (m, 2H), 5.45 (s, 2H), 7.35 (m, 2H), 7.45 (m, 2H), 8.30 (s, 1H), 9.20 (s, 1H). HPLC (254, 224 nm): >95% purity.</div></div><div id="sec5_81" class="NLM_sec NLM_sec_level_3"><div id="ac_i111" class="anchor-spacer"></div><h4 class="article-section__title" id="_i111"> 3-(Dimethylsulfamoyl)-1-(4-fluorobenzyl)-4-(2-hydroxyethyl)-<i>N</i>-(tetrahydro-2<i>H</i>-pyran-2-yloxy)-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine-5-carboxamide (<b>47c</b>)</h4><div class="NLM_p last">To a stirring suspension of dimethylsulfamide <b>46c</b> (0.100 g, 0.25 mmol) in THF (2 mL) was added <i>O</i>-(tetrahydro-2<i>H</i>-pyran-2-yl)hydroxylamine (NH<sub>2</sub>OTHP, 0.059 g, 0.50 mmol), followed by lithium hexamethyl disilazide (LiHMDS, 0.084 g, 0.50 mmol), and the mixture was stirred until LCMS showed complete disappearance of starting material and formation of the desired product. The reaction was quenched with water, and dichloromethane was added. The dichloromethane was washed with saturated ammonium chloride solution and then dried over sodium sulfate, filtered, and concentrated under reduced pressure. The crude solid was purified by flash chromatography (silica gel, 1â5% methanol:chloroform) to provide the product <b>47c</b> as a white solid (0.070 g, 54%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 1.60 (m, 2H), 1.75 (m, 4H), 2.60 (s, 6H), 3.65 (m, 2H), 3.82 (s, 1H), 3.90 (m, 2H), 4.00 (m, 2H), 5.15 (s, 1H), 5.80 (s, 2H), 7.15 (m, 2H), 7.30 (m, 2H), 8.05 (s, 1H), 10.55 (brs, 1H). LC-MS <i>m</i>/<i>z</i> 521.1 (M + H)<sup>+</sup>. HPLC >95% purity. HPLC (254, 224 nm): >95% purity.</div></div><div id="sec5_82" class="NLM_sec NLM_sec_level_3"><div id="ac_i112" class="anchor-spacer"></div><h4 class="article-section__title" id="_i112"> 3-(4-Fluorobenzyl)-<i>N</i>,<i>N</i>-dimethyl-6-oxo-7-(tetrahydro-2<i>H</i>-pyran-2-yloxy)-6,7,8,9-tetrahydro-3<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridine-1-sulfonamide (<b>48c</b>)</h4><div class="NLM_p last">To a stirring solution of the alcohol <b>47c</b> (0.88 g, 1.69 mmol) and di-isopropyl ethylamine (0.88 mL, 5.07 mmol) in dichloromethane (16 mL) at room temperature was added toluenesulfonyl chloride (0.35 g, 1.86 mmol) and the reaction stirred overnight. The reaction mixture was diluted with dichloromethane, washed with water, and dried over sodium sulfate. The dichloromethane was filtered and concentrated under reduced pressure to give the crude product, which was purified by flash column chromatography (silica gel, 5% methanol:chloroform) to provide pure cyclized product <b>48c</b> (0.276 g, 33%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 1.60 (3H, m), 1.95 (3H, m), 2.80 (s, 6H), 3.70 (m, 1H), 3.80 (m, 2H), 3.95 (m, 2H), 4.15 (m, 1H), 5.25 (s, 1H), 5.45 (s, 2H), 7.05 (m, 2H), 7.20 (m, 2H), 7.95 (s, 1H), 8.80 (s, 1H). LC-MS <i>m</i>/<i>z</i> 503.10 (M + H)<sup>+</sup>. HPLC (254, 224 nm): >95% purity.</div></div><div id="sec5_83" class="NLM_sec NLM_sec_level_3"><div id="ac_i113" class="anchor-spacer"></div><h4 class="article-section__title" id="_i113"> 3-(4-Fluorobenzyl)-7-hydroxy-<i>N</i>,<i>N</i>-dimethyl-6-oxo-6,7,8,9-tetrahydro-3<i>H</i>-pyrrolo[2,3-<i>c</i>]-1,7-naphthyridine-1-sulfonamide (<b>49c</b>)</h4><div class="NLM_p last">To a stirring solution of the THP protected <i>N</i>-hydroxydihydropyridone <b>48c</b> (0.276 g, 0.55 mmol) in methanol/water (1:1, 1 mL) was added <i>p</i>-toluenesulfonic acid monohydrate (0.209 g, 1.10 mmol) and the reaction stirred overnight at room temperature. The mixture was concentrated under reduced pressure to provide a white solid that was filtered to provide the pure product <b>49c</b> as the tosylate salt (0.133 g, 40%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 2.75 (s, 6H), 3.63 (m, 2H), 3.82 (m, 2H), 5.69 (s, 2H), 7.21 (m, 2H), 7.47 (m, 2H), 8.63 (s, 1H), 9.01 (s, 1H). LC-MS <i>m</i>/<i>z</i> 419.2 (M + H)<sup>+</sup>. HRMS Calcd for C<sub>19</sub>H<sub>20</sub>FN<sub>4</sub>O4S + H<sup>+</sup>: 419.1184. Found: 419.1181.</div></div><div id="sec5_84" class="NLM_sec NLM_sec_level_3"><div id="ac_i114" class="anchor-spacer"></div><h4 class="article-section__title" id="_i114"> 7-(4-Fluorobenzyl)-9-(morpholin-4-ylsulfonyl)-1,7-dihydropyrano[3,4-<i>b</i>]pyrrolo[3,2-<i>d</i>]pyridin-4(2<i>H</i>)-one (<b>46a</b>)</h4><div class="NLM_p last">As described for the preparation of <b>46c</b>, sulfonyl chloride <b>45</b> was reacted with morpholine (DMF), in the presence of Et<sub>3</sub>N, to give <b>46a</b> in 78% yield. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 1.86 (m, 1H), 3.15 (m, 4H), 3.60â3.75 (5H), 4.61 (m, 2H), 5.48 (s, 2H), 7.11 (m, 2H), 7.19 (m, 2H), 7.96 (s, 1H), 8.93 (s, 1H). LC-MS <i>m</i>/<i>z</i> 446.0 (M + H)<sup>+</sup>. HPLC (254, 224 nm): >95% purity.</div></div><div id="sec5_85" class="NLM_sec NLM_sec_level_3"><div id="ac_i115" class="anchor-spacer"></div><h4 class="article-section__title" id="_i115"> 1-(4-Fluorobenzyl)-4-(2-hydroxyethyl)-3-(morpholin-4-ylsulfonyl)-<i>N</i>-(tetrahydro-2<i>H</i>-pyran-2-yloxy)-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine-5-carboxamide (<b>47a</b>)</h4><div class="NLM_p last">As described for the preparation of <b>47c</b>, sulfonamide <b>46a</b>, as a solution in THF, was treated with H<sub>2</sub>NOTHP and LiHMDS to give <b>47a</b> in 51% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 1.30â1.90 (8H), 3.55â3.70 (6H), 3.70 (m, 2H), 3.90 (m, 4H), 4.75 (m, 1H), 5.65 (s, 2H), 7.12 (m, 2H), 7.24 (m, 2H), 7.81 (s, 1H), 8.71 (s, 1H), 10.62 (brs, 1H). LC/MS (APCI): <i>m</i>/<i>z</i> 563.2 (M + H)<sup>+</sup>. HPLC (254, 224 nm): >95% purity.</div></div><div id="sec5_86" class="NLM_sec NLM_sec_level_3"><div id="ac_i116" class="anchor-spacer"></div><h4 class="article-section__title" id="_i116"> 3-(4-Fluorobenzyl)-1-(morpholin-4-ylsulfonyl)-7-(tetrahydro-2<i>H</i>-pyran-2-yloxy)-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6-one (<b>48a</b>)</h4><div class="NLM_p last">As described for the preparation of <b>48c</b>, sulfonamide <b>47a</b> was cyclized by treatment with <i>p</i>-TsCl and <i>i</i>-Pr<sub>2</sub>NEt in CH<sub>2</sub>Cl<sub>2</sub> to give <i>N</i>-OTHP lactam <b>48a</b> in 35% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 1.30â1.90 (8H), 3.55â3.70 (6H), 3.95 (m, 4H), 4.10 (m, 4H), 4.73 (m, 1H), 5.67 (s, 2H), 7.12 (m, 2H), 7.24 (m, 2H), 7.79 (s, 1H), 8.82 (s, 1H). LC/MS (APCI) <i>m</i>/<i>z</i> 545.1 (M + H)<sup>+</sup>. HPLC (254, 224 nM) >95% purity. HPLC (254, 224 nm): >95% purity.</div></div><div id="sec5_87" class="NLM_sec NLM_sec_level_3"><div id="ac_i117" class="anchor-spacer"></div><h4 class="article-section__title" id="_i117"> 3-(4-Fluorobenzyl)-7-hydroxy-1-(morpholinosulfonyl)-8,9-dihydro-3<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6(7<i>H</i>)-one (<b>49a</b>)</h4><div class="NLM_p last">Procedure followed according to the preparation of <b>49c</b> to provide the product <b>49a</b> as the tosylate salt (41%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 3.47â3.80 (4H), 3.85â4.27 (8H), 5.51 (s, 2H), 7.04 (m, 2H), 7.18â7.30 (3H), 8.00 (s, 1H), 9.29 (s, 1H). LC/MS (APCI) <i>m</i>/<i>z</i> 461.0 (M + H)<sup>+</sup>. HPLC (260, 222 nm): >95% purity.</div></div><div id="sec5_88" class="NLM_sec NLM_sec_level_3"><div id="ac_i118" class="anchor-spacer"></div><h4 class="article-section__title" id="_i118"> 7-(4-Fluorobenzyl)-<i>N</i>-(2-methoxyethyl)-<i>N</i>-methyl-4-oxo-1,2,4,7-tetrahydropyrano[3,4-<i>b</i>]pyrrolo[3,2-<i>d</i>]pyridine-9-sulfonamide (<b>46b</b>)</h4><div class="NLM_p last">As described for the preparation of <b>46c</b>, sulfonyl chloride <b>45</b> was reacted with <i>N</i>-methyl-2-methoxyethylamine (DMF), in the presence of Et<sub>3</sub>N, to give <b>46b</b> in 69% yield. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 1.86 (m, 1H), 2.90 (m, 1H), 2.92 (s, 3H), 3.21 (s, 3H), 3.40 (m, 1H), 3.49 (m, 1H), 3.74 (m, 2H), 4.61 (m, 2H), 5.46 (s, 2H), 7.10 (m, 2H), 7.21 (m, 2H), 7.97 (s, 1H), 8.58 (s, 1H). LC/MS (APCI) <i>m</i>/<i>z</i> 448.1 (M + H)<sup>+</sup>. HPLC (254, 224 nm): >95% purity.</div></div><div id="sec5_89" class="NLM_sec NLM_sec_level_3"><div id="ac_i119" class="anchor-spacer"></div><h4 class="article-section__title" id="_i119"> 1-(4-Fluorobenzyl)-4-(2-hydroxyethyl)-3-[(2-methoxyethyl)(methyl)sulfamoyl]-<i>N</i>-(tetrahydro-2<i>H</i>-pyran-2-yloxy)-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine-5-carboxamide (<b>47b</b>)</h4><div class="NLM_p last">As described for the preparation of <b>47c</b>, sulfonamide <b>46b</b>, as a solution in THF, was treated with H<sub>2</sub>NOTHP and LiHMDS to give <b>47b</b> in 40% yield. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 1.45â1.95 (6H), 2.91 (s, 3H), 3.28 (s, 3H), 3.30â3.85 (6H), 3.93 (m, 2H), 4.05 (m, 2H), 5.10 (m, 1H), 5.40 (s, 2H), 7.05â7.25 (4H), 8.00 (s, 1H), 8.52 (s, 1H), 10.36 (brs, 1H). LC/MS (APCI) <i>m</i>/<i>z</i>: 565.1 (M + H)<sup>+</sup>. HPLC (260, 222 nm): >95% purity.</div></div><div id="sec5_90" class="NLM_sec NLM_sec_level_3"><div id="ac_i120" class="anchor-spacer"></div><h4 class="article-section__title" id="_i120"> 3-(4-Fluorobenzyl)-<i>N</i>-(2-methoxyethyl)-<i>N</i>-methyl-6-oxo-7-(tetrahydro-2<i>H</i>-pyran-2-yloxy)-6,7,8,9-tetrahydro-3<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridine-1-sulfonamide (<b>48b</b>)</h4><div class="NLM_p last">As described for the preparation of <b>48c</b>, sulfonamide <b>47b</b> was cyclized by treatment with <i>p</i>-TsCl and <i>i</i>-Pr<sub>2</sub>NEt in CH<sub>2</sub>Cl<sub>2</sub> to give <i>N</i>-OTHP lactam <b>48b</b> in 37% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 1.30â1.95 (6H), 2.75 (s, 3H), 3.17 (s, 3H), 3.30 (m, 1H), 3.60â3.75 (5H), 3.95 (m, 2H), 4.13 (m, 2H), 4.90 (m, 1H), 5.50 (s, 2H), 7.12 (m, 2H), 7.24 (m, 2H), 7.64 (s, 1H), 8.81 (s, 1H). LC/MS (APCI) <i>m</i>/<i>z</i>: 546.1 (M + H)<sup>+</sup>. HPLC (254, 224 nm): >95% purity.</div></div><div id="sec5_91" class="NLM_sec NLM_sec_level_3"><div id="ac_i121" class="anchor-spacer"></div><h4 class="article-section__title" id="_i121"> 3-(4-Fluorobenzyl)-7-hydroxy-<i>N</i>-(2-methoxyethyl)-<i>N</i>-methyl-6-oxo-6,7,8,9-tetrahydro-3<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridine-1-sulfonamide (<b>49b</b>)</h4><div class="NLM_p last">Procedure followed according to the preparation of <b>49c</b> to provide the product <b>49b</b> as the tosylate salt (39%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 2.86 (s, 3H), 3.19 (s, 3H), 3.36 (m, 2H), 3.47 (m, 2H), 3.69 (m, 2H), 3.94 (m, 2H), 5.65 (s, 2H), 6.94 (m, 2H), 7.26 (m, 2H), 8.16 (s, 1H), 9.64 (s, 1H). LC/MS (APCI) <i>m</i>/<i>z</i>: 463.1 (M + H)<sup>+</sup>. HPLC (260, 222 nm): >95% purity.</div></div><div id="sec5_92" class="NLM_sec NLM_sec_level_3"><div id="ac_i122" class="anchor-spacer"></div><h4 class="article-section__title" id="_i122"> 7-(4-Fluorobenzyl)-9-(pyrrolidin-1-ylsulfonyl)-1,7-dihydropyrano[3,4-<i>b</i>]pyrrolo[3,2-<i>d</i>]pyridin-4(2<i>H</i>)-one (<b>46d</b>)</h4><div class="NLM_p last">As described for the preparation of <b>46c</b>, sulfonyl chloride <b>45</b> was reacted with pyrrolidine (DMF), in the presence of Et<sub>3</sub>N, to give <b>46d</b> in 69% yield. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 1.92 (m, 4H), 3.29 (m, 4H), 3.77 (m, 2H), 4.61 (m, 2H), 5.47 (s, 2H), 7.09 (m, 2H), 7.20 (m, 2H), 7.95 (s, 1H), 8.91 (s, 1H). LC/MS (APCI) <i>m</i>/<i>z</i>: 430.1 (M + H)<sup>+</sup>. HPLC (254, 224 nm): >95% purity.</div></div><div id="sec5_93" class="NLM_sec NLM_sec_level_3"><div id="ac_i123" class="anchor-spacer"></div><h4 class="article-section__title" id="_i123"> 1-(4-Fluorobenzyl)-4-(2-hydroxyethyl)-3-(pyrrolidin-1-ylsulfonyl)-<i>N</i>-(tetrahydro-2<i>H</i>-pyran-2-yloxy)-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine-5-carboxamide (<b>47d</b>)</h4><div class="NLM_p last">As described for the preparation of <b>47c</b>, sulfonamide <b>46d</b>, as a solution in THF, was treated with H<sub>2</sub>NOTHP and LiHMDS to give <b>47d</b> in 44% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 1.31â1.95 (12H), 2.70 (m, 2H), 2.95 (m, 2H), 3.63 (m, 2H), 3.74 (m, 2H), 3.96 (m, 2H), 4.77 (m, 1H), 5.52 (s, 2H), 7.09 (m, 2H), 7.24 (m, 2H), 7.78 (s, 1H), 8.71 (s, 1H). LC/MS (APCI) <i>m</i>/<i>z</i> 547.2 (M + H)<sup>+</sup>. HPLC (254, 224 nm): >95% purity.</div></div><div id="sec5_94" class="NLM_sec NLM_sec_level_3"><div id="ac_i124" class="anchor-spacer"></div><h4 class="article-section__title" id="_i124"> 3-(4-Fluorobenzyl)-1-(pyrrolidin-1-ylsulfonyl)-7-(tetrahydro-2<i>H</i>-pyran-2-yloxy)-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6-one (<b>48d</b>)</h4><div class="NLM_p last">As described for the preparation of <b>48c</b>, sulfonamide <b>47d</b> was cyclized by treatment with <i>p</i>-TsCl and <i>i</i>-Pr<sub>2</sub>NEt in CH<sub>2</sub>Cl<sub>2</sub> to give <i>N</i>-OTHP lactam <b>48d</b> in 34% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 1.36â2.00 (12H), 2.71 (m, 2H), 2.96 (m, 2H), 3.55â3.65 (6H), 4.00 (m, 2H), 4.12 (m, 2H), 4.97 (m, 1H), 5.52 (s, 2H), 7.09 (m, 2H), 7.25 (m, 2H), 7.75 (s, 1H), 8.84 (s, 1H). LC/MS (APCI) <i>m</i>/<i>z</i> 529.1 (M + H)<sup>+</sup>. HPLC (254, 224 nM) >95% purity.</div></div><div id="sec5_95" class="NLM_sec NLM_sec_level_3"><div id="ac_i125" class="anchor-spacer"></div><h4 class="article-section__title" id="_i125"> 3-(4-Fluorobenzyl)-7-hydroxy-1-(pyrrolidin-1-ylsulfonyl)-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>]-1,7-naphthyridin-6-one (<b>49d</b>)</h4><div class="NLM_p last">Procedure followed according to the preparation of <b>49c</b> to provide the product <b>49d</b> as the tosylate salt (42%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 1.83 (m, 4H), 3.23 (m, 4H), 3.75 (m, 2H), 3.98 (m, 2H), 5.78 (s, 2H), 7.24 (m, 2H), 7.47 (m, 2H), 8.84 (s, 1H), 9.24 (s, 1H). LC/MS (APCI) <i>m</i>/<i>z</i> 445.0 (M + H)<sup>+</sup>. HPLC (254, 224 nM) >95% purity.</div></div><div id="sec5_96" class="NLM_sec NLM_sec_level_3"><div id="ac_i126" class="anchor-spacer"></div><h4 class="article-section__title" id="_i126"> 7-(4-Fluorobenzyl)-9-[(4-methylpiperidin-1-yl)sulfonyl]-1,7-dihydropyrano[3,4-<i>b</i>]pyrrolo[3,2-<i>d</i>]pyridin-4(2<i>H</i>)-one (<b>46e</b>)</h4><div class="NLM_p last">As described for the preparation of <b>46c</b>, sulfonyl chloride <b>45</b> was reacted with 4-methylpiperidine (DMF), in the presence of Et<sub>3</sub>N, to give <b>46e</b> in 74% yield. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ 0.95 (d, <i>J</i> = 6.0 Hz, 3H), 1.10â1.90 (5H), 2.66 (m, 2H), 3.60â3.80 (4H), 4.61 (m, 2H), 5.47 (s, 2H), 7.10 (m, 2H), 7.21 (m, 2H), 7.94 (s, 1H), 8.91 (s, 1H). LC/MS (APCI) <i>m</i>/<i>z</i> 458.1 (M + H)<sup>+</sup>. HPLC (254, 224 nm): >95% purity.</div></div><div id="sec5_97" class="NLM_sec NLM_sec_level_3"><div id="ac_i127" class="anchor-spacer"></div><h4 class="article-section__title" id="_i127"> 1-(4-Fluorobenzyl)-4-(2-hydroxyethyl)-3-[(4-methylpiperidin-1-yl)sulfonyl]-<i>N</i>-(tetrahydro-2<i>H</i>-pyran-2-yloxy)-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine-5-carboxamide (<b>47e</b>)</h4><div class="NLM_p last">As described for the preparation of <b>47c</b>, sulfonamide <b>46e</b>, as a solution in THF, was treated with H<sub>2</sub>NOTHP and LiHMDS to give <b>47e</b> in 57% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 0.90 (d, <i>J</i> = 7.07 Hz, 3H), 1.20â1.92 (13H), 3.06 (m, 2H), 3.63 (m, 2H), 3.73 (m, 2H), 3.96 (m, 2H), 4.77 (m, 1H), 5.,52 (s, 2H), 7.10 (m, 2H), 7.23 (m, 2H), 7.93 (s, 1H), 8.71 (s, 1H). LC/MS (APCI): <i>m</i>/<i>z</i> 575.2 (M + H)<sup>+</sup>. HPLC (254, 224 nm): >95% purity.</div></div><div id="sec5_98" class="NLM_sec NLM_sec_level_3"><div id="ac_i128" class="anchor-spacer"></div><h4 class="article-section__title" id="_i128"> 3-(4-Fluorobenzyl)-1-[(4-methylpiperidin-1-yl)sulfonyl]-7-(tetrahydro-2<i>H</i>-pyran-2-yloxy)-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6-one (<b>48e</b>)</h4><div class="NLM_p last">As described for the preparation of <b>48c</b>, sulfonamide <b>47e</b> was cyclized by treatment with <i>p</i>-TsCl and <i>i</i>-Pr<sub>2</sub>NEt in CH<sub>2</sub>Cl<sub>2</sub> to give <i>N</i>-OTHP lactam <b>48e</b> in 40% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 0.91 (d, <i>J</i> = 7.06 Hz, 3H), 1.20â1.96 (13H), 3.07 (m, 2H), 3.55â3.75 (6H), 4.00 (m, 2H), 4.11 (m, 2H), 4.96 (m, 1H), 5.53 (s, 2H), 7.11 (m, 2H), 7.24 (m, 2H), 7.90 (s, 1H), 8.84 (s, 1H). LC/MS (APCI) <i>m</i>/<i>z</i> 557.1 (M + H)<sup>+</sup>. HPLC (254, 224 nM) >95% purity.</div></div><div id="sec5_99" class="NLM_sec NLM_sec_level_3"><div id="ac_i129" class="anchor-spacer"></div><h4 class="article-section__title" id="_i129"> 3-(4-Fluorobenzyl)-7-hydroxy-1-[(4-methylpiperidin-1-yl)sulfonyl]-3,7,8,9-tetrahydro-6<i>H</i>-pyrrolo[2,3-<i>c</i>]-1,7-naphthyridin-6-one (<b>49e</b>)</h4><div class="NLM_p last">Procedure followed according to the preparation of <b>49c</b> to provide the product <b>49e</b> as the tosylate salt (45%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 0.93 (d, <i>J</i> = 6.25 Hz, 3H), 1.16 (m, 2H), 1.47 (m, 1H), 1.40 (m, 2H), 2.62 (m, 2H), 3.96 (m, 2H), 5.79 (s, 2H), 7.22 (m, 2H), 7.44 (m, 2H), 8.90 (s, 1), 9.32 (s, 1H). LC/MS (APCI) <i>m</i>/<i>z</i>: 473.1 (M + H)<sup>+</sup>. HPLC (254, 224 nM) >95% purity.</div></div></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50661" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50661" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ted W. Johnson</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, La Jolla Laboratories, 10770 Science Center Drive, San Diego, California 92121, United States </span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a8dccdcc86df86c2c7c0c6dbc7c6e8d8cec1d2cdda86cbc7c588dcdfc29898e8d1c9c0c7c786cbc7c588dbd8dcc9c6c1dbe8dbcacbcfc4c7cac9c486c6cddc88dbd8dcc9c6c1dbe8cfc5c9c1c486cbc7c5"><span class="__cf_email__" data-cfemail="6d190809431a43070205031e02032d1d0b0417081f430e0200">[emailÂ protected]</span> <span class="__cf_email__" data-cfemail="1561627f2525556c747d7a7a3b767a78">[emailÂ protected]</span> <span class="__cf_email__" data-cfemail="d9aaa9adb8b7b0aa99aabbbabeb5b6bbb8b5f7b7bcad">[emailÂ protected]</span> <span class="__cf_email__" data-cfemail="9eedeeeafff0f7eddef9f3fff7f2b0fdf1f3">[emailÂ protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven P. Tanis</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, La Jolla Laboratories, 10770 Science Center Drive, San Diego, California 92121, United States </span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#9ce8f9f8b2ebb2f6f3f4f2eff3f2dcecfaf5e6f9eeb2fff3f1bce8ebf6acacdce5fdf4f3f3b2fff3f1bcefece8fdf2f5efdceffefffbf0f3fefdf0b2f2f9e8bcefece8fdf2f5efdcfbf1fdf5f0b2fff3f1"><span class="__cf_email__" data-cfemail="116574753f663f7b7e797f627e7f516177786b74633f727e7c">[emailÂ protected]</span> <span class="__cf_email__" data-cfemail="4135362b7171013820292e2e6f222e2c">[emailÂ protected]</span> <span class="__cf_email__" data-cfemail="8efdfefaefe0e7fdcefdecede9e2e1ecefe2a0e0ebfa">[emailÂ protected]</span> <span class="__cf_email__" data-cfemail="12616266737c7b6152757f737b7e3c717d7f">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Scott L. Butler</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, La Jolla Laboratories, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Deepak Dalvie</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, La Jolla Laboratories, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dorothy M. DeLisle</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, La Jolla Laboratories, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Klaus R. Dress</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, La Jolla Laboratories, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Erik J. Flahive</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, La Jolla Laboratories, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qiyue Hu</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, La Jolla Laboratories, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jon E. Kuehler</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, La Jolla Laboratories, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Atsuo Kuki</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, La Jolla Laboratories, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wen Liu</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, La Jolla Laboratories, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guy A. McClellan</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, La Jolla Laboratories, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qinghai Peng</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, La Jolla Laboratories, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael B. Plewe</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, La Jolla Laboratories, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul F. Richardson</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, La Jolla Laboratories, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Graham L. Smith</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, La Jolla Laboratories, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jim Solowiej</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, La Jolla Laboratories, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Khanh T. Tran</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, La Jolla Laboratories, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hai Wang</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, La Jolla Laboratories, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaoming Yu</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, La Jolla Laboratories, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Junhu Zhang</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, La Jolla Laboratories, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Huichun Zhu</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, La Jolla Laboratories, 10770 Science Center Drive, San Diego, California 92121, United States </span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm200208d" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i130">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11575" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11575" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Dr. Martin Edwards, Dr. Simon Bailey, and Dr. Stacie Canan for helpful discussions.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i131" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i131"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i132" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i132"> Abbreviations Used</h2><tr><td class="NLM_term">CC<sub>50</sub></td><td class="NLM_def"><p class="first last">50% cytotoxic concentration</p></td></tr><tr><td class="NLM_term">CPE</td><td class="NLM_def"><p class="first last">cytopathic effect</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DIEA</td><td class="NLM_def"><p class="first last">di-isopropyl ethylamine</p></td></tr><tr><td class="NLM_term">D<i>t</i>BAD</td><td class="NLM_def"><p class="first last">di-<i>t</i>-butyl azodicarboxylate</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">dimethylamino pyridine</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethylsulfoxide</p></td></tr><tr><td class="NLM_term">EC<sub>50</sub></td><td class="NLM_def"><p class="first last">50% effective concentration</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">extraction ratio</p></td></tr><tr><td class="NLM_term"><i>F</i></td><td class="NLM_def"><p class="first last">bioavailability</p></td></tr><tr><td class="NLM_term"><i>H</i></td><td class="NLM_def"><p class="first last">high</p></td></tr><tr><td class="NLM_term">HIV</td><td class="NLM_def"><p class="first last">human immunodeficiency virus</p></td></tr><tr><td class="NLM_term">HIV-1</td><td class="NLM_def"><p class="first last">human immunodeficiency virus type 1</p></td></tr><tr><td class="NLM_term">hHEP</td><td class="NLM_def"><p class="first last">human hepatocyte</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsome</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">50% inhibitory concentration</p></td></tr><tr><td class="NLM_term">IN</td><td class="NLM_def"><p class="first last">integrase</p></td></tr><tr><td class="NLM_term"><i>L</i></td><td class="NLM_def"><p class="first last">low</p></td></tr><tr><td class="NLM_term">LC-MS</td><td class="NLM_def"><p class="first last">liquid chromatographyâmass spectrometry</p></td></tr><tr><td class="NLM_term">LipE</td><td class="NLM_def"><p class="first last">lipophilic efficiency</p></td></tr><tr><td class="NLM_term">log <i>D</i></td><td class="NLM_def"><p class="first last">octanol:buffer (pH 7.4) distribution coefficient</p></td></tr><tr><td class="NLM_term"><i>M</i></td><td class="NLM_def"><p class="first last">medium</p></td></tr><tr><td class="NLM_term">NIS</td><td class="NLM_def"><p class="first last"><i>N</i>-iodosuccinimide</p></td></tr><tr><td class="NLM_term">NMM</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl morpholine</p></td></tr><tr><td class="NLM_term">PR</td><td class="NLM_def"><p class="first last">protease</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">RT</td><td class="NLM_def"><p class="first last">reverse transcriptase</p></td></tr><tr><td class="NLM_term">rt</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">2-(trimethylsilyl)ethoxymethyl</p></td></tr><tr><td class="NLM_term">SFC</td><td class="NLM_def"><p class="first last">supercritical fluid chromatography</p></td></tr><tr><td class="NLM_term">SPA</td><td class="NLM_def"><p class="first last">scintillation proximity assay</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin-layer chromatography</p></td></tr><tr><td class="NLM_term">tPSA</td><td class="NLM_def"><p class="first last">topological polar surface area</p></td></tr><tr><td class="NLM_term">Vdss</td><td class="NLM_def"><p class="first last">volume of distribution</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i133">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02715" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02715" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 43 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Castro, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loureiro, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pujol-Luz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souza, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albuquerque, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabral, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frugulhetti, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, C. R.</span><span> </span><span class="NLM_article-title">HIV-1 reverse transcriptase: a therapeutical target in the spotlight</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">313</span><span class="NLM_x">â</span> <span class="NLM_lpage">324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm200208d&amp;key=10.2174%2F092986706775476089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm200208d&amp;key=16475939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm200208d&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVequ74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=313-324&issue=3&author=H.+C.+Castroauthor=N.+I.+Loureiroauthor=M.+Pujol-Luzauthor=A.+M.+Souzaauthor=M.+G.+Albuquerqueauthor=D.+O.+Santosauthor=L.+M.+Cabralauthor=I.+C.+Frugulhettiauthor=C.+R.+Rodrigues&title=HIV-1+reverse+transcriptase%3A+a+therapeutical+target+in+the+spotlight"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">HIV-1 reverse transcriptase: a therapeutical target in the spotlight</span></div><div class="casAuthors">Castro, H. C.; Loureiro, N. I. V.; Pujol-Luz, M.; Souza, A. M. T.; Albuquerque, M. G.; Santos, D. O.; Cabral, L. M.; Frugulhetti, I. C.; Rodrigues, C. R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">313-324</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Human Immunodeficiency Virus type 1 Reverse Transcriptase (HIV-1 RT) is one of the most important targets for treatment of Acquired Immune Deficiency Syndrome (AIDS).  It catalyzes the reverse transcription of HIV-RNA into a double stranded DNA, and the knowledge of its substrate specificity and catalytic mechanism has guided the development of several inhibitors widely used on current HIV/AIDS therapy.  However, mutations in HIV-1 RT structure can lead to the emergence of drug-resistant virus strains.  The goal of this review is to summarize relevant structural features of HIV-1 RT and its inhibitors in such a way that this cost-effective target in the development of new antiretroviral drugs is particularly highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFTpO08ZoPwLVg90H21EOLACvtfcHk0lib_F5EtYZr5A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVequ74%253D&md5=b515ca8f480ae3177c0292a007a6def4</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F092986706775476089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986706775476089%26sid%3Dliteratum%253Aachs%26aulast%3DCastro%26aufirst%3DH.%2BC.%26aulast%3DLoureiro%26aufirst%3DN.%2BI.%26aulast%3DPujol-Luz%26aufirst%3DM.%26aulast%3DSouza%26aufirst%3DA.%2BM.%26aulast%3DAlbuquerque%26aufirst%3DM.%2BG.%26aulast%3DSantos%26aufirst%3DD.%2BO.%26aulast%3DCabral%26aufirst%3DL.%2BM.%26aulast%3DFrugulhetti%26aufirst%3DI.%2BC.%26aulast%3DRodrigues%26aufirst%3DC.%2BR.%26atitle%3DHIV-1%2520reverse%2520transcriptase%253A%2520a%2520therapeutical%2520target%2520in%2520the%2520spotlight%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2006%26volume%3D13%26issue%3D3%26spage%3D313%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Mastrolorenzo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusconi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbaro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Inhibitors of HIV-1 protease: current state of the art 10 years after their introduction. From antiretroviral drugs to antifungal, antibacterial and antitumor agents based on aspartic protease inhibitors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">26</span><span class="NLM_x">) </span> <span class="NLM_fpage">2734</span><span class="NLM_x">â</span> <span class="NLM_lpage">2748</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm200208d&amp;key=10.2174%2F092986707782360141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm200208d&amp;key=18045120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm200208d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlSkurc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=2734-2748&issue=26&author=A.+Mastrolorenzoauthor=S.+Rusconiauthor=A.+Scozzafavaauthor=G.+Barbaroauthor=C.+T.+Supuran&title=Inhibitors+of+HIV-1+protease%3A+current+state+of+the+art+10+years+after+their+introduction.+From+antiretroviral+drugs+to+antifungal%2C+antibacterial+and+antitumor+agents+based+on+aspartic+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of HIV-1 protease: current state of the art 10 years after their introduction. From antiretroviral drugs to antifungal, antibacterial and antitumor agents based on aspartic protease inhibitors</span></div><div class="casAuthors">Mastrolorenzo, Antonio; Rusconi, Stefano; Scozzafava, Andrea; Barbaro, Giuseppe; Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">2734-2748</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The introduction of highly active antiretroviral therapy (HAART) in 1996 dramatically changed the course of HIV infection.  This therapy involves the use of at least three agents from two distinct classes of antivirals: a protease inhibitor (PI) in combination with two nucleoside/nucleotide reverse transcriptase inhibitors (N(t)RTIs), or a non-nucleoside reverse transcriptase inhibitor (NNRTI) in combination with NRTIs.  Nine drugs contg. PIs are clin. available: the first generation ones, saquinavir, ritonavir, indinavir, nelfinavir, and amprenavir, and the second generation ones, fosamprenavir (the amprenavir prodrug), lopinavir, atazanavir, and tipranavir.  Many other compds. are in advanced clin. evaluation, such as among others TMC-114, whereas a lot of different other effective HIV protease inhibitors were reported, mainly by using amprenavir and TMC-114 as lead mols.  The main goals of research in this field are: (i) the design of better pharmacol. agents, devoid of severe side effects, resistance problems and with simple administration schedules (preferably once daily), and (ii) achieving eradication of the virus, and possibly, a definitive cure of the disease.  A review on the pharmacol. and interactions of these agents with other drugs is presented here, with emphasis on how these pharmacol. interferences may improve the clin. use of antivirals, or how side effects due to PI drugs may be managed better by taking them into account (such as for example ritonavir boosting of other PIs which reduces dosages and administration schedules of these drugs).  Except for being highly effective in the treatment of HIV infection, recent reports showed this class of drugs to be effective as antitumor agents, as antibacterials (for example against Mycobacterium tuberculosis infection), antifungals (against Candida albicans), antimalarials, antiSARS and anti-influenza agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLJvBZLu-Pt7Vg90H21EOLACvtfcHk0lib_F5EtYZr5A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlSkurc%253D&md5=34fcb8056ab9fab31202407b8385af91</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2174%2F092986707782360141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986707782360141%26sid%3Dliteratum%253Aachs%26aulast%3DMastrolorenzo%26aufirst%3DA.%26aulast%3DRusconi%26aufirst%3DS.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DBarbaro%26aufirst%3DG.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DInhibitors%2520of%2520HIV-1%2520protease%253A%2520current%2520state%2520of%2520the%2520art%252010%2520years%2520after%2520their%2520introduction.%2520From%2520antiretroviral%2520drugs%2520to%2520antifungal%252C%2520antibacterial%2520and%2520antitumor%2520agents%2520based%2520on%2520aspartic%2520protease%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2007%26volume%3D14%26issue%3D26%26spage%3D2734%26epage%3D2748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Al-Mawsawi, L. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Safi, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neamati, N.</span><span> </span><span class="NLM_article-title">Anti-infectives: clinical progress of HIV-1 integrase inhibitors</span> <span class="citation_source-journal">Expert Opin. Emerging Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">213</span><span class="NLM_x">â</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm200208d&amp;key=10.1517%2F14728214.13.2.213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm200208d&amp;key=18537517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm200208d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmvVCktLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=213-225&issue=2&author=L.+Q.+Al-Mawsawiauthor=R.+I.+Al-Safiauthor=N.+Neamati&title=Anti-infectives%3A+clinical+progress+of+HIV-1+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-infectives Clinical progress of HIV-1 integrase inhibitors</span></div><div class="casAuthors">Al-Mawsawi, Laith Q.; Al-Safi, Rasha I.; Neamati, Nouri</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-225</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>;
        ISSN:<span class="NLM_cas:issn">1472-8214</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: HIV-1 integrase (IN) represents a therapeutically advantageous viral target to treat HIV/AIDS in the clinic.  Over a decade of progress in the field has resulted in IN inhibitor chem. classes that display specificity for strand transfer catalysis of the enzyme, thus blocking viral DNA integration into host cell nuclear DNA, an essential step for viral infectivity.  Objective: In this manuscript we provide an update on recent HIV-1 IN inhibitors that have been clin. evaluated, which include MK-0518, MK-2048, GS-9137, GS-9160, GS-9224, GSK-364735, and BMS-707035.  The information presented here can aid in the IN drug developmental process.  Methods: We have limited the scope of this review to information available on the clin. evaluation of promising strand transfer-specific IN inhibitors and their potential drug-drug interaction profiles with other antiretroviral agents.  Results/conclusion: The development of strand transfer-specific inhibitor classes is an important achievement for the IN drug design and development field.  However, continued drug development is needed given that the ability of HIV to replicate under therapeutic pressure will undoubtedly lead to the emergence of IN drug-resistant viral strains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeKFAcwGuyR7Vg90H21EOLACvtfcHk0lgfCqTtHM5R2A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmvVCktLs%253D&md5=6b61057a498cd0f05a0acc166c5848ad</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1517%2F14728214.13.2.213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728214.13.2.213%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Mawsawi%26aufirst%3DL.%2BQ.%26aulast%3DAl-Safi%26aufirst%3DR.%2BI.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DAnti-infectives%253A%2520clinical%2520progress%2520of%2520HIV-1%2520integrase%2520inhibitors%26jtitle%3DExpert%2520Opin.%2520Emerging%2520Drugs%26date%3D2008%26volume%3D13%26issue%3D2%26spage%3D213%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Pace, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span> </span><span class="NLM_article-title">Integrase inhibitors for the treatment of HIV infection</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">471</span><span class="NLM_x">â</span> <span class="NLM_lpage">479</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2008&pages=471-479&issue=4&author=P.+Paceauthor=M.+Rowley&title=Integrase+inhibitors+for+the+treatment+of+HIV+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPace%26aufirst%3DP.%26aulast%3DRowley%26aufirst%3DM.%26atitle%3DIntegrase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520HIV%2520infection%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2008%26volume%3D11%26issue%3D4%26spage%3D471%26epage%3D479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Anker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corales, R. B.</span><span> </span><span class="NLM_article-title">Raltegravir (MK-0518): a novel integrase inhibitor for the treatment of HIV infection</span> <span class="citation_source-journal">Expert Opin. Invest. Drug.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">97</span><span class="NLM_x">â</span> <span class="NLM_lpage">103</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm200208d&amp;key=10.1517%2F13543784.17.1.97" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm200208d&amp;key=18095922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm200208d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFSmsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=97-103&issue=1&author=M.+Ankerauthor=R.+B.+Corales&title=Raltegravir+%28MK-0518%29%3A+a+novel+integrase+inhibitor+for+the+treatment+of+HIV+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Raltegravir (MK-0518): a novel integrase inhibitor for the treatment of HIV infection</span></div><div class="casAuthors">Anker, Mary; Corales, Roberto B.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">97-103</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Integrase is essential for HIV-1 replication; however, potent inhibition of the isolated enzyme in biochem. assays has not readily translated into antiviral activity in a manner consistent with inhibition of integration.  Raltegravir is a novel HIV-1 integrase strand transfer inhibitor with potent in vitro activity against wild-type and multi-class resistant HIV-1 virus (in vitro IC95 for HIV-1 in 50% normal human serum = 33 nM).  Inhibition of integrase prevents insertion of HIV DNA into the human DNA genome, thus blocking the ability of HIV to replicate.  Raltegravir is administered orally every 12 h and does not require boosting with low-dose ritonavir (RTV) to achieve therapeutic concns.  Raltegravir is not a potent inhibitor or inducer of cytochrome P 450 3A4, and it is predominantly metabolized by glucuronidation, specifically by the enzyme UDP-glucuronosyltransferase 1A1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTuPqYi82xZbVg90H21EOLACvtfcHk0lgfCqTtHM5R2A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFSmsA%253D%253D&md5=4e4b335a994ef71281d9b935a20939fa</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1517%2F13543784.17.1.97&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.17.1.97%26sid%3Dliteratum%253Aachs%26aulast%3DAnker%26aufirst%3DM.%26aulast%3DCorales%26aufirst%3DR.%2BB.%26atitle%3DRaltegravir%2520%2528MK-0518%2529%253A%2520a%2520novel%2520integrase%2520inhibitor%2520for%2520the%2520treatment%2520of%2520HIV%2520infection%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drug.%26date%3D2008%26volume%3D17%26issue%3D1%26spage%3D97%26epage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Summa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrocchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crescenzi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donghi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiore, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez Paz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzel, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteagudo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muraglia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nizi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orvieto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pace, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pescatore, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarpelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stillmock, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span> </span><span class="NLM_article-title">Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">5843</span><span class="NLM_x">â</span> <span class="NLM_lpage">5855</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800245z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5843-5855&issue=18&author=V.+Summaauthor=A.+Petrocchiauthor=F.+Bonelliauthor=B.+Crescenziauthor=M.+Donghiauthor=M.+Ferraraauthor=F.+Fioreauthor=C.+Gardelliauthor=O.+Gonzalez+Pazauthor=D.+J.+Hazudaauthor=P.+Jonesauthor=O.+Kinzelauthor=R.+Lauferauthor=E.+Monteagudoauthor=E.+Muragliaauthor=E.+Niziauthor=F.+Orvietoauthor=P.+Paceauthor=G.+Pescatoreauthor=R.+Scarpelliauthor=K.+Stillmockauthor=M.+V.+Witmerauthor=M.+Rowley&title=Discovery+of+raltegravir%2C+a+potent%2C+selective+orally+bioavailable+HIV-integrase+inhibitor+for+the+treatment+of+HIV-AIDS+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm800245z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800245z%26sid%3Dliteratum%253Aachs%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DBonelli%26aufirst%3DF.%26aulast%3DCrescenzi%26aufirst%3DB.%26aulast%3DDonghi%26aufirst%3DM.%26aulast%3DFerrara%26aufirst%3DM.%26aulast%3DFiore%26aufirst%3DF.%26aulast%3DGardelli%26aufirst%3DC.%26aulast%3DGonzalez%2BPaz%26aufirst%3DO.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DKinzel%26aufirst%3DO.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DMuraglia%26aufirst%3DE.%26aulast%3DNizi%26aufirst%3DE.%26aulast%3DOrvieto%26aufirst%3DF.%26aulast%3DPace%26aufirst%3DP.%26aulast%3DPescatore%26aufirst%3DG.%26aulast%3DScarpelli%26aufirst%3DR.%26aulast%3DStillmock%26aufirst%3DK.%26aulast%3DWitmer%26aufirst%3DM.%2BV.%26aulast%3DRowley%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520raltegravir%252C%2520a%2520potent%252C%2520selective%2520orally%2520bioavailable%2520HIV-integrase%2520inhibitor%2520for%2520the%2520treatment%2520of%2520HIV-AIDS%2520infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D18%26spage%3D5843%26epage%3D5855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Shimura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodama, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakagami, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuzaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamataka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, M.</span><span> </span><span class="NLM_article-title">Broad antiretroviral activity and resistance profile of the novel human immunodeficiency virus integrase inhibitor elvitegravir (JTK-303/GS-9137)</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">764</span><span class="NLM_x">â</span> <span class="NLM_lpage">774</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm200208d&amp;key=10.1128%2FJVI.01534-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm200208d&amp;key=17977962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm200208d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtFCmug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2008&pages=764-774&issue=2&author=K.+Shimuraauthor=E.+Kodamaauthor=Y.+Sakagamiauthor=Y.+Matsuzakiauthor=W.+Watanabeauthor=K.+Yamatakaauthor=Y.+Watanabeauthor=Y.+Ohataauthor=S.+Doiauthor=M.+Satoauthor=M.+Kanoauthor=S.+Ikedaauthor=M.+Matsuoka&title=Broad+antiretroviral+activity+and+resistance+profile+of+the+novel+human+immunodeficiency+virus+integrase+inhibitor+elvitegravir+%28JTK-303%2FGS-9137%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Broad antiretroviral activity and resistance profile of the novel human immunodeficiency virus integrase inhibitor elvitegravir (JTK-303/GS-9137)</span></div><div class="casAuthors">Shimura, Kazuya; Kodama, Eiichi; Sakagami, Yasuko; Matsuzaki, Yuji; Watanabe, Wataru; Yamataka, Kazunobu; Watanabe, Yasuo; Ohata, Yoshitsugu; Doi, Satoki; Sato, Motohide; Kano, Mitsuki; Ikeda, Satoru; Matsuoka, Masao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">764-774</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Integrase (IN), an essential enzyme of human immunodeficiency virus (HIV), is an attractive antiretroviral drug target.  The antiviral activity and resistance profile in vitro of a novel IN inhibitor, elvitegravir (EVG) (also known as JTK-303/GS-9137), currently being developed for the treatment of HIV-1 infection are described.  EVG blocked the integration of HIV-1 cDNA through the inhibition of DNA strand transfer.  EVG inhibited the replication of HIV-1, including various subtypes and multiple-drug-resistant clin. isolates, and HIV-2 strains with a 50% effective concn. in the subnanomolar to nanomolar range.  EVG-resistant variants were selected in two independent inductions, and a total of 8 amino acid substitutions in the catalytic core domain of IN were obsd.  Among the obsd. IN mutations, T66I and E92Q substitutions mainly contributed to EVG resistance.  These two primary resistance mutations are located in the active site, and other secondary mutations identified are proximal to these primary mutations.  The EVG-selected IN mutations, some of which represent novel IN inhibitor resistance mutations, conferred reduced susceptibility to other IN inhibitors, suggesting that a common mechanism is involved in resistance and potential cross-resistance.  The replication capacity of EVG-resistant variants was significantly reduced relative to both wild-type virus and other IN inhibitor-resistant variants selected by L-870,810.  EVG and L-870,810 both inhibited the replication of murine leukemia virus and simian immunodeficiency virus, suggesting that IN inhibitors bind to a conformationally conserved region of various retroviral IN enzymes and are an ideal drug for a range of retroviral infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4hiIK948jhbVg90H21EOLACvtfcHk0ljh1CH9u2hfIw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtFCmug%253D%253D&md5=00943d23a3723e064acef209f36a9267</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1128%2FJVI.01534-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.01534-07%26sid%3Dliteratum%253Aachs%26aulast%3DShimura%26aufirst%3DK.%26aulast%3DKodama%26aufirst%3DE.%26aulast%3DSakagami%26aufirst%3DY.%26aulast%3DMatsuzaki%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DW.%26aulast%3DYamataka%26aufirst%3DK.%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DOhata%26aufirst%3DY.%26aulast%3DDoi%26aufirst%3DS.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DKano%26aufirst%3DM.%26aulast%3DIkeda%26aufirst%3DS.%26aulast%3DMatsuoka%26aufirst%3DM.%26atitle%3DBroad%2520antiretroviral%2520activity%2520and%2520resistance%2520profile%2520of%2520the%2520novel%2520human%2520immunodeficiency%2520virus%2520integrase%2520inhibitor%2520elvitegravir%2520%2528JTK-303%252FGS-9137%2529%26jtitle%3DJ.%2520Virol.%26date%3D2008%26volume%3D82%26issue%3D2%26spage%3D764%26epage%3D774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Min, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borland, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piscitelli, S. C.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and safety of S/GSK1349572, a next-generation HIV integrase inhibitor, in healthy volunteers</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">254</span><span class="NLM_x">â</span> <span class="NLM_lpage">258</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=254-258&issue=1&author=S.+Minauthor=I.+Songauthor=J.+Borlandauthor=S.+Chenauthor=Y.+Louauthor=T.+Fujiwaraauthor=S.+C.+Piscitelli&title=Pharmacokinetics+and+safety+of+S%2FGSK1349572%2C+a+next-generation+HIV+integrase+inhibitor%2C+in+healthy+volunteers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMin%26aufirst%3DS.%26aulast%3DSong%26aufirst%3DI.%26aulast%3DBorland%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DLou%26aufirst%3DY.%26aulast%3DFujiwara%26aufirst%3DT.%26aulast%3DPiscitelli%26aufirst%3DS.%2BC.%26atitle%3DPharmacokinetics%2520and%2520safety%2520of%2520S%252FGSK1349572%252C%2520a%2520next-generation%2520HIV%2520integrase%2520inhibitor%252C%2520in%2520healthy%2520volunteers%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26issue%3D1%26spage%3D254%26epage%3D258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Sato, A.; Kobayashi, M.; Yoshinaga, T.; Fujiwara, T.; Underwood, M.; Johns, B.; Foster, S.; Hazen, R.; Ferris, R.; Brown, K.; Garvey, E.</span><span> </span><span class="NLM_article-title">S/GSK1349572 is a Potent Next Generation HIV Integrase Inhibitor</span>. In <span class="NLM_conf-name">Fifth IAS Conference on HIV Pathogenesis, Treatment, and Prevention</span>, <span class="NLM_conf-loc">Cape Town, South Africa</span>, <span class="NLM_conf-date">July 19â22, 2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sato%2C+A.%3B+Kobayashi%2C+M.%3B+Yoshinaga%2C+T.%3B+Fujiwara%2C+T.%3B+Underwood%2C+M.%3B+Johns%2C+B.%3B+Foster%2C+S.%3B+Hazen%2C+R.%3B+Ferris%2C+R.%3B+Brown%2C+K.%3B+Garvey%2C+E.+S%2FGSK1349572+is+a+Potent+Next+Generation+HIV+Integrase+Inhibitor.+In+Fifth+IAS+Conference+on+HIV+Pathogenesis%2C+Treatment%2C+and+Prevention%2C+Cape+Town%2C+South+Africa%2C+July+19%E2%88%9222%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DA.%26atitle%3DS%252FGSK1349572%2520is%2520a%2520Potent%2520Next%2520Generation%2520HIV%2520Integrase%2520Inhibitor" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Johns, B.; Kawasuji, T.; Taishi, T.; Yoshida, H.; Garvey, E.; Spreen, W.; Underwood, M.; Sato, A.; Yoshinaga, T.; Fujiwara, T.</span>, <span> </span><span class="NLM_article-title">The Discovery of S/GSK1349572: A Once-Daily Next Generation Integrase Inhibitor with a Superior Resistance Profile</span>. In <span class="NLM_conf-name">17th Conference on Retroviruses and Opportunistic Infections</span>, <span class="NLM_conf-loc">San Francisco</span>, <span class="NLM_conf-date">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Johns%2C+B.%3B+Kawasuji%2C+T.%3B+Taishi%2C+T.%3B+Yoshida%2C+H.%3B+Garvey%2C+E.%3B+Spreen%2C+W.%3B+Underwood%2C+M.%3B+Sato%2C+A.%3B+Yoshinaga%2C+T.%3B+Fujiwara%2C+T.%2C+The+Discovery+of+S%2FGSK1349572%3A+A+Once-Daily+Next+Generation+Integrase+Inhibitor+with+a+Superior+Resistance+Profile.+In+17th+Conference+on+Retroviruses+and+Opportunistic+Infections%2C+San+Francisco%2C+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DJohns%26aufirst%3DB.%26atitle%3DThe%2520Discovery%2520of%2520S%252FGSK1349572%253A%2520A%2520Once-Daily%2520Next%2520Generation%2520Integrase%2520Inhibitor%2520with%2520a%2520Superior%2520Resistance%2520Profile" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Serrao, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramkumar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neamati, N.</span><span> </span><span class="NLM_article-title">Raltegravir, elvitegravir, and metoogravir: the birth of âme-tooâ HIV-1 integrase inhibitors</span> <span class="citation_source-journal">Retrovirology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=25&author=E.+Serraoauthor=S.+Oddeauthor=K.+Ramkumarauthor=N.+Neamati&title=Raltegravir%2C+elvitegravir%2C+and+metoogravir%3A+the+birth+of+%E2%80%9Cme-too%E2%80%9D+HIV-1+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSerrao%26aufirst%3DE.%26aulast%3DOdde%26aufirst%3DS.%26aulast%3DRamkumar%26aufirst%3DK.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DRaltegravir%252C%2520elvitegravir%252C%2520and%2520metoogravir%253A%2520the%2520birth%2520of%2520%25E2%2580%259Cme-too%25E2%2580%259D%2520HIV-1%2520integrase%2520inhibitors%26jtitle%3DRetrovirology%26date%3D2009%26volume%3D6%26spage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Plewe, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dress, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuehler, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowlin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahavendran, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanis, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span> </span><span class="NLM_article-title">Azaindole hydroxamic acids are potent HIV-1 integrase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">7211</span><span class="NLM_x">â</span> <span class="NLM_lpage">7219</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900862n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7211-7219&issue=22&author=M.+B.+Pleweauthor=S.+L.+Butlerauthor=K.+R.+Dressauthor=Q.+Huauthor=T.+W.+Johnsonauthor=J.+E.+Kuehlerauthor=A.+Kukiauthor=H.+Lamauthor=W.+Liuauthor=D.+Nowlinauthor=Q.+Pengauthor=S.+V.+Rahavendranauthor=S.+P.+Tanisauthor=K.+T.+Tranauthor=H.+Wangauthor=A.+Yangauthor=J.+Zhang&title=Azaindole+hydroxamic+acids+are+potent+HIV-1+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm900862n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900862n%26sid%3Dliteratum%253Aachs%26aulast%3DPlewe%26aufirst%3DM.%2BB.%26aulast%3DButler%26aufirst%3DS.%2BL.%26aulast%3DDress%26aufirst%3DK.%2BR.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DKuehler%26aufirst%3DJ.%2BE.%26aulast%3DKuki%26aufirst%3DA.%26aulast%3DLam%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DNowlin%26aufirst%3DD.%26aulast%3DPeng%26aufirst%3DQ.%26aulast%3DRahavendran%26aufirst%3DS.%2BV.%26aulast%3DTanis%26aufirst%3DS.%2BP.%26aulast%3DTran%26aufirst%3DK.%2BT.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DAzaindole%2520hydroxamic%2520acids%2520are%2520potent%2520HIV-1%2520integrase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D22%26spage%3D7211%26epage%3D7219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Tanis, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plewe, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delisle, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dress, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuehler, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solowiej, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span> </span><span class="NLM_article-title">Azaindole <i>N</i>-Methyl Hydroxamic Acids as HIV-1 Integrase Inhibitors-II. The Impact of Physicochemical Properties on ADME and PK</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">7429</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=7429&author=S.+P.+Tanisauthor=M.+B.+Pleweauthor=T.+W.+Johnsonauthor=S.+L.+Butlerauthor=D.+Davieauthor=X.+Yuauthor=D.+Delisleauthor=K.+R.+Dressauthor=Q.+Huauthor=B.+Huangauthor=J.+E.+Kuehlerauthor=A.+Kukiauthor=W.+Liuauthor=Q.+Pengauthor=G.+L.+Smithauthor=J.+Solowiejauthor=K.+T.+Tranauthor=H.+Wangauthor=A.+Yangauthor=C.+Yinauthor=J.+Zhangauthor=H.+Zhu&title=Azaindole+N-Methyl+Hydroxamic+Acids+as+HIV-1+Integrase+Inhibitors-II.+The+Impact+of+Physicochemical+Properties+on+ADME+and+PK"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTanis%26aufirst%3DS.%2BP.%26aulast%3DPlewe%26aufirst%3DM.%2BB.%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DButler%26aufirst%3DS.%2BL.%26aulast%3DDavie%26aufirst%3DD.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DDelisle%26aufirst%3DD.%26aulast%3DDress%26aufirst%3DK.%2BR.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DKuehler%26aufirst%3DJ.%2BE.%26aulast%3DKuki%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DPeng%26aufirst%3DQ.%26aulast%3DSmith%26aufirst%3DG.%2BL.%26aulast%3DSolowiej%26aufirst%3DJ.%26aulast%3DTran%26aufirst%3DK.%2BT.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DA.%26aulast%3DYin%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DH.%26atitle%3DAzaindole%2520N-Methyl%2520Hydroxamic%2520Acids%2520as%2520HIV-1%2520Integrase%2520Inhibitors-II.%2520The%2520Impact%2520of%2520Physicochemical%2520Properties%2520on%2520ADME%2520and%2520PK%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D7429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felock, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hastings, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pramanik, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, A. L.</span><span> </span><span class="NLM_article-title">Differential divalent cation requirements uncouple the assembly and catalytic reactions of human immunodeficiency virus type 1 integrase</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">7005</span><span class="NLM_x">â</span> <span class="NLM_lpage">7011</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm200208d&amp;key=9261430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm200208d&amp;key=1%3ACAS%3A528%3ADyaK2sXlsVOjtro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1997&pages=7005-7011&issue=9&author=D.+J.+Hazudaauthor=P.+J.+Felockauthor=J.+C.+Hastingsauthor=B.+Pramanikauthor=A.+L.+Wolfe&title=Differential+divalent+cation+requirements+uncouple+the+assembly+and+catalytic+reactions+of+human+immunodeficiency+virus+type+1+integrase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Differential divalent cation requirements uncoupled the assembly and catalytic reactions of human immunodeficiency virus type 1 integrase</span></div><div class="casAuthors">Hazuda, Daria J.; Felock, Peter J.; Hastings, Jeffrey C.; Pramanik, Bernali; Wolfe, Abigail L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">7005-7011</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Previous in vitro analyses have shown that the human immunodeficiency virus type 1 (HIV-1) integrase uses either manganese or magnesium to assemble as a stable complex on the donor substrate and to catalyze strand transfer.  We now demonstrate that subsequent to assembly, catalysis of both 3' end processing and strand transfer requires a divalent cation cofactor and that the divalent cation requirements for assembly and catalysis can be functionally distinguished based on the ability to utilize calcium and cobalt, resp.  The different divalent cation requirements manifest by these processes are exploited to uncouple assembly and catalysis, thus staging the reaction.  Staged 3' end processing and strand transfer assays are then used in conjunction with exonuclease III protection anal. to investigate the effects of integrase inhibitors on each step in the reaction.  Anal. of a series of related inhibitors demonstrates that these types of compds. affect assembly and not either catalytic process, therefore reconciling the apparent disparate results obtained for such inhibitors in assays using isolated pre-integration complexes.  These studies provide evidence for a distinct role of the divalent cation cofactor in assembly and catalysis and have implications for both the identification and characterization of integrase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZfMUmmKmUirVg90H21EOLACvtfcHk0liR60LpI3RaLA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlsVOjtro%253D&md5=c5ce1c183540f6d4262e660181d59d6e</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DFelock%26aufirst%3DP.%2BJ.%26aulast%3DHastings%26aufirst%3DJ.%2BC.%26aulast%3DPramanik%26aufirst%3DB.%26aulast%3DWolfe%26aufirst%3DA.%2BL.%26atitle%3DDifferential%2520divalent%2520cation%2520requirements%2520uncouple%2520the%2520assembly%2520and%2520catalytic%2520reactions%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520integrase%26jtitle%3DJ.%2520Virol.%26date%3D1997%26volume%3D71%26issue%3D9%26spage%3D7005%26epage%3D7011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Konsavage, W. M.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudol, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzman, M.</span><span> </span><span class="NLM_article-title">Effects of varying the spacing within the D,D-35-E motif in the catalytic region of retroviral integrase</span> <span class="citation_source-journal">Virology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">379</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">223</span><span class="NLM_x">â</span> <span class="NLM_lpage">233</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=379&publication_year=2008&pages=223-233&issue=2&author=W.+M.+Konsavageauthor=M.+Sudolauthor=M.+Katzman&title=Effects+of+varying+the+spacing+within+the+D%2CD-35-E+motif+in+the+catalytic+region+of+retroviral+integrase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKonsavage%26aufirst%3DW.%2BM.%26aulast%3DSudol%26aufirst%3DM.%26aulast%3DKatzman%26aufirst%3DM.%26atitle%3DEffects%2520of%2520varying%2520the%2520spacing%2520within%2520the%2520D%252CD-35-E%2520motif%2520in%2520the%2520catalytic%2520region%2520of%2520retroviral%2520integrase%26jtitle%3DVirology%26date%3D2008%26volume%3D379%26issue%3D2%26spage%3D223%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Bacchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biemmi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carcelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Compari, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisicaro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogolino, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sechi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotriffer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neamati, N.</span><span> </span><span class="NLM_article-title">From ligand to complexes. Part 2. Remarks on human immunodeficiency virus type 1 integrase inhibition by beta-diketo acid metal complexes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">7253</span><span class="NLM_x">â</span> <span class="NLM_lpage">7264</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800893q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7253-7264&issue=22&author=A.+Bacchiauthor=M.+Biemmiauthor=M.+Carcelliauthor=F.+Cartaauthor=C.+Compariauthor=E.+Fisicaroauthor=D.+Rogolinoauthor=M.+Sechiauthor=M.+Sippelauthor=C.+A.+Sotrifferauthor=T.+W.+Sanchezauthor=N.+Neamati&title=From+ligand+to+complexes.+Part+2.+Remarks+on+human+immunodeficiency+virus+type+1+integrase+inhibition+by+beta-diketo+acid+metal+complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm800893q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800893q%26sid%3Dliteratum%253Aachs%26aulast%3DBacchi%26aufirst%3DA.%26aulast%3DBiemmi%26aufirst%3DM.%26aulast%3DCarcelli%26aufirst%3DM.%26aulast%3DCarta%26aufirst%3DF.%26aulast%3DCompari%26aufirst%3DC.%26aulast%3DFisicaro%26aufirst%3DE.%26aulast%3DRogolino%26aufirst%3DD.%26aulast%3DSechi%26aufirst%3DM.%26aulast%3DSippel%26aufirst%3DM.%26aulast%3DSotriffer%26aufirst%3DC.%2BA.%26aulast%3DSanchez%26aufirst%3DT.%2BW.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DFrom%2520ligand%2520to%2520complexes.%2520Part%25202.%2520Remarks%2520on%2520human%2520immunodeficiency%2520virus%2520type%25201%2520integrase%2520inhibition%2520by%2520beta-diketo%2520acid%2520metal%2520complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D22%26spage%3D7253%26epage%3D7264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Sechi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carcelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Compari, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duce, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisicaro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogolino, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derudas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Mawsawi, L. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neamati, N.</span><span> </span><span class="NLM_article-title">From ligand to complexes: inhibition of human immunodeficiency virus type 1 integrase by beta-diketo acid metal complexes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">4248</span><span class="NLM_x">â</span> <span class="NLM_lpage">4260</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060193m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4248-4260&issue=14&author=M.+Sechiauthor=A.+Bacchiauthor=M.+Carcelliauthor=C.+Compariauthor=E.+Duceauthor=E.+Fisicaroauthor=D.+Rogolinoauthor=P.+Gatesauthor=M.+Derudasauthor=L.+Q.+Al-Mawsawiauthor=N.+Neamati&title=From+ligand+to+complexes%3A+inhibition+of+human+immunodeficiency+virus+type+1+integrase+by+beta-diketo+acid+metal+complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm060193m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060193m%26sid%3Dliteratum%253Aachs%26aulast%3DSechi%26aufirst%3DM.%26aulast%3DBacchi%26aufirst%3DA.%26aulast%3DCarcelli%26aufirst%3DM.%26aulast%3DCompari%26aufirst%3DC.%26aulast%3DDuce%26aufirst%3DE.%26aulast%3DFisicaro%26aufirst%3DE.%26aulast%3DRogolino%26aufirst%3DD.%26aulast%3DGates%26aufirst%3DP.%26aulast%3DDerudas%26aufirst%3DM.%26aulast%3DAl-Mawsawi%26aufirst%3DL.%2BQ.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DFrom%2520ligand%2520to%2520complexes%253A%2520inhibition%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520integrase%2520by%2520beta-diketo%2520acid%2520metal%2520complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26issue%3D14%26spage%3D4248%26epage%3D4260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="note"><p class="first last">Calculations were performed with Jaguar 7.7, Schrodinger, LLC, Portland, Oregon, 2010. A conformational search was first performed using the OPLS2005 force field in water with Mixed torsional/Low-mode sampling method. This resulted in total four representative conformers, global_min a and conf1-conf3 b-d. Further geometry optimization of those four conformers are performed in Jaguar using ab initio calculations with basis set of B3LYP/6-31G** and PBF solvation model in water. No imaginary frequencies were found for any of the four conformations. The final single point energies were obtained at B3LYP/ CC_PVTZ(-F)++ level with PBF solvation model in water. Conf4 e was derived by twisting the two torsion angles to the presumed binding orientation with the pyridine nitrogen, the carbonyl, and the hydroxamate oxygen all coplanar based on the global_min conformation from above and performing constrained minimization of the rest of the structure using basis set of B3LYP/6-31G** and PBF solvation model in water. One imaginary frequency was found at â96.684. The final single point energies were obtained at B3LYP/ CC_PVTZ(-F)++ level with PBF solvation model in water.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Echavarren, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stille, J. K.</span><span> </span><span class="NLM_article-title">Palladium-catalyzed coupling of aryl triflates with organostannanes</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">5478</span><span class="NLM_x">â</span> <span class="NLM_lpage">5486</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00252a029" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm200208d&amp;key=1%3ACAS%3A528%3ADyaL2sXltFGgs7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=1987&pages=5478-5486&author=A.+M.+Echavarrenauthor=J.+K.+Stille&title=Palladium-catalyzed+coupling+of+aryl+triflates+with+organostannanes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-catalyzed coupling of aryl triflates with organostannanes</span></div><div class="casAuthors">Echavarren, Antonio M.; Stille, J. K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5478-86</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">The Pd-catalyzed coupling reaction of aryl triflates with alkyl, vinyl, acetylenic, and aryl tin reagents in the presence of LiCl takes place in high yields under mild conditions.  Thus, reaction of p-AcC6H4O3SCF3 with CH2:CHSnBu3 in the presence of Pd(PPh3)4 and LiCl gave 95% p-AcC6H4CH:CH2.  However, allyltrialkyltin reagents coupled in lower yields, and unselective transfer of the allyl group was obsd.  The aryl coupling reaction was applied to a synthesis of the quinoline alkaloid dubamine.  The Pd-catalyzed coupling of aryl triflates with Me3SnSnMe3 gave aryltrimethylstannanes or homocoupled products depending on the amt. of tin reagent.  p-BrC6H4O3SCF3 could be coupled selectively with CH2:CHSnBu3 through either the C-Br or the C-O bond by using different Pd catalysts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNS3Xv2kfNQbVg90H21EOLACvtfcHk0liVKr2h2ZEbhw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXltFGgs7k%253D&md5=82f6c5209a7709f01fbc0808a6a50446</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fja00252a029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00252a029%26sid%3Dliteratum%253Aachs%26aulast%3DEchavarren%26aufirst%3DA.%2BM.%26aulast%3DStille%26aufirst%3DJ.%2BK.%26atitle%3DPalladium-catalyzed%2520coupling%2520of%2520aryl%2520triflates%2520with%2520organostannanes%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1987%26volume%3D109%26spage%3D5478%26epage%3D5486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Wollenberg, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albizati, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peries, R.</span><span> </span><span class="NLM_article-title">A nucleophilic acetaldehyde equivalent. Preparation and synthetic applications of cis-2-ethoxyvynillithium</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">7365</span><span class="NLM_x">â</span> <span class="NLM_lpage">7367</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00464a051" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1977&pages=7365-7367&author=R.+H.+Wollenbergauthor=K.+F.+Albizatiauthor=R.+Peries&title=A+nucleophilic+acetaldehyde+equivalent.+Preparation+and+synthetic+applications+of+cis-2-ethoxyvynillithium"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fja00464a051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00464a051%26sid%3Dliteratum%253Aachs%26aulast%3DWollenberg%26aufirst%3DR.%2BH.%26aulast%3DAlbizati%26aufirst%3DK.%2BF.%26aulast%3DPeries%26aufirst%3DR.%26atitle%3DA%2520nucleophilic%2520acetaldehyde%2520equivalent.%2520Preparation%2520and%2520synthetic%2520applications%2520of%2520cis-2-ethoxyvynillithium%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1977%26volume%3D99%26spage%3D7365%26epage%3D7367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Littke, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, G. C.</span><span> </span><span class="NLM_article-title">A versatile catalyst for Heck reactions of aryl chlorides and aryl bromides under mild conditions</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x"> (</span><span class="NLM_issue">29</span><span class="NLM_x">) </span> <span class="NLM_fpage">6989</span><span class="NLM_x">â</span> <span class="NLM_lpage">7000</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja010988c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2001&pages=6989-7000&issue=29&author=A.+F.+Littkeauthor=G.+C.+Fu&title=A+versatile+catalyst+for+Heck+reactions+of+aryl+chlorides+and+aryl+bromides+under+mild+conditions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fja010988c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja010988c%26sid%3Dliteratum%253Aachs%26aulast%3DLittke%26aufirst%3DA.%2BF.%26aulast%3DFu%26aufirst%3DG.%2BC.%26atitle%3DA%2520versatile%2520catalyst%2520for%2520Heck%2520reactions%2520of%2520aryl%2520chlorides%2520and%2520aryl%2520bromides%2520under%2520mild%2520conditions%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2001%26volume%3D123%26issue%3D29%26spage%3D6989%26epage%3D7000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Ullrich, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binder, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mereiter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyerin, M.</span><span> </span><span class="NLM_article-title">Conformationally constrained nicotines: polycyclic, bridged, and spiro-annulated analogues as novel ligands for the nicotinic acetylcholine receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">4047</span><span class="NLM_x">â</span> <span class="NLM_lpage">4054</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020916b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=4047-4054&issue=18&author=T.+Ullrichauthor=S.+Krichauthor=D.+Binderauthor=K.+Mereiterauthor=D.+J.+Andersonauthor=M.+D.+Meyerauthor=M.+Pyerin&title=Conformationally+constrained+nicotines%3A+polycyclic%2C+bridged%2C+and+spiro-annulated+analogues+as+novel+ligands+for+the+nicotinic+acetylcholine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm020916b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020916b%26sid%3Dliteratum%253Aachs%26aulast%3DUllrich%26aufirst%3DT.%26aulast%3DKrich%26aufirst%3DS.%26aulast%3DBinder%26aufirst%3DD.%26aulast%3DMereiter%26aufirst%3DK.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DMeyer%26aufirst%3DM.%2BD.%26aulast%3DPyerin%26aufirst%3DM.%26atitle%3DConformationally%2520constrained%2520nicotines%253A%2520polycyclic%252C%2520bridged%252C%2520and%2520spiro-annulated%2520analogues%2520as%2520novel%2520ligands%2520for%2520the%2520nicotinic%2520acetylcholine%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26issue%3D18%26spage%3D4047%26epage%3D4054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Masaguer, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravina, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fueyo, J.</span><span> </span><span class="NLM_article-title">Alkylation of 3-ehtyl-2-methyl-4-oxo-4,5,6,7-tetrahydroindole with bromoesters: benzene sulfonyl as a convenient nitrogen protecting group</span> <span class="citation_source-journal">Heterocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1303</span><span class="NLM_x">â</span> <span class="NLM_lpage">1309</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1992&pages=1303-1309&author=C.+F.+Masaguerauthor=E.+Ravinaauthor=J.+Fueyo&title=Alkylation+of+3-ehtyl-2-methyl-4-oxo-4%2C5%2C6%2C7-tetrahydroindole+with+bromoesters%3A+benzene+sulfonyl+as+a+convenient+nitrogen+protecting+group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMasaguer%26aufirst%3DC.%2BF.%26aulast%3DRavina%26aufirst%3DE.%26aulast%3DFueyo%26aufirst%3DJ.%26atitle%3DAlkylation%2520of%25203-ehtyl-2-methyl-4-oxo-4%252C5%252C6%252C7-tetrahydroindole%2520with%2520bromoesters%253A%2520benzene%2520sulfonyl%2520as%2520a%2520convenient%2520nitrogen%2520protecting%2520group%26jtitle%3DHeterocycles%26date%3D1992%26volume%3D34%26spage%3D1303%26epage%3D1309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishida, H.</span><span> </span><span class="NLM_article-title">Use of <i>N</i>,<i>N</i>-dimethyl(methylene)ammonium chloride inthe functionalization of indoles</span> <span class="citation_source-journal">Heterocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">â</span> <span class="NLM_lpage">58</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1980&pages=55-58&author=A.+P.+Kozikowskiauthor=H.+Ishida&title=Use+of+N%2CN-dimethyl%28methylene%29ammonium+chloride+inthe+functionalization+of+indoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26aulast%3DIshida%26aufirst%3DH.%26atitle%3DUse%2520of%2520N%252CN-dimethyl%2528methylene%2529ammonium%2520chloride%2520inthe%2520functionalization%2520of%2520indoles%26jtitle%3DHeterocycles%26date%3D1980%26volume%3D14%26spage%3D55%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Kashdan, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rapaport, H.</span><span> </span><span class="NLM_article-title">Synthesis of 1,2,3,4-tetrahydroisoquinolines</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">2638</span><span class="NLM_x">â</span> <span class="NLM_lpage">2643</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=2638-2643&author=D.+S.+Kashdanauthor=J.+A.+Schwartzauthor=H.+Rapaport&title=Synthesis+of+1%2C2%2C3%2C4-tetrahydroisoquinolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKashdan%26aufirst%3DD.%2BS.%26aulast%3DSchwartz%26aufirst%3DJ.%2BA.%26aulast%3DRapaport%26aufirst%3DH.%26atitle%3DSynthesis%2520of%25201%252C2%252C3%252C4-tetrahydroisoquinolines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2008%26volume%3D47%26spage%3D2638%26epage%3D2643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Schnute, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brideau, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collier, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cudahy, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knechtel, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oien, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sackett, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephan, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wathen, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wieber, J. L.</span><span> </span><span class="NLM_article-title">Synthesis of 4-oxo-4,7-dihydrofuro[2,3-<i>b</i>]pyridine-5-carboxamides with broad-spectrum human herpesvirus polymerase inhibition</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3856</span><span class="NLM_x">â</span> <span class="NLM_lpage">3859</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=3856-3859&author=M.+E.+Schnuteauthor=R.+J.+Brideauauthor=S.+A.+Collierauthor=M.+M.+Cudahyauthor=T.+A.+Hopkinsauthor=M.+L.+Knechtelauthor=N.+L.+Oienauthor=R.+S.+Sackettauthor=A.+Scottauthor=M.+L.+Stephanauthor=M.+W.+Wathenauthor=J.+L.+Wieber&title=Synthesis+of+4-oxo-4%2C7-dihydrofuro%5B2%2C3-b%5Dpyridine-5-carboxamides+with+broad-spectrum+human+herpesvirus+polymerase+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchnute%26aufirst%3DM.%2BE.%26aulast%3DBrideau%26aufirst%3DR.%2BJ.%26aulast%3DCollier%26aufirst%3DS.%2BA.%26aulast%3DCudahy%26aufirst%3DM.%2BM.%26aulast%3DHopkins%26aufirst%3DT.%2BA.%26aulast%3DKnechtel%26aufirst%3DM.%2BL.%26aulast%3DOien%26aufirst%3DN.%2BL.%26aulast%3DSackett%26aufirst%3DR.%2BS.%26aulast%3DScott%26aufirst%3DA.%26aulast%3DStephan%26aufirst%3DM.%2BL.%26aulast%3DWathen%26aufirst%3DM.%2BW.%26aulast%3DWieber%26aufirst%3DJ.%2BL.%26atitle%3DSynthesis%2520of%25204-oxo-4%252C7-dihydrofuro%255B2%252C3-b%255Dpyridine-5-carboxamides%2520with%2520broad-spectrum%2520human%2520herpesvirus%2520polymerase%2520inhibition%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D3856%26epage%3D3859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolkenberg, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanderson, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carella, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ecto, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabryelski, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGaughey, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, T. M.</span><span> </span><span class="NLM_article-title">Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">554</span><span class="NLM_x">â</span> <span class="NLM_lpage">559</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=554-559&issue=2&author=Z.+Zhaoauthor=S.+E.+Wolkenbergauthor=P.+E.+Sandersonauthor=M.+Luauthor=V.+Munshiauthor=G.+Moyerauthor=M.+Fengauthor=A.+V.+Carellaauthor=L.+T.+Ectoauthor=L.+J.+Gabryelskiauthor=M.+T.+Laiauthor=S.+G.+Prasadauthor=Y.+Yanauthor=G.+B.+McGaugheyauthor=M.+D.+Millerauthor=C.+W.+Lindsleyauthor=G.+D.+Hartmanauthor=J.+P.+Vaccaauthor=T.+M.+Williams&title=Novel+indole-3-sulfonamides+as+potent+HIV+non-nucleoside+reverse+transcriptase+inhibitors+%28NNRTIs%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DWolkenberg%26aufirst%3DS.%2BE.%26aulast%3DSanderson%26aufirst%3DP.%2BE.%26aulast%3DLu%26aufirst%3DM.%26aulast%3DMunshi%26aufirst%3DV.%26aulast%3DMoyer%26aufirst%3DG.%26aulast%3DFeng%26aufirst%3DM.%26aulast%3DCarella%26aufirst%3DA.%2BV.%26aulast%3DEcto%26aufirst%3DL.%2BT.%26aulast%3DGabryelski%26aufirst%3DL.%2BJ.%26aulast%3DLai%26aufirst%3DM.%2BT.%26aulast%3DPrasad%26aufirst%3DS.%2BG.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DMcGaughey%26aufirst%3DG.%2BB.%26aulast%3DMiller%26aufirst%3DM.%2BD.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DWilliams%26aufirst%3DT.%2BM.%26atitle%3DNovel%2520indole-3-sulfonamides%2520as%2520potent%2520HIV%2520non-nucleoside%2520reverse%2520transcriptase%2520inhibitors%2520%2528NNRTIs%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D2%26spage%3D554%26epage%3D559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Ryckmans, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correia, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutt, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, T.</span><span> </span><span class="NLM_article-title">Rapid assessment of a novel series of selective CB(2) agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">4406</span><span class="NLM_x">â</span> <span class="NLM_lpage">4409</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm200208d&amp;key=10.1016%2Fj.bmcl.2009.05.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm200208d&amp;key=19500981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm200208d&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4406-4409&issue=15&author=T.+Ryckmansauthor=M.+P.+Edwardsauthor=V.+A.+Horneauthor=A.+M.+Correiaauthor=D.+R.+Owenauthor=L.+R.+Thompsonauthor=I.+Tranauthor=M.+F.+Tuttauthor=T.+Young&title=Rapid+assessment+of+a+novel+series+of+selective+CB%282%29+agonists+using+parallel+synthesis+protocols%3A+A+Lipophilic+Efficiency+%28LipE%29+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis</span></div><div class="casAuthors">Ryckmans, Thomas; Edwards, Martin P.; Horne, Val A.; Correia, Ana Monica; Owen, Dafydd R.; Thompson, Lisa R.; Tran, Isabelle; Tutt, Michelle F.; Young, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4406-4409</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of libraries were designed using the 1-(cyclopropylmethyl)-2-alkyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-5-ium templates 2a-b, and Sulfonamide derivs. 11a-n proved to be potent agonists of the CB2 receptor.  Anal. of the Lipophilic Efficiency (LipE) of potent compds. provided new insight for the design of potent, metabolically stable CB2 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1cihq9YHuO7Vg90H21EOLACvtfcHk0ljUCaDU3twThg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D&md5=b62d97e5f52a594cfdd510f32d2e566f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.05.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.05.062%26sid%3Dliteratum%253Aachs%26aulast%3DRyckmans%26aufirst%3DT.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26aulast%3DHorne%26aufirst%3DV.%2BA.%26aulast%3DCorreia%26aufirst%3DA.%2BM.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DThompson%26aufirst%3DL.%2BR.%26aulast%3DTran%26aufirst%3DI.%26aulast%3DTutt%26aufirst%3DM.%2BF.%26aulast%3DYoung%26aufirst%3DT.%26atitle%3DRapid%2520assessment%2520of%2520a%2520novel%2520series%2520of%2520selective%2520CB%25282%2529%2520agonists%2520using%2520parallel%2520synthesis%2520protocols%253A%2520A%2520Lipophilic%2520Efficiency%2520%2528LipE%2529%2520analysis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26issue%3D15%26spage%3D4406%26epage%3D4409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Antonio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grillasca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taskinen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elovaara, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burchell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piet, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ethell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouzzine, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fournel-Gigleux, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magdalou, J.</span><span> </span><span class="NLM_article-title">Characterization of catechol glucuronidation in rat liver</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">199</span><span class="NLM_x">â</span> <span class="NLM_lpage">207</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2002&pages=199-207&issue=2&author=L.+Antonioauthor=J.+P.+Grillascaauthor=J.+Taskinenauthor=E.+Elovaaraauthor=B.+Burchellauthor=M.+H.+Pietauthor=B.+Ethellauthor=M.+Ouzzineauthor=S.+Fournel-Gigleuxauthor=J.+Magdalou&title=Characterization+of+catechol+glucuronidation+in+rat+liver"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAntonio%26aufirst%3DL.%26aulast%3DGrillasca%26aufirst%3DJ.%2BP.%26aulast%3DTaskinen%26aufirst%3DJ.%26aulast%3DElovaara%26aufirst%3DE.%26aulast%3DBurchell%26aufirst%3DB.%26aulast%3DPiet%26aufirst%3DM.%2BH.%26aulast%3DEthell%26aufirst%3DB.%26aulast%3DOuzzine%26aufirst%3DM.%26aulast%3DFournel-Gigleux%26aufirst%3DS.%26aulast%3DMagdalou%26aufirst%3DJ.%26atitle%3DCharacterization%2520of%2520catechol%2520glucuronidation%2520in%2520rat%2520liver%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2002%26volume%3D30%26issue%3D2%26spage%3D199%26epage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Ouzzine, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barre, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Netter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magdalou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fournel-Gigleux, S.</span><span> </span><span class="NLM_article-title">The human UDP-glucuronosyltransferases: structural aspects and drug glucuronidation</span> <span class="citation_source-journal">Drug Metab. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">287</span><span class="NLM_x">â</span> <span class="NLM_lpage">303</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm200208d&amp;key=10.1081%2FDMR-120026397" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm200208d&amp;key=14705862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm200208d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXps1ygs7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2003&pages=287-303&issue=4&author=M.+Ouzzineauthor=L.+Barreauthor=P.+Netterauthor=J.+Magdalouauthor=S.+Fournel-Gigleux&title=The+human+UDP-glucuronosyltransferases%3A+structural+aspects+and+drug+glucuronidation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The human UDP-glucuronosyltransferases: Structural aspects and drug glucuronidation</span></div><div class="casAuthors">Ouzzine, Mohamed; Barre, Lydia; Netter, Patrick; Magdalou, Jacques; Fournel-Gigleux, Sylvie</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">287-303</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">A review on the recent structural and functional information on human UDP-glucuronosyltransferase (UGTs).  It discusses the mol. events and mechanisms that account for the glucuronidation of drugs and endogenous compds.  It focuses on the identification of amino acids and peptide domains that are crit. for the binding of substrates and effectors to the active site, for the organization of the protein and its interaction with the membrane phospholipids and on the mechanisms that account for the glucuronidation process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLrhTr7EKZ7rVg90H21EOLACvtfcHk0lg7cjyXd2tPIg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXps1ygs7s%253D&md5=552a33a2e81510a1d089049a8ff309f5</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1081%2FDMR-120026397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FDMR-120026397%26sid%3Dliteratum%253Aachs%26aulast%3DOuzzine%26aufirst%3DM.%26aulast%3DBarre%26aufirst%3DL.%26aulast%3DNetter%26aufirst%3DP.%26aulast%3DMagdalou%26aufirst%3DJ.%26aulast%3DFournel-Gigleux%26aufirst%3DS.%26atitle%3DThe%2520human%2520UDP-glucuronosyltransferases%253A%2520structural%2520aspects%2520and%2520drug%2520glucuronidation%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D2003%26volume%3D35%26issue%3D4%26spage%3D287%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Exner, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hradil, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mollin, J.</span><span> </span><span class="NLM_article-title">Dissociation of Hydroxamic Acids</span> <span class="citation_source-journal">Collect. Czech. Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1109</span><span class="NLM_x">â</span> <span class="NLM_lpage">1121</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm200208d&amp;key=10.1135%2Fcccc19931109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm200208d&amp;key=1%3ACAS%3A528%3ADyaK3sXlvVSgsrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1993&pages=1109-1121&author=O.+Exnerauthor=M.+Hradilauthor=J.+Mollin&title=Dissociation+of+Hydroxamic+Acids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Dissociation of hydroxamic acids: solvent effects</span></div><div class="casAuthors">Exner, Otto; Hradil, Martin; Mollin, Jiri</div><div class="citationInfo"><span class="NLM_cas:title">Collection of Czechoslovak Chemical Communications</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1109-21</span>CODEN:
                <span class="NLM_cas:coden">CCCCAK</span>;
        ISSN:<span class="NLM_cas:issn">0010-0765</span>.
    </div><div class="casAbstract">The dissocn. consts. of benzohydroxamic, 4-chlorobenzohydroxamic, and 4-nitrobenzohydroxamic acids, and their N-Me and O-Me derivs., were measured spectrophotometrically or potentiometrically in mixts. of 2-propanol and water.  The results were extrapolated to zero ionic strength.  The ratio of dissocn. consts. of the O-Me and N-Me derivs. can be taken to represent - with some approxn. - the ratio of NH and OH acidities of the parent acid.  This ratio increases with substitution by electron-attracting substituents, and decreases with solvent permittivity: some irregularities might be attributable to the effects of mixed solvents.  It follows that 4-nitrobenzohydroxamic acid behaves essentially as N-acid in all solvents, 4-chlorobenzohydroxamic acid only in 90% 2-propanol or 80% methyl Cellosolve.  In benzohydroxamic acid the NH and OH acidities are comparable, the latter prevails slightly in water, the former in less polar solvents.  Some apparent discrepancies in the literature can be explained in the same terms, only a few results have not yet been explained.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfZ8bGQHcJD7Vg90H21EOLACvtfcHk0lg7cjyXd2tPIg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXlvVSgsrw%253D&md5=b0be00573962599ba735e75c1ae3b037</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1135%2Fcccc19931109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1135%252Fcccc19931109%26sid%3Dliteratum%253Aachs%26aulast%3DExner%26aufirst%3DO.%26aulast%3DHradil%26aufirst%3DM.%26aulast%3DMollin%26aufirst%3DJ.%26atitle%3DDissociation%2520of%2520Hydroxamic%2520Acids%26jtitle%3DCollect.%2520Czech.%2520Chem.%2520Commun.%26date%3D1993%26volume%3D58%26spage%3D1109%26epage%3D1121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Johnson, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dress, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M.</span><span> </span><span class="NLM_article-title">Using the Golden Triangle to optimize clearance and oral absorption</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">5560</span><span class="NLM_x">â</span> <span class="NLM_lpage">5564</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5560-5564&issue=19&author=T.+W.+Johnsonauthor=K.+R.+Dressauthor=M.+Edwards&title=Using+the+Golden+Triangle+to+optimize+clearance+and+oral+absorption"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DDress%26aufirst%3DK.%2BR.%26aulast%3DEdwards%26aufirst%3DM.%26atitle%3DUsing%2520the%2520Golden%2520Triangle%2520to%2520optimize%2520clearance%2520and%2520oral%2520absorption%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26issue%3D19%26spage%3D5560%26epage%3D5564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Skiles, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yost, G. S.</span><span> </span><span class="NLM_article-title">Mechanistic studies on the cytochrome P450-catalyzed dehydrogenation of 3-methylindole</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">291</span><span class="NLM_x">â</span> <span class="NLM_lpage">297</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx9501187" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1996&pages=291-297&issue=1&author=G.+L.+Skilesauthor=G.+S.+Yost&title=Mechanistic+studies+on+the+cytochrome+P450-catalyzed+dehydrogenation+of+3-methylindole"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Ftx9501187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx9501187%26sid%3Dliteratum%253Aachs%26aulast%3DSkiles%26aufirst%3DG.%2BL.%26aulast%3DYost%26aufirst%3DG.%2BS.%26atitle%3DMechanistic%2520studies%2520on%2520the%2520cytochrome%2520P450-catalyzed%2520dehydrogenation%2520of%25203-methylindole%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D1996%26volume%3D9%26issue%3D1%26spage%3D291%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Baranczewski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanczak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kautiainen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, P. O.</span><span> </span><span class="NLM_article-title">Introduction to early in vitro identification of metabolites of new chemical entities in drug discovery and development</span> <span class="citation_source-journal">Pharmacol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">341</span><span class="NLM_x">â</span> <span class="NLM_lpage">352</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm200208d&amp;key=16845208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm200208d&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVKrtbnN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2006&pages=341-352&issue=3&author=P.+Baranczewskiauthor=A.+Stanczakauthor=A.+Kautiainenauthor=P.+Sandinauthor=P.+O.+Edlund&title=Introduction+to+early+in+vitro+identification+of+metabolites+of+new+chemical+entities+in+drug+discovery+and+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Introduction to early in vitro identification of metabolites of new chemical entities in drug discovery and development</span></div><div class="casAuthors">Baranczewski, Pawel; Stanczak, Andrzej; Kautiainen, Antti; Sandin, Per; Edlund, Per-Olof</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reports</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">341-352</span>CODEN:
                <span class="NLM_cas:coden">PRHEDU</span>;
        ISSN:<span class="NLM_cas:issn">1734-1140</span>.
    
            (<span class="NLM_cas:orgname">Polish Academy of Sciences, Institute of Pharmacology</span>)
        </div><div class="casAbstract">A review.  The introduction of combinatorial chem. and robotics for high throughput screening has changed the way drugs are discovered today compared with 10-15 years ago when fewer compds. were tested in animal or organ models.  The introduction of new anal. techniques, esp. liq. chromatog./mass spectrometry (LC/MS) has made it possible to characterize the chem. properties, permeability, metabolic stability and metabolic fate of a large no. of screening hits for further development in a funnel-like manner.  The purpose of this contribution is to discuss principles and recent strategies for metabolite identification and to give an introduction to biotransformation studies.  Metabolites are exptl. generated with the use of animal and human recombinant expressed enzymes, and different liver and other tissue fractions like microsomes and slices.  For sepn. and identification of structurally diverse metabolites, LC/MS and tandem mass spectrometry (LC/MS/MS) techniques are commonly used.  The LC/MS and LC/MS/MS techniques are rapid, sensitive, easy to automate and robust, and therefore, they are the methods of choice for these studies.  The outcome of the metabolite identification studies is detection of metabolites that could be pharmacol. active and contribute to the efficacy of a new chem. entity (NCE), and elimination of compds. that form reactive intermediates and/or toxic metabolites that could cause adverse effects of NCE.  If such information is available at an early stage during the drug discovery process, the chem. structure of the compd. may be modified to reduce the risk of idiosyncratic and/or adverse drag reactions during clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwWTbo1izuk7Vg90H21EOLACvtfcHk0lg7cjyXd2tPIg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVKrtbnN&md5=214271dbac0532c6a9db5823536df6b6</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaranczewski%26aufirst%3DP.%26aulast%3DStanczak%26aufirst%3DA.%26aulast%3DKautiainen%26aufirst%3DA.%26aulast%3DSandin%26aufirst%3DP.%26aulast%3DEdlund%26aufirst%3DP.%2BO.%26atitle%3DIntroduction%2520to%2520early%2520in%2520vitro%2520identification%2520of%2520metabolites%2520of%2520new%2520chemical%2520entities%2520in%2520drug%2520discovery%2520and%2520development%26jtitle%3DPharmacol.%2520Rep.%26date%3D2006%26volume%3D58%26issue%3D3%26spage%3D341%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Flipo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dassonneville, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez-Poulain, R.</span><span> </span><span class="NLM_article-title">Hydroxamates: relationships between structure and plasma stability</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">6790</span><span class="NLM_x">â</span> <span class="NLM_lpage">6802</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900648x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6790-6802&issue=21&author=M.+Flipoauthor=J.+Chartonauthor=A.+Hocineauthor=S.+Dassonnevilleauthor=B.+Deprezauthor=R.+Deprez-Poulain&title=Hydroxamates%3A+relationships+between+structure+and+plasma+stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm900648x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900648x%26sid%3Dliteratum%253Aachs%26aulast%3DFlipo%26aufirst%3DM.%26aulast%3DCharton%26aufirst%3DJ.%26aulast%3DHocine%26aufirst%3DA.%26aulast%3DDassonneville%26aufirst%3DS.%26aulast%3DDeprez%26aufirst%3DB.%26aulast%3DDeprez-Poulain%26aufirst%3DR.%26atitle%3DHydroxamates%253A%2520relationships%2520between%2520structure%2520and%2520plasma%2520stability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D21%26spage%3D6790%26epage%3D6802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Summers, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazdiyasni, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holms, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratajczyk, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyer, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, G. W.</span><span> </span><span class="NLM_article-title">Hydroxamic acid inhibitors of 5-lipoxygenase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">574</span><span class="NLM_x">â</span> <span class="NLM_lpage">80</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00386a022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1987&pages=574-80&issue=3&author=J.+B.+Summersauthor=H.+Mazdiyasniauthor=J.+H.+Holmsauthor=J.+D.+Ratajczykauthor=R.+D.+Dyerauthor=G.+W.+Carter&title=Hydroxamic+acid+inhibitors+of+5-lipoxygenase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm00386a022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00386a022%26sid%3Dliteratum%253Aachs%26aulast%3DSummers%26aufirst%3DJ.%2BB.%26aulast%3DMazdiyasni%26aufirst%3DH.%26aulast%3DHolms%26aufirst%3DJ.%2BH.%26aulast%3DRatajczyk%26aufirst%3DJ.%2BD.%26aulast%3DDyer%26aufirst%3DR.%2BD.%26aulast%3DCarter%26aufirst%3DG.%2BW.%26atitle%3DHydroxamic%2520acid%2520inhibitors%2520of%25205-lipoxygenase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1987%26volume%3D30%26issue%3D3%26spage%3D574%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="note"><p class="first last">Based on 24 h coverage of free EC<sub>90</sub> (6 nM). Free fraction in 100% human plasma is 24%.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="note"><p class="first last">Î´-DNA polymerase, Î²-DNA polymerase, Î±-DNA polymerase, carbonic anhydrase, matrix metalloproteinase (MMP-1, 2, 3, 7, 8, 9, 13), all show 0% inhbition at 10 uM.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Weislow, O. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiser, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fine, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bader, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, M. R.</span><span> </span><span class="NLM_article-title">New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">577</span><span class="NLM_x">â</span> <span class="NLM_lpage">586</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm200208d&amp;key=10.1093%2Fjnci%2F81.8.577" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm200208d&amp;key=2495366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm200208d&amp;key=1%3ACAS%3A528%3ADyaL1MXkvV2lt78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1989&pages=577-586&issue=8&author=O.+S.+Weislowauthor=R.+Kiserauthor=D.+L.+Fineauthor=J.+Baderauthor=R.+H.+Shoemakerauthor=M.+R.+Boyd&title=New+soluble-formazan+assay+for+HIV-1+cytopathic+effects%3A+application+to+high-flux+screening+of+synthetic+and+natural+products+for+AIDS-antiviral+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">New soluble-formazan assay for HIV-1 cytopathic effects:  application to high-flux screening of synthetic and natural products for AIDS-antiviral activity</span></div><div class="casAuthors">Weislow, Owen S.; Kiser, Rebecca; Fine, Donald L.; Bader, John; Shoemaker, Robert H.; Boyd, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">577-86</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">An effective and optimally safe microculture method was developed for the rapid and convenient assay of the in vitro cytopathic effects of human immunodeficiency virus (HIV-1) on human lymphoblastoid or other suitable host cells.  The assay procedure is applicable to the evaluation of drug effects on in vitro infections induced directly in cultured host cells by cell-free HIV-1 or by coculture with H9 cells chronically infected with HIV-1.  The assay uses a newly developed tetrazolium reagent that is metabolically reduced by viable cells to yield a sol., colored formazan product measureable by conventional colorimetric techniques.  This simple microassay minimizes the no. of plate manipulations typically required with other assay methods and, coupled with computerized data collection and anal., facilitates large-scale screening of agents for potential antiviral activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDJZMdwKZfgbVg90H21EOLACvtfcHk0lhFxc2tE-y35A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXkvV2lt78%253D&md5=c39a027f4ddc6bb5d7b1108c1b128be6</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F81.8.577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F81.8.577%26sid%3Dliteratum%253Aachs%26aulast%3DWeislow%26aufirst%3DO.%2BS.%26aulast%3DKiser%26aufirst%3DR.%26aulast%3DFine%26aufirst%3DD.%2BL.%26aulast%3DBader%26aufirst%3DJ.%26aulast%3DShoemaker%26aufirst%3DR.%2BH.%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26atitle%3DNew%2520soluble-formazan%2520assay%2520for%2520HIV-1%2520cytopathic%2520effects%253A%2520application%2520to%2520high-flux%2520screening%2520of%2520synthetic%2520and%2520natural%2520products%2520for%2520AIDS-antiviral%2520activity%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1989%26volume%3D81%26issue%3D8%26spage%3D577%26epage%3D586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Hu, Q.; Kuki, A.; Nowlin, D. M.; Plewe, M. B.; Wang, H.; Zhang, J. HIV</span><span> </span><span class="NLM_article-title">Integrase Inhibitors, Pharmceutical Compositions and Methods for their Use</span>. U.S. Patent 7,368,571, <span class="NLM_month">May</span><span class="NLM_day">6</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=Q.+Hu&author=A.+Kuki&author=D.+M.+Nowlin&author=M.+B.+Plewe&author=H.+Wang&author=J.+HIV+Zhang&title=Integrase+Inhibitors%2C+Pharmceutical+Compositions+and+Methods+for+their+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DQ.%26atitle%3DIntegrase%2520Inhibitors%252C%2520Pharmceutical%2520Compositions%2520and%2520Methods%2520for%2520their%2520Use%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Chen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krucinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miercke, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finer-Moore, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leavitt, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroud, R. M.</span><span> </span><span class="NLM_article-title">Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: a model for viral DNA binding</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">8233</span><span class="NLM_x">â</span> <span class="NLM_lpage">8238</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=8233-8238&issue=15&author=J.+C.+Chenauthor=J.+Krucinskiauthor=L.+J.+Mierckeauthor=J.+S.+Finer-Mooreauthor=A.+H.+Tangauthor=A.+D.+Leavittauthor=R.+M.+Stroud&title=Crystal+structure+of+the+HIV-1+integrase+catalytic+core+and+C-terminal+domains%3A+a+model+for+viral+DNA+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BC.%26aulast%3DKrucinski%26aufirst%3DJ.%26aulast%3DMiercke%26aufirst%3DL.%2BJ.%26aulast%3DFiner-Moore%26aufirst%3DJ.%2BS.%26aulast%3DTang%26aufirst%3DA.%2BH.%26aulast%3DLeavitt%26aufirst%3DA.%2BD.%26aulast%3DStroud%26aufirst%3DR.%2BM.%26atitle%3DCrystal%2520structure%2520of%2520the%2520HIV-1%2520integrase%2520catalytic%2520core%2520and%2520C-terminal%2520domains%253A%2520a%2520model%2520for%2520viral%2520DNA%2520binding%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26issue%3D15%26spage%3D8233%26epage%3D8238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Wee, A. G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, A. Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnenberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Djerassi, C.</span><span> </span><span class="NLM_article-title">Magnetic circular dichroism studies. 66. Synthesis of demethyl monosubstituted porphyrins. The effect of substituent conformation on the magnetic circular dichroism spectra of ethoxycarbonyl porphyrins</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">3327</span><span class="NLM_x">â</span> <span class="NLM_lpage">3336</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00192a015" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1984&pages=3327-3336&author=A.+G.+H.+Weeauthor=A.+Y.+L.+Shuauthor=E.+Bunnenbergauthor=C.+Djerassi&title=Magnetic+circular+dichroism+studies.+66.+Synthesis+of+demethyl+monosubstituted+porphyrins.+The+effect+of+substituent+conformation+on+the+magnetic+circular+dichroism+spectra+of+ethoxycarbonyl+porphyrins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjo00192a015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00192a015%26sid%3Dliteratum%253Aachs%26aulast%3DWee%26aufirst%3DA.%2BG.%2BH.%26aulast%3DShu%26aufirst%3DA.%2BY.%2BL.%26aulast%3DBunnenberg%26aufirst%3DE.%26aulast%3DDjerassi%26aufirst%3DC.%26atitle%3DMagnetic%2520circular%2520dichroism%2520studies.%252066.%2520Synthesis%2520of%2520demethyl%2520monosubstituted%2520porphyrins.%2520The%2520effect%2520of%2520substituent%2520conformation%2520on%2520the%2520magnetic%2520circular%2520dichroism%2520spectra%2520of%2520ethoxycarbonyl%2520porphyrins%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1984%26volume%3D49%26spage%3D3327%26epage%3D3336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Ginzel, K.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brungs, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steckhan, E.</span><span> </span><span class="NLM_article-title">Indirect electrochemical Î±-methoxylation of <i>N</i>-acyl and <i>N</i>-carboalkoxy Î±-amino acid esters and application as cationic glycine equivalents</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1691</span><span class="NLM_x">â</span> <span class="NLM_lpage">1701</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1989&pages=1691-1701&author=K.-D.+Ginzelauthor=P.+Brungsauthor=E.+Steckhan&title=Indirect+electrochemical+%CE%B1-methoxylation+of+N-acyl+and+N-carboalkoxy+%CE%B1-amino+acid+esters+and+application+as+cationic+glycine+equivalents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGinzel%26aufirst%3DK.-D.%26aulast%3DBrungs%26aufirst%3DP.%26aulast%3DSteckhan%26aufirst%3DE.%26atitle%3DIndirect%2520electrochemical%2520%25CE%25B1-methoxylation%2520of%2520N-acyl%2520and%2520N-carboalkoxy%2520%25CE%25B1-amino%2520acid%2520esters%2520and%2520application%2520as%2520cationic%2520glycine%2520equivalents%26jtitle%3DTetrahedron%26date%3D1989%26volume%3D45%26spage%3D1691%26epage%3D1701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':[],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':[],'ref38':[],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 31 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Arindam Talukdar, Dipyaman Ganguly, Swarnali Roy, Nirmal Das, <span class="NLM_string-name hlFld-ContribAuthor">Dipika Sarkar</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Evolution and Translational Potential for Agonists and Antagonists of Endosomal Toll-like Receptors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (12)
                                     , 8010-8041. <a href="https://doi.org/10.1021/acs.jmedchem.1c00300" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00300</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00300%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructural%252BEvolution%252Band%252BTranslational%252BPotential%252Bfor%252BAgonists%252Band%252BAntagonists%252Bof%252BEndosomal%252BToll-like%252BReceptors%26aulast%3DTalukdar%26aufirst%3DArindam%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D16022021%26date%3D10062021%26volume%3D64%26issue%3D12%26spage%3D8010%26epage%3D8041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ted W. Johnson, Rebecca A. Gallego, <span class="NLM_string-name hlFld-ContribAuthor">Martin P. Edwards</span>. </span><span class="cited-content_cbyCitation_article-title">Lipophilic Efficiency as an Important Metric in Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (15)
                                     , 6401-6420. <a href="https://doi.org/10.1021/acs.jmedchem.8b00077" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00077</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00077%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLipophilic%252BEfficiency%252Bas%252Ban%252BImportant%252BMetric%252Bin%252BDrug%252BDesign%26aulast%3DJohnson%26aufirst%3DTed%2BW.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D16012018%26date%3D17042018%26date%3D28032018%26volume%3D61%26issue%3D15%26spage%3D6401%26epage%3D6420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Christophe  Pannecouque</span>, <span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, and <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>  . </span><span class="cited-content_cbyCitation_article-title">Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (7)
                                     , 2849-2878. <a href="https://doi.org/10.1021/acs.jmedchem.5b00497" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00497</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00497%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAnti-HIV%252BDrug%252BDiscovery%252Band%252BDevelopment%25253A%252BCurrent%252BInnovations%252Band%252BFuture%252BTrends%26aulast%3DZhan%26aufirst%3DPeng%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D27032015%26date%3D05112015%26date%3D14042016%26date%3D28102015%26volume%3D59%26issue%3D7%26spage%3D2849%26epage%3D2878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Santiago  Royo</span>, <span class="hlFld-ContribAuthor ">Robert S. L.  Chapman</span>, <span class="hlFld-ContribAuthor ">Alisia M.  Sim</span>, <span class="hlFld-ContribAuthor ">Lucy R.  Peacock</span>, and <span class="hlFld-ContribAuthor ">Steven D.  Bull</span>  . </span><span class="cited-content_cbyCitation_article-title">Aza-Conjugate Addition Methodology for the Synthesis of N-Hydroxy-isoindolin-1-ones. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2016,</strong> <em>18 </em>
                                    (5)
                                     , 1146-1149. <a href="https://doi.org/10.1021/acs.orglett.6b00261" title="DOI URL">https://doi.org/10.1021/acs.orglett.6b00261</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.6b00261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.6b00261%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DAza-Conjugate%252BAddition%252BMethodology%252Bfor%252Bthe%252BSynthesis%252Bof%252BN-Hydroxy-isoindolin-1-ones%26aulast%3DRoyo%26aufirst%3DSantiago%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D26012016%26date%3D22022016%26date%3D04032016%26volume%3D18%26issue%3D5%26spage%3D1146%26epage%3D1149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manabu  Watanabe</span>, <span class="hlFld-ContribAuthor ">Mai  Kasai</span>, <span class="hlFld-ContribAuthor ">Hideyuki  Tomizawa</span>, <span class="hlFld-ContribAuthor ">Masamitsu  Aoki</span>, <span class="hlFld-ContribAuthor ">Kazuo  Eiho</span>, <span class="hlFld-ContribAuthor ">Yoshiaki  Isobe</span>, and <span class="hlFld-ContribAuthor ">Shigehiro  Asano</span>  . </span><span class="cited-content_cbyCitation_article-title">Dihydropyrrolo[2,3-d]pyrimidines: Selective Toll-Like Receptor 9 Antagonists from Scaffold Morphing Efforts. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>5 </em>
                                    (11)
                                     , 1235-1239. <a href="https://doi.org/10.1021/ml5003184" title="DOI URL">https://doi.org/10.1021/ml5003184</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml5003184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml5003184%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDihydropyrrolo%25255B2%25252C3-d%25255Dpyrimidines%25253A%252BSelective%252BToll-Like%252BReceptor%252B9%252BAntagonists%252Bfrom%252BScaffold%252BMorphing%252BEfforts%26aulast%3DWatanabe%26aufirst%3DManabu%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D31072014%26date%3D02102014%26date%3D06102014%26date%3D13112014%26date%3D02102014%26volume%3D5%26issue%3D11%26spage%3D1235%26epage%3D1239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xue Zhi  Zhao</span>, <span class="hlFld-ContribAuthor ">Steven J.  Smith</span>, <span class="hlFld-ContribAuthor ">Mathieu  MÃ©tifiot</span>, <span class="hlFld-ContribAuthor ">Barry C.  Johnson</span>, <span class="hlFld-ContribAuthor ">Christophe  Marchand</span>, <span class="hlFld-ContribAuthor ">Yves  Pommier</span>, <span class="hlFld-ContribAuthor ">Stephen H.  Hughes</span>, and <span class="hlFld-ContribAuthor ">Terrence R.  Burke, Jr.</span>  . </span><span class="cited-content_cbyCitation_article-title">Bicyclic 1-Hydroxy-2-oxo-1,2-dihydropyridine-3-carboxamide-Containing HIV-1 Integrase Inhibitors Having High Antiviral Potency against Cells Harboring Raltegravir-Resistant Integrase Mutants. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (4)
                                     , 1573-1582. <a href="https://doi.org/10.1021/jm401902n" title="DOI URL">https://doi.org/10.1021/jm401902n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401902n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401902n%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBicyclic%252B1-Hydroxy-2-oxo-1%25252C2-dihydropyridine-3-carboxamide-Containing%252BHIV-1%252BIntegrase%252BInhibitors%252BHaving%252BHigh%252BAntiviral%252BPotency%252Bagainst%252BCells%252BHarboring%252BRaltegravir-Resistant%252BIntegrase%252BMutants%26aulast%3DZhao%26aufirst%3DXue%2BZhi%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D11122013%26date%3D10022014%26date%3D27022014%26date%3D28012014%26volume%3D57%26issue%3D4%26spage%3D1573%26epage%3D1582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander  Dreger</span>, <span class="hlFld-ContribAuthor ">Omar  Kharwb</span>, <span class="hlFld-ContribAuthor ">Oriana  Agoglitta</span>, <span class="hlFld-ContribAuthor ">Emre F.  BÃ¼lbÃ¼l</span>, <span class="hlFld-ContribAuthor ">Jelena  Melesina</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Sippl</span>, <span class="hlFld-ContribAuthor ">Ralph  Holl</span>. </span><span class="cited-content_cbyCitation_article-title">Chiral Pool Synthesis, Biological Evaluation and Molecular Docking Studies of
              C
              âFuranosidic LpxC Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (8)
                                     , 871-886. <a href="https://doi.org/10.1002/cmdc.201900068" title="DOI URL">https://doi.org/10.1002/cmdc.201900068</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900068%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DChiral%252BPool%252BSynthesis%25252C%252BBiological%252BEvaluation%252Band%252BMolecular%252BDocking%252BStudies%252Bof%252BC%252B%2525E2%252580%252590Furanosidic%252BLpxC%252BInhibitors%26aulast%3DDreger%26aufirst%3DAlexander%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D8%26spage%3D871%26epage%3D886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sangeetha  Balasubramanian</span>, <span class="hlFld-ContribAuthor ">Muthukumaran  Rajagopalan</span>, <span class="hlFld-ContribAuthor ">Ravi Shankar  Bojja</span>, <span class="hlFld-ContribAuthor ">Anna Marie  Skalka</span>, <span class="hlFld-ContribAuthor ">Mark D.  Andrake</span>, <span class="hlFld-ContribAuthor ">Amutha  Ramaswamy</span>. </span><span class="cited-content_cbyCitation_article-title">The conformational feasibility for the formation of reaching dimer in ASV and HIV integrase: a molecular dynamics study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2017,</strong> <em>35 </em>
                                    (16)
                                     , 3469-3485. <a href="https://doi.org/10.1080/07391102.2016.1257955" title="DOI URL">https://doi.org/10.1080/07391102.2016.1257955</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2016.1257955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2016.1257955%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DThe%252Bconformational%252Bfeasibility%252Bfor%252Bthe%252Bformation%252Bof%252Breaching%252Bdimer%252Bin%252BASV%252Band%252BHIV%252Bintegrase%25253A%252Ba%252Bmolecular%252Bdynamics%252Bstudy%26aulast%3DBalasubramanian%26aufirst%3DSangeetha%26date%3D2017%26date%3D2016%26volume%3D35%26issue%3D16%26spage%3D3469%26epage%3D3485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiqiang  Cheng</span>, <span class="hlFld-ContribAuthor ">Ping  Gao</span>, <span class="hlFld-ContribAuthor ">Lin  Sun</span>, <span class="hlFld-ContribAuthor ">Ye  Tian</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of spirocyclic or phosphate substituted quinolizine derivatives as novel HIV-1 integrase inhibitors: a patent evaluation of WO2016094197A1, WO2016094198A1 and WO2016154527A1. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2017,</strong> <em>27 </em>
                                    (11)
                                     , 1277-1286. <a href="https://doi.org/10.1080/13543776.2017.1360283" title="DOI URL">https://doi.org/10.1080/13543776.2017.1360283</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2017.1360283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2017.1360283%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DIdentification%252Bof%252Bspirocyclic%252Bor%252Bphosphate%252Bsubstituted%252Bquinolizine%252Bderivatives%252Bas%252Bnovel%252BHIV-1%252Bintegrase%252Binhibitors%25253A%252Ba%252Bpatent%252Bevaluation%252Bof%252BWO2016094197A1%25252C%252BWO2016094198A1%252Band%252BWO2016154527A1%26aulast%3DCheng%26aufirst%3DXiqiang%26date%3D2017%26date%3D2017%26volume%3D27%26issue%3D11%26spage%3D1277%26epage%3D1286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vivek K.  Vyas</span>, <span class="hlFld-ContribAuthor ">Shreya  Shah</span>, <span class="hlFld-ContribAuthor ">Manjunath  Ghate</span>. </span><span class="cited-content_cbyCitation_article-title">Generation of new leads as HIV-1 integrase inhibitors: 3D QSAR, docking and molecular dynamics simulation. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2017,</strong> <em>26 </em>
                                    (3)
                                     , 532-550. <a href="https://doi.org/10.1007/s00044-016-1772-y" title="DOI URL">https://doi.org/10.1007/s00044-016-1772-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-016-1772-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-016-1772-y%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DGeneration%252Bof%252Bnew%252Bleads%252Bas%252BHIV-1%252Bintegrase%252Binhibitors%25253A%252B3D%252BQSAR%25252C%252Bdocking%252Band%252Bmolecular%252Bdynamics%252Bsimulation%26aulast%3DVyas%26aufirst%3DVivek%2BK.%26date%3D2017%26date%3D2017%26volume%3D26%26issue%3D3%26spage%3D532%26epage%3D550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">GyÃ¶rgy G.  Ferenczy</span>, <span class="hlFld-ContribAuthor ">GyÃ¶rgy M.  KeserÅ±</span>. </span><span class="cited-content_cbyCitation_article-title">Ligand Efficiency Metrics and their Use in Fragment Optimizations. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 75-98. <a href="https://doi.org/10.1002/9783527683604.ch04" title="DOI URL">https://doi.org/10.1002/9783527683604.ch04</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527683604.ch04&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527683604.ch04%26sid%3Dliteratum%253Aachs%26atitle%3DLigand%252BEfficiency%252BMetrics%252Band%252Btheir%252BUse%252Bin%252BFragment%252BOptimizations%26aulast%3DFerenczy%26aufirst%3DGy%25C3%25B6rgy%2BG.%26date%3D2016%26date%3D2016%26spage%3D75%26epage%3D98%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DFragment-based%252BDrug%252BDiscovery%252BLessons%252Band%252BOutlook%26aulast%3DErlanson%26aufirst%3DDaniel%2BA.%26date%3D2016%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Athina  Geronikaki</span>, <span class="hlFld-ContribAuthor ">Phaedra  Eleftheriou</span>, <span class="hlFld-ContribAuthor ">Vladimir  Poroikov</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-HIV Agents: Current Status and Recent Trends. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 37-95. <a href="https://doi.org/10.1007/7355_2015_5001" title="DOI URL">https://doi.org/10.1007/7355_2015_5001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2015_5001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2015_5001%26sid%3Dliteratum%253Aachs%26atitle%3DAnti-HIV%252BAgents%25253A%252BCurrent%252BStatus%252Band%252BRecent%252BTrends%26aulast%3DGeronikaki%26aufirst%3DAthina%26date%3D2016%26date%3D2016%26spage%3D37%26epage%3D95%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DCommunicable%252BDiseases%252Bof%252Bthe%252BDeveloping%252BWorld%26aulast%3DSaxena%26aufirst%3DAnil%2BKumar%26date%3D2018%26volume%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rahul V.  Patel</span>, <span class="hlFld-ContribAuthor ">Se Won  Park</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrroloaryls and pyrroloheteroaryls: Inhibitors of the HIV fusion/attachment, reverse transcriptase and integrase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (17)
                                     , 5247-5263. <a href="https://doi.org/10.1016/j.bmc.2015.06.016" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.06.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.06.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.06.016%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DPyrroloaryls%252Band%252Bpyrroloheteroaryls%25253A%252BInhibitors%252Bof%252Bthe%252BHIV%252Bfusion%25252Fattachment%25252C%252Breverse%252Btranscriptase%252Band%252Bintegrase%26aulast%3DPatel%26aufirst%3DRahul%2BV.%26date%3D2015%26volume%3D23%26issue%3D17%26spage%3D5247%26epage%3D5263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mostafa  Zakariazadeh</span>, <span class="hlFld-ContribAuthor ">Abolfazl  Barzegar</span>, <span class="hlFld-ContribAuthor ">Somaieh  Soltani</span>, <span class="hlFld-ContribAuthor ">Hassan  Aryapour</span>. </span><span class="cited-content_cbyCitation_article-title">Developing 2D-QSAR models for naphthyridine derivatives against HIV-1 integrase activity. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2015,</strong> <em>24 </em>
                                    (6)
                                     , 2485-2504. <a href="https://doi.org/10.1007/s00044-014-1305-5" title="DOI URL">https://doi.org/10.1007/s00044-014-1305-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-014-1305-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-014-1305-5%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DDeveloping%252B2D-QSAR%252Bmodels%252Bfor%252Bnaphthyridine%252Bderivatives%252Bagainst%252BHIV-1%252Bintegrase%252Bactivity%26aulast%3DZakariazadeh%26aufirst%3DMostafa%26date%3D2015%26date%3D2014%26volume%3D24%26issue%3D6%26spage%3D2485%26epage%3D2504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anh  Mai</span>, <span class="hlFld-ContribAuthor ">Wim  De Borggraeve</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of
              
                N
              
              -Hydroxypyrazin-2(1
              
                H
              
              )-ones via Selective
              
                O
              
              -Debenzylation of 1-Benzyloxypyrazin-2(1
              
                H
              
              )-ones Using Flow Methodology. </span><span class="cited-content_cbyCitation_journal-name">Journal of Flow Chemistry</span><span> <strong>2015,</strong> <em>5 </em>
                                    (1)
                                     , 6-10. <a href="https://doi.org/10.1556/JFC-D-14-00036" title="DOI URL">https://doi.org/10.1556/JFC-D-14-00036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1556/JFC-D-14-00036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1556%2FJFC-D-14-00036%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Flow%2520Chemistry%26atitle%3DSynthesis%252Bof%252BN%252B-Hydroxypyrazin-2%2525281%252BH%252B%252529-ones%252Bvia%252BSelective%252BO%252B-Debenzylation%252Bof%252B1-Benzyloxypyrazin-2%2525281%252BH%252B%252529-ones%252BUsing%252BFlow%252BMethodology%26aulast%3DMai%26aufirst%3DAnh%26date%3D2015%26volume%3D5%26issue%3D1%26spage%3D6%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maxim A.  Nechayev</span>, <span class="hlFld-ContribAuthor ">Nikolay Yu.  Gorobets</span>, <span class="hlFld-ContribAuthor ">Svetlana V.  Shishkina</span>, <span class="hlFld-ContribAuthor ">Oleg V.  Shishkin</span>, <span class="hlFld-ContribAuthor ">Sergiy M.  Kovalenko</span>. </span><span class="cited-content_cbyCitation_article-title">Microwave-assisted acid-catalyzed nucleophilic heteroaromatic substitution: the synthesis of 7-amino-6-azaindoles. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2015,</strong> <em>71 </em>
                                    (8)
                                     , 1311-1321. <a href="https://doi.org/10.1016/j.tet.2014.12.057" title="DOI URL">https://doi.org/10.1016/j.tet.2014.12.057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2014.12.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2014.12.057%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DMicrowave-assisted%252Bacid-catalyzed%252Bnucleophilic%252Bheteroaromatic%252Bsubstitution%25253A%252Bthe%252Bsynthesis%252Bof%252B7-amino-6-azaindoles%26aulast%3DNechayev%26aufirst%3DMaxim%2BA.%26date%3D2015%26volume%3D71%26issue%3D8%26spage%3D1311%26epage%3D1321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zengjun  Fang</span>, <span class="hlFld-ContribAuthor ">Yuâning  Song</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Qingzhu  Zhang</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Conformational restriction: an effective tactic in 'follow-on'-based drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2014,</strong> <em>6 </em>
                                    (8)
                                     , 885-901. <a href="https://doi.org/10.4155/fmc.14.50" title="DOI URL">https://doi.org/10.4155/fmc.14.50</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.14.50&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.14.50%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DConformational%252Brestriction%25253A%252Ban%252Beffective%252Btactic%252Bin%252B%252527follow-on%252527-based%252Bdrug%252Bdiscovery%26aulast%3DFang%26aufirst%3DZengjun%26date%3D2014%26volume%3D6%26issue%3D8%26spage%3D885%26epage%3D901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Swarup  De</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Groaz</span>, <span class="hlFld-ContribAuthor ">Piet  Herdewijn</span>. </span><span class="cited-content_cbyCitation_article-title">Tailoring Peptide-Nucleotide Conjugates (PNCs) for Nucleotide Delivery in Bacterial Cells. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>2014 </em>
                                    (11)
                                     , 2322-2348. <a href="https://doi.org/10.1002/ejoc.201301781" title="DOI URL">https://doi.org/10.1002/ejoc.201301781</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201301781&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201301781%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DTailoring%252BPeptide-Nucleotide%252BConjugates%252B%252528PNCs%252529%252Bfor%252BNucleotide%252BDelivery%252Bin%252BBacterial%252BCells%26aulast%3DDe%26aufirst%3DSwarup%26date%3D2014%26date%3D2014%26volume%3D2014%26issue%3D11%26spage%3D2322%26epage%3D2348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefano  Lancianesi</span>, <span class="hlFld-ContribAuthor ">Alessandro  Palmieri</span>, <span class="hlFld-ContribAuthor ">Marino  Petrini</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 3-(2-Nitroalkyl)pyrroles from Sulfonylpyrroles and their Conversion to 6-Azaindole Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2013,</strong> <em>355 </em>
                                    (16)
                                     , 3285-3289. <a href="https://doi.org/10.1002/adsc.201300701" title="DOI URL">https://doi.org/10.1002/adsc.201300701</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201300701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201300701%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DSynthesis%252Bof%252B3-%2525282-Nitroalkyl%252529pyrroles%252Bfrom%252BSulfonylpyrroles%252Band%252Btheir%252BConversion%252Bto%252B6-Azaindole%252BDerivatives%26aulast%3DLancianesi%26aufirst%3DStefano%26date%3D2013%26date%3D2013%26volume%3D355%26issue%3D16%26spage%3D3285%26epage%3D3289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.  Yu</span>, <span class="hlFld-ContribAuthor ">P.  Wang</span>, <span class="hlFld-ContribAuthor ">Y.  Li</span>, <span class="hlFld-ContribAuthor ">Y.  Liu</span>, <span class="hlFld-ContribAuthor ">G.  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Docking-based CoMFA and CoMSIA study of azaindole carboxylic acid derivatives as promising HIV-1 integrase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">SAR and QSAR in Environmental Research</span><span> <strong>2013,</strong> <em>24 </em>
                                    (10)
                                     , 819-839. <a href="https://doi.org/10.1080/1062936X.2013.820792" title="DOI URL">https://doi.org/10.1080/1062936X.2013.820792</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/1062936X.2013.820792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F1062936X.2013.820792%26sid%3Dliteratum%253Aachs%26jtitle%3DSAR%2520and%2520QSAR%2520in%2520Environmental%2520Research%26atitle%3DDocking-based%252BCoMFA%252Band%252BCoMSIA%252Bstudy%252Bof%252Bazaindole%252Bcarboxylic%252Bacid%252Bderivatives%252Bas%252Bpromising%252BHIV-1%252Bintegrase%252Binhibitors%26aulast%3DYu%26aufirst%3DS.%26date%3D2013%26volume%3D24%26issue%3D10%26spage%3D819%26epage%3D839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yujiro  Hoshino</span>, <span class="hlFld-ContribAuthor ">Masanori  Oyaizu</span>, <span class="hlFld-ContribAuthor ">Yoko  Koyanagi</span>, <span class="hlFld-ContribAuthor ">Kiyoshi  Honda</span>. </span><span class="cited-content_cbyCitation_article-title">Enantiomerically Enriched Bicyclic Hydroxamic Acids in One Step from
              Î±
              -Aminohydroxamic Acids and Keto Acids via Cyclocondensation. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2013,</strong> <em>43 </em>
                                    (18)
                                     , 2484-2492. <a href="https://doi.org/10.1080/00397911.2012.717162" title="DOI URL">https://doi.org/10.1080/00397911.2012.717162</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2012.717162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2012.717162%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DEnantiomerically%252BEnriched%252BBicyclic%252BHydroxamic%252BAcids%252Bin%252BOne%252BStep%252Bfrom%252B%2525CE%2525B1%252B-Aminohydroxamic%252BAcids%252Band%252BKeto%252BAcids%252Bvia%252BCyclocondensation%26aulast%3DHoshino%26aufirst%3DYujiro%26date%3D2013%26date%3D2013%26volume%3D43%26issue%3D18%26spage%3D2484%26epage%3D2492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">B.  Sangeetha</span>, <span class="hlFld-ContribAuthor ">R.  Muthukumaran</span>, <span class="hlFld-ContribAuthor ">R.  Amutha</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore modelling and electronic feature analysis of hydroxamic acid derivatives, the HIV integrase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">SAR and QSAR in Environmental Research</span><span> <strong>2013,</strong> <em>24 </em>
                                    (9)
                                     , 753-771. <a href="https://doi.org/10.1080/1062936X.2013.792870" title="DOI URL">https://doi.org/10.1080/1062936X.2013.792870</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/1062936X.2013.792870&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F1062936X.2013.792870%26sid%3Dliteratum%253Aachs%26jtitle%3DSAR%2520and%2520QSAR%2520in%2520Environmental%2520Research%26atitle%3DPharmacophore%252Bmodelling%252Band%252Belectronic%252Bfeature%252Banalysis%252Bof%252Bhydroxamic%252Bacid%252Bderivatives%25252C%252Bthe%252BHIV%252Bintegrase%252Binhibitors%26aulast%3DSangeetha%26aufirst%3DB.%26date%3D2013%26volume%3D24%26issue%3D9%26spage%3D753%26epage%3D771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jean-Yves  MÃ©rour</span>, <span class="hlFld-ContribAuthor ">Sylvain  Routier</span>, <span class="hlFld-ContribAuthor ">Franck  Suzenet</span>, <span class="hlFld-ContribAuthor ">BenoÃ®t  Joseph</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the synthesis and properties of 4-, 5-, 6-Â orÂ 7-azaindoles. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2013,</strong> <em>69 </em>
                                    (24)
                                     , 4767-4834. <a href="https://doi.org/10.1016/j.tet.2013.03.081" title="DOI URL">https://doi.org/10.1016/j.tet.2013.03.081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2013.03.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2013.03.081%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bsynthesis%252Band%252Bproperties%252Bof%252B4-%25252C%252B5-%25252C%252B6-%2525C2%2525A0or%2525C2%2525A07-azaindoles%26aulast%3DM%25C3%25A9rour%26aufirst%3DJean-Yves%26date%3D2013%26volume%3D69%26issue%3D24%26spage%3D4767%26epage%3D4834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter K.  Quashie</span>, <span class="hlFld-ContribAuthor ">Thibault  MesplÃ¨de</span>, <span class="hlFld-ContribAuthor ">Mark A.  Wainberg</span>. </span><span class="cited-content_cbyCitation_article-title">HIV Drug Resistance and the Advent of Integrase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Current Infectious Disease Reports</span><span> <strong>2013,</strong> <em>15 </em>
                                    (1)
                                     , 85-100. <a href="https://doi.org/10.1007/s11908-012-0305-1" title="DOI URL">https://doi.org/10.1007/s11908-012-0305-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11908-012-0305-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11908-012-0305-1%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Infectious%2520Disease%2520Reports%26atitle%3DHIV%252BDrug%252BResistance%252Band%252Bthe%252BAdvent%252Bof%252BIntegrase%252BInhibitors%26aulast%3DQuashie%26aufirst%3DPeter%2BK.%26date%3D2013%26date%3D2012%26volume%3D15%26issue%3D1%26spage%3D85%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David C.  Pryde</span>, <span class="hlFld-ContribAuthor ">Rob  Webster</span>, <span class="hlFld-ContribAuthor ">Scott L.  Butler</span>, <span class="hlFld-ContribAuthor ">Edward J.  Murray</span>, <span class="hlFld-ContribAuthor ">Kevin  Whitby</span>, <span class="hlFld-ContribAuthor ">Chris  Pickford</span>, <span class="hlFld-ContribAuthor ">Mike  Westby</span>, <span class="hlFld-ContribAuthor ">Michael J.  Palmer</span>, <span class="hlFld-ContribAuthor ">David J.  Bull</span>, <span class="hlFld-ContribAuthor ">Hannah  Vuong</span>, <span class="hlFld-ContribAuthor ">David C.  Blakemore</span>, <span class="hlFld-ContribAuthor ">Darren  Stead</span>, <span class="hlFld-ContribAuthor ">Christopher  Ashcroft</span>, <span class="hlFld-ContribAuthor ">Iain  Gardner</span>, <span class="hlFld-ContribAuthor ">Claire  Bru</span>, <span class="hlFld-ContribAuthor ">Wai-Yee  Cheung</span>, <span class="hlFld-ContribAuthor ">Ieuan O.  Roberts</span>, <span class="hlFld-ContribAuthor ">Jennifer  Morton</span>, <span class="hlFld-ContribAuthor ">Richard A.  Bissell</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of an HIV integrase inhibitor with an excellent resistance profile. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2013,</strong> <em>4 </em>
                                    (4)
                                     , 709. <a href="https://doi.org/10.1039/c3md00014a" title="DOI URL">https://doi.org/10.1039/c3md00014a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3md00014a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3md00014a%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDiscovery%252Bof%252Ban%252BHIV%252Bintegrase%252Binhibitor%252Bwith%252Ban%252Bexcellent%252Bresistance%252Bprofile%26aulast%3DPryde%26aufirst%3DDavid%2BC.%26date%3D2013%26volume%3D4%26issue%3D4%26spage%3D709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dominga  Rogolino</span>, <span class="hlFld-ContribAuthor ">Mauro  Carcelli</span>, <span class="hlFld-ContribAuthor ">Mario  Sechi</span>, <span class="hlFld-ContribAuthor ">Nouri  Neamati</span>. </span><span class="cited-content_cbyCitation_article-title">Viral enzymes containing magnesium: Metal binding as a successful strategy in drug design. </span><span class="cited-content_cbyCitation_journal-name">Coordination Chemistry Reviews</span><span> <strong>2012,</strong> <em>256 </em>
                                    (23-24)
                                     , 3063-3086. <a href="https://doi.org/10.1016/j.ccr.2012.07.006" title="DOI URL">https://doi.org/10.1016/j.ccr.2012.07.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ccr.2012.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ccr.2012.07.006%26sid%3Dliteratum%253Aachs%26jtitle%3DCoordination%2520Chemistry%2520Reviews%26atitle%3DViral%252Benzymes%252Bcontaining%252Bmagnesium%25253A%252BMetal%252Bbinding%252Bas%252Ba%252Bsuccessful%252Bstrategy%252Bin%252Bdrug%252Bdesign%26aulast%3DRogolino%26aufirst%3DDominga%26date%3D2012%26volume%3D256%26issue%3D23-24%26spage%3D3063%26epage%3D3086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter K  Quashie</span>, <span class="hlFld-ContribAuthor ">Richard D  Sloan</span>, <span class="hlFld-ContribAuthor ">Mark A  Wainberg</span>. </span><span class="cited-content_cbyCitation_article-title">Novel therapeutic strategies targeting HIV integrase. </span><span class="cited-content_cbyCitation_journal-name">BMC Medicine</span><span> <strong>2012,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/1741-7015-10-34" title="DOI URL">https://doi.org/10.1186/1741-7015-10-34</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/1741-7015-10-34&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2F1741-7015-10-34%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Medicine%26atitle%3DNovel%252Btherapeutic%252Bstrategies%252Btargeting%252BHIV%252Bintegrase%26aulast%3DQuashie%26aufirst%3DPeter%2BK%26date%3D2012%26date%3D2012%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joseph S.  Warmus</span>, <span class="hlFld-ContribAuthor ">Cheryl L.  Quinn</span>, <span class="hlFld-ContribAuthor ">Clarke  Taylor</span>, <span class="hlFld-ContribAuthor ">Sean T.  Murphy</span>, <span class="hlFld-ContribAuthor ">Timothy A.  Johnson</span>, <span class="hlFld-ContribAuthor ">Chris  Limberakis</span>, <span class="hlFld-ContribAuthor ">Daniel  Ortwine</span>, <span class="hlFld-ContribAuthor ">Joel  Bronstein</span>, <span class="hlFld-ContribAuthor ">Paul  Pagano</span>, <span class="hlFld-ContribAuthor ">John D.  Knafels</span>, <span class="hlFld-ContribAuthor ">Sandra  Lightle</span>, <span class="hlFld-ContribAuthor ">Igor  Mochalkin</span>, <span class="hlFld-ContribAuthor ">Roger  Brideau</span>, <span class="hlFld-ContribAuthor ">Terry  Podoll</span>. </span><span class="cited-content_cbyCitation_article-title">Structure based design of an in vivo active hydroxamic acid inhibitor of P. aeruginosa LpxC. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (7)
                                     , 2536-2543. <a href="https://doi.org/10.1016/j.bmcl.2012.01.140" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.01.140</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.01.140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.01.140%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure%252Bbased%252Bdesign%252Bof%252Ban%252Bin%252Bvivo%252Bactive%252Bhydroxamic%252Bacid%252Binhibitor%252Bof%252BP.%252Baeruginosa%252BLpxC%26aulast%3DWarmus%26aufirst%3DJoseph%2BS.%26date%3D2012%26volume%3D22%26issue%3D7%26spage%3D2536%26epage%3D2543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michal  Å Ã¡la</span>, <span class="hlFld-ContribAuthor ">Hubert  HÅebabeckÃ½</span>, <span class="hlFld-ContribAuthor ">Pieter  Leyssen</span>, <span class="hlFld-ContribAuthor ">Milan  Dejmek</span>, <span class="hlFld-ContribAuthor ">Martin  DraÄÃ­nskÃ½</span>, <span class="hlFld-ContribAuthor ">Armando M.  De Palma</span>, <span class="hlFld-ContribAuthor ">Johan  Neyts</span>, <span class="hlFld-ContribAuthor ">Radim  Nencka</span>. </span><span class="cited-content_cbyCitation_article-title">Novel substituted 9-norbornylpurines and their activities against RNA viruses. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (5)
                                     , 1963-1968. <a href="https://doi.org/10.1016/j.bmcl.2012.01.040" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.01.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.01.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.01.040%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNovel%252Bsubstituted%252B9-norbornylpurines%252Band%252Btheir%252Bactivities%252Bagainst%252BRNA%252Bviruses%26aulast%3D%25C5%25A0%25C3%25A1la%26aufirst%3DMichal%26date%3D2012%26volume%3D22%26issue%3D5%26spage%3D1963%26epage%3D1968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark A.  Wainberg</span>. </span><span class="cited-content_cbyCitation_article-title">The Need for Development of New HIV-1 Reverse Transcriptase and Integrase Inhibitors in the Aftermath of Antiviral Drug Resistance. </span><span class="cited-content_cbyCitation_journal-name">Scientifica</span><span> <strong>2012,</strong> <em>2012 </em>, 1-28. <a href="https://doi.org/10.6064/2012/238278" title="DOI URL">https://doi.org/10.6064/2012/238278</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.6064/2012/238278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.6064%2F2012%2F238278%26sid%3Dliteratum%253Aachs%26jtitle%3DScientifica%26atitle%3DThe%252BNeed%252Bfor%252BDevelopment%252Bof%252BNew%252BHIV-1%252BReverse%252BTranscriptase%252Band%252BIntegrase%252BInhibitors%252Bin%252Bthe%252BAftermath%252Bof%252BAntiviral%252BDrug%252BResistance%26aulast%3DWainberg%26aufirst%3DMark%2BA.%26date%3D2012%26volume%3D2012%26spage%3D1%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elena  Borsini</span>, <span class="hlFld-ContribAuthor ">Gianluigi  Broggini</span>, <span class="hlFld-ContribAuthor ">Andrea  Fasana</span>, <span class="hlFld-ContribAuthor ">Chiara  Baldassarri</span>, <span class="hlFld-ContribAuthor ">Angelo M  Manzo</span>, <span class="hlFld-ContribAuthor ">Alcide D  Perboni</span>. </span><span class="cited-content_cbyCitation_article-title">Access to pyrrolo-pyridines by gold-catalyzed hydroarylation of pyrroles tethered to terminal alkynes. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2011,</strong> <em>7 </em>, 1468-1474. <a href="https://doi.org/10.3762/bjoc.7.170" title="DOI URL">https://doi.org/10.3762/bjoc.7.170</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.7.170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.7.170%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DAccess%252Bto%252Bpyrrolo-pyridines%252Bby%252Bgold-catalyzed%252Bhydroarylation%252Bof%252Bpyrroles%252Btethered%252Bto%252Bterminal%252Balkynes%26aulast%3DBorsini%26aufirst%3DElena%26date%3D2011%26date%3D2011%26volume%3D7%26spage%3D1468%26epage%3D1474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0027.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200208d&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0004.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Metal binding of DKA (A), dihydroxypyrimidine carboxamide (B), and azaindole hydroxamate (C).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200208d&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0005.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Conformational analysis of picolinamide-<i>N</i>-methyl hydroxamate <b>6</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200208d&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0006.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Evolution of azaindole hydroxamate based HIV-integrase inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200208d&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0007.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. The Synthesis of Tetrahydro-pyrrolo-naphthyridinone <b>7</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200208d&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 4-FPhCH<sub>2</sub>Br, KO<i>t-</i>Bu, THF, 95%; (b) (1) NBS (3 equiv), EtOAc, rt; (2) (PhCO<sub>2</sub>)<sub>2</sub>, reflux, 88%; (c) TsNHCH<sub>2</sub>CO<sub>2</sub>Me, KO<i>t-</i>Bu, THF, rt, 81%; (d) LiHMDS, THF, â78 Â°C, 86%; (e) H<sub>2</sub> (40 psi), Pd/C, MeOH, 95%; (f) Tf<sub>2</sub>O, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 0 Â°C, 90%; (g) PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, LiCl, (<i>Z</i>)-EtOCHCHSn(<i>n</i>-Bu)<sub>3</sub>, 1,4-dioxane, 70 Â°C, 70%; (h) LiOH, aq MeOH, 50 Â°C; (i) HOAc, 100 Â°C, 92%; (j) H<sub>2</sub> (35 psi), Pd/Al<sub>2</sub>O<sub>3</sub>, MeOH, 81%; (k) H<sub>2</sub>NOTHP, LiHMDS, THF, 57%; (l) D<i>t-</i>BAD, PPh<sub>3</sub>, THF, rt, 1:1 <i>N</i>- vs <i>O</i>-, 37% isolated; (m) 1 N aq HCl, 24%.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0008.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Improved End-Game for the Synthesis of Tetrahydro-pyrrolo-naphthyridinone <b>7</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200208d&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) C<sub>4</sub>H<sub>9</sub>OCHâCH<sub>2</sub> Pd<sub>2</sub>(dba)<sub>3</sub>, (<i>c</i>-C<sub>6</sub>H<sub>11</sub>)<sub>2</sub>NMe, (<i>t</i>-Bu)<sub>3</sub>PHBF<sub>4</sub>, LiCl, 1,4-dioxane, 70 Â°C, 86%; (b) H<sub>2</sub>NOSEM, <i>p</i>-TsOH, THF, 94%; (c) NaBH<sub>3</sub>CN, HOAc, rt, 84%; (d) HCl, THF, rt, 80%.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0009.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Late Stage Functionalization: The Synthesis of Differentially Benzyl Substituted Tetrahydro-pyrrolo-naphthyridinones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200208d&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) PhSO<sub>2</sub>Cl, <i>n</i>-Bu<sub>4</sub>NBr, toluene, aq NaOH, 86%; (b) (1) NBS, CCl<sub>4</sub>, (PhCO<sub>2</sub>)<sub>2</sub>, reflux, 92%; (c) TsNHCH<sub>2</sub>CO<sub>2</sub>Me, KO<i>t-</i>Bu, THF, rt, 81%; (d) LiHMDS, THF, â78 Â°C, 63%; (e) Tf<sub>2</sub>O, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 0 Â°C, 86%; (f) C<sub>4</sub>H<sub>9</sub>OCHâCH<sub>2</sub> Pd<sub>2</sub>(dba)<sub>3</sub>, (<i>c</i>-C<sub>6</sub>H<sub>11</sub>)<sub>2</sub>NMe, (<i>t</i>-Bu)<sub>3</sub>PHBF<sub>4</sub>, LiCl, 1,4-dioxane, 70 Â°C, 84%; (g) NaOEt, ethanol, 84%; (h) H<sub>2</sub>NOSEM, <i>p</i>-TsOH, THF; (i) NaBH<sub>3</sub>CN, HOAc, rt, 76%; (j) ArCH<sub>2</sub>Br, NaH, THF, 40â72%; (k) H<sub>2</sub>SO<sub>4</sub>, <i>i</i>-PrOH, 78â95%.</p></p></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0010.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Î²-Functionalization of the Pyrrolo-Ring of <b>22</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200208d&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Me<sub>2</sub>NâCH<sub>2</sub> Cl, MeCN, reflux, 89%; (b) NIS, DMF, 92% or NBS, DMF, 97%.</p></p></figure><figure data-id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0011.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of 1-Substituted 3-(4-fluorobenzyl)-7-hydroxy-8,9-dihydro-3<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6(7<i>H</i>)-ones from Compound <b>34</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200208d&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) EtOCOCl or PhOCOCl, DCM, rt; (b) R<sub>1</sub>R<sub>2</sub>NH, <i>i</i>-Pr<sub>2</sub>NEt; (c) R<sub>1</sub>OH, <i>i</i>-Pr<sub>2</sub>NEt, THF; (d) HCl, 1,4-dioxane.</p></p></figure><figure data-id="sch6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0012.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Carbon Chain Extended 1-Substituted 3-(4-fluorobenzyl)-7-hydroxy-8,9-dihydro-3<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6(7<i>H</i>)-ones from Compounds <b>35</b> via Palladium Chemistry<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200208d&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R<sub>1</sub>-alkyne, PdCl<sub>2</sub>(Ph<sub>3</sub>P)<sub>2</sub>, CuI-SMe<sub>2</sub>, Et<sub>3</sub>N, DMF, or R<sub>1</sub>-CH<sub>2</sub>âCH<sub>2</sub>, tri-<i>o</i>-tolylphosphine, Pd(OAc)<sub>2</sub>, Et<sub>3</sub>N, DMF; (b) H<sub>2</sub> (1 atm), Pd(OH)<sub>2</sub>, MeOH; (c) HCl, 1,4,-dioxane, MeOH.</p></p></figure><figure data-id="sch7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/medium/jm-2011-00208d_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0013.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. The Synthesis of 1-Sulfonamido-substituted 3-(4-fluorobenzyl)-7-hydroxy-8,9-dihydro-3<i>H</i>-pyrrolo[2,3-<i>c</i>][1,7]naphthyridin-6(7<i>H</i>)-ones from Lactone <b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-9/jm200208d/production/images/large/jm-2011-00208d_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200208d&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ClSO<sub>3</sub>H, SOCl<sub>2</sub>, 100%; (b) R<sub>1</sub>R<sub>2</sub>NH, Et<sub>3</sub>N, DMF, 69â78%; (c) H<sub>2</sub>NOTHP, LiHMDS, THF, 40â57%; (d) <i>p</i>-TsCl, <i>i</i>-Pr<sub>2</sub>NEt, CH<sub>2</sub>Cl<sub>2</sub>, 33â40%; (e) <i>p</i>-TsOH, MeOH, H<sub>2</sub>O, 39â45%.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i133">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38537" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38537" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 43 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Castro, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loureiro, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pujol-Luz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souza, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albuquerque, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabral, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frugulhetti, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues, C. R.</span><span> </span><span class="NLM_article-title">HIV-1 reverse transcriptase: a therapeutical target in the spotlight</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">313</span><span class="NLM_x">â</span> <span class="NLM_lpage">324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm200208d&amp;key=10.2174%2F092986706775476089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm200208d&amp;key=16475939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm200208d&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVequ74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=313-324&issue=3&author=H.+C.+Castroauthor=N.+I.+Loureiroauthor=M.+Pujol-Luzauthor=A.+M.+Souzaauthor=M.+G.+Albuquerqueauthor=D.+O.+Santosauthor=L.+M.+Cabralauthor=I.+C.+Frugulhettiauthor=C.+R.+Rodrigues&title=HIV-1+reverse+transcriptase%3A+a+therapeutical+target+in+the+spotlight"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">HIV-1 reverse transcriptase: a therapeutical target in the spotlight</span></div><div class="casAuthors">Castro, H. C.; Loureiro, N. I. V.; Pujol-Luz, M.; Souza, A. M. T.; Albuquerque, M. G.; Santos, D. O.; Cabral, L. M.; Frugulhetti, I. C.; Rodrigues, C. R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">313-324</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Human Immunodeficiency Virus type 1 Reverse Transcriptase (HIV-1 RT) is one of the most important targets for treatment of Acquired Immune Deficiency Syndrome (AIDS).  It catalyzes the reverse transcription of HIV-RNA into a double stranded DNA, and the knowledge of its substrate specificity and catalytic mechanism has guided the development of several inhibitors widely used on current HIV/AIDS therapy.  However, mutations in HIV-1 RT structure can lead to the emergence of drug-resistant virus strains.  The goal of this review is to summarize relevant structural features of HIV-1 RT and its inhibitors in such a way that this cost-effective target in the development of new antiretroviral drugs is particularly highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFTpO08ZoPwLVg90H21EOLACvtfcHk0lhLYITFJpMO-Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVequ74%253D&md5=b515ca8f480ae3177c0292a007a6def4</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F092986706775476089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986706775476089%26sid%3Dliteratum%253Aachs%26aulast%3DCastro%26aufirst%3DH.%2BC.%26aulast%3DLoureiro%26aufirst%3DN.%2BI.%26aulast%3DPujol-Luz%26aufirst%3DM.%26aulast%3DSouza%26aufirst%3DA.%2BM.%26aulast%3DAlbuquerque%26aufirst%3DM.%2BG.%26aulast%3DSantos%26aufirst%3DD.%2BO.%26aulast%3DCabral%26aufirst%3DL.%2BM.%26aulast%3DFrugulhetti%26aufirst%3DI.%2BC.%26aulast%3DRodrigues%26aufirst%3DC.%2BR.%26atitle%3DHIV-1%2520reverse%2520transcriptase%253A%2520a%2520therapeutical%2520target%2520in%2520the%2520spotlight%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2006%26volume%3D13%26issue%3D3%26spage%3D313%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Mastrolorenzo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusconi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scozzafava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbaro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supuran, C. T.</span><span> </span><span class="NLM_article-title">Inhibitors of HIV-1 protease: current state of the art 10 years after their introduction. From antiretroviral drugs to antifungal, antibacterial and antitumor agents based on aspartic protease inhibitors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">26</span><span class="NLM_x">) </span> <span class="NLM_fpage">2734</span><span class="NLM_x">â</span> <span class="NLM_lpage">2748</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm200208d&amp;key=10.2174%2F092986707782360141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm200208d&amp;key=18045120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm200208d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlSkurc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=2734-2748&issue=26&author=A.+Mastrolorenzoauthor=S.+Rusconiauthor=A.+Scozzafavaauthor=G.+Barbaroauthor=C.+T.+Supuran&title=Inhibitors+of+HIV-1+protease%3A+current+state+of+the+art+10+years+after+their+introduction.+From+antiretroviral+drugs+to+antifungal%2C+antibacterial+and+antitumor+agents+based+on+aspartic+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of HIV-1 protease: current state of the art 10 years after their introduction. From antiretroviral drugs to antifungal, antibacterial and antitumor agents based on aspartic protease inhibitors</span></div><div class="casAuthors">Mastrolorenzo, Antonio; Rusconi, Stefano; Scozzafava, Andrea; Barbaro, Giuseppe; Supuran, Claudiu T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">2734-2748</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The introduction of highly active antiretroviral therapy (HAART) in 1996 dramatically changed the course of HIV infection.  This therapy involves the use of at least three agents from two distinct classes of antivirals: a protease inhibitor (PI) in combination with two nucleoside/nucleotide reverse transcriptase inhibitors (N(t)RTIs), or a non-nucleoside reverse transcriptase inhibitor (NNRTI) in combination with NRTIs.  Nine drugs contg. PIs are clin. available: the first generation ones, saquinavir, ritonavir, indinavir, nelfinavir, and amprenavir, and the second generation ones, fosamprenavir (the amprenavir prodrug), lopinavir, atazanavir, and tipranavir.  Many other compds. are in advanced clin. evaluation, such as among others TMC-114, whereas a lot of different other effective HIV protease inhibitors were reported, mainly by using amprenavir and TMC-114 as lead mols.  The main goals of research in this field are: (i) the design of better pharmacol. agents, devoid of severe side effects, resistance problems and with simple administration schedules (preferably once daily), and (ii) achieving eradication of the virus, and possibly, a definitive cure of the disease.  A review on the pharmacol. and interactions of these agents with other drugs is presented here, with emphasis on how these pharmacol. interferences may improve the clin. use of antivirals, or how side effects due to PI drugs may be managed better by taking them into account (such as for example ritonavir boosting of other PIs which reduces dosages and administration schedules of these drugs).  Except for being highly effective in the treatment of HIV infection, recent reports showed this class of drugs to be effective as antitumor agents, as antibacterials (for example against Mycobacterium tuberculosis infection), antifungals (against Candida albicans), antimalarials, antiSARS and anti-influenza agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLJvBZLu-Pt7Vg90H21EOLACvtfcHk0lg5MOH-Ar0jSg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlSkurc%253D&md5=34fcb8056ab9fab31202407b8385af91</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2174%2F092986707782360141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986707782360141%26sid%3Dliteratum%253Aachs%26aulast%3DMastrolorenzo%26aufirst%3DA.%26aulast%3DRusconi%26aufirst%3DS.%26aulast%3DScozzafava%26aufirst%3DA.%26aulast%3DBarbaro%26aufirst%3DG.%26aulast%3DSupuran%26aufirst%3DC.%2BT.%26atitle%3DInhibitors%2520of%2520HIV-1%2520protease%253A%2520current%2520state%2520of%2520the%2520art%252010%2520years%2520after%2520their%2520introduction.%2520From%2520antiretroviral%2520drugs%2520to%2520antifungal%252C%2520antibacterial%2520and%2520antitumor%2520agents%2520based%2520on%2520aspartic%2520protease%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2007%26volume%3D14%26issue%3D26%26spage%3D2734%26epage%3D2748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Al-Mawsawi, L. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Safi, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neamati, N.</span><span> </span><span class="NLM_article-title">Anti-infectives: clinical progress of HIV-1 integrase inhibitors</span> <span class="citation_source-journal">Expert Opin. Emerging Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">213</span><span class="NLM_x">â</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm200208d&amp;key=10.1517%2F14728214.13.2.213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm200208d&amp;key=18537517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm200208d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmvVCktLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=213-225&issue=2&author=L.+Q.+Al-Mawsawiauthor=R.+I.+Al-Safiauthor=N.+Neamati&title=Anti-infectives%3A+clinical+progress+of+HIV-1+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-infectives Clinical progress of HIV-1 integrase inhibitors</span></div><div class="casAuthors">Al-Mawsawi, Laith Q.; Al-Safi, Rasha I.; Neamati, Nouri</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-225</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>;
        ISSN:<span class="NLM_cas:issn">1472-8214</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: HIV-1 integrase (IN) represents a therapeutically advantageous viral target to treat HIV/AIDS in the clinic.  Over a decade of progress in the field has resulted in IN inhibitor chem. classes that display specificity for strand transfer catalysis of the enzyme, thus blocking viral DNA integration into host cell nuclear DNA, an essential step for viral infectivity.  Objective: In this manuscript we provide an update on recent HIV-1 IN inhibitors that have been clin. evaluated, which include MK-0518, MK-2048, GS-9137, GS-9160, GS-9224, GSK-364735, and BMS-707035.  The information presented here can aid in the IN drug developmental process.  Methods: We have limited the scope of this review to information available on the clin. evaluation of promising strand transfer-specific IN inhibitors and their potential drug-drug interaction profiles with other antiretroviral agents.  Results/conclusion: The development of strand transfer-specific inhibitor classes is an important achievement for the IN drug design and development field.  However, continued drug development is needed given that the ability of HIV to replicate under therapeutic pressure will undoubtedly lead to the emergence of IN drug-resistant viral strains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeKFAcwGuyR7Vg90H21EOLACvtfcHk0lg5MOH-Ar0jSg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmvVCktLs%253D&md5=6b61057a498cd0f05a0acc166c5848ad</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1517%2F14728214.13.2.213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728214.13.2.213%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Mawsawi%26aufirst%3DL.%2BQ.%26aulast%3DAl-Safi%26aufirst%3DR.%2BI.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DAnti-infectives%253A%2520clinical%2520progress%2520of%2520HIV-1%2520integrase%2520inhibitors%26jtitle%3DExpert%2520Opin.%2520Emerging%2520Drugs%26date%3D2008%26volume%3D13%26issue%3D2%26spage%3D213%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Pace, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span> </span><span class="NLM_article-title">Integrase inhibitors for the treatment of HIV infection</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">471</span><span class="NLM_x">â</span> <span class="NLM_lpage">479</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2008&pages=471-479&issue=4&author=P.+Paceauthor=M.+Rowley&title=Integrase+inhibitors+for+the+treatment+of+HIV+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPace%26aufirst%3DP.%26aulast%3DRowley%26aufirst%3DM.%26atitle%3DIntegrase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520HIV%2520infection%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2008%26volume%3D11%26issue%3D4%26spage%3D471%26epage%3D479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Anker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corales, R. B.</span><span> </span><span class="NLM_article-title">Raltegravir (MK-0518): a novel integrase inhibitor for the treatment of HIV infection</span> <span class="citation_source-journal">Expert Opin. Invest. Drug.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">97</span><span class="NLM_x">â</span> <span class="NLM_lpage">103</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm200208d&amp;key=10.1517%2F13543784.17.1.97" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm200208d&amp;key=18095922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm200208d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFSmsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=97-103&issue=1&author=M.+Ankerauthor=R.+B.+Corales&title=Raltegravir+%28MK-0518%29%3A+a+novel+integrase+inhibitor+for+the+treatment+of+HIV+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Raltegravir (MK-0518): a novel integrase inhibitor for the treatment of HIV infection</span></div><div class="casAuthors">Anker, Mary; Corales, Roberto B.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">97-103</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Integrase is essential for HIV-1 replication; however, potent inhibition of the isolated enzyme in biochem. assays has not readily translated into antiviral activity in a manner consistent with inhibition of integration.  Raltegravir is a novel HIV-1 integrase strand transfer inhibitor with potent in vitro activity against wild-type and multi-class resistant HIV-1 virus (in vitro IC95 for HIV-1 in 50% normal human serum = 33 nM).  Inhibition of integrase prevents insertion of HIV DNA into the human DNA genome, thus blocking the ability of HIV to replicate.  Raltegravir is administered orally every 12 h and does not require boosting with low-dose ritonavir (RTV) to achieve therapeutic concns.  Raltegravir is not a potent inhibitor or inducer of cytochrome P 450 3A4, and it is predominantly metabolized by glucuronidation, specifically by the enzyme UDP-glucuronosyltransferase 1A1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTuPqYi82xZbVg90H21EOLACvtfcHk0lgEcS4T9pJmkg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFSmsA%253D%253D&md5=4e4b335a994ef71281d9b935a20939fa</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1517%2F13543784.17.1.97&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.17.1.97%26sid%3Dliteratum%253Aachs%26aulast%3DAnker%26aufirst%3DM.%26aulast%3DCorales%26aufirst%3DR.%2BB.%26atitle%3DRaltegravir%2520%2528MK-0518%2529%253A%2520a%2520novel%2520integrase%2520inhibitor%2520for%2520the%2520treatment%2520of%2520HIV%2520infection%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drug.%26date%3D2008%26volume%3D17%26issue%3D1%26spage%3D97%26epage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Summa, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrocchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crescenzi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donghi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiore, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez Paz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzel, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteagudo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muraglia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nizi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orvieto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pace, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pescatore, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarpelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stillmock, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span> </span><span class="NLM_article-title">Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">5843</span><span class="NLM_x">â</span> <span class="NLM_lpage">5855</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800245z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5843-5855&issue=18&author=V.+Summaauthor=A.+Petrocchiauthor=F.+Bonelliauthor=B.+Crescenziauthor=M.+Donghiauthor=M.+Ferraraauthor=F.+Fioreauthor=C.+Gardelliauthor=O.+Gonzalez+Pazauthor=D.+J.+Hazudaauthor=P.+Jonesauthor=O.+Kinzelauthor=R.+Lauferauthor=E.+Monteagudoauthor=E.+Muragliaauthor=E.+Niziauthor=F.+Orvietoauthor=P.+Paceauthor=G.+Pescatoreauthor=R.+Scarpelliauthor=K.+Stillmockauthor=M.+V.+Witmerauthor=M.+Rowley&title=Discovery+of+raltegravir%2C+a+potent%2C+selective+orally+bioavailable+HIV-integrase+inhibitor+for+the+treatment+of+HIV-AIDS+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm800245z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800245z%26sid%3Dliteratum%253Aachs%26aulast%3DSumma%26aufirst%3DV.%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DBonelli%26aufirst%3DF.%26aulast%3DCrescenzi%26aufirst%3DB.%26aulast%3DDonghi%26aufirst%3DM.%26aulast%3DFerrara%26aufirst%3DM.%26aulast%3DFiore%26aufirst%3DF.%26aulast%3DGardelli%26aufirst%3DC.%26aulast%3DGonzalez%2BPaz%26aufirst%3DO.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DKinzel%26aufirst%3DO.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DMuraglia%26aufirst%3DE.%26aulast%3DNizi%26aufirst%3DE.%26aulast%3DOrvieto%26aufirst%3DF.%26aulast%3DPace%26aufirst%3DP.%26aulast%3DPescatore%26aufirst%3DG.%26aulast%3DScarpelli%26aufirst%3DR.%26aulast%3DStillmock%26aufirst%3DK.%26aulast%3DWitmer%26aufirst%3DM.%2BV.%26aulast%3DRowley%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520raltegravir%252C%2520a%2520potent%252C%2520selective%2520orally%2520bioavailable%2520HIV-integrase%2520inhibitor%2520for%2520the%2520treatment%2520of%2520HIV-AIDS%2520infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D18%26spage%3D5843%26epage%3D5855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Shimura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodama, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakagami, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuzaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamataka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, M.</span><span> </span><span class="NLM_article-title">Broad antiretroviral activity and resistance profile of the novel human immunodeficiency virus integrase inhibitor elvitegravir (JTK-303/GS-9137)</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">764</span><span class="NLM_x">â</span> <span class="NLM_lpage">774</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm200208d&amp;key=10.1128%2FJVI.01534-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm200208d&amp;key=17977962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm200208d&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtFCmug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2008&pages=764-774&issue=2&author=K.+Shimuraauthor=E.+Kodamaauthor=Y.+Sakagamiauthor=Y.+Matsuzakiauthor=W.+Watanabeauthor=K.+Yamatakaauthor=Y.+Watanabeauthor=Y.+Ohataauthor=S.+Doiauthor=M.+Satoauthor=M.+Kanoauthor=S.+Ikedaauthor=M.+Matsuoka&title=Broad+antiretroviral+activity+and+resistance+profile+of+the+novel+human+immunodeficiency+virus+integrase+inhibitor+elvitegravir+%28JTK-303%2FGS-9137%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Broad antiretroviral activity and resistance profile of the novel human immunodeficiency virus integrase inhibitor elvitegravir (JTK-303/GS-9137)</span></div><div class="casAuthors">Shimura, Kazuya; Kodama, Eiichi; Sakagami, Yasuko; Matsuzaki, Yuji; Watanabe, Wataru; Yamataka, Kazunobu; Watanabe, Yasuo; Ohata, Yoshitsugu; Doi, Satoki; Sato, Motohide; Kano, Mitsuki; Ikeda, Satoru; Matsuoka, Masao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">764-774</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Integrase (IN), an essential enzyme of human immunodeficiency virus (HIV), is an attractive antiretroviral drug target.  The antiviral activity and resistance profile in vitro of a novel IN inhibitor, elvitegravir (EVG) (also known as JTK-303/GS-9137), currently being developed for the treatment of HIV-1 infection are described.  EVG blocked the integration of HIV-1 cDNA through the inhibition of DNA strand transfer.  EVG inhibited the replication of HIV-1, including various subtypes and multiple-drug-resistant clin. isolates, and HIV-2 strains with a 50% effective concn. in the subnanomolar to nanomolar range.  EVG-resistant variants were selected in two independent inductions, and a total of 8 amino acid substitutions in the catalytic core domain of IN were obsd.  Among the obsd. IN mutations, T66I and E92Q substitutions mainly contributed to EVG resistance.  These two primary resistance mutations are located in the active site, and other secondary mutations identified are proximal to these primary mutations.  The EVG-selected IN mutations, some of which represent novel IN inhibitor resistance mutations, conferred reduced susceptibility to other IN inhibitors, suggesting that a common mechanism is involved in resistance and potential cross-resistance.  The replication capacity of EVG-resistant variants was significantly reduced relative to both wild-type virus and other IN inhibitor-resistant variants selected by L-870,810.  EVG and L-870,810 both inhibited the replication of murine leukemia virus and simian immunodeficiency virus, suggesting that IN inhibitors bind to a conformationally conserved region of various retroviral IN enzymes and are an ideal drug for a range of retroviral infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4hiIK948jhbVg90H21EOLACvtfcHk0ljQI6Muf1-bRQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtFCmug%253D%253D&md5=00943d23a3723e064acef209f36a9267</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1128%2FJVI.01534-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.01534-07%26sid%3Dliteratum%253Aachs%26aulast%3DShimura%26aufirst%3DK.%26aulast%3DKodama%26aufirst%3DE.%26aulast%3DSakagami%26aufirst%3DY.%26aulast%3DMatsuzaki%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DW.%26aulast%3DYamataka%26aufirst%3DK.%26aulast%3DWatanabe%26aufirst%3DY.%26aulast%3DOhata%26aufirst%3DY.%26aulast%3DDoi%26aufirst%3DS.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DKano%26aufirst%3DM.%26aulast%3DIkeda%26aufirst%3DS.%26aulast%3DMatsuoka%26aufirst%3DM.%26atitle%3DBroad%2520antiretroviral%2520activity%2520and%2520resistance%2520profile%2520of%2520the%2520novel%2520human%2520immunodeficiency%2520virus%2520integrase%2520inhibitor%2520elvitegravir%2520%2528JTK-303%252FGS-9137%2529%26jtitle%3DJ.%2520Virol.%26date%3D2008%26volume%3D82%26issue%3D2%26spage%3D764%26epage%3D774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Min, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borland, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piscitelli, S. C.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and safety of S/GSK1349572, a next-generation HIV integrase inhibitor, in healthy volunteers</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">254</span><span class="NLM_x">â</span> <span class="NLM_lpage">258</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=254-258&issue=1&author=S.+Minauthor=I.+Songauthor=J.+Borlandauthor=S.+Chenauthor=Y.+Louauthor=T.+Fujiwaraauthor=S.+C.+Piscitelli&title=Pharmacokinetics+and+safety+of+S%2FGSK1349572%2C+a+next-generation+HIV+integrase+inhibitor%2C+in+healthy+volunteers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMin%26aufirst%3DS.%26aulast%3DSong%26aufirst%3DI.%26aulast%3DBorland%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DLou%26aufirst%3DY.%26aulast%3DFujiwara%26aufirst%3DT.%26aulast%3DPiscitelli%26aufirst%3DS.%2BC.%26atitle%3DPharmacokinetics%2520and%2520safety%2520of%2520S%252FGSK1349572%252C%2520a%2520next-generation%2520HIV%2520integrase%2520inhibitor%252C%2520in%2520healthy%2520volunteers%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26issue%3D1%26spage%3D254%26epage%3D258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Sato, A.; Kobayashi, M.; Yoshinaga, T.; Fujiwara, T.; Underwood, M.; Johns, B.; Foster, S.; Hazen, R.; Ferris, R.; Brown, K.; Garvey, E.</span><span> </span><span class="NLM_article-title">S/GSK1349572 is a Potent Next Generation HIV Integrase Inhibitor</span>. In <span class="NLM_conf-name">Fifth IAS Conference on HIV Pathogenesis, Treatment, and Prevention</span>, <span class="NLM_conf-loc">Cape Town, South Africa</span>, <span class="NLM_conf-date">July 19â22, 2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sato%2C+A.%3B+Kobayashi%2C+M.%3B+Yoshinaga%2C+T.%3B+Fujiwara%2C+T.%3B+Underwood%2C+M.%3B+Johns%2C+B.%3B+Foster%2C+S.%3B+Hazen%2C+R.%3B+Ferris%2C+R.%3B+Brown%2C+K.%3B+Garvey%2C+E.+S%2FGSK1349572+is+a+Potent+Next+Generation+HIV+Integrase+Inhibitor.+In+Fifth+IAS+Conference+on+HIV+Pathogenesis%2C+Treatment%2C+and+Prevention%2C+Cape+Town%2C+South+Africa%2C+July+19%E2%88%9222%2C+2009."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DA.%26atitle%3DS%252FGSK1349572%2520is%2520a%2520Potent%2520Next%2520Generation%2520HIV%2520Integrase%2520Inhibitor" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Johns, B.; Kawasuji, T.; Taishi, T.; Yoshida, H.; Garvey, E.; Spreen, W.; Underwood, M.; Sato, A.; Yoshinaga, T.; Fujiwara, T.</span>, <span> </span><span class="NLM_article-title">The Discovery of S/GSK1349572: A Once-Daily Next Generation Integrase Inhibitor with a Superior Resistance Profile</span>. In <span class="NLM_conf-name">17th Conference on Retroviruses and Opportunistic Infections</span>, <span class="NLM_conf-loc">San Francisco</span>, <span class="NLM_conf-date">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Johns%2C+B.%3B+Kawasuji%2C+T.%3B+Taishi%2C+T.%3B+Yoshida%2C+H.%3B+Garvey%2C+E.%3B+Spreen%2C+W.%3B+Underwood%2C+M.%3B+Sato%2C+A.%3B+Yoshinaga%2C+T.%3B+Fujiwara%2C+T.%2C+The+Discovery+of+S%2FGSK1349572%3A+A+Once-Daily+Next+Generation+Integrase+Inhibitor+with+a+Superior+Resistance+Profile.+In+17th+Conference+on+Retroviruses+and+Opportunistic+Infections%2C+San+Francisco%2C+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DJohns%26aufirst%3DB.%26atitle%3DThe%2520Discovery%2520of%2520S%252FGSK1349572%253A%2520A%2520Once-Daily%2520Next%2520Generation%2520Integrase%2520Inhibitor%2520with%2520a%2520Superior%2520Resistance%2520Profile" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Serrao, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramkumar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neamati, N.</span><span> </span><span class="NLM_article-title">Raltegravir, elvitegravir, and metoogravir: the birth of âme-tooâ HIV-1 integrase inhibitors</span> <span class="citation_source-journal">Retrovirology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=25&author=E.+Serraoauthor=S.+Oddeauthor=K.+Ramkumarauthor=N.+Neamati&title=Raltegravir%2C+elvitegravir%2C+and+metoogravir%3A+the+birth+of+%E2%80%9Cme-too%E2%80%9D+HIV-1+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSerrao%26aufirst%3DE.%26aulast%3DOdde%26aufirst%3DS.%26aulast%3DRamkumar%26aufirst%3DK.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DRaltegravir%252C%2520elvitegravir%252C%2520and%2520metoogravir%253A%2520the%2520birth%2520of%2520%25E2%2580%259Cme-too%25E2%2580%259D%2520HIV-1%2520integrase%2520inhibitors%26jtitle%3DRetrovirology%26date%3D2009%26volume%3D6%26spage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Plewe, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dress, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuehler, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowlin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahavendran, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanis, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span> </span><span class="NLM_article-title">Azaindole hydroxamic acids are potent HIV-1 integrase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">7211</span><span class="NLM_x">â</span> <span class="NLM_lpage">7219</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900862n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7211-7219&issue=22&author=M.+B.+Pleweauthor=S.+L.+Butlerauthor=K.+R.+Dressauthor=Q.+Huauthor=T.+W.+Johnsonauthor=J.+E.+Kuehlerauthor=A.+Kukiauthor=H.+Lamauthor=W.+Liuauthor=D.+Nowlinauthor=Q.+Pengauthor=S.+V.+Rahavendranauthor=S.+P.+Tanisauthor=K.+T.+Tranauthor=H.+Wangauthor=A.+Yangauthor=J.+Zhang&title=Azaindole+hydroxamic+acids+are+potent+HIV-1+integrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm900862n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900862n%26sid%3Dliteratum%253Aachs%26aulast%3DPlewe%26aufirst%3DM.%2BB.%26aulast%3DButler%26aufirst%3DS.%2BL.%26aulast%3DDress%26aufirst%3DK.%2BR.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DKuehler%26aufirst%3DJ.%2BE.%26aulast%3DKuki%26aufirst%3DA.%26aulast%3DLam%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DNowlin%26aufirst%3DD.%26aulast%3DPeng%26aufirst%3DQ.%26aulast%3DRahavendran%26aufirst%3DS.%2BV.%26aulast%3DTanis%26aufirst%3DS.%2BP.%26aulast%3DTran%26aufirst%3DK.%2BT.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DAzaindole%2520hydroxamic%2520acids%2520are%2520potent%2520HIV-1%2520integrase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D22%26spage%3D7211%26epage%3D7219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Tanis, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plewe, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delisle, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dress, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuehler, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solowiej, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span> </span><span class="NLM_article-title">Azaindole <i>N</i>-Methyl Hydroxamic Acids as HIV-1 Integrase Inhibitors-II. The Impact of Physicochemical Properties on ADME and PK</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">7429</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=7429&author=S.+P.+Tanisauthor=M.+B.+Pleweauthor=T.+W.+Johnsonauthor=S.+L.+Butlerauthor=D.+Davieauthor=X.+Yuauthor=D.+Delisleauthor=K.+R.+Dressauthor=Q.+Huauthor=B.+Huangauthor=J.+E.+Kuehlerauthor=A.+Kukiauthor=W.+Liuauthor=Q.+Pengauthor=G.+L.+Smithauthor=J.+Solowiejauthor=K.+T.+Tranauthor=H.+Wangauthor=A.+Yangauthor=C.+Yinauthor=J.+Zhangauthor=H.+Zhu&title=Azaindole+N-Methyl+Hydroxamic+Acids+as+HIV-1+Integrase+Inhibitors-II.+The+Impact+of+Physicochemical+Properties+on+ADME+and+PK"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTanis%26aufirst%3DS.%2BP.%26aulast%3DPlewe%26aufirst%3DM.%2BB.%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DButler%26aufirst%3DS.%2BL.%26aulast%3DDavie%26aufirst%3DD.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DDelisle%26aufirst%3DD.%26aulast%3DDress%26aufirst%3DK.%2BR.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DKuehler%26aufirst%3DJ.%2BE.%26aulast%3DKuki%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DPeng%26aufirst%3DQ.%26aulast%3DSmith%26aufirst%3DG.%2BL.%26aulast%3DSolowiej%26aufirst%3DJ.%26aulast%3DTran%26aufirst%3DK.%2BT.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DA.%26aulast%3DYin%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DH.%26atitle%3DAzaindole%2520N-Methyl%2520Hydroxamic%2520Acids%2520as%2520HIV-1%2520Integrase%2520Inhibitors-II.%2520The%2520Impact%2520of%2520Physicochemical%2520Properties%2520on%2520ADME%2520and%2520PK%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D7429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felock, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hastings, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pramanik, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, A. L.</span><span> </span><span class="NLM_article-title">Differential divalent cation requirements uncouple the assembly and catalytic reactions of human immunodeficiency virus type 1 integrase</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">7005</span><span class="NLM_x">â</span> <span class="NLM_lpage">7011</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm200208d&amp;key=9261430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm200208d&amp;key=1%3ACAS%3A528%3ADyaK2sXlsVOjtro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1997&pages=7005-7011&issue=9&author=D.+J.+Hazudaauthor=P.+J.+Felockauthor=J.+C.+Hastingsauthor=B.+Pramanikauthor=A.+L.+Wolfe&title=Differential+divalent+cation+requirements+uncouple+the+assembly+and+catalytic+reactions+of+human+immunodeficiency+virus+type+1+integrase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Differential divalent cation requirements uncoupled the assembly and catalytic reactions of human immunodeficiency virus type 1 integrase</span></div><div class="casAuthors">Hazuda, Daria J.; Felock, Peter J.; Hastings, Jeffrey C.; Pramanik, Bernali; Wolfe, Abigail L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">7005-7011</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Previous in vitro analyses have shown that the human immunodeficiency virus type 1 (HIV-1) integrase uses either manganese or magnesium to assemble as a stable complex on the donor substrate and to catalyze strand transfer.  We now demonstrate that subsequent to assembly, catalysis of both 3' end processing and strand transfer requires a divalent cation cofactor and that the divalent cation requirements for assembly and catalysis can be functionally distinguished based on the ability to utilize calcium and cobalt, resp.  The different divalent cation requirements manifest by these processes are exploited to uncouple assembly and catalysis, thus staging the reaction.  Staged 3' end processing and strand transfer assays are then used in conjunction with exonuclease III protection anal. to investigate the effects of integrase inhibitors on each step in the reaction.  Anal. of a series of related inhibitors demonstrates that these types of compds. affect assembly and not either catalytic process, therefore reconciling the apparent disparate results obtained for such inhibitors in assays using isolated pre-integration complexes.  These studies provide evidence for a distinct role of the divalent cation cofactor in assembly and catalysis and have implications for both the identification and characterization of integrase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZfMUmmKmUirVg90H21EOLACvtfcHk0lhjsz80MHkxAg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlsVOjtro%253D&md5=c5ce1c183540f6d4262e660181d59d6e</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DFelock%26aufirst%3DP.%2BJ.%26aulast%3DHastings%26aufirst%3DJ.%2BC.%26aulast%3DPramanik%26aufirst%3DB.%26aulast%3DWolfe%26aufirst%3DA.%2BL.%26atitle%3DDifferential%2520divalent%2520cation%2520requirements%2520uncouple%2520the%2520assembly%2520and%2520catalytic%2520reactions%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520integrase%26jtitle%3DJ.%2520Virol.%26date%3D1997%26volume%3D71%26issue%3D9%26spage%3D7005%26epage%3D7011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Konsavage, W. M.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudol, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzman, M.</span><span> </span><span class="NLM_article-title">Effects of varying the spacing within the D,D-35-E motif in the catalytic region of retroviral integrase</span> <span class="citation_source-journal">Virology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">379</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">223</span><span class="NLM_x">â</span> <span class="NLM_lpage">233</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=379&publication_year=2008&pages=223-233&issue=2&author=W.+M.+Konsavageauthor=M.+Sudolauthor=M.+Katzman&title=Effects+of+varying+the+spacing+within+the+D%2CD-35-E+motif+in+the+catalytic+region+of+retroviral+integrase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKonsavage%26aufirst%3DW.%2BM.%26aulast%3DSudol%26aufirst%3DM.%26aulast%3DKatzman%26aufirst%3DM.%26atitle%3DEffects%2520of%2520varying%2520the%2520spacing%2520within%2520the%2520D%252CD-35-E%2520motif%2520in%2520the%2520catalytic%2520region%2520of%2520retroviral%2520integrase%26jtitle%3DVirology%26date%3D2008%26volume%3D379%26issue%3D2%26spage%3D223%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Bacchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biemmi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carcelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Compari, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisicaro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogolino, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sechi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotriffer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neamati, N.</span><span> </span><span class="NLM_article-title">From ligand to complexes. Part 2. Remarks on human immunodeficiency virus type 1 integrase inhibition by beta-diketo acid metal complexes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">7253</span><span class="NLM_x">â</span> <span class="NLM_lpage">7264</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800893q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7253-7264&issue=22&author=A.+Bacchiauthor=M.+Biemmiauthor=M.+Carcelliauthor=F.+Cartaauthor=C.+Compariauthor=E.+Fisicaroauthor=D.+Rogolinoauthor=M.+Sechiauthor=M.+Sippelauthor=C.+A.+Sotrifferauthor=T.+W.+Sanchezauthor=N.+Neamati&title=From+ligand+to+complexes.+Part+2.+Remarks+on+human+immunodeficiency+virus+type+1+integrase+inhibition+by+beta-diketo+acid+metal+complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm800893q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800893q%26sid%3Dliteratum%253Aachs%26aulast%3DBacchi%26aufirst%3DA.%26aulast%3DBiemmi%26aufirst%3DM.%26aulast%3DCarcelli%26aufirst%3DM.%26aulast%3DCarta%26aufirst%3DF.%26aulast%3DCompari%26aufirst%3DC.%26aulast%3DFisicaro%26aufirst%3DE.%26aulast%3DRogolino%26aufirst%3DD.%26aulast%3DSechi%26aufirst%3DM.%26aulast%3DSippel%26aufirst%3DM.%26aulast%3DSotriffer%26aufirst%3DC.%2BA.%26aulast%3DSanchez%26aufirst%3DT.%2BW.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DFrom%2520ligand%2520to%2520complexes.%2520Part%25202.%2520Remarks%2520on%2520human%2520immunodeficiency%2520virus%2520type%25201%2520integrase%2520inhibition%2520by%2520beta-diketo%2520acid%2520metal%2520complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D22%26spage%3D7253%26epage%3D7264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Sechi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carcelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Compari, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duce, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisicaro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogolino, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derudas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Mawsawi, L. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neamati, N.</span><span> </span><span class="NLM_article-title">From ligand to complexes: inhibition of human immunodeficiency virus type 1 integrase by beta-diketo acid metal complexes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">4248</span><span class="NLM_x">â</span> <span class="NLM_lpage">4260</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060193m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4248-4260&issue=14&author=M.+Sechiauthor=A.+Bacchiauthor=M.+Carcelliauthor=C.+Compariauthor=E.+Duceauthor=E.+Fisicaroauthor=D.+Rogolinoauthor=P.+Gatesauthor=M.+Derudasauthor=L.+Q.+Al-Mawsawiauthor=N.+Neamati&title=From+ligand+to+complexes%3A+inhibition+of+human+immunodeficiency+virus+type+1+integrase+by+beta-diketo+acid+metal+complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm060193m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060193m%26sid%3Dliteratum%253Aachs%26aulast%3DSechi%26aufirst%3DM.%26aulast%3DBacchi%26aufirst%3DA.%26aulast%3DCarcelli%26aufirst%3DM.%26aulast%3DCompari%26aufirst%3DC.%26aulast%3DDuce%26aufirst%3DE.%26aulast%3DFisicaro%26aufirst%3DE.%26aulast%3DRogolino%26aufirst%3DD.%26aulast%3DGates%26aufirst%3DP.%26aulast%3DDerudas%26aufirst%3DM.%26aulast%3DAl-Mawsawi%26aufirst%3DL.%2BQ.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DFrom%2520ligand%2520to%2520complexes%253A%2520inhibition%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520integrase%2520by%2520beta-diketo%2520acid%2520metal%2520complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26issue%3D14%26spage%3D4248%26epage%3D4260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="note"><p class="first last">Calculations were performed with Jaguar 7.7, Schrodinger, LLC, Portland, Oregon, 2010. A conformational search was first performed using the OPLS2005 force field in water with Mixed torsional/Low-mode sampling method. This resulted in total four representative conformers, global_min a and conf1-conf3 b-d. Further geometry optimization of those four conformers are performed in Jaguar using ab initio calculations with basis set of B3LYP/6-31G** and PBF solvation model in water. No imaginary frequencies were found for any of the four conformations. The final single point energies were obtained at B3LYP/ CC_PVTZ(-F)++ level with PBF solvation model in water. Conf4 e was derived by twisting the two torsion angles to the presumed binding orientation with the pyridine nitrogen, the carbonyl, and the hydroxamate oxygen all coplanar based on the global_min conformation from above and performing constrained minimization of the rest of the structure using basis set of B3LYP/6-31G** and PBF solvation model in water. One imaginary frequency was found at â96.684. The final single point energies were obtained at B3LYP/ CC_PVTZ(-F)++ level with PBF solvation model in water.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Echavarren, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stille, J. K.</span><span> </span><span class="NLM_article-title">Palladium-catalyzed coupling of aryl triflates with organostannanes</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">5478</span><span class="NLM_x">â</span> <span class="NLM_lpage">5486</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00252a029" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm200208d&amp;key=1%3ACAS%3A528%3ADyaL2sXltFGgs7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=1987&pages=5478-5486&author=A.+M.+Echavarrenauthor=J.+K.+Stille&title=Palladium-catalyzed+coupling+of+aryl+triflates+with+organostannanes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-catalyzed coupling of aryl triflates with organostannanes</span></div><div class="casAuthors">Echavarren, Antonio M.; Stille, J. K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5478-86</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">The Pd-catalyzed coupling reaction of aryl triflates with alkyl, vinyl, acetylenic, and aryl tin reagents in the presence of LiCl takes place in high yields under mild conditions.  Thus, reaction of p-AcC6H4O3SCF3 with CH2:CHSnBu3 in the presence of Pd(PPh3)4 and LiCl gave 95% p-AcC6H4CH:CH2.  However, allyltrialkyltin reagents coupled in lower yields, and unselective transfer of the allyl group was obsd.  The aryl coupling reaction was applied to a synthesis of the quinoline alkaloid dubamine.  The Pd-catalyzed coupling of aryl triflates with Me3SnSnMe3 gave aryltrimethylstannanes or homocoupled products depending on the amt. of tin reagent.  p-BrC6H4O3SCF3 could be coupled selectively with CH2:CHSnBu3 through either the C-Br or the C-O bond by using different Pd catalysts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNS3Xv2kfNQbVg90H21EOLACvtfcHk0liM7X9ApAzocg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXltFGgs7k%253D&md5=82f6c5209a7709f01fbc0808a6a50446</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fja00252a029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00252a029%26sid%3Dliteratum%253Aachs%26aulast%3DEchavarren%26aufirst%3DA.%2BM.%26aulast%3DStille%26aufirst%3DJ.%2BK.%26atitle%3DPalladium-catalyzed%2520coupling%2520of%2520aryl%2520triflates%2520with%2520organostannanes%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1987%26volume%3D109%26spage%3D5478%26epage%3D5486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Wollenberg, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albizati, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peries, R.</span><span> </span><span class="NLM_article-title">A nucleophilic acetaldehyde equivalent. Preparation and synthetic applications of cis-2-ethoxyvynillithium</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">7365</span><span class="NLM_x">â</span> <span class="NLM_lpage">7367</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00464a051" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1977&pages=7365-7367&author=R.+H.+Wollenbergauthor=K.+F.+Albizatiauthor=R.+Peries&title=A+nucleophilic+acetaldehyde+equivalent.+Preparation+and+synthetic+applications+of+cis-2-ethoxyvynillithium"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fja00464a051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00464a051%26sid%3Dliteratum%253Aachs%26aulast%3DWollenberg%26aufirst%3DR.%2BH.%26aulast%3DAlbizati%26aufirst%3DK.%2BF.%26aulast%3DPeries%26aufirst%3DR.%26atitle%3DA%2520nucleophilic%2520acetaldehyde%2520equivalent.%2520Preparation%2520and%2520synthetic%2520applications%2520of%2520cis-2-ethoxyvynillithium%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1977%26volume%3D99%26spage%3D7365%26epage%3D7367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Littke, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, G. C.</span><span> </span><span class="NLM_article-title">A versatile catalyst for Heck reactions of aryl chlorides and aryl bromides under mild conditions</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x"> (</span><span class="NLM_issue">29</span><span class="NLM_x">) </span> <span class="NLM_fpage">6989</span><span class="NLM_x">â</span> <span class="NLM_lpage">7000</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja010988c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2001&pages=6989-7000&issue=29&author=A.+F.+Littkeauthor=G.+C.+Fu&title=A+versatile+catalyst+for+Heck+reactions+of+aryl+chlorides+and+aryl+bromides+under+mild+conditions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fja010988c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja010988c%26sid%3Dliteratum%253Aachs%26aulast%3DLittke%26aufirst%3DA.%2BF.%26aulast%3DFu%26aufirst%3DG.%2BC.%26atitle%3DA%2520versatile%2520catalyst%2520for%2520Heck%2520reactions%2520of%2520aryl%2520chlorides%2520and%2520aryl%2520bromides%2520under%2520mild%2520conditions%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2001%26volume%3D123%26issue%3D29%26spage%3D6989%26epage%3D7000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Ullrich, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binder, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mereiter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyerin, M.</span><span> </span><span class="NLM_article-title">Conformationally constrained nicotines: polycyclic, bridged, and spiro-annulated analogues as novel ligands for the nicotinic acetylcholine receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">4047</span><span class="NLM_x">â</span> <span class="NLM_lpage">4054</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020916b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=4047-4054&issue=18&author=T.+Ullrichauthor=S.+Krichauthor=D.+Binderauthor=K.+Mereiterauthor=D.+J.+Andersonauthor=M.+D.+Meyerauthor=M.+Pyerin&title=Conformationally+constrained+nicotines%3A+polycyclic%2C+bridged%2C+and+spiro-annulated+analogues+as+novel+ligands+for+the+nicotinic+acetylcholine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm020916b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020916b%26sid%3Dliteratum%253Aachs%26aulast%3DUllrich%26aufirst%3DT.%26aulast%3DKrich%26aufirst%3DS.%26aulast%3DBinder%26aufirst%3DD.%26aulast%3DMereiter%26aufirst%3DK.%26aulast%3DAnderson%26aufirst%3DD.%2BJ.%26aulast%3DMeyer%26aufirst%3DM.%2BD.%26aulast%3DPyerin%26aufirst%3DM.%26atitle%3DConformationally%2520constrained%2520nicotines%253A%2520polycyclic%252C%2520bridged%252C%2520and%2520spiro-annulated%2520analogues%2520as%2520novel%2520ligands%2520for%2520the%2520nicotinic%2520acetylcholine%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26issue%3D18%26spage%3D4047%26epage%3D4054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Masaguer, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravina, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fueyo, J.</span><span> </span><span class="NLM_article-title">Alkylation of 3-ehtyl-2-methyl-4-oxo-4,5,6,7-tetrahydroindole with bromoesters: benzene sulfonyl as a convenient nitrogen protecting group</span> <span class="citation_source-journal">Heterocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1303</span><span class="NLM_x">â</span> <span class="NLM_lpage">1309</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1992&pages=1303-1309&author=C.+F.+Masaguerauthor=E.+Ravinaauthor=J.+Fueyo&title=Alkylation+of+3-ehtyl-2-methyl-4-oxo-4%2C5%2C6%2C7-tetrahydroindole+with+bromoesters%3A+benzene+sulfonyl+as+a+convenient+nitrogen+protecting+group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMasaguer%26aufirst%3DC.%2BF.%26aulast%3DRavina%26aufirst%3DE.%26aulast%3DFueyo%26aufirst%3DJ.%26atitle%3DAlkylation%2520of%25203-ehtyl-2-methyl-4-oxo-4%252C5%252C6%252C7-tetrahydroindole%2520with%2520bromoesters%253A%2520benzene%2520sulfonyl%2520as%2520a%2520convenient%2520nitrogen%2520protecting%2520group%26jtitle%3DHeterocycles%26date%3D1992%26volume%3D34%26spage%3D1303%26epage%3D1309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishida, H.</span><span> </span><span class="NLM_article-title">Use of <i>N</i>,<i>N</i>-dimethyl(methylene)ammonium chloride inthe functionalization of indoles</span> <span class="citation_source-journal">Heterocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">â</span> <span class="NLM_lpage">58</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1980&pages=55-58&author=A.+P.+Kozikowskiauthor=H.+Ishida&title=Use+of+N%2CN-dimethyl%28methylene%29ammonium+chloride+inthe+functionalization+of+indoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26aulast%3DIshida%26aufirst%3DH.%26atitle%3DUse%2520of%2520N%252CN-dimethyl%2528methylene%2529ammonium%2520chloride%2520inthe%2520functionalization%2520of%2520indoles%26jtitle%3DHeterocycles%26date%3D1980%26volume%3D14%26spage%3D55%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Kashdan, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rapaport, H.</span><span> </span><span class="NLM_article-title">Synthesis of 1,2,3,4-tetrahydroisoquinolines</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">2638</span><span class="NLM_x">â</span> <span class="NLM_lpage">2643</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=2638-2643&author=D.+S.+Kashdanauthor=J.+A.+Schwartzauthor=H.+Rapaport&title=Synthesis+of+1%2C2%2C3%2C4-tetrahydroisoquinolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKashdan%26aufirst%3DD.%2BS.%26aulast%3DSchwartz%26aufirst%3DJ.%2BA.%26aulast%3DRapaport%26aufirst%3DH.%26atitle%3DSynthesis%2520of%25201%252C2%252C3%252C4-tetrahydroisoquinolines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2008%26volume%3D47%26spage%3D2638%26epage%3D2643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Schnute, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brideau, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collier, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cudahy, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knechtel, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oien, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sackett, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephan, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wathen, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wieber, J. L.</span><span> </span><span class="NLM_article-title">Synthesis of 4-oxo-4,7-dihydrofuro[2,3-<i>b</i>]pyridine-5-carboxamides with broad-spectrum human herpesvirus polymerase inhibition</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3856</span><span class="NLM_x">â</span> <span class="NLM_lpage">3859</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=3856-3859&author=M.+E.+Schnuteauthor=R.+J.+Brideauauthor=S.+A.+Collierauthor=M.+M.+Cudahyauthor=T.+A.+Hopkinsauthor=M.+L.+Knechtelauthor=N.+L.+Oienauthor=R.+S.+Sackettauthor=A.+Scottauthor=M.+L.+Stephanauthor=M.+W.+Wathenauthor=J.+L.+Wieber&title=Synthesis+of+4-oxo-4%2C7-dihydrofuro%5B2%2C3-b%5Dpyridine-5-carboxamides+with+broad-spectrum+human+herpesvirus+polymerase+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchnute%26aufirst%3DM.%2BE.%26aulast%3DBrideau%26aufirst%3DR.%2BJ.%26aulast%3DCollier%26aufirst%3DS.%2BA.%26aulast%3DCudahy%26aufirst%3DM.%2BM.%26aulast%3DHopkins%26aufirst%3DT.%2BA.%26aulast%3DKnechtel%26aufirst%3DM.%2BL.%26aulast%3DOien%26aufirst%3DN.%2BL.%26aulast%3DSackett%26aufirst%3DR.%2BS.%26aulast%3DScott%26aufirst%3DA.%26aulast%3DStephan%26aufirst%3DM.%2BL.%26aulast%3DWathen%26aufirst%3DM.%2BW.%26aulast%3DWieber%26aufirst%3DJ.%2BL.%26atitle%3DSynthesis%2520of%25204-oxo-4%252C7-dihydrofuro%255B2%252C3-b%255Dpyridine-5-carboxamides%2520with%2520broad-spectrum%2520human%2520herpesvirus%2520polymerase%2520inhibition%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D3856%26epage%3D3859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolkenberg, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanderson, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carella, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ecto, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabryelski, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGaughey, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, T. M.</span><span> </span><span class="NLM_article-title">Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">554</span><span class="NLM_x">â</span> <span class="NLM_lpage">559</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=554-559&issue=2&author=Z.+Zhaoauthor=S.+E.+Wolkenbergauthor=P.+E.+Sandersonauthor=M.+Luauthor=V.+Munshiauthor=G.+Moyerauthor=M.+Fengauthor=A.+V.+Carellaauthor=L.+T.+Ectoauthor=L.+J.+Gabryelskiauthor=M.+T.+Laiauthor=S.+G.+Prasadauthor=Y.+Yanauthor=G.+B.+McGaugheyauthor=M.+D.+Millerauthor=C.+W.+Lindsleyauthor=G.+D.+Hartmanauthor=J.+P.+Vaccaauthor=T.+M.+Williams&title=Novel+indole-3-sulfonamides+as+potent+HIV+non-nucleoside+reverse+transcriptase+inhibitors+%28NNRTIs%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DWolkenberg%26aufirst%3DS.%2BE.%26aulast%3DSanderson%26aufirst%3DP.%2BE.%26aulast%3DLu%26aufirst%3DM.%26aulast%3DMunshi%26aufirst%3DV.%26aulast%3DMoyer%26aufirst%3DG.%26aulast%3DFeng%26aufirst%3DM.%26aulast%3DCarella%26aufirst%3DA.%2BV.%26aulast%3DEcto%26aufirst%3DL.%2BT.%26aulast%3DGabryelski%26aufirst%3DL.%2BJ.%26aulast%3DLai%26aufirst%3DM.%2BT.%26aulast%3DPrasad%26aufirst%3DS.%2BG.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DMcGaughey%26aufirst%3DG.%2BB.%26aulast%3DMiller%26aufirst%3DM.%2BD.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DWilliams%26aufirst%3DT.%2BM.%26atitle%3DNovel%2520indole-3-sulfonamides%2520as%2520potent%2520HIV%2520non-nucleoside%2520reverse%2520transcriptase%2520inhibitors%2520%2528NNRTIs%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D2%26spage%3D554%26epage%3D559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Ryckmans, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correia, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutt, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, T.</span><span> </span><span class="NLM_article-title">Rapid assessment of a novel series of selective CB(2) agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">4406</span><span class="NLM_x">â</span> <span class="NLM_lpage">4409</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm200208d&amp;key=10.1016%2Fj.bmcl.2009.05.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm200208d&amp;key=19500981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm200208d&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4406-4409&issue=15&author=T.+Ryckmansauthor=M.+P.+Edwardsauthor=V.+A.+Horneauthor=A.+M.+Correiaauthor=D.+R.+Owenauthor=L.+R.+Thompsonauthor=I.+Tranauthor=M.+F.+Tuttauthor=T.+Young&title=Rapid+assessment+of+a+novel+series+of+selective+CB%282%29+agonists+using+parallel+synthesis+protocols%3A+A+Lipophilic+Efficiency+%28LipE%29+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis</span></div><div class="casAuthors">Ryckmans, Thomas; Edwards, Martin P.; Horne, Val A.; Correia, Ana Monica; Owen, Dafydd R.; Thompson, Lisa R.; Tran, Isabelle; Tutt, Michelle F.; Young, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4406-4409</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of libraries were designed using the 1-(cyclopropylmethyl)-2-alkyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-5-ium templates 2a-b, and Sulfonamide derivs. 11a-n proved to be potent agonists of the CB2 receptor.  Anal. of the Lipophilic Efficiency (LipE) of potent compds. provided new insight for the design of potent, metabolically stable CB2 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1cihq9YHuO7Vg90H21EOLACvtfcHk0lgjglyDJms4zg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D&md5=b62d97e5f52a594cfdd510f32d2e566f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.05.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.05.062%26sid%3Dliteratum%253Aachs%26aulast%3DRyckmans%26aufirst%3DT.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26aulast%3DHorne%26aufirst%3DV.%2BA.%26aulast%3DCorreia%26aufirst%3DA.%2BM.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DThompson%26aufirst%3DL.%2BR.%26aulast%3DTran%26aufirst%3DI.%26aulast%3DTutt%26aufirst%3DM.%2BF.%26aulast%3DYoung%26aufirst%3DT.%26atitle%3DRapid%2520assessment%2520of%2520a%2520novel%2520series%2520of%2520selective%2520CB%25282%2529%2520agonists%2520using%2520parallel%2520synthesis%2520protocols%253A%2520A%2520Lipophilic%2520Efficiency%2520%2528LipE%2529%2520analysis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26issue%3D15%26spage%3D4406%26epage%3D4409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Antonio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grillasca, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taskinen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elovaara, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burchell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piet, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ethell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouzzine, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fournel-Gigleux, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magdalou, J.</span><span> </span><span class="NLM_article-title">Characterization of catechol glucuronidation in rat liver</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">199</span><span class="NLM_x">â</span> <span class="NLM_lpage">207</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2002&pages=199-207&issue=2&author=L.+Antonioauthor=J.+P.+Grillascaauthor=J.+Taskinenauthor=E.+Elovaaraauthor=B.+Burchellauthor=M.+H.+Pietauthor=B.+Ethellauthor=M.+Ouzzineauthor=S.+Fournel-Gigleuxauthor=J.+Magdalou&title=Characterization+of+catechol+glucuronidation+in+rat+liver"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAntonio%26aufirst%3DL.%26aulast%3DGrillasca%26aufirst%3DJ.%2BP.%26aulast%3DTaskinen%26aufirst%3DJ.%26aulast%3DElovaara%26aufirst%3DE.%26aulast%3DBurchell%26aufirst%3DB.%26aulast%3DPiet%26aufirst%3DM.%2BH.%26aulast%3DEthell%26aufirst%3DB.%26aulast%3DOuzzine%26aufirst%3DM.%26aulast%3DFournel-Gigleux%26aufirst%3DS.%26aulast%3DMagdalou%26aufirst%3DJ.%26atitle%3DCharacterization%2520of%2520catechol%2520glucuronidation%2520in%2520rat%2520liver%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2002%26volume%3D30%26issue%3D2%26spage%3D199%26epage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Ouzzine, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barre, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Netter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magdalou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fournel-Gigleux, S.</span><span> </span><span class="NLM_article-title">The human UDP-glucuronosyltransferases: structural aspects and drug glucuronidation</span> <span class="citation_source-journal">Drug Metab. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">287</span><span class="NLM_x">â</span> <span class="NLM_lpage">303</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm200208d&amp;key=10.1081%2FDMR-120026397" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm200208d&amp;key=14705862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm200208d&amp;key=1%3ACAS%3A528%3ADC%252BD3sXps1ygs7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2003&pages=287-303&issue=4&author=M.+Ouzzineauthor=L.+Barreauthor=P.+Netterauthor=J.+Magdalouauthor=S.+Fournel-Gigleux&title=The+human+UDP-glucuronosyltransferases%3A+structural+aspects+and+drug+glucuronidation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The human UDP-glucuronosyltransferases: Structural aspects and drug glucuronidation</span></div><div class="casAuthors">Ouzzine, Mohamed; Barre, Lydia; Netter, Patrick; Magdalou, Jacques; Fournel-Gigleux, Sylvie</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">287-303</span>CODEN:
                <span class="NLM_cas:coden">DMTRAR</span>;
        ISSN:<span class="NLM_cas:issn">0360-2532</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">A review on the recent structural and functional information on human UDP-glucuronosyltransferase (UGTs).  It discusses the mol. events and mechanisms that account for the glucuronidation of drugs and endogenous compds.  It focuses on the identification of amino acids and peptide domains that are crit. for the binding of substrates and effectors to the active site, for the organization of the protein and its interaction with the membrane phospholipids and on the mechanisms that account for the glucuronidation process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLrhTr7EKZ7rVg90H21EOLACvtfcHk0lgjglyDJms4zg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXps1ygs7s%253D&md5=552a33a2e81510a1d089049a8ff309f5</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1081%2FDMR-120026397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FDMR-120026397%26sid%3Dliteratum%253Aachs%26aulast%3DOuzzine%26aufirst%3DM.%26aulast%3DBarre%26aufirst%3DL.%26aulast%3DNetter%26aufirst%3DP.%26aulast%3DMagdalou%26aufirst%3DJ.%26aulast%3DFournel-Gigleux%26aufirst%3DS.%26atitle%3DThe%2520human%2520UDP-glucuronosyltransferases%253A%2520structural%2520aspects%2520and%2520drug%2520glucuronidation%26jtitle%3DDrug%2520Metab.%2520Rev.%26date%3D2003%26volume%3D35%26issue%3D4%26spage%3D287%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Exner, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hradil, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mollin, J.</span><span> </span><span class="NLM_article-title">Dissociation of Hydroxamic Acids</span> <span class="citation_source-journal">Collect. Czech. Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1109</span><span class="NLM_x">â</span> <span class="NLM_lpage">1121</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm200208d&amp;key=10.1135%2Fcccc19931109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm200208d&amp;key=1%3ACAS%3A528%3ADyaK3sXlvVSgsrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1993&pages=1109-1121&author=O.+Exnerauthor=M.+Hradilauthor=J.+Mollin&title=Dissociation+of+Hydroxamic+Acids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Dissociation of hydroxamic acids: solvent effects</span></div><div class="casAuthors">Exner, Otto; Hradil, Martin; Mollin, Jiri</div><div class="citationInfo"><span class="NLM_cas:title">Collection of Czechoslovak Chemical Communications</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1109-21</span>CODEN:
                <span class="NLM_cas:coden">CCCCAK</span>;
        ISSN:<span class="NLM_cas:issn">0010-0765</span>.
    </div><div class="casAbstract">The dissocn. consts. of benzohydroxamic, 4-chlorobenzohydroxamic, and 4-nitrobenzohydroxamic acids, and their N-Me and O-Me derivs., were measured spectrophotometrically or potentiometrically in mixts. of 2-propanol and water.  The results were extrapolated to zero ionic strength.  The ratio of dissocn. consts. of the O-Me and N-Me derivs. can be taken to represent - with some approxn. - the ratio of NH and OH acidities of the parent acid.  This ratio increases with substitution by electron-attracting substituents, and decreases with solvent permittivity: some irregularities might be attributable to the effects of mixed solvents.  It follows that 4-nitrobenzohydroxamic acid behaves essentially as N-acid in all solvents, 4-chlorobenzohydroxamic acid only in 90% 2-propanol or 80% methyl Cellosolve.  In benzohydroxamic acid the NH and OH acidities are comparable, the latter prevails slightly in water, the former in less polar solvents.  Some apparent discrepancies in the literature can be explained in the same terms, only a few results have not yet been explained.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfZ8bGQHcJD7Vg90H21EOLACvtfcHk0lhY--3i9obKaw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXlvVSgsrw%253D&md5=b0be00573962599ba735e75c1ae3b037</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1135%2Fcccc19931109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1135%252Fcccc19931109%26sid%3Dliteratum%253Aachs%26aulast%3DExner%26aufirst%3DO.%26aulast%3DHradil%26aufirst%3DM.%26aulast%3DMollin%26aufirst%3DJ.%26atitle%3DDissociation%2520of%2520Hydroxamic%2520Acids%26jtitle%3DCollect.%2520Czech.%2520Chem.%2520Commun.%26date%3D1993%26volume%3D58%26spage%3D1109%26epage%3D1121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Johnson, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dress, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M.</span><span> </span><span class="NLM_article-title">Using the Golden Triangle to optimize clearance and oral absorption</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">5560</span><span class="NLM_x">â</span> <span class="NLM_lpage">5564</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5560-5564&issue=19&author=T.+W.+Johnsonauthor=K.+R.+Dressauthor=M.+Edwards&title=Using+the+Golden+Triangle+to+optimize+clearance+and+oral+absorption"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DDress%26aufirst%3DK.%2BR.%26aulast%3DEdwards%26aufirst%3DM.%26atitle%3DUsing%2520the%2520Golden%2520Triangle%2520to%2520optimize%2520clearance%2520and%2520oral%2520absorption%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26issue%3D19%26spage%3D5560%26epage%3D5564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Skiles, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yost, G. S.</span><span> </span><span class="NLM_article-title">Mechanistic studies on the cytochrome P450-catalyzed dehydrogenation of 3-methylindole</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">291</span><span class="NLM_x">â</span> <span class="NLM_lpage">297</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx9501187" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1996&pages=291-297&issue=1&author=G.+L.+Skilesauthor=G.+S.+Yost&title=Mechanistic+studies+on+the+cytochrome+P450-catalyzed+dehydrogenation+of+3-methylindole"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Ftx9501187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx9501187%26sid%3Dliteratum%253Aachs%26aulast%3DSkiles%26aufirst%3DG.%2BL.%26aulast%3DYost%26aufirst%3DG.%2BS.%26atitle%3DMechanistic%2520studies%2520on%2520the%2520cytochrome%2520P450-catalyzed%2520dehydrogenation%2520of%25203-methylindole%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D1996%26volume%3D9%26issue%3D1%26spage%3D291%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Baranczewski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanczak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kautiainen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, P. O.</span><span> </span><span class="NLM_article-title">Introduction to early in vitro identification of metabolites of new chemical entities in drug discovery and development</span> <span class="citation_source-journal">Pharmacol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">341</span><span class="NLM_x">â</span> <span class="NLM_lpage">352</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm200208d&amp;key=16845208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm200208d&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVKrtbnN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2006&pages=341-352&issue=3&author=P.+Baranczewskiauthor=A.+Stanczakauthor=A.+Kautiainenauthor=P.+Sandinauthor=P.+O.+Edlund&title=Introduction+to+early+in+vitro+identification+of+metabolites+of+new+chemical+entities+in+drug+discovery+and+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Introduction to early in vitro identification of metabolites of new chemical entities in drug discovery and development</span></div><div class="casAuthors">Baranczewski, Pawel; Stanczak, Andrzej; Kautiainen, Antti; Sandin, Per; Edlund, Per-Olof</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reports</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">341-352</span>CODEN:
                <span class="NLM_cas:coden">PRHEDU</span>;
        ISSN:<span class="NLM_cas:issn">1734-1140</span>.
    
            (<span class="NLM_cas:orgname">Polish Academy of Sciences, Institute of Pharmacology</span>)
        </div><div class="casAbstract">A review.  The introduction of combinatorial chem. and robotics for high throughput screening has changed the way drugs are discovered today compared with 10-15 years ago when fewer compds. were tested in animal or organ models.  The introduction of new anal. techniques, esp. liq. chromatog./mass spectrometry (LC/MS) has made it possible to characterize the chem. properties, permeability, metabolic stability and metabolic fate of a large no. of screening hits for further development in a funnel-like manner.  The purpose of this contribution is to discuss principles and recent strategies for metabolite identification and to give an introduction to biotransformation studies.  Metabolites are exptl. generated with the use of animal and human recombinant expressed enzymes, and different liver and other tissue fractions like microsomes and slices.  For sepn. and identification of structurally diverse metabolites, LC/MS and tandem mass spectrometry (LC/MS/MS) techniques are commonly used.  The LC/MS and LC/MS/MS techniques are rapid, sensitive, easy to automate and robust, and therefore, they are the methods of choice for these studies.  The outcome of the metabolite identification studies is detection of metabolites that could be pharmacol. active and contribute to the efficacy of a new chem. entity (NCE), and elimination of compds. that form reactive intermediates and/or toxic metabolites that could cause adverse effects of NCE.  If such information is available at an early stage during the drug discovery process, the chem. structure of the compd. may be modified to reduce the risk of idiosyncratic and/or adverse drag reactions during clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwWTbo1izuk7Vg90H21EOLACvtfcHk0lhY--3i9obKaw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVKrtbnN&md5=214271dbac0532c6a9db5823536df6b6</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaranczewski%26aufirst%3DP.%26aulast%3DStanczak%26aufirst%3DA.%26aulast%3DKautiainen%26aufirst%3DA.%26aulast%3DSandin%26aufirst%3DP.%26aulast%3DEdlund%26aufirst%3DP.%2BO.%26atitle%3DIntroduction%2520to%2520early%2520in%2520vitro%2520identification%2520of%2520metabolites%2520of%2520new%2520chemical%2520entities%2520in%2520drug%2520discovery%2520and%2520development%26jtitle%3DPharmacol.%2520Rep.%26date%3D2006%26volume%3D58%26issue%3D3%26spage%3D341%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Flipo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dassonneville, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deprez-Poulain, R.</span><span> </span><span class="NLM_article-title">Hydroxamates: relationships between structure and plasma stability</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">6790</span><span class="NLM_x">â</span> <span class="NLM_lpage">6802</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900648x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6790-6802&issue=21&author=M.+Flipoauthor=J.+Chartonauthor=A.+Hocineauthor=S.+Dassonnevilleauthor=B.+Deprezauthor=R.+Deprez-Poulain&title=Hydroxamates%3A+relationships+between+structure+and+plasma+stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm900648x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900648x%26sid%3Dliteratum%253Aachs%26aulast%3DFlipo%26aufirst%3DM.%26aulast%3DCharton%26aufirst%3DJ.%26aulast%3DHocine%26aufirst%3DA.%26aulast%3DDassonneville%26aufirst%3DS.%26aulast%3DDeprez%26aufirst%3DB.%26aulast%3DDeprez-Poulain%26aufirst%3DR.%26atitle%3DHydroxamates%253A%2520relationships%2520between%2520structure%2520and%2520plasma%2520stability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D21%26spage%3D6790%26epage%3D6802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Summers, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazdiyasni, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holms, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratajczyk, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyer, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, G. W.</span><span> </span><span class="NLM_article-title">Hydroxamic acid inhibitors of 5-lipoxygenase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">574</span><span class="NLM_x">â</span> <span class="NLM_lpage">80</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00386a022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1987&pages=574-80&issue=3&author=J.+B.+Summersauthor=H.+Mazdiyasniauthor=J.+H.+Holmsauthor=J.+D.+Ratajczykauthor=R.+D.+Dyerauthor=G.+W.+Carter&title=Hydroxamic+acid+inhibitors+of+5-lipoxygenase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm00386a022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00386a022%26sid%3Dliteratum%253Aachs%26aulast%3DSummers%26aufirst%3DJ.%2BB.%26aulast%3DMazdiyasni%26aufirst%3DH.%26aulast%3DHolms%26aufirst%3DJ.%2BH.%26aulast%3DRatajczyk%26aufirst%3DJ.%2BD.%26aulast%3DDyer%26aufirst%3DR.%2BD.%26aulast%3DCarter%26aufirst%3DG.%2BW.%26atitle%3DHydroxamic%2520acid%2520inhibitors%2520of%25205-lipoxygenase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1987%26volume%3D30%26issue%3D3%26spage%3D574%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="note"><p class="first last">Based on 24 h coverage of free EC<sub>90</sub> (6 nM). Free fraction in 100% human plasma is 24%.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="note"><p class="first last">Î´-DNA polymerase, Î²-DNA polymerase, Î±-DNA polymerase, carbonic anhydrase, matrix metalloproteinase (MMP-1, 2, 3, 7, 8, 9, 13), all show 0% inhbition at 10 uM.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Weislow, O. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiser, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fine, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bader, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, M. R.</span><span> </span><span class="NLM_article-title">New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">577</span><span class="NLM_x">â</span> <span class="NLM_lpage">586</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm200208d&amp;key=10.1093%2Fjnci%2F81.8.577" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm200208d&amp;key=2495366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm200208d&amp;key=1%3ACAS%3A528%3ADyaL1MXkvV2lt78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1989&pages=577-586&issue=8&author=O.+S.+Weislowauthor=R.+Kiserauthor=D.+L.+Fineauthor=J.+Baderauthor=R.+H.+Shoemakerauthor=M.+R.+Boyd&title=New+soluble-formazan+assay+for+HIV-1+cytopathic+effects%3A+application+to+high-flux+screening+of+synthetic+and+natural+products+for+AIDS-antiviral+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">New soluble-formazan assay for HIV-1 cytopathic effects:  application to high-flux screening of synthetic and natural products for AIDS-antiviral activity</span></div><div class="casAuthors">Weislow, Owen S.; Kiser, Rebecca; Fine, Donald L.; Bader, John; Shoemaker, Robert H.; Boyd, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">577-86</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">An effective and optimally safe microculture method was developed for the rapid and convenient assay of the in vitro cytopathic effects of human immunodeficiency virus (HIV-1) on human lymphoblastoid or other suitable host cells.  The assay procedure is applicable to the evaluation of drug effects on in vitro infections induced directly in cultured host cells by cell-free HIV-1 or by coculture with H9 cells chronically infected with HIV-1.  The assay uses a newly developed tetrazolium reagent that is metabolically reduced by viable cells to yield a sol., colored formazan product measureable by conventional colorimetric techniques.  This simple microassay minimizes the no. of plate manipulations typically required with other assay methods and, coupled with computerized data collection and anal., facilitates large-scale screening of agents for potential antiviral activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDJZMdwKZfgbVg90H21EOLACvtfcHk0lim9hQsPRG0cA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXkvV2lt78%253D&md5=c39a027f4ddc6bb5d7b1108c1b128be6</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F81.8.577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F81.8.577%26sid%3Dliteratum%253Aachs%26aulast%3DWeislow%26aufirst%3DO.%2BS.%26aulast%3DKiser%26aufirst%3DR.%26aulast%3DFine%26aufirst%3DD.%2BL.%26aulast%3DBader%26aufirst%3DJ.%26aulast%3DShoemaker%26aufirst%3DR.%2BH.%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26atitle%3DNew%2520soluble-formazan%2520assay%2520for%2520HIV-1%2520cytopathic%2520effects%253A%2520application%2520to%2520high-flux%2520screening%2520of%2520synthetic%2520and%2520natural%2520products%2520for%2520AIDS-antiviral%2520activity%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1989%26volume%3D81%26issue%3D8%26spage%3D577%26epage%3D586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Hu, Q.; Kuki, A.; Nowlin, D. M.; Plewe, M. B.; Wang, H.; Zhang, J. HIV</span><span> </span><span class="NLM_article-title">Integrase Inhibitors, Pharmceutical Compositions and Methods for their Use</span>. U.S. Patent 7,368,571, <span class="NLM_month">May</span><span class="NLM_day">6</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=Q.+Hu&author=A.+Kuki&author=D.+M.+Nowlin&author=M.+B.+Plewe&author=H.+Wang&author=J.+HIV+Zhang&title=Integrase+Inhibitors%2C+Pharmceutical+Compositions+and+Methods+for+their+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DQ.%26atitle%3DIntegrase%2520Inhibitors%252C%2520Pharmceutical%2520Compositions%2520and%2520Methods%2520for%2520their%2520Use%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Chen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krucinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miercke, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finer-Moore, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leavitt, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroud, R. M.</span><span> </span><span class="NLM_article-title">Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: a model for viral DNA binding</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">8233</span><span class="NLM_x">â</span> <span class="NLM_lpage">8238</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=8233-8238&issue=15&author=J.+C.+Chenauthor=J.+Krucinskiauthor=L.+J.+Mierckeauthor=J.+S.+Finer-Mooreauthor=A.+H.+Tangauthor=A.+D.+Leavittauthor=R.+M.+Stroud&title=Crystal+structure+of+the+HIV-1+integrase+catalytic+core+and+C-terminal+domains%3A+a+model+for+viral+DNA+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BC.%26aulast%3DKrucinski%26aufirst%3DJ.%26aulast%3DMiercke%26aufirst%3DL.%2BJ.%26aulast%3DFiner-Moore%26aufirst%3DJ.%2BS.%26aulast%3DTang%26aufirst%3DA.%2BH.%26aulast%3DLeavitt%26aufirst%3DA.%2BD.%26aulast%3DStroud%26aufirst%3DR.%2BM.%26atitle%3DCrystal%2520structure%2520of%2520the%2520HIV-1%2520integrase%2520catalytic%2520core%2520and%2520C-terminal%2520domains%253A%2520a%2520model%2520for%2520viral%2520DNA%2520binding%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26issue%3D15%26spage%3D8233%26epage%3D8238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Wee, A. G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, A. Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnenberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Djerassi, C.</span><span> </span><span class="NLM_article-title">Magnetic circular dichroism studies. 66. Synthesis of demethyl monosubstituted porphyrins. The effect of substituent conformation on the magnetic circular dichroism spectra of ethoxycarbonyl porphyrins</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">3327</span><span class="NLM_x">â</span> <span class="NLM_lpage">3336</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00192a015" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1984&pages=3327-3336&author=A.+G.+H.+Weeauthor=A.+Y.+L.+Shuauthor=E.+Bunnenbergauthor=C.+Djerassi&title=Magnetic+circular+dichroism+studies.+66.+Synthesis+of+demethyl+monosubstituted+porphyrins.+The+effect+of+substituent+conformation+on+the+magnetic+circular+dichroism+spectra+of+ethoxycarbonyl+porphyrins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjo00192a015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00192a015%26sid%3Dliteratum%253Aachs%26aulast%3DWee%26aufirst%3DA.%2BG.%2BH.%26aulast%3DShu%26aufirst%3DA.%2BY.%2BL.%26aulast%3DBunnenberg%26aufirst%3DE.%26aulast%3DDjerassi%26aufirst%3DC.%26atitle%3DMagnetic%2520circular%2520dichroism%2520studies.%252066.%2520Synthesis%2520of%2520demethyl%2520monosubstituted%2520porphyrins.%2520The%2520effect%2520of%2520substituent%2520conformation%2520on%2520the%2520magnetic%2520circular%2520dichroism%2520spectra%2520of%2520ethoxycarbonyl%2520porphyrins%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1984%26volume%3D49%26spage%3D3327%26epage%3D3336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Ginzel, K.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brungs, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steckhan, E.</span><span> </span><span class="NLM_article-title">Indirect electrochemical Î±-methoxylation of <i>N</i>-acyl and <i>N</i>-carboalkoxy Î±-amino acid esters and application as cationic glycine equivalents</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1691</span><span class="NLM_x">â</span> <span class="NLM_lpage">1701</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1989&pages=1691-1701&author=K.-D.+Ginzelauthor=P.+Brungsauthor=E.+Steckhan&title=Indirect+electrochemical+%CE%B1-methoxylation+of+N-acyl+and+N-carboalkoxy+%CE%B1-amino+acid+esters+and+application+as+cationic+glycine+equivalents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGinzel%26aufirst%3DK.-D.%26aulast%3DBrungs%26aufirst%3DP.%26aulast%3DSteckhan%26aufirst%3DE.%26atitle%3DIndirect%2520electrochemical%2520%25CE%25B1-methoxylation%2520of%2520N-acyl%2520and%2520N-carboalkoxy%2520%25CE%25B1-amino%2520acid%2520esters%2520and%2520application%2520as%2520cationic%2520glycine%2520equivalents%26jtitle%3DTetrahedron%26date%3D1989%26volume%3D45%26spage%3D1691%26epage%3D1701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm200208d&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm200208d%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2011.54.issue-9%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm200208d" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67994fc82ac721d6","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
